ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-2682334,EPH-Ephrin signaling,9/126,92/10899,1.0721642650227144e-6,5.633079923674576e-4,4.4490567550041233e-4,ACTB/NCSTN/ACTG1/CLTC/ACTR2/ACTR3/EFNB2/EPHA2/EPHB4,9
R-HSA-3928665,EPH-ephrin mediated repulsion of cells,7/126,51/10899,1.7718426728074548e-6,5.633079923674576e-4,4.4490567550041233e-4,ACTB/NCSTN/ACTG1/CLTC/EFNB2/EPHA2/EPHB4,7
R-HSA-446203,Asparagine N-linked glycosylation,15/126,304/10899,2.1527693975826403e-6,5.633079923674576e-4,4.4490567550041233e-4,NUS1/UBC/DOLK/PDIA3/SEC23A/EDEM3/SEL1L/LMAN1/KDELR1/TMEM115/MCFD2/SEC24A/SCFD1/PGM3/MGAT4B,15
R-HSA-8856828,Clathrin-mediated endocytosis,10/126,146/10899,6.99419548895564e-6,0.0010718309415875373,8.465416353939787e-4,UBC/ACTB/ACTG1/CLTC/ACTR2/ACTR3/COPS2/HSPA8/TRIP10/LDLR,10
R-HSA-3928662,EPHB-mediated forward signaling,6/126,42/10899,7.903716717269759e-6,0.0010718309415875373,8.465416353939787e-4,ACTB/ACTG1/ACTR2/ACTR3/EFNB2/EPHB4,6
R-HSA-9656223,Signaling by RAF1 mutants,6/126,43/10899,9.099060666245994e-6,0.0010718309415875373,8.465416353939787e-4,ARAF/ACTB/ACTG1/IQGAP1/ITGB3/JAK2,6
R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,17/126,433/10899,9.55772814154492e-6,0.0010718309415875373,8.465416353939787e-4,ARAF/PRKAR1A/UBC/ACTB/NCSTN/ACTG1/CSNK1A1/CLTC/SEL1L/IQGAP1/PTPN12/ESR2/MET/ITGB3/JAK2/PPFIBP1/RRBP1,17
R-HSA-6802946,Signaling by moderate kinase activity BRAF mutants,6/126,47/10899,1.5432092373373633e-5,0.0011012902284634819,8.698088428628776e-4,ARAF/ACTB/ACTG1/IQGAP1/ITGB3/JAK2,6
R-HSA-6802949,Signaling by RAS mutants,6/126,47/10899,1.5432092373373633e-5,0.0011012902284634819,8.698088428628776e-4,ARAF/ACTB/ACTG1/IQGAP1/ITGB3/JAK2,6
R-HSA-6802955,Paradoxical activation of RAF signaling by kinase inactive BRAF,6/126,47/10899,1.5432092373373633e-5,0.0011012902284634819,8.698088428628776e-4,ARAF/ACTB/ACTG1/IQGAP1/ITGB3/JAK2,6
R-HSA-9649948,Signaling downstream of RAS mutants,6/126,47/10899,1.5432092373373633e-5,0.0011012902284634819,8.698088428628776e-4,ARAF/ACTB/ACTG1/IQGAP1/ITGB3/JAK2,6
R-HSA-983170,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",5/126,29/10899,1.8129112685317422e-5,0.001185946121497848,9.366708220747335e-4,PDIA3/SEC23A/HSPA5/SEC24A/BECN1,5
R-HSA-5673001,RAF/MAP kinase cascade,13/126,280/10899,2.0519500795464347e-5,0.0012390621634184242,9.78622345629838e-4,ARAF/UBC/ACTB/ACTG1/IQGAP1/DUSP5/RASA2/MET/ITGB3/FNTB/CHURC1-FNTB/JAK2/ICMT,13
R-HSA-5684996,MAPK1/MAPK3 signaling,13/126,286/10899,2.5649354015234456e-5,0.0014381959215685033,0.0011358999635318117,ARAF/UBC/ACTB/ACTG1/IQGAP1/DUSP5/RASA2/MET/ITGB3/FNTB/CHURC1-FNTB/JAK2/ICMT,13
R-HSA-418990,Adherens junctions interactions,5/126,33/10899,3.491526529539034e-5,0.0018272322171254277,0.0014431642988761342,CTNND1/ACTB/ACTG1/CTNNA1/PVR,5
R-HSA-6802948,Signaling by high-kinase activity BRAF mutants,5/126,36/10899,5.3943347507626016e-5,0.0026465954870929015,0.002090304715920508,ARAF/ACTB/ACTG1/IQGAP1/ITGB3,5
R-HSA-5674135,MAP2K and MAPK activation,5/126,40/10899,9.073762299095022e-5,0.004166883598898394,0.0032910418233337638,ARAF/ACTB/ACTG1/IQGAP1/ITGB3,5
R-HSA-5683057,MAPK family signaling cascades,13/126,325/10899,9.554637551614152e-5,0.004166883598898394,0.0032910418233337638,ARAF/UBC/ACTB/ACTG1/IQGAP1/DUSP5/RASA2/MET/ITGB3/FNTB/CHURC1-FNTB/JAK2/ICMT,13
R-HSA-6802952,Signaling by BRAF and RAF1 fusions,6/126,67/10899,1.1878598250752245e-4,0.004746131437530567,0.0037485369315528043,ARAF/ACTB/ACTG1/IQGAP1/ITGB3/JAK2,6
R-HSA-1500931,Cell-Cell communication,8/126,129/10899,1.2092054617912272e-4,0.004746131437530567,0.0037485369315528043,CTNND1/ACTB/ACTG1/IQGAP1/CTNNA1/ACTN4/CD151/PVR,8
R-HSA-9012999,RHO GTPase cycle,15/126,449/10899,2.0413683481260354e-4,0.007459138000631836,0.0058912937075054,ACTB/ACTG1/PKN1/CLTC/IQGAP1/LMAN1/STBD1/AKAP12/SLC4A7/COPS2/FLOT2/SCFD1/EPHA2/TRIP10/PGRMC2,15
R-HSA-901042,Calnexin/calreticulin cycle,4/126,26/10899,2.090459057501916e-4,0.007459138000631836,0.0058912937075054,UBC/PDIA3/EDEM3/SEL1L,4
R-HSA-196025,Formation of annular gap junctions,3/126,11/10899,2.3262532878541171e-4,0.0079396036128934,0.0062707697324763155,ACTB/ACTG1/CLTC,3
R-HSA-9648002,RAS processing,4/126,27/10899,2.432183162433965e-4,0.007955265760461095,0.006283139836287744,UBC/FNTB/CHURC1-FNTB/ICMT,4
R-HSA-9679506,SARS-CoV Infections,14/126,413/10899,2.900404699850568e-4,0.009107270757530784,0.007193003655629409,UBC/YWHAZ/CSNK1A1/ATP1A1/SEC23A/SEC24A/BECN1/PTGES3/FNTB/CHURC1-FNTB/JAK2/FURIN/SDC4/MGAT4B,14
R-HSA-190873,Gap junction degradation,3/126,12/10899,3.075516175702695e-4,0.009285693068948522,0.00733392318821412,ACTB/ACTG1/CLTC,3
R-HSA-9013405,RHOD GTPase cycle,5/126,54/10899,3.8328589938714064e-4,0.011143682630329829,0.00880137991185286,LMAN1/STBD1/AKAP12/SLC4A7/PGRMC2,5
R-HSA-6802957,Oncogenic MAPK signaling,6/126,84/10899,4.1237978158087683e-4,0.011561361733606725,0.009131266592147988,ARAF/ACTB/ACTG1/IQGAP1/ITGB3/JAK2,6
R-HSA-373760,L1CAM interactions,7/126,119/10899,4.480581129002824e-4,0.01212846960781799,0.009579173448212935,ACTB/ACTG1/LAMC1/CLTC/RPS6KA3/ITGB3/HSPA8,7
R-HSA-5626467,RHO GTPases activate IQGAPs,4/126,32/10899,4.7659682775255663e-4,0.0124709503261919,0.009849667773552838,ACTB/ACTG1/IQGAP1/CTNNA1,4
R-HSA-5694530,Cargo concentration in the ER,4/126,33/10899,5.375184225742348e-4,0.013379022514662232,0.010566871285465712,SEC23A/LMAN1/MCFD2/SEC24A,4
R-HSA-9664407,Parasite infection,5/126,59/10899,5.794735866223132e-4,0.013379022514662232,0.010566871285465712,ACTB/ACTG1/ACTR2/ACTR3/CRK,5
R-HSA-9664417,Leishmania phagocytosis,5/126,59/10899,5.794735866223132e-4,0.013379022514662232,0.010566871285465712,ACTB/ACTG1/ACTR2/ACTR3/CRK,5
R-HSA-9664422,FCGR3A-mediated phagocytosis,5/126,59/10899,5.794735866223132e-4,0.013379022514662232,0.010566871285465712,ACTB/ACTG1/ACTR2/ACTR3/CRK,5
R-HSA-446728,Cell junction organization,6/126,91/10899,6.332511631238564e-4,0.014202918944349349,0.011217592032479743,CTNND1/ACTB/ACTG1/CTNNA1/CD151/PVR,6
R-HSA-532668,N-glycan trimming in the ER and Calnexin/Calreticulin cycle,4/126,35/10899,6.756374683666675e-4,0.014343184073759624,0.01132837468245983,UBC/PDIA3/EDEM3/SEL1L,4
R-HSA-2029482,Regulation of actin dynamics for phagocytic cup formation,5/126,61/10899,6.760481665338931e-4,0.014343184073759624,0.01132837468245983,ACTB/ACTG1/ACTR2/ACTR3/CRK,5
R-HSA-5663213,RHO GTPases Activate WASPs and WAVEs,4/126,36/10899,7.533492334740483e-4,0.015562609165187577,0.012291487493523948,ACTB/ACTG1/ACTR2/ACTR3,4
R-HSA-421270,Cell-cell junction organization,5/126,64/10899,8.428731483754677e-4,0.016965523627557492,0.013399521845968973,CTNND1/ACTB/ACTG1/CTNNA1/PVR,5
R-HSA-4420097,VEGFA-VEGFR2 Pathway,6/126,99/10899,9.876419456263119e-4,0.018909729934552554,0.014935073324105205,CTNND1/ACTB/ACTG1/ITGB3/CRK/CTNNA1,6
R-HSA-9679191,Potential therapeutics for SARS,6/126,99/10899,9.876419456263119e-4,0.018909729934552554,0.014935073324105205,ATP1A1/PTGES3/FNTB/CHURC1-FNTB/JAK2/FURIN,6
R-HSA-449147,Signaling by Interleukins,14/126,473/10899,0.0011096594513870706,0.020278703791311047,0.01601630108358325,HSP90B1/UBC/HSPA9/YWHAZ/RPS6KA3/PTPN12/DUSP3/PTPN14/CRK/PTPN9/HSPA8/JAK2/LAMA5/MAP2K3,14
R-HSA-204005,COPII-mediated vesicle transport,5/126,68/10899,0.001110807978377548,0.020278703791311047,0.01601630108358325,SEC23A/LMAN1/MCFD2/SEC24A/SCFD1,5
R-HSA-8875878,MET promotes cell motility,4/126,41/10899,0.0012387819812675793,0.02210099671125113,0.017455564281497707,LAMC1/MET/CRK/LAMA5,4
R-HSA-948021,Transport to the Golgi and subsequent modification,8/126,185/10899,0.0013531503583477586,0.023604956251177565,0.018643404937235788,SEC23A/LMAN1/KDELR1/TMEM115/MCFD2/SEC24A/SCFD1/MGAT4B,8
R-HSA-8876384,Listeria monocytogenes entry into host cells,3/126,20/10899,0.0014895201964046014,0.025418985960382872,0.02007614177762724,UBC/CTNND1/MET,3
R-HSA-194138,Signaling by VEGF,6/126,108/10899,0.0015503885599156386,0.025527651383969223,0.020161966698166774,CTNND1/ACTB/ACTG1/ITGB3/CRK/CTNNA1,6
R-HSA-8980692,RHOA GTPase cycle,7/126,147/10899,0.0015609264540516212,0.025527651383969223,0.020161966698166774,PKN1/IQGAP1/LMAN1/STBD1/FLOT2/SCFD1/PGRMC2,7
R-HSA-9008059,Interleukin-37 signaling,3/126,21/10899,0.0017231874801784683,0.027054043438801953,0.02136752475421301,PTPN12/PTPN14/PTPN9,3
R-HSA-901032,ER Quality Control Compartment (ERQC),3/126,21/10899,0.0017231874801784683,0.027054043438801953,0.02136752475421301,UBC/EDEM3/SEL1L,3
R-HSA-2173789,TGF-beta receptor signaling activates SMADs,4/126,46/10899,0.0019093994412827946,0.02938977571386262,0.023212306933241816,UBC/PPP1R15A/ITGB3/FURIN,4
R-HSA-199977,ER to Golgi Anterograde Transport,7/126,154/10899,0.002036622382010939,0.030638283463317848,0.02419838948695168,SEC23A/LMAN1/KDELR1/TMEM115/MCFD2/SEC24A/SCFD1,7
R-HSA-437239,Recycling pathway of L1,4/126,47/10899,0.00206857200452974,0.030638283463317848,0.02419838948695168,ACTB/ACTG1/CLTC/RPS6KA3,4
R-HSA-6806834,Signaling by MET,5/126,79/10899,0.0021712856457411682,0.03156405985012624,0.024929575932583783,UBC/LAMC1/MET/CRK/LAMA5,5
R-HSA-512988,"Interleukin-3, Interleukin-5 and GM-CSF signaling",4/126,48/10899,0.0022366857903653404,0.031923606280668954,0.025213548909572926,UBC/YWHAZ/CRK/JAK2,4
R-HSA-9658195,Leishmania infection,7/126,164/10899,0.002902599607624186,0.04068822664258903,0.03213592422726777,PRKAR1A/ACTB/ACTG1/ACTR2/ACTR3/CRK/FURIN,7
R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,5/126,86/10899,0.003147116514623522,0.04334186778911342,0.034231793667834805,ACTB/ACTG1/ACTR2/ACTR3/CRK,5
R-HSA-9013404,RAC2 GTPase cycle,5/126,88/10899,0.003476058634115801,0.047046655651394896,0.0371578681577896,IQGAP1/LMAN1/STBD1/EPHA2/PGRMC2,5
R-HSA-3371556,Cellular response to heat stress,5/126,89/10899,0.003649483679783348,0.047416432138020215,0.03744992092429622,HSPA9/HSPA5/HSPA4/HSPA8/PTGES3,5
R-HSA-9700206,Signaling by ALK in cancer,4/126,55/10899,0.003684588994164628,0.047416432138020215,0.03744992092429622,PRKAR1A/CLTC/PPFIBP1/RRBP1,4
R-HSA-9725370,Signaling by ALK fusions and activated point mutants,4/126,55/10899,0.003684588994164628,0.047416432138020215,0.03744992092429622,PRKAR1A/CLTC/PPFIBP1/RRBP1,4
R-HSA-114608,Platelet degranulation ,6/126,129/10899,0.003788318943937477,0.04796500598372451,0.03788318943937477,CALU/HSPA5/APLP2/WDR1/ITGB3/ACTN4,6
R-HSA-432722,Golgi Associated Vesicle Biogenesis,4/126,56/10899,0.003933057042898743,0.04900713934405577,0.03870627566027335,CLTC/ACBD3/SORT1/HSPA8,4
R-HSA-170834,Signaling by TGF-beta Receptor Complex,5/126,93/10899,0.004405661110300114,0.052645278922216945,0.04157971074111402,UBC/WWTR1/PPP1R15A/ITGB3/FURIN,5
R-HSA-5213460,RIPK1-mediated regulated necrosis,3/126,29/10899,0.00442622727244117,0.052645278922216945,0.04157971074111402,UBC/BIRC3/FLOT2,3
R-HSA-5675482,Regulation of necroptotic cell death,3/126,29/10899,0.00442622727244117,0.052645278922216945,0.04157971074111402,UBC/BIRC3/FLOT2,3
R-HSA-166520,Signaling by NTRKs,6/126,134/10899,0.004563039622081655,0.052676266225501464,0.04160418478956803,CLTC/RPS6KA3/RALB/DUSP3/CRK/FURIN,6
R-HSA-76005,Response to elevated platelet cytosolic Ca2+,6/126,134/10899,0.004563039622081655,0.052676266225501464,0.04160418478956803,CALU/HSPA5/APLP2/WDR1/ITGB3/ACTN4,6
R-HSA-3000171,Non-integrin membrane-ECM interactions,4/126,59/10899,0.004746030075149548,0.05399468998539703,0.04264548763177855,LAMC1/ITGB3/LAMA5/SDC4,4
R-HSA-8874081,MET activates PTK2 signaling,3/126,30/10899,0.004876946555717706,0.05469147208911999,0.04319581235064254,LAMC1/MET/LAMA5,3
R-HSA-381183,ATF6 (ATF6-alpha) activates chaperone genes,2/126,10/10899,0.005615452961194343,0.0612240357574661,0.0483552893880624,HSP90B1/HSPA5,2
R-HSA-8875656,MET receptor recycling,2/126,10/10899,0.005615452961194343,0.0612240357574661,0.0483552893880624,MET/CRK,2
R-HSA-450294,MAP kinase activation,4/126,64/10899,0.00633947430780203,0.0681710593373232,0.0538421105594145,UBC/RPS6KA3/DUSP3/MAP2K3,4
R-HSA-8875555,MET activates RAP1 and RAC1,2/126,11/10899,0.006811636879507436,0.07129513267217782,0.05630953153726147,MET/CRK,2
R-HSA-9013700,NOTCH4 Activation and Transmission of Signal to the Nucleus,2/126,11/10899,0.006811636879507436,0.07129513267217782,0.05630953153726147,NCSTN/YWHAZ,2
R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,5/126,105/10899,0.0073379822851204375,0.07480929991973433,0.05908505216590483,UBC/RPS6KA3/DUSP3/BIRC3/MAP2K3,5
R-HSA-2187338,Visual phototransduction,5/126,105/10899,0.0073379822851204375,0.07480929991973433,0.05908505216590483,LRP12/FNTB/CHURC1-FNTB/LDLR/SDC4,5
R-HSA-9694516,SARS-CoV-2 Infection,9/126,298/10899,0.00764081995943707,0.07689799574561666,0.06073472275449979,UBC/YWHAZ/CSNK1A1/SEC23A/SEC24A/BECN1/FURIN/SDC4/MGAT4B,9
R-HSA-1474244,Extracellular matrix organization,9/126,300/10899,0.00796738055071166,0.07713235696893476,0.06091982333852173,NCSTN/LAMC1/ADAM9/ITGB3/LAMA5/CD151/FURIN/SDC4/LOXL1,9
R-HSA-381033,ATF6 (ATF6-alpha) activates chaperones,2/126,12/10899,0.008112453931894864,0.07713235696893476,0.06091982333852173,HSP90B1/HSPA5,2
R-HSA-9700645,ALK mutants bind TKIs,2/126,12/10899,0.008112453931894864,0.07713235696893476,0.06091982333852173,PRKAR1A/CLTC,2
R-HSA-2173796,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,3/126,36/10899,0.008156471796829903,0.07713235696893476,0.06091982333852173,UBC/WWTR1/FURIN,3
R-HSA-8957275,Post-translational protein phosphorylation,5/126,108/10899,0.008243020932449385,0.07713235696893476,0.06091982333852173,HSP90B1/PDIA6/LAMC1/CALU/APLP2,5
R-HSA-3371453,Regulation of HSF1-mediated heat shock response,4/126,69/10899,0.008253653484573912,0.07713235696893476,0.06091982333852173,HSPA9/HSPA5/HSPA4/HSPA8,4
R-HSA-9772573,Late SARS-CoV-2 Infection Events,4/126,70/10899,0.008677131882038946,0.07904698987561641,0.06243201748137856,UBC/CSNK1A1/FURIN/MGAT4B,4
R-HSA-8964043,Plasma lipoprotein clearance,3/126,37/10899,0.008802292226110413,0.07904698987561641,0.06243201748137856,UBC/CLTC/LDLR,3
R-HSA-166166,MyD88-independent TLR4 cascade ,5/126,110/10899,0.008887743838471652,0.07904698987561641,0.06243201748137856,UBC/RPS6KA3/DUSP3/BIRC3/MAP2K3,5
R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling ,5/126,110/10899,0.008887743838471652,0.07904698987561641,0.06243201748137856,UBC/RPS6KA3/DUSP3/BIRC3/MAP2K3,5
R-HSA-5696394,DNA Damage Recognition in GG-NER,3/126,38/10899,0.009477285589162764,0.07904698987561641,0.06243201748137856,UBC/ACTB/COPS2,3
R-HSA-9013424,RHOV GTPase cycle,3/126,38/10899,0.009477285589162764,0.07904698987561641,0.06243201748137856,CLTC/IQGAP1/EPHA2,3
R-HSA-9772572,Early SARS-CoV-2 Infection Events,3/126,38/10899,0.009477285589162764,0.07904698987561641,0.06243201748137856,BECN1/FURIN/SDC4,3
R-HSA-5210891,Uptake and function of anthrax toxins,2/126,13/10899,0.009515364218710262,0.07904698987561641,0.06243201748137856,MAP2K3/FURIN,2
R-HSA-1445148,Translocation of SLC2A4 (GLUT4) to the plasma membrane,4/126,72/10899,0.009566196226985424,0.07904698987561641,0.06243201748137856,ACTB/ACTG1/YWHAZ/PRKAG1,4
R-HSA-199992,trans-Golgi Network Vesicle Budding,4/126,72/10899,0.009566196226985424,0.07904698987561641,0.06243201748137856,CLTC/ACBD3/SORT1/HSPA8,4
R-HSA-448424,Interleukin-17 signaling,4/126,72/10899,0.009566196226985424,0.07904698987561641,0.06243201748137856,UBC/RPS6KA3/DUSP3/MAP2K3,4
R-HSA-174824,"Plasma lipoprotein assembly, remodeling, and clearance",4/126,74/10899,0.010512556919757492,0.08420772634703705,0.0665080131658127,UBC/CLTC/FURIN/LDLR,4
R-HSA-9013106,RHOC GTPase cycle,4/126,74/10899,0.010512556919757492,0.08420772634703705,0.0665080131658127,PKN1/IQGAP1/LMAN1/FLOT2,4
R-HSA-9013408,RHOG GTPase cycle,4/126,74/10899,0.010512556919757492,0.08420772634703705,0.0665080131658127,LMAN1/STBD1/EPHA2/PGRMC2,4
R-HSA-187037,Signaling by NTRK1 (TRKA),5/126,115/10899,0.01065051984199629,0.08445109167643522,0.06670022527310808,CLTC/RPS6KA3/RALB/DUSP3/CRK,5
R-HSA-9013420,RHOU GTPase cycle,3/126,40/10899,0.01091580115406517,0.08479440529739266,0.06697137743233561,CLTC/IQGAP1/EPHA2,3
R-HSA-3322077,Glycogen synthesis,2/126,14/10899,0.011017871771126179,0.08479440529739266,0.06697137743233561,UBC/GBE1,2
R-HSA-3371568,Attenuation phase,2/126,14/10899,0.011017871771126179,0.08479440529739266,0.06697137743233561,HSPA8/PTGES3,2
R-HSA-76002,"Platelet activation, signaling and aggregation",8/126,263/10899,0.011235488447690145,0.0856296935090948,0.06763109551036786,YWHAZ/CALU/HSPA5/APLP2/WDR1/ITGB3/CRK/ACTN4,8
R-HSA-163841,"Gamma carboxylation, hypusine formation and arylsulfatase activation",3/126,42/10899,0.012473831600574574,0.09086932341375281,0.07176940193188121,FURIN/ARSJ/ICMT,3
R-HSA-379724,tRNA Aminoacylation,3/126,42/10899,0.012473831600574574,0.09086932341375281,0.07176940193188121,RARS1/IARS2/GARS1,3
R-HSA-9035034,RHOF GTPase cycle,3/126,42/10899,0.012473831600574574,0.09086932341375281,0.07176940193188121,ACTB/AKAP12/SLC4A7,3
R-HSA-372708,p130Cas linkage to MAPK signaling for integrins,2/126,15/10899,0.012617523888024276,0.09086932341375281,0.07176940193188121,ITGB3/CRK,2
R-HSA-5609975,Diseases associated with glycosylation precursor biosynthesis,2/126,15/10899,0.012617523888024276,0.09086932341375281,0.07176940193188121,NUS1/DOLK,2
R-HSA-8875360,InlB-mediated entry of Listeria monocytogenes into host cell,2/126,15/10899,0.012617523888024276,0.09086932341375281,0.07176940193188121,UBC/MET,2
R-HSA-168898,Toll-like Receptor Cascades,6/126,168/10899,0.013230328037009124,0.09404543199190138,0.07427792080889027,HSP90B1/UBC/RPS6KA3/DUSP3/BIRC3/MAP2K3,6
R-HSA-5675221,Negative regulation of MAPK pathway,3/126,43/10899,0.013298143886752933,0.09404543199190138,0.07427792080889027,ARAF/UBC/DUSP5,3
R-HSA-9006936,Signaling by TGFB family members,5/126,122/10899,0.013500632337364446,0.09441050192010211,0.07456625629358385,UBC/WWTR1/PPP1R15A/ITGB3/FURIN,5
R-HSA-1566948,Elastic fibre formation,3/126,44/10899,0.014152871365779342,0.09441050192010211,0.07456625629358385,ITGB3/FURIN/LOXL1,3
R-HSA-975634,Retinoid metabolism and transport,3/126,44/10899,0.014152871365779342,0.09441050192010211,0.07456625629358385,LRP12/LDLR/SDC4,3
R-HSA-9663891,Selective autophagy,4/126,81/10899,0.014294547080472285,0.09441050192010211,0.07456625629358385,UBC/VDAC1/HSPA8/PRKAG1,4
R-HSA-175474,Assembly Of The HIV Virion,2/126,16/10899,0.014311910482155608,0.09441050192010211,0.07456625629358385,UBC/FURIN,2
R-HSA-205043,NRIF signals cell death from the nucleus,2/126,16/10899,0.014311910482155608,0.09441050192010211,0.07456625629358385,UBC/NCSTN,2
R-HSA-3229121,Glycogen storage diseases,2/126,16/10899,0.014311910482155608,0.09441050192010211,0.07456625629358385,UBC/GBE1,2
R-HSA-8866427,VLDLR internalisation and degradation,2/126,16/10899,0.014311910482155608,0.09441050192010211,0.07456625629358385,UBC/CLTC,2
R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),5/126,125/10899,0.014865846897924776,0.09724741512392458,0.07680687563927802,HSP90B1/PDIA6/LAMC1/CALU/APLP2,5
R-HSA-8934593,Regulation of RUNX1 Expression and Activity,2/126,17/10899,0.01609866343544753,0.10358566226906814,0.08181287975391369,CBFB/PML,2
R-HSA-9022699,MECP2 regulates neuronal receptors and channels,2/126,17/10899,0.01609866343544753,0.10358566226906814,0.08181287975391369,MET/SLC2A3,2
R-HSA-190828,Gap junction trafficking,3/126,47/10899,0.01690085496296813,0.10786318004821123,0.08519130143935154,ACTB/ACTG1/CLTC,3
R-HSA-6806667,Metabolism of fat-soluble vitamins,3/126,48/10899,0.01787846624114164,0.11198994389856269,0.08845065632752722,LRP12/LDLR/SDC4,3
R-HSA-1912420,Pre-NOTCH Processing in Golgi,2/126,18/10899,0.017975455963336176,0.11198994389856269,0.08845065632752722,SEL1L/FURIN,2
R-HSA-446353,Cell-extracellular matrix interactions,2/126,18/10899,0.017975455963336176,0.11198994389856269,0.08845065632752722,ACTB/ACTG1,2
R-HSA-157858,Gap junction trafficking and regulation,3/126,49/10899,0.018887018973263683,0.11674259759064559,0.09220434459388571,ACTB/ACTG1/CLTC,3
R-HSA-3928664,Ephrin signaling,2/126,19/10899,0.01994000198800395,0.12040693508140846,0.09509847101971114,EFNB2/EPHB4,2
R-HSA-8964038,LDL clearance,2/126,19/10899,0.01994000198800395,0.12040693508140846,0.09509847101971114,CLTC/LDLR,2
R-HSA-9694614,Attachment and Entry,2/126,19/10899,0.01994000198800395,0.12040693508140846,0.09509847101971114,FURIN/SDC4,2
R-HSA-1632852,Macroautophagy,5/126,136/10899,0.020656702673949125,0.12378253129045849,0.09776454700647678,UBC/VDAC1/BECN1/HSPA8/PRKAG1,5
R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,3/126,51/10899,0.020997156594088125,0.12486945398756955,0.09862300824495937,UBC/WWTR1/FURIN,3
R-HSA-168927,"TICAM1, RIP1-mediated IKK complex recruitment",2/126,20/10899,0.021990055520403864,0.12945943124745382,0.10224821321454952,UBC/BIRC3,2
R-HSA-381070,IRE1alpha activates chaperones,3/126,52/10899,0.02209880737217683,0.12945943124745382,0.10224821321454952,PDIA6/SSR1/HSPA5,3
R-HSA-1474228,Degradation of the extracellular matrix,5/126,140/10899,0.023082448548978025,0.13399440801361204,0.10582997830374455,NCSTN/LAMC1/ADAM9/LAMA5/FURIN,5
R-HSA-381119,Unfolded Protein Response (UPR),4/126,94/10899,0.02338501133485968,0.13399440801361204,0.10582997830374455,HSP90B1/PDIA6/SSR1/HSPA5,4
R-HSA-9013423,RAC3 GTPase cycle,4/126,94/10899,0.02338501133485968,0.13399440801361204,0.10582997830374455,LMAN1/STBD1/EPHA2/PGRMC2,4
R-HSA-379726,Mitochondrial tRNA aminoacylation,2/126,21/10899,0.024123410050953885,0.13623652438848058,0.10760082181001014,IARS2/GARS1,2
R-HSA-6807004,Negative regulation of MET activity,2/126,21/10899,0.024123410050953885,0.13623652438848058,0.10760082181001014,UBC/MET,2
R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,4/126,97/10899,0.025884107232999262,0.1406479584339905,0.11108501175678231,UBC/RPS6KA3/DUSP3/MAP2K3,4
R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,4/126,97/10899,0.025884107232999262,0.1406479584339905,0.11108501175678231,UBC/RPS6KA3/DUSP3/MAP2K3,4
R-HSA-975871,MyD88 cascade initiated on plasma membrane,4/126,97/10899,0.025884107232999262,0.1406479584339905,0.11108501175678231,UBC/RPS6KA3/DUSP3/MAP2K3,4
R-HSA-198753,ERK/MAPK targets,2/126,22/10899,0.026337897948785483,0.1406479584339905,0.11108501175678231,RPS6KA3/DUSP3,2
R-HSA-2979096,NOTCH2 Activation and Transmission of Signal to the Nucleus,2/126,22/10899,0.026337897948785483,0.1406479584339905,0.11108501175678231,UBC/NCSTN,2
R-HSA-5205685,PINK1-PRKN Mediated Mitophagy,2/126,22/10899,0.026337897948785483,0.1406479584339905,0.11108501175678231,UBC/VDAC1,2
R-HSA-912631,Regulation of signaling by CBL,2/126,22/10899,0.026337897948785483,0.1406479584339905,0.11108501175678231,UBC/CRK,2
R-HSA-9613829,Chaperone Mediated Autophagy,2/126,22/10899,0.026337897948785483,0.1406479584339905,0.11108501175678231,UBC/HSPA8,2
R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,5/126,146/10899,0.027055524588264424,0.14350396487694306,0.11334071111299962,UBC/RPS6KA3/DUSP3/BIRC3/MAP2K3,5
R-HSA-5218859,Regulated Necrosis,3/126,57/10899,0.028072909949303438,0.14691489540135466,0.11603469445712089,UBC/BIRC3/FLOT2,3
R-HSA-9694635,Translation of Structural Proteins,3/126,57/10899,0.028072909949303438,0.14691489540135466,0.11603469445712089,UBC/CSNK1A1/MGAT4B,3
R-HSA-112409,RAF-independent MAPK1/3 activation,2/126,23/10899,0.028631389869432464,0.14786605952305582,0.11678593236215874,DUSP5/JAK2,2
R-HSA-373753,Nephrin family interactions,2/126,23/10899,0.028631389869432464,0.14786605952305582,0.11678593236215874,IQGAP1/ACTN4,2
R-HSA-186797,Signaling by PDGF,3/126,58/10899,0.029360693128221017,0.1496632734133344,0.1182053879188119,PTPN12/CRK/FURIN,3
R-HSA-917937,Iron uptake and transport,3/126,58/10899,0.029360693128221017,0.1496632734133344,0.1182053879188119,UBC/ATP6V1C1/ATP6V1A,3
R-HSA-9013406,RHOQ GTPase cycle,3/126,59/10899,0.030679335791778454,0.1521025526507235,0.1201319524120364,IQGAP1/SLC4A7/TRIP10,3
R-HSA-9612973,Autophagy,5/126,151/10899,0.03068101727035456,0.1521025526507235,0.1201319524120364,UBC/VDAC1/BECN1/HSPA8/PRKAG1,5
R-HSA-3371571,HSF1-dependent transactivation,2/126,24/10899,0.031001794170848102,0.1521025526507235,0.1201319524120364,HSPA8/PTGES3,2
R-HSA-379716,Cytosolic tRNA aminoacylation,2/126,24/10899,0.031001794170848102,0.1521025526507235,0.1201319524120364,RARS1/GARS1,2
R-HSA-450302,activated TAK1 mediates p38 MAPK activation,2/126,24/10899,0.031001794170848102,0.1521025526507235,0.1201319524120364,UBC/MAP2K3,2
R-HSA-8940973,RUNX2 regulates osteoblast differentiation,2/126,24/10899,0.031001794170848102,0.1521025526507235,0.1201319524120364,WWTR1/CBFB,2
R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,4/126,103/10899,0.03134879446842307,0.15284971215970256,0.12072206565479691,UBC/RPS6KA3/DUSP3/MAP2K3,4
R-HSA-975155,MyD88 dependent cascade initiated on endosome,4/126,104/10899,0.03232064974383708,0.1566154941290871,0.12369631383443823,UBC/RPS6KA3/DUSP3/MAP2K3,4
R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,4/126,105/10899,0.03331006231645956,0.15816830858461597,0.12492274053816804,UBC/RPS6KA3/DUSP3/MAP2K3,4
R-HSA-9013507,NOTCH3 Activation and Transmission of Signal to the Nucleus,2/126,25/10899,0.03344705633763854,0.15816830858461597,0.12492274053816804,UBC/NCSTN,2
R-HSA-937041,IKK complex recruitment mediated by RIP1,2/126,25/10899,0.03344705633763854,0.15816830858461597,0.12492274053816804,UBC/BIRC3,2
R-HSA-9705462,Inactivation of CSF3 (G-CSF) signaling,2/126,25/10899,0.03344705633763854,0.15816830858461597,0.12492274053816804,UBC/JAK2,2
R-HSA-8856825,Cargo recognition for clathrin-mediated endocytosis,4/126,106/10899,0.03431706343943072,0.16131074730510847,0.12740466666135958,UBC/CLTC/COPS2/LDLR,4
R-HSA-195258,RHO GTPase Effectors,8/126,327/10899,0.03578644702884086,0.16605459403707337,0.13115139911208346,ACTB/ACTG1/PKN1/YWHAZ/IQGAP1/ACTR2/ACTR3/CTNNA1,8
R-HSA-2173788,Downregulation of TGF-beta receptor signaling,2/126,26/10899,0.03596515841340391,0.16605459403707337,0.13115139911208346,UBC/PPP1R15A,2
R-HSA-446219,Synthesis of substrates in N-glycan biosythesis,3/126,63/10899,0.036260758972912165,0.16605459403707337,0.13115139911208346,NUS1/DOLK/PGM3,3
R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,4/126,108/10899,0.03638393652786831,0.16605459403707337,0.13115139911208346,UBC/RPS6KA3/DUSP3/MAP2K3,4
R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,4/126,108/10899,0.03638393652786831,0.16605459403707337,0.13115139911208346,HSP90B1/HSPA8/JAK2/LAMA5,4
R-HSA-3000170,Syndecan interactions,2/126,27/10899,0.03855411844107778,0.17196013054685258,0.13581564450834216,ITGB3/SDC4,2
R-HSA-354192,Integrin signaling,2/126,27/10899,0.03855411844107778,0.17196013054685258,0.13581564450834216,ITGB3/CRK,2
R-HSA-77387,Insulin receptor recycling,2/126,27/10899,0.03855411844107778,0.17196013054685258,0.13581564450834216,ATP6V1C1/ATP6V1A,2
R-HSA-8982491,Glycogen metabolism,2/126,27/10899,0.03855411844107778,0.17196013054685258,0.13581564450834216,UBC/GBE1,2
R-HSA-9619665,EGR2 and SOX10-mediated initiation of Schwann cell myelination,2/126,28/10899,0.04121198991115916,0.18277633943649685,0.14435838273965357,LAMC1/WWTR1,2
R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,4/126,113/10899,0.04186035100064948,0.18357751695815552,0.14499115989051775,UBC/RPS6KA3/DUSP3/MAP2K3,4
R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,4/126,113/10899,0.04186035100064948,0.18357751695815552,0.14499115989051775,UBC/RPS6KA3/DUSP3/MAP2K3,4
R-HSA-5205647,Mitophagy,2/126,29/10899,0.043936861217730855,0.1895078904171358,0.1496750217307315,UBC/VDAC1,2
R-HSA-5218920,VEGFR2 mediated vascular permeability,2/126,29/10899,0.043936861217730855,0.1895078904171358,0.1496750217307315,CTNND1/CTNNA1,2
R-HSA-8863795,Downregulation of ERBB2 signaling,2/126,29/10899,0.043936861217730855,0.1895078904171358,0.1496750217307315,UBC/PTPN12,2
R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,4/126,116/10899,0.045358527655898685,0.19351328374935037,0.15283851710139773,UBC/RPS6KA3/DUSP3/MAP2K3,4
R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,4/126,116/10899,0.045358527655898685,0.19351328374935037,0.15283851710139773,UBC/RPS6KA3/DUSP3/MAP2K3,4
R-HSA-2173795,Downregulation of SMAD2/3:SMAD4 transcriptional activity,2/126,30/10899,0.04672685512216036,0.1951094748451909,0.15409920306244376,UBC/WWTR1,2
R-HSA-3000157,Laminin interactions,2/126,30/10899,0.04672685512216036,0.1951094748451909,0.15409920306244376,LAMC1/LAMA5,2
R-HSA-5357956,TNFR1-induced NFkappaB signaling pathway,2/126,30/10899,0.04672685512216036,0.1951094748451909,0.15409920306244376,UBC/BIRC3,2
R-HSA-9674555,Signaling by CSF3 (G-CSF),2/126,30/10899,0.04672685512216036,0.1951094748451909,0.15409920306244376,UBC/JAK2,2
R-HSA-400253,Circadian Clock,3/126,70/10899,0.047191004484402485,0.19600496571563997,0.15480646973719336,UBC/NRIP1/NPAS2,3
R-HSA-182971,EGFR downregulation,2/126,31/10899,0.04958012822438037,0.19857347273540096,0.15683509948528485,UBC/PTPN12,2
R-HSA-2122948,Activated NOTCH1 Transmits Signal to the Nucleus,2/126,31/10899,0.04958012822438037,0.19857347273540096,0.15683509948528485,UBC/NCSTN,2
R-HSA-445095,Interaction between L1 and Ankyrins,2/126,31/10899,0.04958012822438037,0.19857347273540096,0.15683509948528485,ACTB/ACTG1,2
R-HSA-450282,MAPK targets/ Nuclear events mediated by MAP kinases,2/126,31/10899,0.04958012822438037,0.19857347273540096,0.15683509948528485,RPS6KA3/DUSP3,2
R-HSA-5339562,Uptake and actions of bacterial toxins,2/126,31/10899,0.04958012822438037,0.19857347273540096,0.15683509948528485,MAP2K3/FURIN,2
R-HSA-70268,Pyruvate metabolism,2/126,31/10899,0.04958012822438037,0.19857347273540096,0.15683509948528485,VDAC1/LDHA,2
R-HSA-917977,Transferrin endocytosis and recycling,2/126,31/10899,0.04958012822438037,0.19857347273540096,0.15683509948528485,ATP6V1C1/ATP6V1A,2
R-HSA-8878166,Transcriptional regulation by RUNX2,4/126,121/10899,0.051542121805473906,0.20538358181369043,0.1622137843624052,UBC/WWTR1/CBFB/HIVEP3,4
R-HSA-8939902,Regulation of RUNX2 expression and activity,3/126,73/10899,0.052317499137163465,0.20707775525976582,0.16355185765739466,UBC/CBFB/HIVEP3,3
R-HSA-8941326,RUNX2 regulates bone development,2/126,32/10899,0.05249487044164764,0.20707775525976582,0.16355185765739466,WWTR1/CBFB,2
R-HSA-1980145,Signaling by NOTCH2,2/126,33/10899,0.055469304494679614,0.21771702014161748,0.1719548439335068,UBC/NCSTN,2
R-HSA-3000178,ECM proteoglycans,3/126,76/10899,0.05770181296338877,0.2251167796070618,0.177799239944431,LAMC1/ITGB3/LAMA5,3
R-HSA-9705671,SARS-CoV-2 activates/modulates innate and adaptive immune responses,4/126,126/10899,0.058164906511544066,0.2251167796070618,0.177799239944431,UBC/SEC23A/SEC24A/BECN1,4
R-HSA-187687,Signalling to ERKs,2/126,34/10899,0.058501685401070834,0.2251167796070618,0.177799239944431,RALB/CRK,2
R-HSA-5663084,Diseases of carbohydrate metabolism,2/126,34/10899,0.058501685401070834,0.2251167796070618,0.177799239944431,UBC/GBE1,2
R-HSA-446193,"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",3/126,78/10899,0.061431688669704165,0.23244416096670123,0.1835864710819806,NUS1/DOLK/PGM3,3
R-HSA-432720,Lysosome Vesicle Biogenesis,2/126,35/10899,0.06159029997589026,0.23244416096670123,0.1835864710819806,CLTC/HSPA8,2
R-HSA-9615710,Late endosomal microautophagy,2/126,35/10899,0.06159029997589026,0.23244416096670123,0.1835864710819806,UBC/HSPA8,2
R-HSA-9706574,RHOBTB GTPase Cycle,2/126,35/10899,0.06159029997589026,0.23244416096670123,0.1835864710819806,ACTG1/COPS2,2
R-HSA-1222556,ROS and RNS production in phagocytes,2/126,36/10899,0.0647334663393644,0.24197986226857646,0.191117853001933,ATP6V1C1/ATP6V1A,2
R-HSA-5673000,RAF activation,2/126,36/10899,0.0647334663393644,0.24197986226857646,0.191117853001933,ARAF/JAK2,2
R-HSA-438064,Post NMDA receptor activation events,3/126,80/10899,0.06527165669182611,0.242835310441154,0.191793493596835,PRKAR1A/RPS6KA3/PRKAG1,3
R-HSA-168638,NOD1/2 Signaling Pathway,2/126,37/10899,0.06792953343155034,0.25035062790500945,0.19772915834535779,UBC/BIRC3,2
R-HSA-2514859,"Inactivation, recovery and regulation of the phototransduction cascade",2/126,37/10899,0.06792953343155034,0.25035062790500945,0.19772915834535779,FNTB/CHURC1-FNTB,2
R-HSA-5668914,Diseases of metabolism,6/126,249/10899,0.06876857365467103,0.25225855289213434,0.1992360545135329,NUS1/UBC/DOLK/GBE1/SLC35D1/SDC4,6
R-HSA-9013694,Signaling by NOTCH4,3/126,82/10899,0.06921975279751962,0.2527325857955949,0.199610449927731,UBC/NCSTN/YWHAZ,3
R-HSA-2514856,The phototransduction cascade,2/126,38/10899,0.0711768805339052,0.2586752371255351,0.20430400893991307,FNTB/CHURC1-FNTB,2
R-HSA-5696399,Global Genome Nucleotide Excision Repair (GG-NER),3/126,84/10899,0.073273931620696,0.2650692918075869,0.2093540903448457,UBC/ACTB/COPS2,3
R-HSA-76009,Platelet Aggregation (Plug Formation),2/126,39/10899,0.0744739167976592,0.2681744251658829,0.21180655236031518,ITGB3/CRK,2
R-HSA-5357905,Regulation of TNFR1 signaling,2/126,40/10899,0.07781908077890101,0.2789405406914945,0.22030972640602114,UBC/BIRC3,2
R-HSA-5628897,TP53 Regulates Metabolic Genes,3/126,87/10899,0.07954945039830315,0.2838469025575817,0.22418481475885432,YWHAZ/PRDX1/PRKAG1,3
R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,3/126,88/10899,0.08169199300963932,0.2901729163464564,0.22918115685962165,UBC/YWHAZ/HSPA8,3
R-HSA-3769402,Deactivation of the beta-catenin transactivating complex,2/126,42/10899,0.08464769039927025,0.2948494916259069,0.2328747577172768,UBC/YWHAZ,2
R-HSA-381676,Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,2/126,42/10899,0.08464769039927025,0.2948494916259069,0.2328747577172768,PRKAR1A/IQGAP1,2
R-HSA-9696264,RND3 GTPase cycle,2/126,42/10899,0.08464769039927025,0.2948494916259069,0.2328747577172768,FLOT2/EPHA2,2
R-HSA-9696273,RND1 GTPase cycle,2/126,42/10899,0.08464769039927025,0.2948494916259069,0.2328747577172768,FLOT2/EPHA2,2
R-HSA-9705683,SARS-CoV-2-host interactions,5/126,202/10899,0.08488660523242669,0.2948494916259069,0.2328747577172768,UBC/YWHAZ/SEC23A/SEC24A/BECN1,5
R-HSA-425397,"Transport of vitamins, nucleosides, and related molecules",2/126,43/10899,0.08812815608280769,0.3047603635462733,0.24070245273718402,SLC33A1/SLC35D1,2
R-HSA-6804756,Regulation of TP53 Activity through Phosphorylation,3/126,92/10899,0.09050811967535369,0.3116178681804941,0.24611857104701446,UBC/HUS1/PRKAG1,3
R-HSA-442755,Activation of NMDA receptors and postsynaptic events,3/126,93/10899,0.09277218653844319,0.31801819402916115,0.251173605475261,PRKAR1A/RPS6KA3/PRKAG1,3
R-HSA-5358351,Signaling by Hedgehog,4/126,149/10899,0.09410702565845386,0.32119137018211424,0.2536798082967017,PRKAR1A/UBC/CSNK1A1/SEL1L,4
R-HSA-5357801,Programmed Cell Death,5/126,210/10899,0.09624182345851608,0.3270555472508014,0.2583113876375756,STK24/UBC/YWHAZ/BIRC3/FLOT2,5
R-HSA-8878159,Transcriptional regulation by RUNX3,3/126,96/10899,0.09970371779285793,0.33735956235945463,0.26644959065332724,UBC/WWTR1/CBFB,3
R-HSA-446652,Interleukin-1 family signaling,4/126,153/10899,0.10123251474751481,0.3393638128088148,0.2680325655305289,UBC/PTPN12/PTPN14/PTPN9,4
R-HSA-69231,Cyclin D associated events in G1,2/126,47/10899,0.10245760972699249,0.3393638128088148,0.2680325655305289,UBC/JAK2,2
R-HSA-69236,G1 Phase,2/126,47/10899,0.10245760972699249,0.3393638128088148,0.2680325655305289,UBC/JAK2,2
R-HSA-9020591,Interleukin-12 signaling,2/126,47/10899,0.10245760972699249,0.3393638128088148,0.2680325655305289,HSPA9/JAK2,2
R-HSA-9707616,Heme signaling,2/126,47/10899,0.10245760972699249,0.3393638128088148,0.2680325655305289,NRIP1/NPAS2,2
R-HSA-110056,MAPK3 (ERK1) activation,1/126,10/10899,0.10981742645328496,0.34921848730166133,0.2758158753210574,JAK2,1
R-HSA-159782,Removal of aminoterminal propeptides from gamma-carboxylated proteins,1/126,10/10899,0.10981742645328496,0.34921848730166133,0.2758158753210574,FURIN,1
R-HSA-2151209,Activation of PPARGC1A (PGC-1alpha) by phosphorylation,1/126,10/10899,0.10981742645328496,0.34921848730166133,0.2758158753210574,PRKAG1,1
R-HSA-390450,Folding of actin by CCT/TriC,1/126,10/10899,0.10981742645328496,0.34921848730166133,0.2758158753210574,ACTB,1
R-HSA-425381,Bicarbonate transporters,1/126,10/10899,0.10981742645328496,0.34921848730166133,0.2758158753210574,SLC4A7,1
R-HSA-8877330,RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),1/126,10/10899,0.10981742645328496,0.34921848730166133,0.2758158753210574,CBFB,1
R-HSA-937042,IRAK2 mediated activation of TAK1 complex,1/126,10/10899,0.10981742645328496,0.34921848730166133,0.2758158753210574,UBC,1
R-HSA-75893,TNF signaling,2/126,49/10899,0.10984764229450246,0.34921848730166133,0.2758158753210574,UBC/BIRC3,2
R-HSA-9012852,Signaling by NOTCH3,2/126,49/10899,0.10984764229450246,0.34921848730166133,0.2758158753210574,UBC/NCSTN,2
R-HSA-1227986,Signaling by ERBB2,2/126,50/10899,0.11359435368368677,0.34921848730166133,0.2758158753210574,UBC/PTPN12,2
R-HSA-177929,Signaling by EGFR,2/126,50/10899,0.11359435368368677,0.34921848730166133,0.2758158753210574,UBC/PTPN12,2
R-HSA-381038,XBP1(S) activates chaperone genes,2/126,50/10899,0.11359435368368677,0.34921848730166133,0.2758158753210574,PDIA6/SSR1,2
R-HSA-5633007,Regulation of TP53 Activity,4/126,160/10899,0.11428256296649031,0.34921848730166133,0.2758158753210574,UBC/HUS1/PRKAG1/PML,4
R-HSA-1059683,Interleukin-6 signaling,1/126,11/10899,0.12011800541066275,0.34921848730166133,0.2758158753210574,JAK2,1
R-HSA-159854,"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins",1/126,11/10899,0.12011800541066275,0.34921848730166133,0.2758158753210574,FURIN,1
R-HSA-193692,Regulated proteolysis of p75NTR,1/126,11/10899,0.12011800541066275,0.34921848730166133,0.2758158753210574,NCSTN,1
R-HSA-2586552,Signaling by Leptin,1/126,11/10899,0.12011800541066275,0.34921848730166133,0.2758158753210574,JAK2,1
R-HSA-446107,Type I hemidesmosome assembly,1/126,11/10899,0.12011800541066275,0.34921848730166133,0.2758158753210574,CD151,1
R-HSA-8851805,MET activates RAS signaling,1/126,11/10899,0.12011800541066275,0.34921848730166133,0.2758158753210574,MET,1
R-HSA-9014325,"TICAM1,TRAF6-dependent induction of TAK1 complex",1/126,11/10899,0.12011800541066275,0.34921848730166133,0.2758158753210574,UBC,1
R-HSA-9020956,Interleukin-27 signaling,1/126,11/10899,0.12011800541066275,0.34921848730166133,0.2758158753210574,JAK2,1
R-HSA-9614399,Regulation of localization of FOXO transcription factors,1/126,11/10899,0.12011800541066275,0.34921848730166133,0.2758158753210574,YWHAZ,1
R-HSA-9634285,Constitutive Signaling by Overexpressed ERBB2,1/126,11/10899,0.12011800541066275,0.34921848730166133,0.2758158753210574,PTPN12,1
R-HSA-9645460,Alpha-protein kinase 1 signaling pathway,1/126,11/10899,0.12011800541066275,0.34921848730166133,0.2758158753210574,UBC,1
R-HSA-9664873,Pexophagy,1/126,11/10899,0.12011800541066275,0.34921848730166133,0.2758158753210574,UBC,1
R-HSA-9708530,Regulation of BACH1 activity,1/126,11/10899,0.12011800541066275,0.34921848730166133,0.2758158753210574,UBC,1
R-HSA-72766,Translation,6/126,291/10899,0.12100143783150656,0.34921848730166133,0.2758158753210574,RARS1/SSR1/ETF1/IARS2/EIF4H/GARS1,6
R-HSA-383280,Nuclear Receptor transcription pathway,2/126,52/10899,0.12118483206566477,0.34921848730166133,0.2758158753210574,NRBF2/ESR2,2
R-HSA-3700989,Transcriptional Regulation by TP53,7/126,362/10899,0.12609787452906648,0.34921848730166133,0.2758158753210574,UBC/YWHAZ/PERP/HUS1/PRDX1/PRKAG1/PML,7
R-HSA-6781823,Formation of TC-NER Pre-Incision Complex,2/126,54/10899,0.1288965536969612,0.34921848730166133,0.2758158753210574,UBC/COPS2,2
R-HSA-8848021,Signaling by PTK6,2/126,54/10899,0.1288965536969612,0.34921848730166133,0.2758158753210574,UBC/CRK,2
R-HSA-9006927,Signaling by Non-Receptor Tyrosine Kinases,2/126,54/10899,0.1288965536969612,0.34921848730166133,0.2758158753210574,UBC/CRK,2
R-HSA-9604323,Negative regulation of NOTCH4 signaling,2/126,54/10899,0.1288965536969612,0.34921848730166133,0.2758158753210574,UBC/YWHAZ,2
R-HSA-9662361,Sensory processing of sound by outer hair cells of the cochlea,2/126,54/10899,0.1288965536969612,0.34921848730166133,0.2758158753210574,ACTB/ACTG1,2
R-HSA-210990,PECAM1 interactions,1/126,12/10899,0.13030032827236926,0.34921848730166133,0.2758158753210574,ITGB3,1
R-HSA-3371511,HSF1 activation,1/126,12/10899,0.13030032827236926,0.34921848730166133,0.2758158753210574,PTGES3,1
R-HSA-430116,GP1b-IX-V activation signalling,1/126,12/10899,0.13030032827236926,0.34921848730166133,0.2758158753210574,YWHAZ,1
R-HSA-5689877,Josephin domain DUBs,1/126,12/10899,0.13030032827236926,0.34921848730166133,0.2758158753210574,UBC,1
R-HSA-8984722,Interleukin-35 Signalling,1/126,12/10899,0.13030032827236926,0.34921848730166133,0.2758158753210574,JAK2,1
R-HSA-9013973,TICAM1-dependent activation of IRF3/IRF7,1/126,12/10899,0.13030032827236926,0.34921848730166133,0.2758158753210574,UBC,1
R-HSA-9027276,Erythropoietin activates Phosphoinositide-3-kinase (PI3K),1/126,12/10899,0.13030032827236926,0.34921848730166133,0.2758158753210574,JAK2,1
R-HSA-9755779,SARS-CoV-2 targets host intracellular signalling and regulatory pathways,1/126,12/10899,0.13030032827236926,0.34921848730166133,0.2758158753210574,YWHAZ,1
R-HSA-1655829,Regulation of cholesterol biosynthesis by SREBP (SREBF),2/126,55/10899,0.13279490747452566,0.34921848730166133,0.2758158753210574,SEC23A/SEC24A,2
R-HSA-3371497,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,2/126,55/10899,0.13279490747452566,0.34921848730166133,0.2758158753210574,HSPA8/PTGES3,2
R-HSA-71406,Pyruvate metabolism and Citric Acid (TCA) cycle,2/126,55/10899,0.13279490747452566,0.34921848730166133,0.2758158753210574,VDAC1/LDHA,2
R-HSA-8941858,Regulation of RUNX3 expression and activity,2/126,55/10899,0.13279490747452566,0.34921848730166133,0.2758158753210574,UBC/CBFB,2
R-HSA-9639288,Amino acids regulate mTORC1,2/126,55/10899,0.13279490747452566,0.34921848730166133,0.2758158753210574,ATP6V1C1/ATP6V1A,2
R-HSA-450408,AUF1 (hnRNP D0) binds and destabilizes mRNA,2/126,56/10899,0.1367200502181695,0.34921848730166133,0.2758158753210574,UBC/HSPA8,2
R-HSA-5362768,Hh mutants are degraded by ERAD,2/126,56/10899,0.1367200502181695,0.34921848730166133,0.2758158753210574,UBC/SEL1L,2
R-HSA-5696398,Nucleotide Excision Repair,3/126,111/10899,0.1372322266196852,0.34921848730166133,0.2758158753210574,UBC/ACTB/COPS2,3
R-HSA-977225,Amyloid fiber formation,3/126,111/10899,0.1372322266196852,0.34921848730166133,0.2758158753210574,UBC/NCSTN/FURIN,3
R-HSA-157118,Signaling by NOTCH,5/126,236/10899,0.13808380959263628,0.34921848730166133,0.2758158753210574,UBC/NCSTN/YWHAZ/SEL1L/FURIN,5
R-HSA-1358803,Downregulation of ERBB2:ERBB3 signaling,1/126,13/10899,0.14036574194350715,0.34921848730166133,0.2758158753210574,UBC,1
R-HSA-1663150,The activation of arylsulfatases,1/126,13/10899,0.14036574194350715,0.34921848730166133,0.2758158753210574,ARSJ,1
R-HSA-1679131,Trafficking and processing of endosomal TLR,1/126,13/10899,0.14036574194350715,0.34921848730166133,0.2758158753210574,HSP90B1,1
R-HSA-171007,p38MAPK events,1/126,13/10899,0.14036574194350715,0.34921848730166133,0.2758158753210574,RALB,1
R-HSA-202670,ERKs are inactivated,1/126,13/10899,0.14036574194350715,0.34921848730166133,0.2758158753210574,DUSP3,1
R-HSA-209543,p75NTR recruits signalling complexes,1/126,13/10899,0.14036574194350715,0.34921848730166133,0.2758158753210574,UBC,1
R-HSA-209560,NF-kB is activated and signals survival,1/126,13/10899,0.14036574194350715,0.34921848730166133,0.2758158753210574,UBC,1
R-HSA-5140745,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",1/126,13/10899,0.14036574194350715,0.34921848730166133,0.2758158753210574,CLTC,1
R-HSA-75035,Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,1/126,13/10899,0.14036574194350715,0.34921848730166133,0.2758158753210574,YWHAZ,1
R-HSA-9637687,Suppression of phagosomal maturation,1/126,13/10899,0.14036574194350715,0.34921848730166133,0.2758158753210574,UBC,1
R-HSA-9733458,Induction of Cell-Cell Fusion,1/126,13/10899,0.14036574194350715,0.34921848730166133,0.2758158753210574,FURIN,1
R-HSA-168643,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",2/126,57/10899,0.14067085531885554,0.34921848730166133,0.2758158753210574,UBC/BIRC3,2
R-HSA-447115,Interleukin-12 family signaling,2/126,57/10899,0.14067085531885554,0.34921848730166133,0.2758158753210574,HSPA9/JAK2,2
R-HSA-5610787,Hedgehog 'off' state,3/126,113/10899,0.14256174832713478,0.34921848730166133,0.2758158753210574,PRKAR1A/UBC/CSNK1A1,3
R-HSA-1236394,Signaling by ERBB4,2/126,58/10899,0.14464621825423543,0.34921848730166133,0.2758158753210574,UBC/NCSTN,2
R-HSA-2644602,Signaling by NOTCH1 PEST Domain Mutants in Cancer,2/126,58/10899,0.14464621825423543,0.34921848730166133,0.2758158753210574,UBC/NCSTN,2
R-HSA-2644603,Signaling by NOTCH1 in Cancer,2/126,58/10899,0.14464621825423543,0.34921848730166133,0.2758158753210574,UBC/NCSTN,2
R-HSA-2644606,Constitutive Signaling by NOTCH1 PEST Domain Mutants,2/126,58/10899,0.14464621825423543,0.34921848730166133,0.2758158753210574,UBC/NCSTN,2
R-HSA-2894858,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,2/126,58/10899,0.14464621825423543,0.34921848730166133,0.2758158753210574,UBC/NCSTN,2
R-HSA-2894862,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,2/126,58/10899,0.14464621825423543,0.34921848730166133,0.2758158753210574,UBC/NCSTN,2
R-HSA-5387390,Hh mutants abrogate ligand secretion,2/126,59/10899,0.14864505623537425,0.34921848730166133,0.2758158753210574,UBC/SEL1L,2
R-HSA-169893,Prolonged ERK activation events,1/126,14/10899,0.15031557811061336,0.34921848730166133,0.2758158753210574,CRK,1
R-HSA-174490,Membrane binding and targetting of GAG proteins,1/126,14/10899,0.15031557811061336,0.34921848730166133,0.2758158753210574,UBC,1
R-HSA-174495,"Synthesis And Processing Of GAG, GAGPOL Polyproteins",1/126,14/10899,0.15031557811061336,0.34921848730166133,0.2758158753210574,UBC,1
R-HSA-177504,Retrograde neurotrophin signalling,1/126,14/10899,0.15031557811061336,0.34921848730166133,0.2758158753210574,CLTC,1
R-HSA-3656237,Defective EXT2 causes exostoses 2,1/126,14/10899,0.15031557811061336,0.34921848730166133,0.2758158753210574,SDC4,1
R-HSA-3656253,"Defective EXT1 causes exostoses 1, TRPS2 and CHDS",1/126,14/10899,0.15031557811061336,0.34921848730166133,0.2758158753210574,SDC4,1
R-HSA-442720,CREB1 phosphorylation through the activation of Adenylate Cyclase,1/126,14/10899,0.15031557811061336,0.34921848730166133,0.2758158753210574,PRKAR1A,1
R-HSA-4839735,Signaling by AXIN mutants,1/126,14/10899,0.15031557811061336,0.34921848730166133,0.2758158753210574,CSNK1A1,1
R-HSA-4839744,Signaling by APC mutants,1/126,14/10899,0.15031557811061336,0.34921848730166133,0.2758158753210574,CSNK1A1,1
R-HSA-4839748,Signaling by AMER1 mutants,1/126,14/10899,0.15031557811061336,0.34921848730166133,0.2758158753210574,CSNK1A1,1
R-HSA-5467337,APC truncation mutants have impaired AXIN binding,1/126,14/10899,0.15031557811061336,0.34921848730166133,0.2758158753210574,CSNK1A1,1
R-HSA-5467340,AXIN missense mutants destabilize the destruction complex,1/126,14/10899,0.15031557811061336,0.34921848730166133,0.2758158753210574,CSNK1A1,1
R-HSA-5467348,Truncations of AMER1 destabilize the destruction complex,1/126,14/10899,0.15031557811061336,0.34921848730166133,0.2758158753210574,CSNK1A1,1
R-HSA-5578768,Physiological factors,1/126,14/10899,0.15031557811061336,0.34921848730166133,0.2758158753210574,WWTR1,1
R-HSA-6803205,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,1/126,14/10899,0.15031557811061336,0.34921848730166133,0.2758158753210574,PERP,1
R-HSA-877312,Regulation of IFNG signaling,1/126,14/10899,0.15031557811061336,0.34921848730166133,0.2758158753210574,JAK2,1
R-HSA-8849471,"PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases",1/126,14/10899,0.15031557811061336,0.34921848730166133,0.2758158753210574,CRK,1
R-HSA-9027284,Erythropoietin activates RAS,1/126,14/10899,0.15031557811061336,0.34921848730166133,0.2758158753210574,JAK2,1
R-HSA-9679504,Translation of Replicase and Assembly of the Replication Transcription Complex,1/126,14/10899,0.15031557811061336,0.34921848730166133,0.2758158753210574,BECN1,1
R-HSA-975110,TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,1/126,14/10899,0.15031557811061336,0.34921848730166133,0.2758158753210574,UBC,1
R-HSA-983169,Class I MHC mediated antigen processing & presentation,7/126,381/10899,0.15219591031585444,0.34921848730166133,0.2758158753210574,UBC/TRIP12/PDIA3/SEC23A/HSPA5/SEC24A/BECN1,7
R-HSA-5610783,Degradation of GLI2 by the proteasome,2/126,60/10899,0.15266630785858837,0.34921848730166133,0.2758158753210574,UBC/CSNK1A1,2
R-HSA-5610785,GLI3 is processed to GLI3R by the proteasome,2/126,60/10899,0.15266630785858837,0.34921848730166133,0.2758158753210574,UBC/CSNK1A1,2
R-HSA-198725,Nuclear Events (kinase and transcription factor activation),2/126,61/10899,0.15670893276232464,0.34921848730166133,0.2758158753210574,RPS6KA3/DUSP3,2
R-HSA-2022090,Assembly of collagen fibrils and other multimeric structures,2/126,61/10899,0.15670893276232464,0.34921848730166133,0.2758158753210574,CD151/LOXL1,2
R-HSA-5678895,Defective CFTR causes cystic fibrosis,2/126,61/10899,0.15670893276232464,0.34921848730166133,0.2758158753210574,UBC/SEL1L,2
R-HSA-111447,Activation of BAD and translocation to mitochondria ,1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,YWHAZ,1
R-HSA-1170546,Prolactin receptor signaling,1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,JAK2,1
R-HSA-2032785,YAP1- and WWTR1 (TAZ)-stimulated gene expression,1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,WWTR1,1
R-HSA-2162123,Synthesis of Prostaglandins (PG) and Thromboxanes (TX),1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,PTGES3,1
R-HSA-2691230,Signaling by NOTCH1 HD Domain Mutants in Cancer,1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,UBC,1
R-HSA-2691232,Constitutive Signaling by NOTCH1 HD Domain Mutants,1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,UBC,1
R-HSA-3134975,Regulation of innate immune responses to cytosolic DNA,1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,UBC,1
R-HSA-354194,GRB2:SOS provides linkage to MAPK signaling for Integrins ,1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,ITGB3,1
R-HSA-4839743,Signaling by CTNNB1 phospho-site mutants,1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,CSNK1A1,1
R-HSA-5099900,WNT5A-dependent internalization of FZD4,1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,CLTC,1
R-HSA-5339716,Signaling by GSK3beta mutants,1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,CSNK1A1,1
R-HSA-5358747,CTNNB1 S33 mutants aren't phosphorylated,1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,CSNK1A1,1
R-HSA-5358749,CTNNB1 S37 mutants aren't phosphorylated,1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,CSNK1A1,1
R-HSA-5358751,CTNNB1 S45 mutants aren't phosphorylated,1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,CSNK1A1,1
R-HSA-5358752,CTNNB1 T41 mutants aren't phosphorylated,1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,CSNK1A1,1
R-HSA-71336,Pentose phosphate pathway,1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,PRPS2,1
R-HSA-937039,IRAK1 recruits IKK complex,1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,UBC,1
R-HSA-9648895,Response of EIF2AK1 (HRI) to heme deficiency,1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,PPP1R15A,1
R-HSA-9694631,Maturation of nucleoprotein,1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,CSNK1A1,1
R-HSA-9694676,Translation of Replicase and Assembly of the Replication Transcription Complex,1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,BECN1,1
R-HSA-9706369,Negative regulation of FLT3,1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,UBC,1
R-HSA-9735871,SARS-CoV-1 targets host intracellular signalling and regulatory pathways,1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,YWHAZ,1
R-HSA-975144,IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,UBC,1
R-HSA-975577,N-Glycan antennae elongation,1/126,15/10899,0.16015115341222685,0.34921848730166133,0.2758158753210574,MGAT4B,1
R-HSA-8986944,Transcriptional Regulation by MECP2,2/126,62/10899,0.1607719112890156,0.3496009705315159,0.27611796398667504,MET/SLC2A3,2
R-HSA-425407,SLC-mediated transmembrane transport,5/126,250/10899,0.1634632285726182,0.35447136582736266,0.2799646456216112,SLC33A1/SLC4A7/SLC35D1/SLC2A3/SLC12A4,5
R-HSA-983712,Ion channel transport,4/126,186/10899,0.1685604081223647,0.35816654313739227,0.28288312961169837,UBC/ATP6V1C1/ATP1A1/ATP6V1A,4
R-HSA-1268020,Mitochondrial protein import,2/126,64/10899,0.16895495210631734,0.35816654313739227,0.28288312961169837,HSPA9/VDAC1,2
R-HSA-1442490,Collagen degradation,2/126,64/10899,0.16895495210631734,0.35816654313739227,0.28288312961169837,ADAM9/FURIN,2
R-HSA-110312,Translesion synthesis by REV1,1/126,16/10899,0.16987376960756484,0.35816654313739227,0.28288312961169837,UBC,1
R-HSA-1295596,Spry regulation of FGF signaling,1/126,16/10899,0.16987376960756484,0.35816654313739227,0.28288312961169837,UBC,1
R-HSA-193639,p75NTR signals via NF-kB,1/126,16/10899,0.16987376960756484,0.35816654313739227,0.28288312961169837,UBC,1
R-HSA-2173791,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),1/126,16/10899,0.16987376960756484,0.35816654313739227,0.28288312961169837,UBC,1
R-HSA-392517,Rap1 signalling,1/126,16/10899,0.16987376960756484,0.35816654313739227,0.28288312961169837,YWHAZ,1
R-HSA-5684264,MAP3K8 (TPL2)-dependent MAPK1/3 activation,1/126,16/10899,0.16987376960756484,0.35816654313739227,0.28288312961169837,UBC,1
R-HSA-975163,IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,1/126,16/10899,0.16987376960756484,0.35816654313739227,0.28288312961169837,UBC,1
R-HSA-2132295,MHC class II antigen presentation,3/126,123/10899,0.17018614087929596,0.35816654313739227,0.28288312961169837,CLTC/SEC23A/SEC24A,3
R-HSA-5358346,Hedgehog ligand biogenesis,2/126,65/10899,0.17307307562669427,0.36326835392233964,0.2869125852635039,UBC/SEL1L,2
R-HSA-1234176,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,2/126,66/10899,0.17720767458701367,0.3678733688994983,0.2905496671562916,UBC/EGLN1,2
R-HSA-196854,Metabolism of vitamins and cofactors,4/126,190/10899,0.17762137369906936,0.3678733688994983,0.2905496671562916,SLC2A3/LRP12/LDLR/SDC4,4
R-HSA-164378,PKA activation in glucagon signalling,1/126,17/10899,0.1794847137433221,0.3678733688994983,0.2905496671562916,PRKAR1A,1
R-HSA-196299,Beta-catenin phosphorylation cascade,1/126,17/10899,0.1794847137433221,0.3678733688994983,0.2905496671562916,CSNK1A1,1
R-HSA-450604,KSRP (KHSRP) binds and destabilizes mRNA,1/126,17/10899,0.1794847137433221,0.3678733688994983,0.2905496671562916,YWHAZ,1
R-HSA-5655862,Translesion synthesis by POLK,1/126,17/10899,0.1794847137433221,0.3678733688994983,0.2905496671562916,UBC,1
R-HSA-5656121,Translesion synthesis by POLI,1/126,17/10899,0.1794847137433221,0.3678733688994983,0.2905496671562916,UBC,1
R-HSA-6788467,IL-6-type cytokine receptor ligand interactions,1/126,17/10899,0.1794847137433221,0.3678733688994983,0.2905496671562916,JAK2,1
R-HSA-937072,TRAF6-mediated induction of TAK1 complex within TLR4 complex,1/126,17/10899,0.1794847137433221,0.3678733688994983,0.2905496671562916,UBC,1
R-HSA-5658442,Regulation of RAS by GAPs,2/126,68/10899,0.18552263344160128,0.3782734214328753,0.29876372138647483,UBC/RASA2,2
R-HSA-5685942,HDR through Homologous Recombination (HRR),2/126,68/10899,0.18552263344160128,0.3782734214328753,0.29876372138647483,UBC/HUS1,2
R-HSA-2243919,Crosslinking of collagen fibrils,1/126,18/10899,0.18898525831861535,0.3794205314069387,0.2996697190729962,LOXL1,1
R-HSA-5635838,Activation of SMO,1/126,18/10899,0.18898525831861535,0.3794205314069387,0.2996697190729962,CSNK1A1,1
R-HSA-5676594,TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,1/126,18/10899,0.18898525831861535,0.3794205314069387,0.2996697190729962,BIRC3,1
R-HSA-881907,Gastrin-CREB signalling pathway via PKC and MAPK,1/126,18/10899,0.18898525831861535,0.3794205314069387,0.2996697190729962,RPS6KA3,1
R-HSA-936964,Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,1/126,18/10899,0.18898525831861535,0.3794205314069387,0.2996697190729962,UBC,1
R-HSA-9758274,Regulation of NF-kappa B signaling,1/126,18/10899,0.18898525831861535,0.3794205314069387,0.2996697190729962,UBC,1
R-HSA-9662360,Sensory processing of sound by inner hair cells of the cochlea,2/126,69/10899,0.1897012072773417,0.37988634620590106,0.3000376237549792,ACTB/ACTG1,2
R-HSA-9013026,RHOB GTPase cycle,2/126,70/10899,0.19389268383007513,0.38729200205244013,0.3058866767802712,PKN1/FLOT2,2
R-HSA-110320,Translesion Synthesis by POLH,1/126,19/10899,0.19837666144809363,0.3873773115342127,0.3059540549696967,UBC,1
R-HSA-1236382,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,1/126,19/10899,0.19837666144809363,0.3873773115342127,0.3059540549696967,UBC,1
R-HSA-3000480,Scavenging by Class A Receptors,1/126,19/10899,0.19837666144809363,0.3873773115342127,0.3059540549696967,HSP90B1,1
R-HSA-5637815,Signaling by Ligand-Responsive EGFR Variants in Cancer,1/126,19/10899,0.19837666144809363,0.3873773115342127,0.3059540549696967,UBC,1
R-HSA-6804760,Regulation of TP53 Activity through Methylation,1/126,19/10899,0.19837666144809363,0.3873773115342127,0.3059540549696967,UBC,1
R-HSA-8876725,Protein methylation,1/126,19/10899,0.19837666144809363,0.3873773115342127,0.3059540549696967,HSPA8,1
R-HSA-888590,"GABA synthesis, release, reuptake and degradation",1/126,19/10899,0.19837666144809363,0.3873773115342127,0.3059540549696967,HSPA8,1
R-HSA-8963889,Assembly of active LPL and LIPC lipase complexes,1/126,19/10899,0.19837666144809363,0.3873773115342127,0.3059540549696967,FURIN,1
R-HSA-9725371,Nuclear events stimulated by ALK signaling in cancer,1/126,19/10899,0.19837666144809363,0.3873773115342127,0.3059540549696967,CLTC,1
R-HSA-913531,Interferon Signaling,4/126,200/10899,0.2009659773571451,0.3914597821969204,0.30917842670330015,UBC/ARIH1/JAK2/PML,4
R-HSA-1169408,ISG15 antiviral mechanism,2/126,72/10899,0.20231097166664996,0.3931042395007926,0.310477233745849,UBC/ARIH1,2
R-HSA-163615,PKA activation,1/126,20/10899,0.20766016702323542,0.3947051600804838,0.31174165509541396,PRKAR1A,1
R-HSA-167044,Signalling to RAS,1/126,20/10899,0.20766016702323542,0.3947051600804838,0.31174165509541396,RALB,1
R-HSA-2028269,Signaling by Hippo,1/126,20/10899,0.20766016702323542,0.3947051600804838,0.31174165509541396,WWTR1,1
R-HSA-3560783,"Defective B4GALT7 causes EDS, progeroid type",1/126,20/10899,0.20766016702323542,0.3947051600804838,0.31174165509541396,SDC4,1
R-HSA-3560801,Defective B3GAT3 causes JDSSDHD,1/126,20/10899,0.20766016702323542,0.3947051600804838,0.31174165509541396,SDC4,1
R-HSA-388844,Receptor-type tyrosine-protein phosphatases,1/126,20/10899,0.20766016702323542,0.3947051600804838,0.31174165509541396,PPFIBP1,1
R-HSA-4420332,Defective B3GALT6 causes EDSP2 and SEMDJL1,1/126,20/10899,0.20766016702323542,0.3947051600804838,0.31174165509541396,SDC4,1
R-HSA-9669938,Signaling by KIT in disease,1/126,20/10899,0.20766016702323542,0.3947051600804838,0.31174165509541396,JAK2,1
R-HSA-9670439,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",1/126,20/10899,0.20766016702323542,0.3947051600804838,0.31174165509541396,JAK2,1
R-HSA-1980143,Signaling by NOTCH1,2/126,74/10899,0.21077092420582175,0.3996501823709422,0.3156472777961582,UBC/NCSTN,2
R-HSA-1234174,Cellular response to hypoxia,2/126,75/10899,0.21501454543004386,0.40527868767714714,0.32009272147749196,UBC/EGLN1,2
R-HSA-189200,Cellular hexose transport,1/126,21/10899,0.21683700487184943,0.40527868767714714,0.32009272147749196,SLC2A3,1
R-HSA-445144,Signal transduction by L1,1/126,21/10899,0.21683700487184943,0.40527868767714714,0.32009272147749196,ITGB3,1
R-HSA-4641263,Regulation of FZD by ubiquitination,1/126,21/10899,0.21683700487184943,0.40527868767714714,0.32009272147749196,UBC,1
R-HSA-5620916,VxPx cargo-targeting to cilium,1/126,21/10899,0.21683700487184943,0.40527868767714714,0.32009272147749196,PKD2,1
R-HSA-8849932,Synaptic adhesion-like molecules,1/126,21/10899,0.21683700487184943,0.40527868767714714,0.32009272147749196,FLOT2,1
R-HSA-204998,"Cell death signalling via NRAGE, NRIF and NADE",2/126,76/10899,0.2192662409021156,0.40787677513782167,0.3221447141215917,UBC/NCSTN,2
R-HSA-9659379,Sensory processing of sound,2/126,76/10899,0.2192662409021156,0.40787677513782167,0.3221447141215917,ACTB/ACTG1,2
R-HSA-9678108,SARS-CoV-1 Infection,3/126,141/10899,0.22321698024780928,0.41337549386691563,0.3264876512069907,UBC/YWHAZ/BECN1,3
R-HSA-111931,PKA-mediated phosphorylation of CREB,1/126,22/10899,0.22590839091580484,0.41337549386691563,0.3264876512069907,PRKAR1A,1
R-HSA-1181150,Signaling by NODAL,1/126,22/10899,0.22590839091580484,0.41337549386691563,0.3264876512069907,FURIN,1
R-HSA-1250196,SHC1 events in ERBB2 signaling,1/126,22/10899,0.22590839091580484,0.41337549386691563,0.3264876512069907,PTPN12,1
R-HSA-2024096,HS-GAG degradation,1/126,22/10899,0.22590839091580484,0.41337549386691563,0.3264876512069907,SDC4,1
R-HSA-8862803,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,1/126,22/10899,0.22590839091580484,0.41337549386691563,0.3264876512069907,PRDX1,1
R-HSA-8863678,Neurodegenerative Diseases,1/126,22/10899,0.22590839091580484,0.41337549386691563,0.3264876512069907,PRDX1,1
R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,2/126,78/10899,0.22779088453606405,0.41392556565002375,0.3269221028063882,ESR2/MET,2
R-HSA-422356,Regulation of insulin secretion,2/126,78/10899,0.22779088453606405,0.41392556565002375,0.3269221028063882,PRKAR1A/IQGAP1,2
R-HSA-5619084,ABC transporter disorders,2/126,78/10899,0.22779088453606405,0.41392556565002375,0.3269221028063882,UBC/SEL1L,2
R-HSA-3781865,Diseases of glycosylation,3/126,143/10899,0.22931037954500091,0.41572436014509406,0.32834280673880045,NUS1/DOLK/SDC4,3
R-HSA-6781827,Transcription-Coupled Nucleotide Excision Repair (TC-NER),2/126,79/10899,0.232062387201474,0.4159108994364317,0.3284901371345066,UBC/COPS2,2
R-HSA-74752,Signaling by Insulin receptor,2/126,79/10899,0.232062387201474,0.4159108994364317,0.3284901371345066,ATP6V1C1/ATP6V1A,2
R-HSA-9662851,Anti-inflammatory response favouring Leishmania parasite infection,2/126,79/10899,0.232062387201474,0.4159108994364317,0.3284901371345066,PRKAR1A/FURIN,2
R-HSA-9664433,Leishmania parasite growth and survival,2/126,79/10899,0.232062387201474,0.4159108994364317,0.3284901371345066,PRKAR1A/FURIN,2
R-HSA-9759194,Nuclear events mediated by NFE2L2,2/126,79/10899,0.232062387201474,0.4159108994364317,0.3284901371345066,UBC/PRDX1,2
R-HSA-450321,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,1/126,23/10899,0.23487552732700323,0.4162015551957055,0.3287196996450158,UBC,1
R-HSA-8949215,Mitochondrial calcium ion transport,1/126,23/10899,0.23487552732700323,0.4162015551957055,0.3287196996450158,VDAC1,1
R-HSA-9013418,RHOBTB2 GTPase cycle,1/126,23/10899,0.23487552732700323,0.4162015551957055,0.3287196996450158,ACTG1,1
R-HSA-9013422,RHOBTB1 GTPase cycle,1/126,23/10899,0.23487552732700323,0.4162015551957055,0.3287196996450158,COPS2,1
R-HSA-9637690,Response of Mtb to phagocytosis,1/126,23/10899,0.23487552732700323,0.4162015551957055,0.3287196996450158,UBC,1
R-HSA-1169410,Antiviral mechanism by IFN-stimulated genes,2/126,80/10899,0.23633907259915732,0.4178517387169786,0.3300230293051296,UBC/ARIH1,2
R-HSA-73887,Death Receptor Signalling,3/126,146/10899,0.23850895746645456,0.42074052047453225,0.3323046148970828,UBC/NCSTN/BIRC3,3
R-HSA-174048,APC/C:Cdc20 mediated degradation of Cyclin B,1/126,24/10899,0.24373960268161898,0.4270883663059618,0.3373182001397406,UBC,1
R-HSA-6783589,Interleukin-6 family signaling,1/126,24/10899,0.24373960268161898,0.4270883663059618,0.3373182001397406,JAK2,1
R-HSA-982772,Growth hormone receptor signaling,1/126,24/10899,0.24373960268161898,0.4270883663059618,0.3373182001397406,JAK2,1
R-HSA-195253,Degradation of beta-catenin by the destruction complex,2/126,83/10899,0.24919345550489297,0.43278145591354816,0.3418146530782164,UBC/CSNK1A1,2
R-HSA-5689880,Ub-specific processing proteases,4/126,220/10899,0.2501061767681487,0.43278145591354816,0.3418146530782164,UBC/VDAC1/BIRC3/BECN1,4
R-HSA-9018519,Estrogen-dependent gene expression,3/126,150/10899,0.25087104853699443,0.43278145591354816,0.3418146530782164,CBFB/NRIP1/PTGES3,3
R-HSA-156588,Glucuronidation,1/126,25/10899,0.2525017921126179,0.43278145591354816,0.3418146530782164,SLC35D1,1
R-HSA-1643713,Signaling by EGFR in Cancer,1/126,25/10899,0.2525017921126179,0.43278145591354816,0.3418146530782164,UBC,1
R-HSA-400685,Sema4D in semaphorin signaling,1/126,25/10899,0.2525017921126179,0.43278145591354816,0.3418146530782164,MET,1
R-HSA-5696397,Gap-filling DNA repair synthesis and ligation in GG-NER,1/126,25/10899,0.2525017921126179,0.43278145591354816,0.3418146530782164,UBC,1
R-HSA-8854691,Interleukin-20 family signaling,1/126,25/10899,0.2525017921126179,0.43278145591354816,0.3418146530782164,JAK2,1
R-HSA-9006335,Signaling by Erythropoietin,1/126,25/10899,0.2525017921126179,0.43278145591354816,0.3418146530782164,JAK2,1
R-HSA-9734009,Defective Intrinsic Pathway for Apoptosis,1/126,25/10899,0.2525017921126179,0.43278145591354816,0.3418146530782164,PRDX1,1
R-HSA-8939211,ESR-mediated signaling,4/126,223/10899,0.25770161174968015,0.43990171799945654,0.3474382995664498,CBFB/ESR2/NRIP1/PTGES3,4
R-HSA-5632684,Hedgehog 'on' state,2/126,85/10899,0.2577768029041401,0.43990171799945654,0.3474382995664498,UBC/CSNK1A1,2
R-HSA-1227990,Signaling by ERBB2 in Cancer,1/126,26/10899,0.26116325746058655,0.4406096066605615,0.3479973963433734,PTPN12,1
R-HSA-179409,APC-Cdc20 mediated degradation of Nek2A,1/126,26/10899,0.26116325746058655,0.4406096066605615,0.3479973963433734,UBC,1
R-HSA-180024,DARPP-32 events,1/126,26/10899,0.26116325746058655,0.4406096066605615,0.3479973963433734,PRKAR1A,1
R-HSA-1971475,A tetrasaccharide linker sequence is required for GAG synthesis,1/126,26/10899,0.26116325746058655,0.4406096066605615,0.3479973963433734,SDC4,1
R-HSA-975576,N-glycan antennae elongation in the medial/trans-Golgi,1/126,26/10899,0.26116325746058655,0.4406096066605615,0.3479973963433734,MGAT4B,1
R-HSA-6794362,Protein-protein interactions at synapses,2/126,86/10899,0.26207072502476386,0.4406096066605615,0.3479973963433734,FLOT2/PPFIBP1,2
R-HSA-5688426,Deubiquitination,5/126,298/10899,0.262120619503799,0.4406096066605615,0.3479973963433734,UBC/ACTB/VDAC1/BIRC3/BECN1,5
R-HSA-1368108,"BMAL1:CLOCK,NPAS2 activates circadian gene expression",1/126,27/10899,0.2697251474228757,0.4504983845254413,0.35580764128124026,NPAS2,1
R-HSA-912526,Interleukin receptor SHC signaling,1/126,27/10899,0.2697251474228757,0.4504983845254413,0.35580764128124026,JAK2,1
R-HSA-9635486,Infection with Mycobacterium tuberculosis,1/126,27/10899,0.2697251474228757,0.4504983845254413,0.35580764128124026,UBC,1
R-HSA-1483191,Synthesis of PC,1/126,28/10899,0.2781885977010874,0.46052385820464253,0.3637258497922018,PCYT1A,1
R-HSA-389957,Prefoldin mediated transfer of substrate  to CCT/TriC,1/126,28/10899,0.2781885977010874,0.46052385820464253,0.3637258497922018,ACTB,1
R-HSA-9682385,FLT3 signaling in disease,1/126,28/10899,0.2781885977010874,0.46052385820464253,0.3637258497922018,UBC,1
R-HSA-1236974,ER-Phagosome pathway,2/126,90/10899,0.2792475879049807,0.46052385820464253,0.3637258497922018,UBC/PDIA3,2
R-HSA-1474290,Collagen formation,2/126,90/10899,0.2792475879049807,0.46052385820464253,0.3637258497922018,CD151/LOXL1,2
R-HSA-9616222,Transcriptional regulation of granulopoiesis,2/126,90/10899,0.2792475879049807,0.46052385820464253,0.3637258497922018,CBFB/PML,2
R-HSA-9006925,Intracellular signaling by second messengers,5/126,309/10899,0.2865535307392525,0.46476335526928336,0.3670742423782875,PRKAR1A/UBC/ESR2/MET/PML,5
R-HSA-162588,Budding and maturation of HIV virion,1/126,29/10899,0.2865547311469212,0.46476335526928336,0.3670742423782875,UBC,1
R-HSA-186763,Downstream signal transduction,1/126,29/10899,0.2865547311469212,0.46476335526928336,0.3670742423782875,CRK,1
R-HSA-380972,Energy dependent regulation of mTOR by LKB1-AMPK,1/126,29/10899,0.2865547311469212,0.46476335526928336,0.3670742423782875,PRKAG1,1
R-HSA-442742,CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,1/126,29/10899,0.2865547311469212,0.46476335526928336,0.3670742423782875,RPS6KA3,1
R-HSA-5654732,Negative regulation of FGFR3 signaling,1/126,29/10899,0.2865547311469212,0.46476335526928336,0.3670742423782875,UBC,1
R-HSA-9619483,Activation of AMPK downstream of NMDARs,1/126,29/10899,0.2865547311469212,0.46476335526928336,0.3670742423782875,PRKAG1,1
R-HSA-9683701,Translation of Structural Proteins,1/126,29/10899,0.2865547311469212,0.46476335526928336,0.3670742423782875,UBC,1
R-HSA-4086400,PCP/CE pathway,2/126,92/10899,0.28782885023509375,0.4649087395772605,0.36718906820114844,UBC/CLTC,2
R-HSA-877300,Interferon gamma signaling,2/126,92/10899,0.28782885023509375,0.4649087395772605,0.36718906820114844,JAK2/PML,2
R-HSA-9609507,Protein localization,3/126,163/10899,0.2916168458812611,0.46944697050004197,0.37077340345226245,UBC/HSPA9/VDAC1,3
R-HSA-110314,Recognition of DNA damage by PCNA-containing replication complex,1/126,30/10899,0.2948246579063958,0.46944697050004197,0.37077340345226245,UBC,1
R-HSA-114452,Activation of BH3-only proteins,1/126,30/10899,0.2948246579063958,0.46944697050004197,0.37077340345226245,YWHAZ,1
R-HSA-3928663,EPHA-mediated growth cone collapse,1/126,30/10899,0.2948246579063958,0.46944697050004197,0.37077340345226245,EPHA2,1
R-HSA-525793,Myogenesis,1/126,30/10899,0.2948246579063958,0.46944697050004197,0.37077340345226245,CTNNA1,1
R-HSA-6804758,Regulation of TP53 Activity through Acetylation,1/126,30/10899,0.2948246579063958,0.46944697050004197,0.37077340345226245,PML,1
R-HSA-8866652,Synthesis of active ubiquitin: roles of E1 and E2 enzymes,1/126,30/10899,0.2948246579063958,0.46944697050004197,0.37077340345226245,UBC,1
R-HSA-69473,G2/M DNA damage checkpoint,2/126,94/10899,0.2963996388777763,0.47099942615193197,0.37199954676967883,YWHAZ/HUS1,2
R-HSA-1592230,Mitochondrial biogenesis,2/126,95/10899,0.3006798399899735,0.4738139209492698,0.374222459858022,HSPA9/PRKAG1,2
R-HSA-5625740,RHO GTPases activate PKNs,2/126,95/10899,0.3006798399899735,0.4738139209492698,0.374222459858022,PKN1/YWHAZ,2
R-HSA-9692914,SARS-CoV-1-host interactions,2/126,95/10899,0.3006798399899735,0.4738139209492698,0.374222459858022,UBC/YWHAZ,2
R-HSA-8951664,Neddylation,4/126,240/10899,0.3015127934238758,0.4738139209492698,0.374222459858022,UBC/FEM1C/FEM1B/COPS2,4
R-HSA-2022928,HS-GAG biosynthesis,1/126,31/10899,0.302999475562463,0.4738139209492698,0.374222459858022,SDC4,1
R-HSA-4641262,Disassembly of the destruction complex and recruitment of AXIN to the membrane,1/126,31/10899,0.302999475562463,0.4738139209492698,0.374222459858022,CSNK1A1,1
R-HSA-5654733,Negative regulation of FGFR4 signaling,1/126,31/10899,0.302999475562463,0.4738139209492698,0.374222459858022,UBC,1
R-HSA-8949613,Cristae formation,1/126,31/10899,0.302999475562463,0.4738139209492698,0.374222459858022,HSPA9,1
R-HSA-69481,G2/M Checkpoints,3/126,167/10899,0.3042679321192275,0.47485154416221387,0.37504198392429633,UBC/YWHAZ/HUS1,3
R-HSA-983231,Factors involved in megakaryocyte development and platelet production,3/126,168/10899,0.3074354160767737,0.47788260544361943,0.3774359431529224,PRKAR1A/ACTB/JAK2,3
R-HSA-193704,p75 NTR receptor-mediated signalling,2/126,97/10899,0.3092274280096754,0.47788260544361943,0.3774359431529224,UBC/NCSTN,2
R-HSA-5693607,Processing of DNA double-strand break ends,2/126,97/10899,0.3092274280096754,0.47788260544361943,0.3774359431529224,UBC/HUS1,2
R-HSA-1251985,Nuclear signaling by ERBB4,1/126,32/10899,0.3110802692760376,0.47788260544361943,0.3774359431529224,NCSTN,1
R-HSA-381042,PERK regulates gene expression,1/126,32/10899,0.3110802692760376,0.47788260544361943,0.3774359431529224,HSPA5,1
R-HSA-389958,Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,1/126,32/10899,0.3110802692760376,0.47788260544361943,0.3774359431529224,ACTB,1
R-HSA-5656169,Termination of translesion DNA synthesis,1/126,32/10899,0.3110802692760376,0.47788260544361943,0.3774359431529224,UBC,1
R-HSA-917729,Endosomal Sorting Complex Required For Transport (ESCRT),1/126,32/10899,0.3110802692760376,0.47788260544361943,0.3774359431529224,UBC,1
R-HSA-1592389,Activation of Matrix Metalloproteinases,1/126,33/10899,0.31906811192545537,0.48540400748349316,0.3833764135538417,FURIN,1
R-HSA-163359,Glucagon signaling in metabolic regulation,1/126,33/10899,0.31906811192545537,0.48540400748349316,0.3833764135538417,PRKAR1A,1
R-HSA-2559585,Oncogene Induced Senescence,1/126,33/10899,0.31906811192545537,0.48540400748349316,0.3833764135538417,UBC,1
R-HSA-5654726,Negative regulation of FGFR1 signaling,1/126,33/10899,0.31906811192545537,0.48540400748349316,0.3833764135538417,UBC,1
R-HSA-8963899,Plasma lipoprotein remodeling,1/126,33/10899,0.31906811192545537,0.48540400748349316,0.3833764135538417,FURIN,1
R-HSA-6807878,COPI-mediated anterograde transport,2/126,101/10899,0.32625846813724124,0.49358998159968276,0.38984176890675587,KDELR1/TMEM115,2
R-HSA-4791275,Signaling by WNT in cancer,1/126,34/10899,0.32696406424437585,0.49358998159968276,0.38984176890675587,CSNK1A1,1
R-HSA-5579029,Metabolic disorders of biological oxidation enzymes,1/126,34/10899,0.32696406424437585,0.49358998159968276,0.38984176890675587,SLC35D1,1
R-HSA-5654727,Negative regulation of FGFR2 signaling,1/126,34/10899,0.32696406424437585,0.49358998159968276,0.38984176890675587,UBC,1
R-HSA-5668541,TNFR2 non-canonical NF-kB pathway,2/126,102/10899,0.3305003115350994,0.4960664331836578,0.39179769245078705,UBC/BIRC3,2
R-HSA-5689603,UCH proteinases,2/126,102/10899,0.3305003115350994,0.4960664331836578,0.39179769245078705,UBC/ACTB,2
R-HSA-9755511,KEAP1-NFE2L2 pathway,2/126,102/10899,0.3305003115350994,0.4960664331836578,0.39179769245078705,UBC/PRDX1,2
R-HSA-5619115,Disorders of transmembrane transporters,3/126,176/10899,0.33280745687184765,0.4985760565732832,0.39377981538272055,UBC/SEL1L/SLC33A1,3
R-HSA-382556,ABC-family proteins mediated transport,2/126,103/10899,0.3347349548653469,0.4986599664936467,0.393846088186065,UBC/SEL1L,2
R-HSA-936440,Negative regulators of DDX58/IFIH1 signaling,1/126,35/10899,0.33476917495815517,0.4986599664936467,0.393846088186065,UBC,1
R-HSA-9709570,Impaired BRCA2 binding to RAD51,1/126,35/10899,0.33476917495815517,0.4986599664936467,0.393846088186065,HUS1,1
R-HSA-112316,Neuronal System,6/126,410/10899,0.3372932709110198,0.5014682152749064,0.3960640681152127,PRKAR1A/RPS6KA3/FLOT2/HSPA8/PRKAG1/PPFIBP1,6
R-HSA-2219528,PI3K/AKT Signaling in Cancer,2/126,104/10899,0.3389619994705575,0.5029965398570655,0.39727115249857403,ESR2/MET,2
R-HSA-390522,Striated Muscle Contraction,1/126,36/10899,0.34248448091869177,0.505215332135398,0.3990235744254099,TPM1,1
R-HSA-6804757,Regulation of TP53 Degradation,1/126,36/10899,0.34248448091869177,0.505215332135398,0.3990235744254099,UBC,1
R-HSA-1236975,Antigen processing-Cross presentation,2/126,105/10899,0.34318105672031707,0.505215332135398,0.3990235744254099,UBC/PDIA3,2
R-HSA-109581,Apoptosis,3/126,180/10899,0.34549220117277224,0.505215332135398,0.3990235744254099,STK24/UBC/YWHAZ,3
R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",2/126,106/10899,0.34739174783590154,0.505215332135398,0.3990235744254099,ESR2/MET,2
R-HSA-73894,DNA Repair,5/126,336/10899,0.3480466075818017,0.505215332135398,0.3990235744254099,UBC/ACTB/HUS1/COPS2/PNKP,5
R-HSA-111933,Calmodulin induced events,1/126,37/10899,0.350111007237779,0.505215332135398,0.3990235744254099,PRKAR1A,1
R-HSA-111997,CaM pathway,1/126,37/10899,0.350111007237779,0.505215332135398,0.3990235744254099,PRKAR1A,1
R-HSA-176187,Activation of ATR in response to replication stress,1/126,37/10899,0.350111007237779,0.505215332135398,0.3990235744254099,HUS1,1
R-HSA-2129379,Molecules associated with elastic fibres,1/126,37/10899,0.350111007237779,0.505215332135398,0.3990235744254099,ITGB3,1
R-HSA-3299685,Detoxification of Reactive Oxygen Species,1/126,37/10899,0.350111007237779,0.505215332135398,0.3990235744254099,PRDX1,1
R-HSA-5685938,HDR through Single Strand Annealing (SSA),1/126,37/10899,0.350111007237779,0.505215332135398,0.3990235744254099,HUS1,1
R-HSA-5689901,Metalloprotease DUBs,1/126,37/10899,0.350111007237779,0.505215332135398,0.3990235744254099,UBC,1
R-HSA-6806003,Regulation of TP53 Expression and Degradation,1/126,37/10899,0.350111007237779,0.505215332135398,0.3990235744254099,UBC,1
R-HSA-9694548,Maturation of spike protein,1/126,37/10899,0.350111007237779,0.505215332135398,0.3990235744254099,MGAT4B,1
R-HSA-163685,Integration of energy metabolism,2/126,108/10899,0.3557865647747527,0.5086142525795057,0.40170807210101084,PRKAR1A/IQGAP1,2
R-HSA-425393,Transport of inorganic cations/anions and amino acids/oligopeptides,2/126,108/10899,0.3557865647747527,0.5086142525795057,0.40170807210101084,SLC4A7/SLC12A4,2
R-HSA-111465,Apoptotic cleavage of cellular proteins,1/126,38/10899,0.3576497674189645,0.5086142525795057,0.40170807210101084,STK24,1
R-HSA-3232142,SUMOylation of ubiquitinylation proteins,1/126,38/10899,0.3576497674189645,0.5086142525795057,0.40170807210101084,PML,1
R-HSA-8939243,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,1/126,38/10899,0.3576497674189645,0.5086142525795057,0.40170807210101084,CBFB,1
R-HSA-8950505,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,1/126,38/10899,0.3576497674189645,0.5086142525795057,0.40170807210101084,HSPA9,1
R-HSA-9013407,RHOH GTPase cycle,1/126,38/10899,0.3576497674189645,0.5086142525795057,0.40170807210101084,SLC4A7,1
R-HSA-9607240,FLT3 Signaling,1/126,38/10899,0.3576497674189645,0.5086142525795057,0.40170807210101084,UBC,1
R-HSA-1912422,Pre-NOTCH Expression and Processing,2/126,109/10899,0.3599699807581491,0.5109881282009893,0.40358298023517625,SEL1L/FURIN,2
R-HSA-9013149,RAC1 GTPase cycle,3/126,185/10899,0.36132047438556225,0.5119793725499393,0.40436587386109857,PKN1/IQGAP1/EPHA2,3
R-HSA-110313,Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,1/126,39/10899,0.36510176348794643,0.5136288249785627,0.4056686260977183,UBC,1
R-HSA-111996,Ca-dependent events,1/126,39/10899,0.36510176348794643,0.5136288249785627,0.4056686260977183,PRKAR1A,1
R-HSA-5689896,Ovarian tumor domain proteases,1/126,39/10899,0.36510176348794643,0.5136288249785627,0.4056686260977183,UBC,1
R-HSA-73933,Resolution of Abasic Sites (AP sites),1/126,39/10899,0.36510176348794643,0.5136288249785627,0.4056686260977183,PNKP,1
R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),2/126,112/10899,0.37246019245195217,0.517539370212816,0.40875720959483564,UBC/RPS6KA3,2
R-HSA-5654741,Signaling by FGFR3,1/126,40/10899,0.37246798612151155,0.517539370212816,0.40875720959483564,UBC,1
R-HSA-5693616,Presynaptic phase of homologous DNA pairing and strand exchange,1/126,40/10899,0.37246798612151155,0.517539370212816,0.40875720959483564,HUS1,1
R-HSA-6783310,Fanconi Anemia Pathway,1/126,40/10899,0.37246798612151155,0.517539370212816,0.40875720959483564,UBC,1
R-HSA-9664323,FCGR3A-mediated IL10 synthesis,1/126,40/10899,0.37246798612151155,0.517539370212816,0.40875720959483564,PRKAR1A,1
R-HSA-9692916,SARS-CoV-1 activates/modulates innate immune responses,1/126,40/10899,0.37246798612151155,0.517539370212816,0.40875720959483564,UBC,1
R-HSA-1257604,PIP3 activates AKT signaling,4/126,267/10899,0.37249648938884217,0.517539370212816,0.40875720959483564,UBC/ESR2/MET/PML,4
R-HSA-199418,Negative regulation of the PI3K/AKT network,2/126,113/10899,0.3766025067605073,0.5211392796552946,0.4116004501736085,ESR2/MET,2
R-HSA-165159,MTOR signalling,1/126,41/10899,0.3797494147750424,0.5211392796552946,0.4116004501736085,PRKAG1,1
R-HSA-3560782,Diseases associated with glycosaminoglycan metabolism,1/126,41/10899,0.3797494147750424,0.5211392796552946,0.4116004501736085,SDC4,1
R-HSA-5654743,Signaling by FGFR4,1/126,41/10899,0.3797494147750424,0.5211392796552946,0.4116004501736085,UBC,1
R-HSA-5696400,Dual Incision in GG-NER,1/126,41/10899,0.3797494147750424,0.5211392796552946,0.4116004501736085,UBC,1
R-HSA-9675136,Diseases of DNA Double-Strand Break Repair,1/126,41/10899,0.3797494147750424,0.5211392796552946,0.4116004501736085,HUS1,1
R-HSA-9701190,Defective homologous recombination repair (HRR) due to BRCA2 loss of function,1/126,41/10899,0.3797494147750424,0.5211392796552946,0.4116004501736085,HUS1,1
R-HSA-112315,Transmission across Chemical Synapses,4/126,270/10899,0.38039848056367365,0.5211392796552946,0.4116004501736085,PRKAR1A/RPS6KA3/HSPA8/PRKAG1,4
R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,1/126,42/10899,0.38694701780859786,0.5291871236580998,0.4179567091312382,HSP90B1,1
R-HSA-1433557,Signaling by SCF-KIT,1/126,43/10899,0.3940617526115928,0.5315094085912377,0.4197908704797037,JAK2,1
R-HSA-1489509,DAG and IP3 signaling,1/126,43/10899,0.3940617526115928,0.5315094085912377,0.4197908704797037,PRKAR1A,1
R-HSA-432040,Vasopressin regulates renal water homeostasis via Aquaporins,1/126,43/10899,0.3940617526115928,0.5315094085912377,0.4197908704797037,PRKAR1A,1
R-HSA-5693579,Homologous DNA Pairing and Strand Exchange,1/126,43/10899,0.3940617526115928,0.5315094085912377,0.4197908704797037,HUS1,1
R-HSA-5696395,Formation of Incision Complex in GG-NER,1/126,43/10899,0.3940617526115928,0.5315094085912377,0.4197908704797037,UBC,1
R-HSA-9646399,Aggrephagy,1/126,43/10899,0.3940617526115928,0.5315094085912377,0.4197908704797037,UBC,1
R-HSA-9660821,ADORA2B mediated anti-inflammatory cytokines production,1/126,43/10899,0.3940617526115928,0.5315094085912377,0.4197908704797037,PRKAR1A,1
R-HSA-9696270,RND2 GTPase cycle,1/126,43/10899,0.3940617526115928,0.5315094085912377,0.4197908704797037,EPHA2,1
R-HSA-2559583,Cellular Senescence,3/126,197/10899,0.39904732194515924,0.5373107165127787,0.424372795207545,UBC/RPS6KA3/MAP2K3,3
R-HSA-451927,Interleukin-2 family signaling,1/126,44/10899,0.40109456572608615,0.5382209129828677,0.425091676496023,JAK2,1
R-HSA-5633008,TP53 Regulates Transcription of Cell Death Genes,1/126,44/10899,0.40109456572608615,0.5382209129828677,0.425091676496023,PERP,1
R-HSA-3899300,SUMOylation of transcription cofactors,1/126,45/10899,0.4080463929686944,0.5438309312061547,0.4295225189144152,NRIP1,1
R-HSA-445355,Smooth Muscle Contraction,1/126,45/10899,0.4080463929686944,0.5438309312061547,0.4295225189144152,TPM1,1
R-HSA-445989,TAK1-dependent IKK and NF-kappa-B activation  ,1/126,45/10899,0.4080463929686944,0.5438309312061547,0.4295225189144152,UBC,1
R-HSA-9634597,GPER1 signaling,1/126,45/10899,0.4080463929686944,0.5438309312061547,0.4295225189144152,PRKAR1A,1
R-HSA-1660662,Glycosphingolipid metabolism,1/126,46/10899,0.4149181595511474,0.5520521275383911,0.4360156930876465,ARSJ,1
R-HSA-9024446,NR1H2 and NR1H3-mediated signaling,1/126,47/10899,0.42171078019949837,0.5601403764071171,0.4424038641686785,NRIP1,1
R-HSA-112314,Neurotransmitter receptors and postsynaptic signal transmission,3/126,205/10899,0.4238787547068722,0.5611211171077483,0.4431784619194954,PRKAR1A/RPS6KA3/PRKAG1,3
R-HSA-397014,Muscle contraction,3/126,205/10899,0.4238787547068722,0.5611211171077483,0.4431784619194954,WWTR1/ATP1A1/TPM1,3
R-HSA-2559580,Oxidative Stress Induced Senescence,2/126,125/10899,0.42536804908502257,0.5621446439928329,0.4439868525803266,UBC/MAP2K3,2
R-HSA-2122947,NOTCH1 Intracellular Domain Regulates Transcription,1/126,48/10899,0.4284251592720072,0.5642848154841034,0.44567717910846394,UBC,1
R-HSA-73893,DNA Damage Bypass,1/126,48/10899,0.4284251592720072,0.5642848154841034,0.44567717910846394,UBC,1
R-HSA-1793185,Chondroitin sulfate/dermatan sulfate metabolism,1/126,50/10899,0.4416227589816647,0.5773408132866805,0.4559889225958496,SDC4,1
R-HSA-211733,Regulation of activated PAK-2p34 by proteasome mediated degradation,1/126,50/10899,0.4416227589816647,0.5773408132866805,0.4559889225958496,UBC,1
R-HSA-373752,Netrin-1 signaling,1/126,50/10899,0.4416227589816647,0.5773408132866805,0.4559889225958496,UNC5C,1
R-HSA-5654736,Signaling by FGFR1,1/126,50/10899,0.4416227589816647,0.5773408132866805,0.4559889225958496,UBC,1
R-HSA-6809371,Formation of the cornified envelope,2/126,130/10899,0.4451105438463424,0.5773408132866805,0.4559889225958496,PERP/FURIN,2
R-HSA-8939236,RUNX1 regulates transcription of genes involved in differentiation of HSCs,2/126,130/10899,0.4451105438463424,0.5773408132866805,0.4559889225958496,UBC/CBFB,2
R-HSA-71387,Metabolism of carbohydrates,4/126,295/10899,0.4456343600508488,0.5773408132866805,0.4559889225958496,UBC/PRPS2/GBE1/SDC4,4
R-HSA-112043,PLC beta mediated events,1/126,51/10899,0.4481077375389797,0.5773408132866805,0.4559889225958496,PRKAR1A,1
R-HSA-112310,Neurotransmitter release cycle,1/126,51/10899,0.4481077375389797,0.5773408132866805,0.4559889225958496,HSPA8,1
R-HSA-5620920,Cargo trafficking to the periciliary membrane,1/126,51/10899,0.4481077375389797,0.5773408132866805,0.4559889225958496,PKD2,1
R-HSA-9675135,Diseases of DNA repair,1/126,51/10899,0.4481077375389797,0.5773408132866805,0.4559889225958496,HUS1,1
R-HSA-5576891,Cardiac conduction,2/126,132/10899,0.4529031923016924,0.5773408132866805,0.4559889225958496,WWTR1/ATP1A1,2
R-HSA-5693567,HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),2/126,132/10899,0.4529031923016924,0.5773408132866805,0.4559889225958496,UBC/HUS1,2
R-HSA-180534,Vpu mediated degradation of CD4,1/126,52/10899,0.4545179905874759,0.5773408132866805,0.4559889225958496,UBC,1
R-HSA-349425,Autodegradation of the E3 ubiquitin ligase COP1,1/126,52/10899,0.4545179905874759,0.5773408132866805,0.4559889225958496,UBC,1
R-HSA-445717,Aquaporin-mediated transport,1/126,52/10899,0.4545179905874759,0.5773408132866805,0.4559889225958496,PRKAR1A,1
R-HSA-69601,Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,1/126,52/10899,0.4545179905874759,0.5773408132866805,0.4559889225958496,UBC,1
R-HSA-69610,p53-Independent DNA Damage Response,1/126,52/10899,0.4545179905874759,0.5773408132866805,0.4559889225958496,UBC,1
R-HSA-69613,p53-Independent G1/S DNA damage checkpoint,1/126,52/10899,0.4545179905874759,0.5773408132866805,0.4559889225958496,UBC,1
R-HSA-75153,Apoptotic execution phase,1/126,52/10899,0.4545179905874759,0.5773408132866805,0.4559889225958496,STK24,1
R-HSA-75815,Ubiquitin-dependent degradation of Cyclin D,1/126,52/10899,0.4545179905874759,0.5773408132866805,0.4559889225958496,UBC,1
R-HSA-9762114,GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,1/126,52/10899,0.4545179905874759,0.5773408132866805,0.4559889225958496,UBC,1
R-HSA-9006931,Signaling by Nuclear Receptors,4/126,299/10899,0.45590860239163644,0.5781716524675842,0.45664512678968433,CBFB/ESR2/NRIP1/PTGES3,4
R-HSA-169911,Regulation of Apoptosis,1/126,53/10899,0.4608543723691648,0.5835011004996683,0.4608543723691648,UBC,1
R-HSA-180585,Vif-mediated degradation of APOBEC3G,1/126,54/10899,0.4671177274384516,0.5895296077800394,0.46561574117659166,UBC,1
R-HSA-8854050,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,1/126,54/10899,0.4671177274384516,0.5895296077800394,0.46561574117659166,UBC,1
R-HSA-162599,Late Phase of HIV Life Cycle,2/126,136/10899,0.46830191206357363,0.5900754429693504,0.46604684667642965,UBC/FURIN,2
R-HSA-202733,Cell surface interactions at the vascular wall,2/126,137/10899,0.472111805193426,0.5906955155092638,0.46653658549776245,ITGB3/SDC4,2
R-HSA-109606,Intrinsic Pathway for Apoptosis,1/126,55/10899,0.47330889077111704,0.5906955155092638,0.46653658549776245,YWHAZ,1
R-HSA-1638091,Heparan sulfate/heparin (HS-GAG) metabolism,1/126,55/10899,0.47330889077111704,0.5906955155092638,0.46653658549776245,SDC4,1
R-HSA-174113,SCF-beta-TrCP mediated degradation of Emi1,1/126,55/10899,0.47330889077111704,0.5906955155092638,0.46653658549776245,UBC,1
R-HSA-4641257,Degradation of AXIN,1/126,55/10899,0.47330889077111704,0.5906955155092638,0.46653658549776245,UBC,1
R-HSA-9013409,RHOJ GTPase cycle,1/126,55/10899,0.47330889077111704,0.5906955155092638,0.46653658549776245,SLC4A7,1
R-HSA-5693538,Homology Directed Repair,2/126,138/10899,0.47590549179415975,0.5929933508863736,0.4683514363688556,UBC/HUS1,2
R-HSA-112040,G-protein mediated events,1/126,56/10899,0.4794286878720797,0.595492911360099,0.4703256115200782,PRKAR1A,1
R-HSA-5578775,Ion homeostasis,1/126,56/10899,0.4794286878720797,0.595492911360099,0.4703256115200782,ATP1A1,1
R-HSA-5663220,RHO GTPases Activate Formins,2/126,140/10899,0.4834437049914849,0.5981722118916747,0.47244174697176855,ACTB/ACTG1,2
R-HSA-6807070,PTEN Regulation,2/126,140/10899,0.4834437049914849,0.5981722118916747,0.47244174697176855,UBC/PML,2
R-HSA-4641258,Degradation of DVL,1/126,57/10899,0.4854779348819588,0.5981722118916747,0.47244174697176855,UBC,1
R-HSA-69541,Stabilization of p53,1/126,57/10899,0.4854779348819588,0.5981722118916747,0.47244174697176855,UBC,1
R-HSA-936837,Ion transport by P-type ATPases,1/126,57/10899,0.4854779348819588,0.5981722118916747,0.47244174697176855,ATP1A1,1
R-HSA-6798695,Neutrophil degranulation,6/126,482/10899,0.48615779769030376,0.5981722118916747,0.47244174697176855,NCSTN/IQGAP1/ACTR2/STBD1/SLC2A3/HSPA8,6
R-HSA-72649,Translation initiation complex formation,1/126,58/10899,0.49145743868244485,0.6028032646339363,0.4760993937236185,EIF4H,1
R-HSA-72702,Ribosomal scanning and start codon recognition,1/126,58/10899,0.49145743868244485,0.6028032646339363,0.4760993937236185,EIF4H,1
R-HSA-2142753,Arachidonic acid metabolism,1/126,59/10899,0.49736799700049783,0.6062637851636503,0.4788325436961315,PTGES3,1
R-HSA-5676590,NIK-->noncanonical NF-kB signaling,1/126,59/10899,0.49736799700049783,0.6062637851636503,0.4788325436961315,UBC,1
R-HSA-72662,"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",1/126,59/10899,0.49736799700049783,0.6062637851636503,0.4788325436961315,EIF4H,1
R-HSA-8866654,E3 ubiquitin ligases ubiquitinate target proteins,1/126,59/10899,0.49736799700049783,0.6062637851636503,0.4788325436961315,UBC,1
R-HSA-187577,SCF(Skp2)-mediated degradation of p27/p21,1/126,60/10899,0.5032103985113778,0.6105412099403889,0.48221089192744093,UBC,1
R-HSA-5607761,Dectin-1 mediated noncanonical NF-kB signaling,1/126,60/10899,0.5032103985113778,0.6105412099403889,0.48221089192744093,UBC,1
R-HSA-5610780,Degradation of GLI1 by the proteasome,1/126,60/10899,0.5032103985113778,0.6105412099403889,0.48221089192744093,UBC,1
R-HSA-3858494,Beta-catenin independent WNT signaling,2/126,146/10899,0.5056562574661623,0.6125619785662614,0.48380691300774786,UBC/CLTC,2
R-HSA-201681,TCF dependent signaling in response to WNT,3/126,233/10899,0.507626227666292,0.6140009071156228,0.4849433916072434,UBC/YWHAZ/CSNK1A1,3
R-HSA-162587,HIV Life Cycle,2/126,149/10899,0.5165310265267073,0.6228523130928806,0.49193431097781654,UBC/FURIN,2
R-HSA-453279,Mitotic G1 phase and G1/S transition,2/126,149/10899,0.5165310265267073,0.6228523130928806,0.49193431097781654,UBC/JAK2,2
R-HSA-9033241,Peroxisomal protein import,1/126,63/10899,0.5203364153096866,0.6264786595369692,0.494798431736205,UBC,1
R-HSA-8878171,Transcriptional regulation by RUNX1,3/126,239/10899,0.5247701403590559,0.6293329429867206,0.49705277025702777,UBC/CBFB/PML,3
R-HSA-174084,Autodegradation of Cdh1 by Cdh1:APC/C,1/126,64/10899,0.5259138988525971,0.6293329429867206,0.49705277025702777,UBC,1
R-HSA-1834949,Cytosolic sensors of pathogen-associated DNA ,1/126,64/10899,0.5259138988525971,0.6293329429867206,0.49705277025702777,UBC,1
R-HSA-4608870,Asymmetric localization of PCP proteins,1/126,64/10899,0.5259138988525971,0.6293329429867206,0.49705277025702777,UBC,1
R-HSA-373755,Semaphorin interactions,1/126,65/10899,0.5314270367155021,0.6320760966994987,0.4992193375206232,MET,1
R-HSA-6782210,Gap-filling DNA repair synthesis and ligation in TC-NER,1/126,65/10899,0.5314270367155021,0.6320760966994987,0.4992193375206232,UBC,1
R-HSA-8873719,RAB geranylgeranylation,1/126,65/10899,0.5314270367155021,0.6320760966994987,0.4992193375206232,RAB21,1
R-HSA-9614085,FOXO-mediated transcription,1/126,65/10899,0.5314270367155021,0.6320760966994987,0.4992193375206232,YWHAZ,1
R-HSA-8957322,Metabolism of steroids,2/126,154/10899,0.5343043086222674,0.6345368869417246,0.5011628915972857,SEC23A/SEC24A,2
R-HSA-6782135,Dual incision in TC-NER,1/126,66/10899,0.5368765653636325,0.6347109997145354,0.5013004074178498,UBC,1
R-HSA-69563,p53-Dependent G1 DNA Damage Response,1/126,66/10899,0.5368765653636325,0.6347109997145354,0.5013004074178498,UBC,1
R-HSA-69580,p53-Dependent G1/S DNA damage checkpoint,1/126,66/10899,0.5368765653636325,0.6347109997145354,0.5013004074178498,UBC,1
R-HSA-195721,Signaling by WNT,4/126,332/10899,0.537890533812708,0.6349534872826703,0.5014919262614722,UBC/YWHAZ/CSNK1A1/CLTC,4
R-HSA-9711097,Cellular response to starvation,2/126,156/10899,0.5412889594886467,0.637240452285474,0.503298191614005,ATP6V1C1/ATP6V1A,2
R-HSA-1169091,Activation of NF-kappaB in B cells,1/126,67/10899,0.5422632129002505,0.637240452285474,0.503298191614005,UBC,1
R-HSA-5625886,Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,1/126,67/10899,0.5422632129002505,0.637240452285474,0.503298191614005,PKN1,1
R-HSA-174154,APC/C:Cdc20 mediated degradation of Securin,1/126,68/10899,0.5475876991608273,0.6415766325988796,0.5067229454921088,UBC,1
R-HSA-69615,G1/S DNA Damage Checkpoints,1/126,68/10899,0.5475876991608273,0.6415766325988796,0.5067229454921088,UBC,1
R-HSA-8948751,Regulation of PTEN stability and activity,1/126,69/10899,0.5528507358061725,0.6467776864498441,0.5108307842024247,UBC,1
R-HSA-68949,Orc1 removal from chromatin,1/126,71/10899,0.5631952665725948,0.6578992325289983,0.519614680468763,UBC,1
R-HSA-174184,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,1/126,73/10899,0.5733023384664517,0.6667293862165402,0.5265888145914076,UBC,1
R-HSA-5654738,Signaling by FGFR2,1/126,73/10899,0.5733023384664517,0.6667293862165402,0.5265888145914076,UBC,1
R-HSA-69017,CDK-mediated phosphorylation and removal of Cdc6,1/126,73/10899,0.5733023384664517,0.6667293862165402,0.5265888145914076,UBC,1
R-HSA-174178,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,1/126,74/10899,0.5782685222234467,0.6705181535382654,0.5295812168072924,UBC,1
R-HSA-179419,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,1/126,74/10899,0.5782685222234467,0.6705181535382654,0.5295812168072924,UBC,1
R-HSA-5693532,DNA Double-Strand Break Repair,2/126,168/10899,0.581673296471126,0.6734712945867757,0.5319136339411477,UBC/HUS1,2
R-HSA-176409,APC/C:Cdc20 mediated degradation of mitotic proteins,1/126,76/10899,0.588029507998956,0.6793695020871198,0.5365720908204004,UBC,1
R-HSA-9010553,Regulation of expression of SLITs and ROBOs,2/126,171/10899,0.5913570429031237,0.6793695020871198,0.5365720908204004,UBC/ETF1,2
R-HSA-176814,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,1/126,77/10899,0.5928256164709261,0.6793695020871198,0.5365720908204004,UBC,1
R-HSA-3108214,SUMOylation of DNA damage response and repair proteins,1/126,77/10899,0.5928256164709261,0.6793695020871198,0.5365720908204004,PML,1
R-HSA-5693565,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,1/126,77/10899,0.5928256164709261,0.6793695020871198,0.5365720908204004,UBC,1
R-HSA-8852276,The role of GTSE1 in G2/M progression after G2 checkpoint,1/126,77/10899,0.5928256164709261,0.6793695020871198,0.5365720908204004,UBC,1
R-HSA-9009391,Extra-nuclear estrogen signaling,1/126,77/10899,0.5928256164709261,0.6793695020871198,0.5365720908204004,ESR2,1
R-HSA-5693606,DNA Double Strand Break Response,1/126,78/10899,0.5975663272752749,0.6838040333980916,0.5400745231933972,UBC,1
R-HSA-3214858,RMTs methylate histone arginines,1/126,79/10899,0.6022522752249391,0.6871628430982226,0.54272734104573,JAK2,1
R-HSA-8852135,Protein ubiquitination,1/126,79/10899,0.6022522752249391,0.6871628430982226,0.54272734104573,UBC,1
R-HSA-176408,Regulation of APC/C activators between G1/S and early anaphase,1/126,81/10899,0.6114623858110838,0.6966588865917283,0.5502274008749957,UBC,1
R-HSA-1428517,The citric acid (TCA) cycle and respiratory electron transport,2/126,178/10899,0.6133071207294354,0.6977479561921837,0.551087557756884,VDAC1/LDHA,2
R-HSA-168928,DDX58/IFIH1-mediated induction of interferon-alpha/beta,1/126,82/10899,0.6159877823157799,0.6987722675113978,0.5518965679707856,UBC,1
R-HSA-2871837,FCERI mediated NF-kB activation,1/126,82/10899,0.6159877823157799,0.6987722675113978,0.5518965679707856,UBC,1
R-HSA-1168372,Downstream signaling events of B Cell Receptor (BCR),1/126,83/10899,0.6204608838622541,0.7018181467318003,0.554302230539766,UBC,1
R-HSA-69202,Cyclin E associated events during G1/S transition ,1/126,83/10899,0.6204608838622541,0.7018181467318003,0.554302230539766,UBC,1
R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,2/126,182/10899,0.6254445870005396,0.7064374112164369,0.5579505668206253,NRIP1/PML,2
R-HSA-216083,Integrin cell surface interactions,1/126,85/10899,0.6292525934035401,0.7086991188260817,0.5597368836588161,ITGB3,1
R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,1/126,85/10899,0.6292525934035401,0.7086991188260817,0.5597368836588161,UBC,1
R-HSA-190236,Signaling by FGFR,1/126,87/10899,0.63784222935592,0.7173440545048672,0.5665647309465193,UBC,1
R-HSA-174143,APC/C-mediated degradation of cell cycle proteins,1/126,88/10899,0.6420627139194748,0.7179761117190708,0.5670639353704764,UBC,1
R-HSA-2565942,Regulation of PLK1 Activity at G2/M Transition,1/126,88/10899,0.6420627139194748,0.7179761117190708,0.5670639353704764,UBC,1
R-HSA-418346,Platelet homeostasis,1/126,88/10899,0.6420627139194748,0.7179761117190708,0.5670639353704764,PAFAH2,1
R-HSA-453276,Regulation of mitotic cell cycle,1/126,88/10899,0.6420627139194748,0.7179761117190708,0.5670639353704764,UBC,1
R-HSA-2990846,SUMOylation,2/126,188/10899,0.6431001951599782,0.7181133046949969,0.5671722916062397,NRIP1/PML,2
R-HSA-5687128,MAPK6/MAPK4 signaling,1/126,89/10899,0.6462343999842373,0.7205880738460599,0.5691268863497545,UBC,1
R-HSA-428157,Sphingolipid metabolism,1/126,90/10899,0.6503578473109703,0.7231316007636143,0.5711357865903706,ARSJ,1
R-HSA-8876198,RAB GEFs exchange GTP for GDP on RABs,1/126,90/10899,0.6503578473109703,0.7231316007636143,0.5711357865903706,RAB21,1
R-HSA-390466,Chaperonin-mediated protein folding,1/126,91/10899,0.6544336092906926,0.7256078860073358,0.5730915787573863,ACTB,1
R-HSA-5250924,B-WICH complex positively regulates rRNA expression,1/126,91/10899,0.6544336092906926,0.7256078860073358,0.5730915787573863,ACTB,1
R-HSA-111885,Opioid Signalling,1/126,92/10899,0.6584622330165784,0.7269941672545908,0.5741864760482118,PRKAR1A,1
R-HSA-69052,Switching of origins to a post-replicative state,1/126,92/10899,0.6584622330165784,0.7269941672545908,0.5741864760482118,UBC,1
R-HSA-73884,Base Excision Repair,1/126,92/10899,0.6584622330165784,0.7269941672545908,0.5741864760482118,PNKP,1
R-HSA-9711123,Cellular response to chemical stress,2/126,194/10899,0.6600998938150596,0.7277786750629519,0.5748060873108666,UBC/PRDX1,2
R-HSA-72764,Eukaryotic Translation Termination,1/126,93/10899,0.6624442593550546,0.7289479857021987,0.5757296192807174,ETF1,1
R-HSA-69620,Cell Cycle Checkpoints,3/126,293/10899,0.6630176583329551,0.7289479857021987,0.5757296192807174,UBC/YWHAZ/HUS1,3
R-HSA-1852241,Organelle biogenesis and maintenance,3/126,296/10899,0.6697877196411695,0.7348637741743963,0.5804019617683132,HSPA9/PKD2/PRKAG1,3
R-HSA-975956,Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),1/126,95/10899,0.6702706526227615,0.7348637741743963,0.5804019617683132,ETF1,1
R-HSA-391251,Protein folding,1/126,97/10899,0.6779169941420717,0.7411766579408444,0.5853879336602849,ACTB,1
R-HSA-8936459,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,1/126,97/10899,0.6779169941420717,0.7411766579408444,0.5853879336602849,CBFB,1
R-HSA-202424,Downstream TCR signaling,1/126,98/10899,0.681673933480907,0.7432139413646,0.5869969982752256,UBC,1
R-HSA-5619102,SLC transporter disorders,1/126,98/10899,0.681673933480907,0.7432139413646,0.5869969982752256,SLC33A1,1
R-HSA-6811434,COPI-dependent Golgi-to-ER retrograde traffic,1/126,99/10899,0.6853873937513826,0.7462262192716163,0.5893761222272639,KDELR1,1
R-HSA-5607764,CLEC7A (Dectin-1) signaling,1/126,101/10899,0.6926858682178201,0.7531279869127268,0.5948271998546377,UBC,1
R-HSA-9645723,Diseases of programmed cell death,1/126,105/10899,0.7067826559332633,0.7673919569953135,0.6060930106205025,PRDX1,1
R-HSA-211945,Phase I - Functionalization of compounds,1/126,106/10899,0.7102054264865716,0.7689810479889085,0.6073480888574818,PTGES3,1
R-HSA-5250913,Positive epigenetic regulation of rRNA expression,1/126,106/10899,0.7102054264865716,0.7689810479889085,0.6073480888574818,ACTB,1
R-HSA-6805567,Keratinization,2/126,214/10899,0.7121386066196809,0.7700121297471756,0.608162446424521,PERP/FURIN,2
R-HSA-156580,Phase II - Conjugation of compounds,1/126,109/10899,0.7202377082989325,0.7766299464487115,0.6133892570677723,SLC35D1,1
R-HSA-2672351,Stimuli-sensing channels,1/126,109/10899,0.7202377082989325,0.7766299464487115,0.6133892570677723,UBC,1
R-HSA-376176,Signaling by ROBO receptors,2/126,218/10899,0.7217169358682611,0.7771574686647257,0.613805898818,UBC/ETF1,2
R-HSA-156827,L13a-mediated translational silencing of Ceruloplasmin expression,1/126,111/10899,0.7267336948482948,0.7814876033642623,0.61722587781636,EIF4H,1
R-HSA-1799339,SRP-dependent cotranslational protein targeting to membrane,1/126,112/10899,0.7299253480230367,0.7817072281010692,0.6173993393919273,SSR1,1
R-HSA-72706,GTP hydrolysis and joining of the 60S ribosomal subunit,1/126,112/10899,0.7299253480230367,0.7817072281010692,0.6173993393919273,EIF4H,1
R-HSA-983705,Signaling by the B Cell Receptor (BCR),1/126,112/10899,0.7299253480230367,0.7817072281010692,0.6173993393919273,UBC,1
R-HSA-211859,Biological oxidations,2/126,222/10899,0.7310278428960735,0.7818213306177353,0.6174894585770648,SLC35D1/PTGES3,2
R-HSA-9020702,Interleukin-1 signaling,1/126,115/10899,0.73928009377569,0.7874285937773632,0.6219181250216117,UBC,1
R-HSA-927802,Nonsense-Mediated Decay (NMD),1/126,115/10899,0.73928009377569,0.7874285937773632,0.6219181250216117,ETF1,1
R-HSA-975957,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),1/126,115/10899,0.73928009377569,0.7874285937773632,0.6219181250216117,ETF1,1
R-HSA-1989781,PPARA activates gene expression,1/126,117/10899,0.7453372711130494,0.7928045498966717,0.6261641031031038,NPAS2,1
R-HSA-2408522,Selenoamino acid metabolism,1/126,118/10899,0.7483132963254175,0.7937214409644017,0.6268882718444956,RARS1,1
R-HSA-162906,HIV Infection,2/126,231/10899,0.7510221613266065,0.7937214409644017,0.6268882718444956,UBC/FURIN,2
R-HSA-400206,Regulation of lipid metabolism by PPARalpha,1/126,119/10899,0.7512548160975164,0.7937214409644017,0.6268882718444956,NPAS2,1
R-HSA-72613,Eukaryotic Translation Initiation,1/126,119/10899,0.7512548160975164,0.7937214409644017,0.6268882718444956,EIF4H,1
R-HSA-72737,Cap-dependent Translation Initiation,1/126,119/10899,0.7512548160975164,0.7937214409644017,0.6268882718444956,EIF4H,1
R-HSA-202403,TCR signaling,1/126,120/10899,0.7541622273379351,0.7957222425541386,0.6284685227816127,UBC,1
R-HSA-69239,Synthesis of DNA,1/126,121/10899,0.7570359224261084,0.7976821464489866,0.6300164723546138,UBC,1
R-HSA-1630316,Glycosaminoglycan metabolism,1/126,124/10899,0.7654585677067737,0.803322159959649,0.6344710053184488,SDC4,1
R-HSA-196849,Metabolism of water-soluble vitamins and cofactors,1/126,124/10899,0.7654585677067737,0.803322159959649,0.6344710053184488,SLC2A3,1
R-HSA-9007101,Rab regulation of trafficking,1/126,124/10899,0.7654585677067737,0.803322159959649,0.6344710053184488,RAB21,1
R-HSA-1483206,Glycerophospholipid biosynthesis,1/126,129/10899,0.7788573326385844,0.8162923980257526,0.6447150150012315,PCYT1A,1
R-HSA-162909,Host Interactions of HIV factors,1/126,130/10899,0.7814445170478267,0.817911927843392,0.6459941340928701,UBC,1
R-HSA-69206,G1/S Transition,1/126,131/10899,0.7840016709945232,0.8194957546347547,0.6472450546159845,UBC,1
R-HSA-8856688,Golgi-to-ER retrograde transport,1/126,133/10899,0.7890272668251073,0.8236521335873793,0.6505277997760193,KDELR1,1
R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,1/126,134/10899,0.7914963885397679,0.8240380172463101,0.6508325741308436,PVR,1
R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,1/126,134/10899,0.7914963885397679,0.8240380172463101,0.6508325741308436,UBC,1
R-HSA-9609690,HCMV Early Events,1/126,135/10899,0.7939368395424609,0.8254839987295784,0.6519746232004314,PML,1
R-HSA-3214847,HATs acetylate histones,1/126,142/10899,0.8102444901797863,0.8402139032907955,0.6636084331723482,ACTB,1
R-HSA-5621481,C-type lectin receptors (CLRs),1/126,142/10899,0.8102444901797863,0.8402139032907955,0.6636084331723482,UBC,1
R-HSA-68867,Assembly of the pre-replicative complex,1/126,143/10899,0.8124671539556854,0.841407276853843,0.6645509702539908,UBC,1
R-HSA-212165,Epigenetic regulation of gene expression,1/126,149/10899,0.8252710009471842,0.8535411538123051,0.6741344144759608,ACTB,1
R-HSA-3247509,Chromatin modifying enzymes,2/126,274/10899,0.8298519043138122,0.8560233178532753,0.6760948497694659,ACTB/JAK2,2
R-HSA-4839726,Chromatin organization,2/126,274/10899,0.8298519043138122,0.8560233178532753,0.6760948497694659,ACTB/JAK2,2
R-HSA-9013148,CDC42 GTPase cycle,1/126,155/10899,0.8372071275928525,0.8624771590031355,0.6811921510598014,IQGAP1,1
R-HSA-168255,Influenza Infection,1/126,156/10899,0.8391162770644927,0.8633109796797206,0.6818507100655118,CLTC,1
R-HSA-418555,G alpha (s) signalling events,1/126,157/10899,0.8410032126588214,0.8641197931114853,0.6824895181262687,PRKAR1A,1
R-HSA-69002,DNA Replication Pre-Initiation,1/126,160/10899,0.8465332857822897,0.8675308477011716,0.6851835994582501,UBC,1
R-HSA-9609646,HCMV Infection,1/126,160/10899,0.8465332857822897,0.8675308477011716,0.6851835994582501,PML,1
R-HSA-69242,S Phase,1/126,163/10899,0.8518724909257511,0.8718642834116227,0.6886061856244665,UBC,1
R-HSA-8978868,Fatty acid metabolism,1/126,177/10899,0.8744512762978744,0.8938076196534264,0.7059372282613049,PTGES3,1
R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,2/126,309/10899,0.8767112001519093,0.8949522654346539,0.7068412797063508,UBC/TRIP12,2
R-HSA-72163,mRNA Splicing - Major Pathway,1/126,185/10899,0.8857837273258127,0.9030392544815102,0.7132284557688362,HSPA8,1
R-HSA-69306,DNA Replication,1/126,188/10899,0.8897665479945011,0.9059231390086684,0.7155061734845534,UBC,1
R-HSA-2467813,Separation of Sister Chromatids,1/126,191/10899,0.8936115482616331,0.9086594111209612,0.7176673055987209,UBC,1
R-HSA-72172,mRNA Splicing,1/126,193/10899,0.8961006584965745,0.9100116648380479,0.7187353276427895,HSPA8,1
R-HSA-69275,G2/M Transition,1/126,196/10899,0.899726394382669,0.9125132036051617,0.7207110652677711,UBC,1
R-HSA-453274,Mitotic G2-G2/M phases,1/126,198/10899,0.9020735285693537,0.9137131870025067,0.7216588228554831,UBC,1
R-HSA-5617833,Cilium Assembly,1/126,201/10899,0.9054924094680115,0.9159399303184945,0.7234175245827601,PKD2,1
R-HSA-6811442,Intra-Golgi and retrograde Golgi-to-ER traffic,1/126,202/10899,0.9066055106464589,0.9159399303184945,0.7234175245827601,KDELR1,1
R-HSA-1483257,Phospholipid metabolism,1/126,212/10899,0.9170454460265242,0.9252964975974568,0.7308074248540425,PCYT1A,1
R-HSA-416476,G alpha (q) signalling events,1/126,216/10899,0.9208894769632963,0.9279823355791882,0.7329287236421614,RPS6KA3,1
R-HSA-68882,Mitotic Anaphase,1/126,236/10899,0.93761390273433,0.9431569873942303,0.7449137989610483,UBC,1
R-HSA-2555396,Mitotic Metaphase and Anaphase,1/126,237/10899,0.9383510919170623,0.9431569873942303,0.7449137989610483,UBC,1
R-HSA-72203,Processing of Capped Intron-Containing Pre-mRNA,1/126,246/10899,0.9446086950329681,0.9482325135561124,0.7489224947831717,HSPA8,1
R-HSA-418594,G alpha (i) signalling events,1/126,318/10899,0.9765499997724503,0.9790443803593532,0.7732579819398713,PRKAR1A,1
R-HSA-71291,Metabolism of amino acids and derivatives,1/126,374/10899,0.988031810307674,0.9892920549636786,0.7813516867229054,RARS1,1
R-HSA-68886,M Phase,1/126,418/10899,0.9929626196671469,0.9929626196671469,0.7842507314568549,UBC,1
HALLMARK_MTORC1_SIGNALING,HALLMARK_MTORC1_SIGNALING,15/78,200/4383,1.5706794440645046e-6,6.596853665070918e-5,5.9520484196128585e-5,HSP90B1/SSR1/HSPA9/ETF1/HSPA5/ACTR2/HSPA4/LDHA/GBE1/ACTR3/PPP1R15A/SLC2A3/PRDX1/MAP2K3/LDLR,15
HALLMARK_PI3K_AKT_MTOR_SIGNALING,HALLMARK_PI3K_AKT_MTOR_SIGNALING,9/78,105/4383,8.484476458335335e-5,0.0017817400562504203,0.0016075850131582739,HSP90B1/CLTC/RPS6KA3/RALB/ACTR2/DUSP3/ACTR3/PRKAG1/MAP2K3,9
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,6/78,113/4383,0.014635087938285624,0.17291320920395253,0.15601191807875414,HSP90B1/PDIA6/SSR1/HSPA9/YWHAZ/HSPA5,6
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,8/78,200/4383,0.024701887029136074,0.17291320920395253,0.15601191807875414,LAMC1/CALU/ITGB3/PDLIM4/TPM1/PVR/SDC4/LOXL1,8
HALLMARK_HYPOXIA,HALLMARK_HYPOXIA,8/78,200/4383,0.024701887029136074,0.17291320920395253,0.15601191807875414,HSPA5/LDHA/STBD1/GBE1/AKAP12/PPP1R15A/SLC2A3/SDC4,8
HALLMARK_TNFA_SIGNALING_VIA_NFKB,HALLMARK_TNFA_SIGNALING_VIA_NFKB,8/78,200/4383,0.024701887029136074,0.17291320920395253,0.15601191807875414,DUSP5/BIRC3/PPP1R15A/SLC2A3/MAP2K3/TRIP10/LDLR/SDC4,8
HALLMARK_TGF_BETA_SIGNALING,HALLMARK_TGF_BETA_SIGNALING,3/78,54/4383,0.07045858135474259,0.42275148812845553,0.3814299141008621,WWTR1/PPP1R15A/FURIN,3
HALLMARK_PROTEIN_SECRETION,HALLMARK_PROTEIN_SECRETION,4/78,96/4383,0.09051716008144012,0.4648204209688102,0.4193868459868964,CLTC/RPS6KA3/ATP1A1/LMAN1,4
HALLMARK_ANDROGEN_RESPONSE,HALLMARK_ANDROGEN_RESPONSE,4/78,100/4383,0.1014382018527429,0.4648204209688102,0.4193868459868964,RPS6KA3/LMAN1/AKAP12/PGM3,4
HALLMARK_UV_RESPONSE_DN,HALLMARK_UV_RESPONSE_DN,5/78,144/4383,0.11216394648973116,0.4648204209688102,0.4193868459868964,LAMC1/RASA2/MET/ITGB3/LDLR,5
HALLMARK_HEDGEHOG_SIGNALING,HALLMARK_HEDGEHOG_SIGNALING,2/78,36/4383,0.13382406051809467,0.4648204209688102,0.4193868459868964,UNC5C/PML,2
HALLMARK_APICAL_JUNCTION,HALLMARK_APICAL_JUNCTION,6/78,200/4383,0.14387298744272697,0.4648204209688102,0.4193868459868964,CTNND1/ACTB/ACTG1/ADAM9/CTNNA1/ACTN4,6
HALLMARK_MYC_TARGETS_V1,HALLMARK_MYC_TARGETS_V1,6/78,200/4383,0.14387298744272697,0.4648204209688102,0.4193868459868964,ETF1/VDAC1/LDHA/PRPS2/EIF4H/PTGES3,6
HALLMARK_APICAL_SURFACE,HALLMARK_APICAL_SURFACE,2/78,44/4383,0.18397565638460756,0.5519269691538227,0.4979792202891633,FLOT2/EPHB4,2
HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,2/78,49/4383,0.2165533614304263,0.6038366605128322,0.5448150320416532,PRDX1/SBNO2,2
HALLMARK_COAGULATION,HALLMARK_COAGULATION,4/78,138/4383,0.230033013528698,0.6038366605128322,0.5448150320416532,ADAM9/WDR1/ITGB3/FURIN,4
HALLMARK_ADIPOGENESIS,HALLMARK_ADIPOGENESIS,5/78,200/4383,0.2829024726945661,0.6601057696206543,0.5955841530411918,ARAF/UBC/APLP2/GBE1/CD151,5
HALLMARK_P53_PATHWAY,HALLMARK_P53_PATHWAY,5/78,200/4383,0.2829024726945661,0.6601057696206543,0.5955841530411918,PTPN14/PPP1R15A/PERP/SLC35D1/EPHA2,5
HALLMARK_CHOLESTEROL_HOMEOSTASIS,HALLMARK_CHOLESTEROL_HOMEOSTASIS,2/78,74/4383,0.3810604368500835,0.8398013255172878,0.7577154816697333,ACTG1/LDLR,2
HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,4/78,200/4383,0.47988647172416443,0.8398013255172878,0.7577154816697333,ADAM9/HSPA5/DUSP5/JAK2,4
HALLMARK_GLYCOLYSIS,HALLMARK_GLYCOLYSIS,4/78,200/4383,0.47988647172416443,0.8398013255172878,0.7577154816697333,RARS1/HSPA5/LDHA/MET,4
HALLMARK_INFLAMMATORY_RESPONSE,HALLMARK_INFLAMMATORY_RESPONSE,4/78,200/4383,0.47988647172416443,0.8398013255172878,0.7577154816697333,MET/ITGB3/PVR/LDLR,4
HALLMARK_OXIDATIVE_PHOSPHORYLATION,HALLMARK_OXIDATIVE_PHOSPHORYLATION,4/78,200/4383,0.47988647172416443,0.8398013255172878,0.7577154816697333,HSPA9/ATP6V1C1/VDAC1/LDHA,4
HALLMARK_XENOBIOTIC_METABOLISM,HALLMARK_XENOBIOTIC_METABOLISM,4/78,200/4383,0.47988647172416443,0.8398013255172878,0.7577154816697333,SLC35D1/PTGES3/SLC12A4/EPHA2,4
HALLMARK_WNT_BETA_CATENIN_SIGNALING,HALLMARK_WNT_BETA_CATENIN_SIGNALING,1/78,42/4383,0.5312782402056538,0.8925474435454984,0.8053059641012016,NCSTN,1
HALLMARK_PEROXISOME,HALLMARK_PEROXISOME,2/78,104/4383,0.5572615292146124,0.9001917010389893,0.8122030385314188,ESR2/PRDX1,2
HALLMARK_MITOTIC_SPINDLE,HALLMARK_MITOTIC_SPINDLE,3/78,199/4383,0.6957284055941965,0.9460525170111598,0.8535812183559336,PKD2/RASA2/ACTN4,3
HALLMARK_ESTROGEN_RESPONSE_LATE,HALLMARK_ESTROGEN_RESPONSE_LATE,3/78,200/4383,0.6990153385972935,0.9460525170111598,0.8535812183559336,NRIP1/PERP/JAK2,3
HALLMARK_G2M_CHECKPOINT,HALLMARK_G2M_CHECKPOINT,3/78,200/4383,0.6990153385972935,0.9460525170111598,0.8535812183559336,HUS1/HSPA8/PML,3
HALLMARK_KRAS_SIGNALING_UP,HALLMARK_KRAS_SIGNALING_UP,3/78,200/4383,0.6990153385972935,0.9460525170111598,0.8535812183559336,AKAP12/BIRC3/PPP1R15A,3
HALLMARK_UV_RESPONSE_UP,HALLMARK_UV_RESPONSE_UP,2/78,158/4383,0.7792231504686155,0.9460525170111598,0.8535812183559336,ATP6V1C1/FURIN,2
HALLMARK_APOPTOSIS,HALLMARK_APOPTOSIS,2/78,161/4383,0.78814825001451,0.9460525170111598,0.8535812183559336,ETF1/BIRC3,2
HALLMARK_IL6_JAK_STAT3_SIGNALING,HALLMARK_IL6_JAK_STAT3_SIGNALING,1/78,87/4383,0.7935856367794432,0.9460525170111598,0.8535812183559336,ITGB3,1
HALLMARK_IL2_STAT5_SIGNALING,HALLMARK_IL2_STAT5_SIGNALING,2/78,199/4383,0.876682717238375,0.9460525170111598,0.8535812183559336,SLC2A3/FURIN,2
HALLMARK_ALLOGRAFT_REJECTION,HALLMARK_ALLOGRAFT_REJECTION,2/78,200/4383,0.8784773372246484,0.9460525170111598,0.8535812183559336,RARS1/JAK2,2
HALLMARK_ESTROGEN_RESPONSE_EARLY,HALLMARK_ESTROGEN_RESPONSE_EARLY,2/78,200/4383,0.8784773372246484,0.9460525170111598,0.8535812183559336,NRIP1/JAK2,2
HALLMARK_HEME_METABOLISM,HALLMARK_HEME_METABOLISM,2/78,200/4383,0.8784773372246484,0.9460525170111598,0.8535812183559336,BCAM/MAP2K3,2
HALLMARK_INTERFERON_GAMMA_RESPONSE,HALLMARK_INTERFERON_GAMMA_RESPONSE,2/78,200/4383,0.8784773372246484,0.9460525170111598,0.8535812183559336,JAK2/PML,2
HALLMARK_MYOGENESIS,HALLMARK_MYOGENESIS,2/78,200/4383,0.8784773372246484,0.9460525170111598,0.8535812183559336,WWTR1/FLII,2
HALLMARK_DNA_REPAIR,HALLMARK_DNA_REPAIR,1/78,150/4383,0.9354765082756067,0.9674379292310384,0.8728763271257489,BCAM,1
HALLMARK_FATTY_ACID_METABOLISM,HALLMARK_FATTY_ACID_METABOLISM,1/78,158/4383,0.9444036928207756,0.9674379292310384,0.8728763271257489,LDHA,1
HALLMARK_E2F_TARGETS,HALLMARK_E2F_TARGETS,1/78,200/4383,0.9746791812972905,0.9746791812972905,0.879409787636653,HUS1,1
TIEN_INTESTINE_PROBIOTICS_24HR_DN,TIEN_INTESTINE_PROBIOTICS_24HR_DN,18/151,215/21728,1.1498006591254676e-14,3.194146231050549e-11,2.3480139775825336e-11,HSP90B1/PDIA6/UBC/ACTG1/HSPA9/PDIA3/ARIH1/CSNK1A1/SEL1L/HSPA5/KDELR1/ACBD3/TMCO3/PPP1R15A/DNAJC10/HSPA8/EPHB4/GARS1,18
ENK_UV_RESPONSE_KERATINOCYTE_DN,ENK_UV_RESPONSE_KERATINOCYTE_DN,23/151,481/21728,3.251003117487646e-13,4.51564333019034e-10,3.319445288382123e-10,TM9SF2/RARS1/PRKAR1A/TRIP12/WWTR1/CSNK1A1/CLTC/SEC23A/ATP6V1A/PKD2/ACTR2/DUSP5/ACBD3/GBE1/ACTR3/BIRC3/SLC2A3/COPS2/EIF4H/CTNNA1/FNTB/SCFD1/PGRMC2,23
SENESE_HDAC3_TARGETS_UP,SENESE_HDAC3_TARGETS_UP,22/151,495/21728,4.721194938038678e-12,4.371826512623816e-9,3.2137256771210653e-9,SEPTIN11/YWHAZ/ATP13A3/IQGAP1/PTPN12/LMAN1/ATP6V1A/ACTR2/HSPA4/CBFB/ITPRID2/BIRC3/MET/ITGB3/PDLIM4/SLC2A3/SCYL2/PPFIBP1/ZBTB38/SLC12A4/NPAS2/ARSJ,22
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,20/151,407/21728,7.882200372097228e-12,5.474188158421525e-9,4.024070716281217e-9,RAB21/LAMC1/FNDC3B/CALU/ADAM9/APLP2/IQGAP1/LMAN1/PKD2/ACTR2/WDR1/PRPS2/SLC33A1/MCFD2/SEC24A/ACTN4/CD151/RRBP1/ARSJ/LOXL1,20
MILI_PSEUDOPODIA_CHEMOTAXIS_DN,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,20/151,428/21728,1.953076075526287e-11,1.085129067562405e-8,7.976773866359994e-9,TM9SF2/PDIA6/DOLK/PDIA3/LAMC1/ATP1A1/SEL1L/HSPA5/APLP2/SLC4A7/LRP12/HSPA8/CTNNA1/SCFD1/SLC12A4/PVR/RRBP1/LDLR/SBNO2/EPHB4,20
BAELDE_DIABETIC_NEPHROPATHY_DN,BAELDE_DIABETIC_NEPHROPATHY_DN,20/151,437/21728,2.8363768686966742e-11,1.3132424902065602e-8,9.653633553107979e-9,HSP90B1/PRKAR1A/RAB21/ACTG1/SEPTIN11/PDIA3/YWHAZ/CALU/ATP13A3/HSPA5/ACBD3/ACTR3/PTPN14/BIRC3/SLC2A3/CTNNA1/BCAM/SDC4/SNX19/LOXL1,20
GRUETZMANN_PANCREATIC_CANCER_UP,GRUETZMANN_PANCREATIC_CANCER_UP,18/151,359/21728,6.783825185774337e-11,2.6922094808687297e-8,1.979040730887551e-8,YWHAZ/CSNK1A1/VDAC1/SEC23A/ADAM9/APLP2/IQGAP1/PTPN12/RALB/DUSP5/CBFB/LDHA/AKAP12/BIRC3/FLOT2/PTPN9/PRDX1/TRIP10,18
IBRAHIM_NRF1_UP,IBRAHIM_NRF1_UP,19/151,419/21728,1.0774068124378578e-10,3.741295156190461e-8,2.7502226528019e-8,PDIA6/RARS1/SSR1/HSPA9/PDIA3/CALU/SEC23A/EDEM3/HSPA5/LMAN1/HSPA4/CBFB/ACBD3/PCYT1A/DNAJC10/EIF4H/HSPA8/PRDX1/SCFD1,19
SENESE_HDAC1_TARGETS_UP,SENESE_HDAC1_TARGETS_UP,19/151,451/21728,3.7254468441352576e-10,1.149921259223083e-7,8.453060675581754e-8,YWHAZ/ATP13A3/IQGAP1/PTPN12/LMAN1/ACTR2/DUSP5/CBFB/ITPRID2/DUSP3/BIRC3/MET/PDLIM4/CTNNA1/SCYL2/PPFIBP1/ZBTB38/NPAS2/SNX19,19
WP_VEGFAVEGFR2_SIGNALING_PATHWAY,WP_VEGFAVEGFR2_SIGNALING_PATHWAY,18/151,438/21728,1.6560093763692554e-9,4.6003940475537916e-7,3.381745463322479e-7,PDIA6/CTNND1/ACTG1/CLTC/CALU/ADAM9/IQGAP1/LMAN1/DUSP5/LDHA/PTPN14/ITGB3/CRK/PTPN9/CTNNA1/EPHA2/MAP2K3/FLII,18
REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,15/151,305/21728,3.729409350799443e-9,9.418453796837139e-7,6.923496785216192e-7,NUS1/UBC/DOLK/PDIA3/SEC23A/EDEM3/SEL1L/LMAN1/KDELR1/TMEM115/MCFD2/SEC24A/SCFD1/PGM3/MGAT4B,15
ZAMORA_NOS2_TARGETS_DN,ZAMORA_NOS2_TARGETS_DN,9/151,81/21728,5.068006798218643e-9,1.173243573787616e-6,8.624502796968569e-7,RARS1/UBC/ACTB/PDIA3/VDAC1/ATP1A1/PCYT1A/ACTN4/CD151,9
REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,17/151,432/21728,9.216086273102554e-9,1.969406743590684e-6,1.4477090987707656e-6,ARAF/PRKAR1A/UBC/ACTB/NCSTN/ACTG1/CSNK1A1/CLTC/SEL1L/IQGAP1/PTPN12/ESR2/MET/ITGB3/JAK2/PPFIBP1/RRBP1,17
REACTOME_EPH_EPHRIN_SIGNALING,REACTOME_EPH_EPHRIN_SIGNALING,9/151,92/21728,1.5817273228835678e-8,3.1385989306932508e-6,2.3071812078151293e-6,ACTB/NCSTN/ACTG1/CLTC/ACTR2/ACTR3/EFNB2/EPHA2/EPHB4,9
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,9/151,101/21728,3.6058335776181376e-8,6.451907360537623e-6,4.742791208913262e-6,HSP90B1/SSR1/VDAC1/DUSP5/LDHA/DNAJC10/SORT1/LDLR/GARS1,9
BORCZUK_MALIGNANT_MESOTHELIOMA_UP,BORCZUK_MALIGNANT_MESOTHELIOMA_UP,14/151,311/21728,3.847320071243295e-8,6.451907360537623e-6,4.742791208913262e-6,RARS1/SSR1/LAMC1/YWHAZ/CALU/RPS6KA3/VDAC1/HSPA4/IARS2/ACBD3/PRPS2/HSPA8/PTGES3/GARS1,14
DAUER_STAT3_TARGETS_UP,DAUER_STAT3_TARGETS_UP,7/151,48/21728,3.948251444533463e-8,6.451907360537623e-6,4.742791208913262e-6,DUSP5/FEM1C/AKAP12/EFNB2/SLC4A7/SLC2A3/LDLR,7
THUM_SYSTOLIC_HEART_FAILURE_UP,THUM_SYSTOLIC_HEART_FAILURE_UP,16/151,430/21728,5.603499070925575e-8,8.648066899461805e-6,6.357186080465273e-6,HSP90B1/PDIA6/ACTB/ACTG1/YWHAZ/CALU/ADAM9/RALB/LMAN1/ACTR2/HSPA4/WDR1/CTNNA1/JAK2/PPFIBP1/LOXL1,16
REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS,REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS,7/151,51/21728,6.10109888411364e-8,8.920448789509313e-6,6.557413759102749e-6,ACTB/NCSTN/ACTG1/CLTC/EFNB2/EPHA2/EPHB4,7
REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,10/151,145/21728,7.20268199845775e-8,1.0004525295857814e-5,7.354317408951597e-6,UBC/ACTB/ACTG1/CLTC/ACTR2/ACTR3/COPS2/HSPA8/TRIP10/LDLR,10
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,13/151,285/21728,1.0331343001967919e-7,1.3666890885460417e-5,1.0046519009432462e-5,HSP90B1/PDIA6/SSR1/PDIA3/FNDC3B/SEL1L/LMAN1/KDELR1/HIVEP3/MCFD2/SEC24A/PVR/RRBP1,13
PHONG_TNF_RESPONSE_NOT_VIA_P38,PHONG_TNF_RESPONSE_NOT_VIA_P38,14/151,341/21728,1.2003445922088734e-7,1.515707853252841e-5,1.1141954587967533e-5,HSP90B1/SEL1L/HSPA5/BIRC3/PDLIM4/DNAJC10/EPHA2/MAP2K3/TRIP10/LDLR/SBNO2/SDC4/ARSJ/MGAT4B,14
YOSHIMURA_MAPK8_TARGETS_DN,YOSHIMURA_MAPK8_TARGETS_DN,14/151,357/21728,2.0999755847835673e-7,2.5364052932733696e-5,1.8645092148650437e-5,ACTG1/HSPA9/YWHAZ/SEL1L/APLP2/MET/PDLIM4/HSPA8/JAK2/SCFD1/ACTN4/LAMA5/SLC12A4/LDLR,14
PID_PDGFRB_PATHWAY,PID_PDGFRB_PATHWAY,9/151,129/21728,3.000536121005796e-7,3.473120560064209e-5,2.5530877520838794e-5,YWHAZ/RPS6KA3/IQGAP1/ACTR2/ACTR3/ITGB3/CRK/JAK2/ACTN4,9
KIM_WT1_TARGETS_UP,KIM_WT1_TARGETS_UP,11/151,216/21728,3.455291995871906e-7,3.839520465812862e-5,2.8224279882069465e-5,ACTB/ACTG1/WWTR1/ATP13A3/DUSP5/CBFB/AKAP12/PDLIM4/EPHA2/MAP2K3/SDC4,11
REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING,REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING,6/151,42/21728,4.3510466533202496e-7,4.6489260011244816e-5,3.417421258073394e-5,ACTB/ACTG1/ACTR2/ACTR3/EFNB2/EPHB4,6
WANG_TUMOR_INVASIVENESS_UP,WANG_TUMOR_INVASIVENESS_UP,14/151,384/21728,5.057170340977376e-7,5.203266373050055e-5,3.8249163592577425e-5,HSP90B1/PRKAR1A/ACTG1/ARIH1/LAMC1/ATP6V1C1/ATP1A1/HSPA5/HSPA4/EGLN1/EIF4H/HSPA8/TPM1/SLC12A4,14
REACTOME_RHO_GTPASE_CYCLE,REACTOME_RHO_GTPASE_CYCLE,15/151,450/21728,6.049270674454284e-7,6.001740690583572e-5,4.411874100917787e-5,ACTB/ACTG1/PKN1/CLTC/IQGAP1/LMAN1/STBD1/AKAP12/SLC4A7/COPS2/FLOT2/SCFD1/EPHA2/TRIP10/PGRMC2,15
REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS,REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS,6/151,45/21728,6.640858998792732e-7,6.361484930567657e-5,4.676321763215208e-5,ARAF/ACTB/ACTG1/IQGAP1/ITGB3/JAK2,6
DAZARD_RESPONSE_TO_UV_SCC_UP,DAZARD_RESPONSE_TO_UV_SCC_UP,8/151,105/21728,7.125178256401186e-7,6.392289393045012e-5,4.69896609545198e-5,PDIA6/PRKAR1A/SSR1/YWHAZ/RALB/PTGES3/SCFD1/RECQL,8
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,15/151,456/21728,7.143262539452716e-7,6.392289393045012e-5,4.69896609545198e-5,LAMC1/ETF1/WWTR1/FNDC3B/ATP1A1/RALB/WDR1/ITPRID2/BIRC3/MET/PERP/CRK/ZBTB38/EPHA2/TRIP10,15
KEGG_ADHERENS_JUNCTION,KEGG_ADHERENS_JUNCTION,7/151,73/21728,7.557670407411694e-7,6.392289393045012e-5,4.69896609545198e-5,CTNND1/ACTB/ACTG1/IQGAP1/MET/CTNNA1/ACTN4,7
MARCHINI_TRABECTEDIN_RESISTANCE_DN,MARCHINI_TRABECTEDIN_RESISTANCE_DN,6/151,46/21728,7.593432324351525e-7,6.392289393045012e-5,4.69896609545198e-5,HSP90B1/ACTG1/PKN1/HSPA5/BCAM/LOXL1,6
OSMAN_BLADDER_CANCER_UP,OSMAN_BLADDER_CANCER_UP,14/151,401/21728,8.471271227153529e-7,6.921526902656618e-5,5.088008105473017e-5,HSP90B1/SDF4/PDIA3/ARIH1/CSNK1A1/EDEM3/IQGAP1/LDHA/GBE1/ACTR3/RASA2/NRIP1/SEC24A/RECQL,14
BLUM_RESPONSE_TO_SALIRASIB_UP,BLUM_RESPONSE_TO_SALIRASIB_UP,11/151,245/21728,1.2001541167787593e-6,9.525794675461123e-5,7.002402967070054e-5,HSP90B1/HSPA9/CSNK1A1/CALU/SEL1L/FEM1B/ACBD3/SLC33A1/PPP1R15A/SCFD1/GARS1,11
REACTOME_SARS_COV_INFECTIONS,REACTOME_SARS_COV_INFECTIONS,9/151,156/21728,1.488933114200852e-6,1.1256925428058944e-4,8.274955602453242e-5,UBC/CSNK1A1/ATP1A1/BECN1/PTGES3/FNTB/JAK2/FURIN/MGAT4B,9
SENESE_HDAC2_TARGETS_UP,SENESE_HDAC2_TARGETS_UP,8/151,116/21728,1.5223597673968954e-6,1.1256925428058944e-4,8.274955602453242e-5,ATP13A3/IQGAP1/PTPN12/LMAN1/CBFB/ITPRID2/PDLIM4/SCYL2,8
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP,TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP,7/151,81/21728,1.5398242126214537e-6,1.1256925428058944e-4,8.274955602453242e-5,TM9SF2/HSP90B1/PDIA6/SSR1/SEL1L/HSPA5/KDELR1,7
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,12/151,307/21728,1.663660712315418e-6,1.1850383227723669e-4,8.711205889046994e-5,RARS1/SSR1/HSPA9/ETF1/VDAC1/ATP13A3/IQGAP1/HSPA4/PRPS2/RECQL/LDLR/GARS1,12
PID_NECTIN_PATHWAY,PID_NECTIN_PATHWAY,5/151,30/21728,1.8787849707452385e-6,1.3048161621825681e-4,9.591691692752007e-5,IQGAP1/ITGB3/CRK/CTNNA1/PVR,5
IKEDA_MIR1_TARGETS_UP,IKEDA_MIR1_TARGETS_UP,6/151,54/21728,2.000132147947708e-6,1.3157611566552073e-4,9.672148247171771e-5,YWHAZ/FNDC3B/CLTC/ATP6V1A/EFNB2/RRBP1,6
PID_RAC1_PATHWAY,PID_RAC1_PATHWAY,6/151,54/21728,2.000132147947708e-6,1.3157611566552073e-4,9.672148247171771e-5,IQGAP1/ACTR2/ACTR3/CRK/CTNNA1/MAP2K3,6
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,9/151,162/21728,2.0366353396750866e-6,1.3157611566552073e-4,9.672148247171771e-5,PDIA6/ETF1/ATP13A3/API5/IARS2/COPS2/ZNF330/PTGES3/GARS1,9
JOHNSTONE_PARVB_TARGETS_3_UP,JOHNSTONE_PARVB_TARGETS_3_UP,14/151,433/21728,2.0879736946565143e-6,1.3182706644899536e-4,9.690595616348415e-5,ARAF/CTNND1/ACTB/ATP1A1/APLP2/IQGAP1/DUSP5/FLOT2/PPFIBP1/MAP2K3/LDLR/SNX19/FLII/MGAT4B,14
WANG_TUMOR_INVASIVENESS_DN,WANG_TUMOR_INVASIVENESS_DN,10/151,211/21728,2.2965556692007216e-6,1.4177403664532455e-4,1.04217964871331e-4,CTNND1/YWHAZ/APLP2/IQGAP1/ATP6V1A/ACTR2/WDR1/PTGES3/PML/FURIN,10
WP_MALIGNANT_PLEURAL_MESOTHELIOMA,WP_MALIGNANT_PLEURAL_MESOTHELIOMA,14/151,446/21728,2.942980389319837e-6,1.77730424381098e-4,1.3064947266088064e-4,ACTB/ACTG1/LAMC1/WWTR1/CSNK1A1/RPS6KA3/MET/ITGB3/BECN1/CTNNA1/PRKAG1/LAMA5/EPHA2/MAP2K3,14
REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS,REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS,5/151,33/21728,3.076900891657933e-6,1.818644824899093e-4,1.3368841500148692e-4,CTNND1/ACTB/ACTG1/CTNNA1/PVR,5
REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,12/151,327/21728,3.193922139964816e-6,1.848482438504637e-4,1.358817752528891e-4,ARAF/UBC/ACTB/ACTG1/IQGAP1/DUSP5/RASA2/MET/ITGB3/FNTB/JAK2/ICMT,12
REACTOME_CELL_CELL_COMMUNICATION,REACTOME_CELL_CELL_COMMUNICATION,8/151,130/21728,3.5862207409532614e-6,2.0331675955853387e-4,1.4945796428462573e-4,CTNND1/ACTB/ACTG1/IQGAP1/CTNNA1/ACTN4/CD151/PVR,8
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,8/151,133/21728,4.250942104358394e-6,2.3618234331815237e-4,1.7361742489379546e-4,HSP90B1/ACTB/YWHAZ/WDR1/LDHA/PRDX1/ACTN4/SDC4,8
HSIAO_HOUSEKEEPING_GENES,HSIAO_HOUSEKEEPING_GENES,13/151,399/21728,4.517198575782162e-6,2.4179954348244729e-4,1.7774662360499707e-4,ARAF/UBC/ACTB/NCSTN/ACTG1/YWHAZ/CLTC/APLP2/IQGAP1/LDHA/EIF4H/BECN1/PRDX1,13
REACTOME_SIGNALING_BY_INTERLEUKINS,REACTOME_SIGNALING_BY_INTERLEUKINS,14/151,463/21728,4.526125363962297e-6,2.4179954348244729e-4,1.7774662360499707e-4,HSP90B1/UBC/HSPA9/YWHAZ/RPS6KA3/PTPN12/DUSP3/PTPN14/CRK/PTPN9/HSPA8/JAK2/LAMA5/MAP2K3,14
REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS,REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS,6/151,65/21728,6.007112796148034e-6,3.1486338391885355e-4,2.3145578598862335e-4,ARAF/ACTB/ACTG1/IQGAP1/ITGB3/JAK2,6
YAGI_AML_WITH_INV_16_TRANSLOCATION,YAGI_AML_WITH_INV_16_TRANSLOCATION,13/151,411/21728,6.219673829872833e-6,3.19967664803458e-4,2.352079382057173e-4,UBC/ARIH1/ETF1/PKD2/CBFB/ITPRID2/SLC4A7/PCDH8/PML/BCAM/SDC4/EPHB4/PGRMC2,13
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,6/151,67/21728,7.175372094831465e-6,3.6242152144439654e-4,2.664157294540295e-4,HSP90B1/SSR1/DUSP5/SORT1/SLC12A4/LDLR,6
SENESE_HDAC1_AND_HDAC2_TARGETS_UP,SENESE_HDAC1_AND_HDAC2_TARGETS_UP,10/151,243/21728,8.032142732431672e-6,3.984516519766997e-4,2.92901445505967e-4,NUS1/IQGAP1/PTPN12/LMAN1/CBFB/BIRC3/PDLIM4/CTNNA1/SCYL2/ZBTB38,10
REACTOME_MAP2K_AND_MAPK_ACTIVATION,REACTOME_MAP2K_AND_MAPK_ACTIVATION,5/151,40/21728,8.202997201115863e-6,3.9978817938069946e-4,2.938839255801436e-4,ARAF/ACTB/ACTG1/IQGAP1/ITGB3,5
AMIT_EGF_RESPONSE_40_HELA,AMIT_EGF_RESPONSE_40_HELA,5/151,42/21728,1.0486842427585751e-5,4.979909490861081e-4,3.6607269191279214e-4,SEC23A/DUSP5/PPP1R15A/SLC2A3/LDLR,5
RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN,RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN,12/151,368/21728,1.0576481640057732e-5,4.979909490861081e-4,3.6607269191279214e-4,PDIA6/SSR1/SEPTIN11/VDAC1/PKD2/IARS2/LDHA/PRPS2/GBE1/AKAP12/HSPA8/PRDX1,12
KEGG_FOCAL_ADHESION,KEGG_FOCAL_ADHESION,9/151,199/21728,1.0890384517675678e-5,5.042248031683839e-4,3.706551923559792e-4,ACTB/ACTG1/LAMC1/BIRC3/MET/ITGB3/CRK/ACTN4/LAMA5,9
LIU_SOX4_TARGETS_DN,LIU_SOX4_TARGETS_DN,11/151,310/21728,1.1409654506629533e-5,5.196068888428991e-4,3.819625494885469e-4,PKN1/APLP2/FEM1B/LDHA/ZNF654/EGLN1/FLOT2/HSPA8/PPFIBP1/SNX19/MGAT4B,11
WELCSH_BRCA1_TARGETS_UP,WELCSH_BRCA1_TARGETS_UP,9/151,201/21728,1.1798654074088054e-5,5.286558228680099e-4,3.886144126270089e-4,TM9SF2/PRKAR1A/SSR1/CSNK1A1/RPS6KA3/SEC23A/HSPA5/IQGAP1/COPS2,9
WP_FOCAL_ADHESION,WP_FOCAL_ADHESION,9/151,202/21728,1.2276527706799901e-5,5.413364122141289e-4,3.979359022755523e-4,ACTB/ACTG1/LAMC1/BIRC3/MET/ITGB3/CRK/ACTN4/LAMA5,9
GROSS_HYPOXIA_VIA_ELK3_DN,GROSS_HYPOXIA_VIA_ELK3_DN,8/151,157/21728,1.4404300032032892e-5,6.252366482654277e-4,4.596108891799969e-4,RARS1/HSPA5/ACBD3/GBE1/AKAP12/PPP1R15A/PDLIM4/ZNF330,8
LAIHO_COLORECTAL_CANCER_SERRATED_UP,LAIHO_COLORECTAL_CANCER_SERRATED_UP,7/151,115/21728,1.593635753294734e-5,6.810954034850418e-4,5.006726091322728e-4,PDIA6/PRKAR1A/LAMC1/CSNK1A1/IQGAP1/SEC24A/HSPA8,7
IKEDA_MIR30_TARGETS_UP,IKEDA_MIR30_TARGETS_UP,7/151,116/21728,1.6862027114221217e-5,7.069125608132157e-4,5.196507779082409e-4,YWHAZ/FNDC3B/SEC23A/NRBF2/NRIP1/SLC4A7/BECN1,7
DURCHDEWALD_SKIN_CARCINOGENESIS_DN,DURCHDEWALD_SKIN_CARCINOGENESIS_DN,10/151,265/21728,1.7049367017453367e-5,7.069125608132157e-4,5.196507779082409e-4,CTNND1/YWHAZ/ATP13A3/APLP2/PTPN12/RALB/MET/NRIP1/SLC4A7/TPM1,10
KEGG_PATHWAYS_IN_CANCER,KEGG_PATHWAYS_IN_CANCER,11/151,325/21728,1.7705375978824155e-5,7.233166833701985e-4,5.317094334197966e-4,HSP90B1/ARAF/LAMC1/RALB/BIRC3/MET/EGLN1/CRK/CTNNA1/PML/LAMA5,11
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,12/151,395/21728,2.1343098559054214e-5,8.59291707203661e-4,6.316645492687288e-4,ACTB/ATP1A1/ADAM9/APLP2/WDR1/HSPA8/TPM1/ACTN4/LAMA5/CD151/SLC12A4/EPHA2,12
REACTOME_L1CAM_INTERACTIONS,REACTOME_L1CAM_INTERACTIONS,7/151,121/21728,2.218313079808328e-5,8.803533908153621e-4,6.471469736583693e-4,ACTB/ACTG1/LAMC1/CLTC/RPS6KA3/ITGB3/HSPA8,7
REACTOME_ONCOGENIC_MAPK_SIGNALING,REACTOME_ONCOGENIC_MAPK_SIGNALING,6/151,82/21728,2.311199219180229e-5,9.042973846313628e-4,6.647481816470934e-4,ARAF/ACTB/ACTG1/IQGAP1/ITGB3/JAK2,6
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,8/151,168/21728,2.3503415880336772e-5,9.068401293829938e-4,6.666173509920078e-4,RPS6KA3/ATP1A1/APLP2/PTPN14/NRIP1/EGLN1/COPS2/CRK,8
TOOKER_GEMCITABINE_RESISTANCE_DN,TOOKER_GEMCITABINE_RESISTANCE_DN,7/151,123/21728,2.4666784530919688e-5,9.386894168067793e-4,6.900297330927786e-4,HSP90B1/PDIA6/SSR1/WWTR1/ATP6V1C1/APLP2/AKAP12,7
REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,4/151,25/21728,2.5306794332978172e-5,9.500307386082887e-4,6.983667283922853e-4,PDIA3/SEC23A/HSPA5/SEC24A,4
MISSIAGLIA_REGULATED_BY_METHYLATION_UP,MISSIAGLIA_REGULATED_BY_METHYLATION_UP,7/151,125/21728,2.7375220040514663e-5,0.001013978150300663,7.453744123312062e-4,DUSP5/BIRC3/PERP/BECN1/RRBP1/MAP2K3/SDC4,7
FOURNIER_ACINAR_DEVELOPMENT_LATE_2,FOURNIER_ACINAR_DEVELOPMENT_LATE_2,10/151,281/21728,2.8160113353318998e-5,0.0010238023108852022,7.525961438055749e-4,HSP90B1/PDIA6/ACTB/ACTG1/LDHA/DNAJC10/PTGES3/PRDX1/EPHA2/LDLR,10
SASSON_RESPONSE_TO_FORSKOLIN_DN,SASSON_RESPONSE_TO_FORSKOLIN_DN,6/151,85/21728,2.837752985534938e-5,0.0010238023108852022,7.525961438055749e-4,STK24/CTNND1/ACTB/ACTR2/AKAP12/MAP2K3,6
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP,8/151,173/21728,2.900794137018286e-5,0.0010329568581205792,7.593256431184584e-4,SEPTIN11/TRIP12/ACTR3/MET/PERP/SORT1/PTGES3/SCYL2,8
DEN_INTERACT_WITH_LCA5,DEN_INTERACT_WITH_LCA5,4/151,26/21728,2.9746777771650947e-5,0.0010329568581205792,7.593256431184584e-4,HSPA9/YWHAZ/HSPA5/HSPA8,4
REACTOME_CALNEXIN_CALRETICULIN_CYCLE,REACTOME_CALNEXIN_CALRETICULIN_CYCLE,4/151,26/21728,2.9746777771650947e-5,0.0010329568581205792,7.593256431184584e-4,UBC/PDIA3/EDEM3/SEL1L,4
REACTOME_RHOD_GTPASE_CYCLE,REACTOME_RHOD_GTPASE_CYCLE,5/151,53/21728,3.326821583481572e-5,0.001129114800935957,8.300112590715609e-4,LMAN1/STBD1/AKAP12/SLC4A7/PGRMC2,5
SWEET_LUNG_CANCER_KRAS_UP,SWEET_LUNG_CANCER_KRAS_UP,13/151,482/21728,3.33288026194199e-5,0.001129114800935957,8.300112590715609e-4,PDIA6/HSPA9/ATP6V1C1/ATP1A1/HSPA5/IQGAP1/KDELR1/LDHA/PCYT1A/HSPA8/ACTN4/RRBP1/GARS1,13
KEGG_VIBRIO_CHOLERAE_INFECTION,KEGG_VIBRIO_CHOLERAE_INFECTION,5/151,54/21728,3.6458836619190065e-5,0.0012202728690133735,8.970214716706243e-4,ACTB/ACTG1/ATP6V1C1/ATP6V1A/KDELR1,5
WP_EBOLA_VIRUS_INFECTION_IN_HOST,WP_EBOLA_VIRUS_INFECTION_IN_HOST,7/151,131/21728,3.70078411734311e-5,0.0012239021759498999,8.996893718854177e-4,ACTB/ACTG1/CLTC/IQGAP1/RASA2/ITGB3/ACTN4,7
CHEN_LUNG_CANCER_SURVIVAL,CHEN_LUNG_CANCER_SURVIVAL,4/151,28/21728,4.030215625273401e-5,0.0013085279549065545,9.618977047170306e-4,ACTB/ACTG1/CALU/HSPA5,4
HOSHIDA_LIVER_CANCER_SUBCLASS_S1,HOSHIDA_LIVER_CANCER_SUBCLASS_S1,9/151,235/21728,4.0508784781124437e-05,0.0013085279549065545,9.618977047170306e-4,PKN1/ADAM9/IQGAP1/RALB/PKD2/DUSP5/CBFB/CD151/TRIP10,9
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,13/151,493/21728,4.202090337888972e-5,0.001341770914787996,9.863345741687364e-4,CTNND1/CLTC/CALU/ADAM9/SEL1L/APLP2/PKD2/PCYT1A/TMCO3/EML1/EFNB2/BCAM/LOXL1,13
REACTOME_CELL_JUNCTION_ORGANIZATION,REACTOME_CELL_JUNCTION_ORGANIZATION,6/151,92/21728,4.44582365246079e-5,0.0014034656939245537,0.0010316863499729584,CTNND1/ACTB/ACTG1/CTNNA1/CD151/PVR,6
WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,4/151,29/21728,4.64985898770149e-5,0.0014513829514421054,0.0010669102822165452,HSP90B1/PDIA6/HSPA5/PPP1R15A,4
REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,8/151,186/21728,4.8572833793846075e-5,0.001499281469770049,0.0011021204392989636,SEC23A/LMAN1/KDELR1/TMEM115/MCFD2/SEC24A/SCFD1/MGAT4B,8
TIEN_INTESTINE_PROBIOTICS_2HR_UP,TIEN_INTESTINE_PROBIOTICS_2HR_UP,4/151,30/21728,5.3363175247210166e-5,0.0016290428663379105,0.0011975079234191755,UBC/KDELR1/HSPA8/EPHB4,4
PROVENZANI_METASTASIS_DN,PROVENZANI_METASTASIS_DN,7/151,142/21728,6.185915095489972e-5,0.0018678774060077329,0.0013730749754291241,PDIA6/HSPA4/PDLIM4/SLC2A3/CTNNA1/TPM1/SDC4,7
REACTOME_GAP_JUNCTION_DEGRADATION,REACTOME_GAP_JUNCTION_DEGRADATION,3/151,12/21728,6.913225827275412e-5,0.0020471292693627933,0.0015048428564904013,ACTB/ACTG1/CLTC,3
REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS,REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS,4/151,32/21728,6.92693129302025e-5,0.0020471292693627933,0.0015048428564904013,ACTB/ACTG1/IQGAP1/CTNNA1,4
JOHNSTONE_PARVB_TARGETS_2_UP,JOHNSTONE_PARVB_TARGETS_2_UP,7/151,145/21728,7.060145951557573e-5,0.0020645353108870463,0.0015176380217198553,ACTB/ACTG1/PKN1/APLP2/CD151/FURIN/SBNO2,7
RAMALHO_STEMNESS_UP,RAMALHO_STEMNESS_UP,8/151,197/21728,7.276723068720403e-5,0.0021057017380109668,0.0015478994247058754,ARIH1/SEC23A/ADAM9/PKD2/IARS2/SLC4A7/PAFAH2/GARS1,8
PHONG_TNF_TARGETS_UP,PHONG_TNF_TARGETS_UP,5/151,63/21728,7.706374709123403e-5,0.002207042158963383,0.0016223946756049267,DUSP5/BIRC3/EPHA2/LDLR/SDC4,5
REACTOME_CARGO_CONCENTRATION_IN_THE_ER,REACTOME_CARGO_CONCENTRATION_IN_THE_ER,4/151,33/21728,7.839930079758804e-5,0.0022223801797520365,0.0016336696406801376,SEC23A/LMAN1/MCFD2/SEC24A,4
REACTOME_RHOA_GTPASE_CYCLE,REACTOME_RHOA_GTPASE_CYCLE,7/151,149/21728,8.380301633110479e-5,0.0023515634279576677,0.0017286321284672333,PKN1/IQGAP1/LMAN1/STBD1/FLOT2/SCFD1/PGRMC2,7
REACTOME_CELL_CELL_JUNCTION_ORGANIZATION,REACTOME_CELL_CELL_JUNCTION_ORGANIZATION,5/151,65/21728,8.955673549545585e-5,0.0024878861120637636,0.0018288428090650986,CTNND1/ACTB/ACTG1/CTNNA1/PVR,5
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,6/151,105/21728,9.318221439060736e-5,0.002547017470052359,0.0018723102163243437,STBD1/GBE1/AKAP12/ZNF654/EGLN1/LOXL1,6
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,9/151,262/21728,9.35189999803242e-5,0.002547017470052359,0.0018723102163243437,RAB21/HSPA9/VDAC1/FEM1C/GBE1/PTPN14/ZNF330/PPFIBP1/FLII,9
MANALO_HYPOXIA_UP,MANALO_HYPOXIA_UP,8/151,205/21728,9.604508310344849e-5,0.0025904198141881545,0.0019042152398639762,FNDC3B/GBE1/SEC24A/SLC2A3/EGLN1/TPM1/PGM3/NPAS2,8
REACTOME_SIGNALING_BY_VEGF,REACTOME_SIGNALING_BY_VEGF,6/151,106/21728,9.821288609750973e-5,0.002623417284412327,0.0019284716500928025,CTNND1/ACTB/ACTG1/ITGB3/CRK/CTNNA1,6
REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE,REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE,4/151,35/21728,9.924036114312561e-5,0.0026256164119581233,0.0019300882267434952,UBC/PDIA3/EDEM3/SEL1L,4
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,12/151,466/21728,1.0453753932434699e-4,0.0027396724928588296,0.0020139307476587207,ACTG1/LAMC1/WWTR1/ACTR2/ITPRID2/AKAP12/MCFD2/MET/TPM1/EPHA2/ARSJ/LOXL1,12
REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,7/151,155/21728,1.0732211308728583e-4,0.0027863628986586923,0.002048252822324983,SEC23A/LMAN1/KDELR1/TMEM115/MCFD2/SEC24A/SCFD1,7
REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES,REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES,4/151,36/21728,1.110446465739068e-4,0.0028070034736535116,0.002063425690154906,ACTB/ACTG1/ACTR2/ACTR3,4
REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT,REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT,5/151,68/21728,1.1114844568102458e-4,0.0028070034736535116,0.002063425690154906,SEC23A/LMAN1/MCFD2/SEC24A/SCFD1,5
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM,5/151,68/21728,1.1114844568102458e-4,0.0028070034736535116,0.002063425690154906,ACTB/YWHAZ/LDHA/PRDX1/SDC4,5
PID_VEGFR1_2_PATHWAY,PID_VEGFR1_2_PATHWAY,5/151,69/21728,1.1916618191242359e-4,0.0029823752554298446,0.002192341326790913,IQGAP1/ITGB3/CTNNA1/PRKAG1/MAP2K3,5
GENTILE_UV_RESPONSE_CLUSTER_D7,GENTILE_UV_RESPONSE_CLUSTER_D7,4/151,37/21728,1.2383478267466514e-4,0.0030443630643382283,0.0022379085085128124,RARS1/MET/TRIP10/PGRMC2,4
VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1,VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1,4/151,37/21728,1.2383478267466514e-4,0.0030443630643382283,0.0022379085085128124,ITGB3/CTNNA1/EPHA2/EPHB4,4
PID_CDC42_PATHWAY,PID_CDC42_PATHWAY,5/151,70/21728,1.276199450371365e-4,0.003109896555378642,0.002286082117932085,IQGAP1/ACTR2/ACTR3/CTNNA1/MAP2K3,5
REACTOME_SARS_COV_2_INFECTION,REACTOME_SARS_COV_2_INFECTION,5/151,71/21728,1.3652561546175195e-4,0.0032966988982160135,0.002423400349565786,UBC/CSNK1A1/BECN1/FURIN/MGAT4B,5
STONER_ESOPHAGEAL_CARCINOGENESIS_UP,STONER_ESOPHAGEAL_CARCINOGENESIS_UP,4/151,38/21728,1.3765913325884002e-4,0.0032966988982160135,0.002423400349565786,PPP1R15A/CRK/PVR/MAP2K3,4
PID_ECADHERIN_NASCENT_AJ_PATHWAY,PID_ECADHERIN_NASCENT_AJ_PATHWAY,4/151,39/21728,1.5256670543314712e-4,0.00362248126233575,0.002662882667928974,CTNND1/IQGAP1/CRK/CTNNA1,4
KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,5/151,74/21728,1.6611694572631907e-4,0.003910787078200969,0.002874816009893479,ACTB/ACTG1/ITGB3/CTNNA1/ACTN4,5
YAMAZAKI_TCEB3_TARGETS_UP,YAMAZAKI_TCEB3_TARGETS_UP,7/151,167/21728,1.7048726018002348e-4,0.0039799462922697915,0.0029256548849999607,PDIA3/LAMC1/CALU/PTPN9/RRBP1/FURIN/EPHB4,7
TSENG_IRS1_TARGETS_UP,TSENG_IRS1_TARGETS_UP,6/151,119/21728,1.855509256218013e-4,0.004231453408147678,0.0031105375362079856,HSPA9/HSPA4/ACTR3/EFNB2/ACTN4/LDLR,6
PID_ECADHERIN_STABILIZATION_PATHWAY,PID_ECADHERIN_STABILIZATION_PATHWAY,4/151,41/21728,1.8583056724046676e-4,0.004231453408147678,0.0031105375362079856,CTNND1/MET/CTNNA1/EPHA2,4
REACTOME_MET_PROMOTES_CELL_MOTILITY,REACTOME_MET_PROMOTES_CELL_MOTILITY,4/151,41/21728,1.8583056724046676e-4,0.004231453408147678,0.0031105375362079856,LAMC1/MET/CRK/LAMA5,4
WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,5/151,76/21728,1.8840731257302289e-4,0.004255248083966322,0.003128028980673208,ACTB/ACTG1/ITGB3/CTNNA1/ACTN4,5
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE,5/151,77/21728,2.003729816787025e-4,0.004489001154059964,0.0032998606490380546,ACTB/YWHAZ/LDHA/PRDX1/SDC4,5
ELVIDGE_HYPOXIA_UP,ELVIDGE_HYPOXIA_UP,7/151,172/21728,2.0440787853490358e-4,0.004542760692559697,0.00333937923669653,STBD1/GBE1/AKAP12/MET/ZNF654/EGLN1/LOXL1,7
SHEN_SMARCA2_TARGETS_UP,SHEN_SMARCA2_TARGETS_UP,11/151,428/21728,2.0743510760987976e-4,0.0045562765436304616,0.0033493147264761075,PRKAR1A/RAB21/TRIP12/RALB/FEM1C/FEM1B/GBE1/ACTR3/COPS2/CTNNA1/SCFD1,11
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN,3/151,17/21728,2.0829629987079504e-4,0.0045562765436304616,0.0033493147264761075,HSP90B1/HSPA5/PVR,3
PID_INTEGRIN3_PATHWAY,PID_INTEGRIN3_PATHWAY,4/151,43/21728,2.240300851496396e-4,0.0048301712116088245,0.003550654446789102,LAMC1/ITGB3/PVR/SDC4,4
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,8/151,232/21728,2.244873734808215e-4,0.0048301712116088245,0.003550654446789102,DUSP5/BIRC3/RASA2/PPP1R15A/PPFIBP1/ZBTB38/EPHA2/SBNO2,8
REACTOME_SIGNALING_BY_MET,REACTOME_SIGNALING_BY_MET,5/151,79/21728,2.260339299888939e-4,0.0048301712116088245,0.003550654446789102,UBC/LAMC1/MET/CRK/LAMA5,5
GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,11/151,438/21728,0.00025285159435956223,0.005268293192132198,0.003872717514583178,STK24/PRKAR1A/ACTB/ACTG1/YWHAZ/VDAC1/PTPN12/HSPA4/MET/DNAJC10/PGRMC2,11
FALVELLA_SMOKERS_WITH_LUNG_CANCER,FALVELLA_SMOKERS_WITH_LUNG_CANCER,5/151,81/21728,2.541221338177518e-4,0.005268293192132198,0.003872717514583178,IQGAP1/ACTR2/WDR1/MET/CTNNA1,5
SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN,SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN,5/151,81/21728,2.541221338177518e-4,0.005268293192132198,0.003872717514583178,PRKAR1A/ARIH1/HSPA5/PTGES3/PRDX1,5
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,5/151,81/21728,2.541221338177518e-4,0.005268293192132198,0.003872717514583178,SEPTIN11/VDAC1/LDHA/LDLR/GARS1,5
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,9/151,300/21728,2.578268389262738e-4,0.005305503396571767,0.003900070701886715,RAB21/DUSP3/PPP1R15A/NRIP1/SLC2A3/COPS2/CRK/ZNF330/PML,9
GARY_CD5_TARGETS_DN,GARY_CD5_TARGETS_DN,11/151,440/21728,2.6287746798522095e-4,0.005357738581105906,0.003938468738337106,HSP90B1/PDIA6/RARS1/ETF1/ATP6V1C1/HSPA5/API5/HSPA4/MET/DNAJC10/PGRMC2,11
REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,9/151,301/21728,2.6422252901782184e-4,0.005357738581105906,0.003938468738337106,NCSTN/LAMC1/ADAM9/ITGB3/LAMA5/CD151/FURIN/SDC4/LOXL1,9
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,8/151,238/21728,2.667513592436024e-4,0.005369820840425561,0.003947350396129585,RAB21/HSPA9/WWTR1/HSPA4/DUSP3/PCYT1A/PPP1R15A/SLC12A4,8
KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,5/151,83/21728,2.8478634897546146e-4,0.005691629334200229,0.004183911526031013,ACTB/ACTG1/ITGB3/PRKAG1/TPM1,5
PID_A6B1_A6B4_INTEGRIN_PATHWAY,PID_A6B1_A6B4_INTEGRIN_PATHWAY,4/151,46/21728,2.9148704238772055e-4,0.0057429149202346645,0.004221611513491436,LAMC1/YWHAZ/MET/LAMA5,4
SESTO_RESPONSE_TO_UV_C5,SESTO_RESPONSE_TO_UV_C5,4/151,46/21728,2.9148704238772055e-4,0.0057429149202346645,0.004221611513491436,IQGAP1/CBFB/LDLR/SDC4,4
BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN,BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN,3/151,19/21728,2.938103612497893e-4,0.005747923827830384,0.004225293556890965,RRBP1/LDLR/SDC4,3
REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,6/151,132/21728,3.2518256204217146e-4,0.006273313592730225,0.004611507093288105,CALU/HSPA5/APLP2/WDR1/ITGB3/ACTN4,6
WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,6/151,132/21728,3.2518256204217146e-4,0.006273313592730225,0.004611507093288105,RPS6KA3/CRK/FLOT2/PRKAG1/MAP2K3/TRIP10,6
LEIN_MEDULLA_MARKERS,LEIN_MEDULLA_MARKERS,5/151,86/21728,3.3594746021669463e-4,0.006285259645272408,0.004620288625602847,ACBD3/PRDX1/CD151/TRIP10/LDLR,5
SASSON_RESPONSE_TO_GONADOTROPHINS_DN,SASSON_RESPONSE_TO_GONADOTROPHINS_DN,5/151,86/21728,3.3594746021669463e-4,0.006285259645272408,0.004620288625602847,STK24/CTNND1/AKAP12/BECN1/MAP2K3,5
PID_AJDISS_2PATHWAY,PID_AJDISS_2PATHWAY,4/151,48/21728,3.438441275091891e-4,0.006285259645272408,0.004620288625602847,CTNND1/IQGAP1/MET/CTNNA1,4
REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING,REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING,4/151,48/21728,3.438441275091891e-4,0.006285259645272408,0.004620288625602847,UBC/YWHAZ/CRK/JAK2,4
WOOD_EBV_EBNA1_TARGETS_DN,WOOD_EBV_EBNA1_TARGETS_DN,4/151,48/21728,3.438441275091891e-4,0.006285259645272408,0.004620288625602847,IQGAP1/ACTR2/AKAP12/TPM1,4
WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,4/151,48/21728,3.438441275091891e-4,0.006285259645272408,0.004620288625602847,ACTB/ACTG1/ITGB3/CTNNA1,4
REACTOME_LISTERIA_MONOCYTOGENES_ENTRY_INTO_HOST_CELLS,REACTOME_LISTERIA_MONOCYTOGENES_ENTRY_INTO_HOST_CELLS,3/151,20/21728,3.4390189563765516e-4,0.006285259645272408,0.004620288625602847,UBC/CTNND1/MET,3
WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,3/151,20/21728,3.4390189563765516e-4,0.006285259645272408,0.004620288625602847,LDHA/EGLN1/PRKAG1,3
REACTOME_SIGNALING_BY_NTRKS,REACTOME_SIGNALING_BY_NTRKS,6/151,134/21728,3.5248658061239264e-4,0.006394032497023664,0.004700247449594904,CLTC/RPS6KA3/RALB/DUSP3/CRK/FURIN,6
REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS,REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS,5/151,87/21728,3.5445680509058476e-4,0.006394032497023664,0.004700247449594904,ATP1A1/PTGES3/FNTB/JAK2/FURIN,5
BILD_HRAS_ONCOGENIC_SIGNATURE,BILD_HRAS_ONCOGENIC_SIGNATURE,8/151,250/21728,3.7088175300389046e-4,0.006612830403114248,0.004861085590558009,CALU/DUSP5/PPP1R15A/SLC2A3/PVR/EPHA2/LDLR/SDC4,8
REACTOME_RECYCLING_PATHWAY_OF_L1,REACTOME_RECYCLING_PATHWAY_OF_L1,4/151,49/21728,3.723986435316429e-4,0.006612830403114248,0.004861085590558009,ACTB/ACTG1/CLTC/RPS6KA3,4
REACTOME_RAC2_GTPASE_CYCLE,REACTOME_RAC2_GTPASE_CYCLE,5/151,88/21728,3.737272762019211e-4,0.006612830403114248,0.004861085590558009,IQGAP1/LMAN1/STBD1/EPHA2/PGRMC2,5
KEGG_INSULIN_SIGNALING_PATHWAY,KEGG_INSULIN_SIGNALING_PATHWAY,6/151,137/21728,3.967731170585272e-4,0.006887709324216231,0.005063148834443366,ARAF/PRKAR1A/CRK/FLOT2/PRKAG1/TRIP10,6
REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC,REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC,3/151,21/21728,3.9917969805572823e-4,0.006887709324216231,0.005063148834443366,UBC/EDEM3/SEL1L,3
REACTOME_INTERLEUKIN_37_SIGNALING,REACTOME_INTERLEUKIN_37_SIGNALING,3/151,21/21728,3.9917969805572823e-4,0.006887709324216231,0.005063148834443366,PTPN12/PTPN14/PTPN9,3
VERRECCHIA_RESPONSE_TO_TGFB1_C5,VERRECCHIA_RESPONSE_TO_TGFB1_C5,3/151,21/21728,3.9917969805572823e-4,0.006887709324216231,0.005063148834443366,ITGB3/CTNNA1/EPHA2,3
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,6/151,140/21728,4.4529397934851264e-4,0.007635967127346717,0.005613192462222967,PDIA3/EDEM3/PERP/SEC24A/SH2D4A/EPHB4,6
GARY_CD5_TARGETS_UP,GARY_CD5_TARGETS_UP,11/151,474/21728,4.921981761471829e-4,0.008316206539406082,0.006113235832839907,PKN1/DUSP5/KDELR1/GBE1/SLC2A3/CTNNA1/PNKP/MAP2K3/LDLR/GARS1/MGAT4B,11
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,8/151,261/21728,4.933919923031074e-4,0.008316206539406082,0.006113235832839907,YWHAZ/CALU/HSPA5/APLP2/WDR1/ITGB3/CRK/ACTN4,8
AFFAR_YY1_TARGETS_UP,AFFAR_YY1_TARGETS_UP,7/151,199/21728,4.939431529884822e-4,0.008316206539406082,0.006113235832839907,UBC/PPP1R15A/PERP/SLC2A3/PAFAH2/TPM1/EPHA2,7
SESTO_RESPONSE_TO_UV_C2,SESTO_RESPONSE_TO_UV_C2,4/151,54/21728,5.411030474061999e-4,0.009055326901773634,0.006656562536258895,ATP13A3/PTPN12/NRIP1/TRIP10,4
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,6/151,146/21728,5.561493220759877e-4,0.009251394112138286,0.006800691363551315,WWTR1/FNDC3B/ACBD3/NRBF2/ZNF330/LDLR,6
ELVIDGE_HYPOXIA_DN,ELVIDGE_HYPOXIA_DN,6/151,147/21728,5.765398693384941e-4,0.009533498553704384,0.007008066080931571,DOLK/ETF1/HSPA4/SORT1/JAK2/SCYL2,6
REACTOME_SIGNALING_BY_ALK_IN_CANCER,REACTOME_SIGNALING_BY_ALK_IN_CANCER,4/151,55/21728,5.804145417080808e-4,0.009540778679674842,0.007013417694884314,PRKAR1A/CLTC/PPFIBP1/RRBP1,4
REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,5/151,97/21728,5.848319575398112e-4,0.00955684222379762,0.007025225991499899,UBC/RPS6KA3/DUSP3/BIRC3/MAP2K3,5
REACTOME_RAS_PROCESSING,REACTOME_RAS_PROCESSING,3/151,24/21728,5.982638571787466e-4,0.00971916371486876,0.007144548371355915,UBC/FNTB/ICMT,3
DIRMEIER_LMP1_RESPONSE_LATE_UP,DIRMEIER_LMP1_RESPONSE_LATE_UP,4/151,56/21728,6.217119885923887e-4,0.00998332892664541,0.007338735977299873,ETF1/ATP13A3/TRIP10/GARS1,4
REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS,REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS,4/151,56/21728,6.217119885923887e-4,0.00998332892664541,0.007338735977299873,CLTC/ACBD3/SORT1/HSPA8,4
FOSTER_TOLERANT_MACROPHAGE_DN,FOSTER_TOLERANT_MACROPHAGE_DN,10/151,414/21728,6.536982077827579e-4,0.010436630007014376,0.00767195718752904,SEPTIN11/DUSP5/TMCO3/SLC4A7/JAK2/PPFIBP1/PML/SLC12A4/TRIP10/SDC4,10
LANDIS_ERBB2_BREAST_TUMORS_324_UP,LANDIS_ERBB2_BREAST_TUMORS_324_UP,6/151,151/21728,6.639755238216787e-4,0.010497226275213854,0.007716501448946565,CTNND1/LMAN1/ATP6V1A/AKAP12/PERP/ACTN4,6
ZAMORA_NOS2_TARGETS_UP,ZAMORA_NOS2_TARGETS_UP,4/151,57/21728,6.650510527133328e-4,0.010497226275213854,0.007716501448946565,ACTG1/ATP6V1C1/PTPN14/HSPA8,4
REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS,REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS,5/151,101/21728,7.030262464295894e-4,0.011033937359216947,0.008111037276677988,HSPA9/HSPA5/HSPA4/HSPA8/PTGES3,5
WP_PROXIMAL_TUBULE_TRANSPORT,WP_PROXIMAL_TUBULE_TRANSPORT,4/151,58/21728,7.104875303066491e-4,0.01104023608602861,0.008115667465005307,ATP6V1C1/ATP1A1/ATP6V1A/SLC12A4,4
LU_AGING_BRAIN_DN,LU_AGING_BRAIN_DN,6/151,153/21728,7.113759033114187e-4,0.01104023608602861,0.008115667465005307,YWHAZ/RPS6KA3/VDAC1/ATP6V1A/DUSP3/HSPA8,6
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,6/151,154/21728,7.360370388304985e-4,0.011338830461615232,0.008335163917825605,PRKAR1A/ACTB/YWHAZ/CLTC/VDAC1/PPP1R15A,6
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,7/151,213/21728,7.387790905516044e-4,0.011338830461615232,0.008335163917825605,ARAF/ACTB/ACTG1/IQGAP1/ITGB3/CRK/ACTN4,7
BILD_SRC_ONCOGENIC_SIGNATURE,BILD_SRC_ONCOGENIC_SIGNATURE,4/151,59/21728,7.580773275294311e-4,0.011494796599397648,0.008449814483282725,ARIH1/CSNK1A1/ITPRID2/PPP1R15A,4
REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,4/151,59/21728,7.580773275294311e-4,0.011494796599397648,0.008449814483282725,LAMC1/ITGB3/LAMA5/SDC4,4
REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,6/151,155/21728,7.613544183906289e-4,0.011494796599397648,0.008449814483282725,HSP90B1/UBC/RPS6KA3/DUSP3/BIRC3/MAP2K3,6
PID_ERBB1_DOWNSTREAM_PATHWAY,PID_ERBB1_DOWNSTREAM_PATHWAY,5/151,105/21728,8.38238476845039e-4,0.012587170209056855,0.009252817326198438,YWHAZ/RPS6KA3/IQGAP1/ACTR2/ACTR3,5
DIRMEIER_LMP1_RESPONSE_EARLY,DIRMEIER_LMP1_RESPONSE_EARLY,4/151,62/21728,9.143269057156559e-4,0.013655914753108022,0.010038450464563512,ACTB/DUSP5/BIRC3/PPP1R15A,4
WP_THERMOGENESIS,WP_THERMOGENESIS,5/151,108/21728,9.517057061976707e-4,0.014138173539129033,0.010392958457773606,ACTB/ACTG1/RPS6KA3/PRKAG1/MAP2K3,5
GRADE_COLON_AND_RECTAL_CANCER_UP,GRADE_COLON_AND_RECTAL_CANCER_UP,8/151,290/21728,9.793859553379194e-4,0.01447199034004649,0.01063834688328983,DOLK/HSPA9/PTPN12/HSPA4/LDHA/PERP/PRDX1/GARS1,8
WP_EGFEGFR_SIGNALING_PATHWAY,WP_EGFEGFR_SIGNALING_PATHWAY,6/151,163/21728,9.889571905819252e-4,0.014536100928235915,0.010685474518122724,RPS6KA3/IQGAP1/PTPN12/RALB/CRK/JAK2,6
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,6/151,164/21728,0.0010207241282784317,0.014924061201881491,0.010970663760998103,LAMC1/FNDC3B/ITPRID2/EFNB2/LDLR/PGRMC2,6
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP,PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP,4/151,64/21728,0.0010302878875734307,0.014952677390368603,0.010991699495022959,HSP90B1/PDIA3/HSPA5/PPP1R15A,4
BRUECKNER_TARGETS_OF_MIRLET7A3_UP,BRUECKNER_TARGETS_OF_MIRLET7A3_UP,5/151,110/21728,0.001033446385511437,0.014952677390368603,0.010991699495022959,PTPN12/DUSP5/AKAP12/PERP/PRDX1,5
HELLER_HDAC_TARGETS_DN,HELLER_HDAC_TARGETS_DN,8/151,293/21728,0.001046161299772815,0.015000471256256928,0.011026832722192582,HSP90B1/HSPA9/PDIA3/HSPA5/SLC33A1/PPP1R15A/PPFIBP1/ZBTB38,8
LANG_MYB_FAMILY_TARGETS,LANG_MYB_FAMILY_TARGETS,3/151,29/21728,0.001052948846281534,0.015000471256256928,0.011026832722192582,IQGAP1/API5/HSPA8,3
REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS,REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS,3/151,29/21728,0.001052948846281534,0.015000471256256928,0.011026832722192582,UBC/BIRC3/FLOT2,3
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,4/151,65/21728,0.0010919751762342798,0.015420814334973266,0.01133582653550382,HSP90B1/SSR1/SEPTIN11/DUSP5,4
DELACROIX_RARG_BOUND_MEF,DELACROIX_RARG_BOUND_MEF,9/151,367/21728,0.0010935566681028557,0.015420814334973266,0.01133582653550382,UBC/PKN1/LAMC1/WWTR1/CALU/PDLIM4/SLC35D1/FURIN/LOXL1,9
DELYS_THYROID_CANCER_UP,DELYS_THYROID_CANCER_UP,10/151,445/21728,0.0011304905451763178,0.015774363024441535,0.011595719854274782,APLP2/DUSP5/MET/NRIP1/PDLIM4/ACTN4/CD151/EPHA2/SDC4/FLII,10
MITSIADES_RESPONSE_TO_APLIDIN_UP,MITSIADES_RESPONSE_TO_APLIDIN_UP,10/151,445/21728,0.0011304905451763178,0.015774363024441535,0.011595719854274782,ARIH1/DUSP5/FEM1C/STBD1/NRBF2/PPP1R15A/SLC2A3/PGM3/MAP2K3/LDLR,10
WANG_LMO4_TARGETS_UP,WANG_LMO4_TARGETS_UP,9/151,369/21728,0.0011356632846970147,0.015774363024441535,0.011595719854274782,TM9SF2/HSP90B1/PRKAR1A/ACTG1/ATP13A3/ITPRID2/NRIP1/CD151/BCAM,9
DORSEY_GAB2_TARGETS,DORSEY_GAB2_TARGETS,3/151,30/21728,0.0011640139208409022,0.015796400416578694,0.01161191952111048,DUSP5/AKAP12/ITGB3,3
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP,GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP,3/151,30/21728,0.0011640139208409022,0.015796400416578694,0.01161191952111048,MFSD5/SLC4A7/SEC24A,3
PID_EPHRINB_REV_PATHWAY,PID_EPHRINB_REV_PATHWAY,3/151,30/21728,0.0011640139208409022,0.015796400416578694,0.01161191952111048,ITGB3/EFNB2/EPHB4,3
REACTOME_MET_ACTIVATES_PTK2_SIGNALING,REACTOME_MET_ACTIVATES_PTK2_SIGNALING,3/151,30/21728,0.0011640139208409022,0.015796400416578694,0.01161191952111048,LAMC1/MET/LAMA5,3
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP,5/151,113/21728,0.0011656810962558072,0.015796400416578694,0.01161191952111048,ATP1A1/WDR1/TMEM115/DUSP3/PRKAG1,5
ELVIDGE_HIF1A_TARGETS_UP,ELVIDGE_HIF1A_TARGETS_UP,4/151,67/21728,0.001223043871192684,0.01649328094258872,0.012124195759396049,DOLK/HSPA4/JAK2/SCYL2,4
PID_P75_NTR_PATHWAY,PID_P75_NTR_PATHWAY,4/151,68/21728,0.0012925373352871638,0.01734622568805672,0.012751194662888878,NCSTN/BIRC3/SORT1/FURIN,4
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,5/151,116/21728,0.001310048070873895,0.01741298344922335,0.01280026823215994,CTNND1/ACTB/ACTG1/CTNNA1/ACTN4,5
REACTOME_PARASITE_INFECTION,REACTOME_PARASITE_INFECTION,5/151,116/21728,0.001310048070873895,0.01741298344922335,0.01280026823215994,ACTB/ACTG1/ACTR2/ACTR3/CRK,5
NAGASHIMA_NRG1_SIGNALING_UP,NAGASHIMA_NRG1_SIGNALING_UP,6/151,173/21728,0.0013432089304843539,0.01776873528040731,0.013061781078394218,STK24/DUSP5/PPP1R15A/EPHA2/MAP2K3/LDLR,6
NOJIMA_SFRP2_TARGETS_UP,NOJIMA_SFRP2_TARGETS_UP,3/151,32/21728,0.0014076761830031418,0.018433410702459452,0.01355038337416973,HSPA9/HSPA5/PPP1R15A,3
REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,3/151,32/21728,0.0014076761830031418,0.018433410702459452,0.01355038337416973,UBC/PPP1R15A/FURIN,3
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,5/151,118/21728,0.0014133608637954872,0.018433410702459452,0.01355038337416973,SSR1/YWHAZ/ATP13A3/LDHA/CTNNA1,5
KEGG_RENAL_CELL_CARCINOMA,KEGG_RENAL_CELL_CARCINOMA,4/151,70/21728,0.001439722054263838,0.018531560880400342,0.013622533480344309,ARAF/MET/EGLN1/CRK,4
WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,4/151,70/21728,0.001439722054263838,0.018531560880400342,0.013622533480344309,HSPA9/HSPA5/HSPA4/HSPA8,4
ALFANO_MYC_TARGETS,ALFANO_MYC_TARGETS,7/151,239/21728,0.0014408989021477588,0.018531560880400342,0.013622533480344309,CTNND1/PTPN12/AKAP12/PPP1R15A/PDLIM4/PCDH8/SDC4,7
WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,8/151,309/21728,0.0014664690019843042,0.018773506394066348,0.013800387406497939,HSP90B1/LAMC1/MET/ITGB3/SLC2A3/JAK2/LAMA5/EPHA2,8
REACTOME_INTERLEUKIN_17_SIGNALING,REACTOME_INTERLEUKIN_17_SIGNALING,4/151,71/21728,0.0015175248267296348,0.019337999856215256,0.014215346035033759,UBC/RPS6KA3/DUSP3/MAP2K3,4
PID_INTEGRIN_A4B1_PATHWAY,PID_INTEGRIN_A4B1_PATHWAY,3/151,33/21728,0.0015406038712236934,0.01945362524663373,0.014300342153942415,PRKAR1A/YWHAZ/CRK,3
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN,3/151,33/21728,0.0015406038712236934,0.01945362524663373,0.014300342153942415,SSR1/CSNK1A1/NRIP1,3
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,6/151,178/21728,0.0015531162223901592,0.019522881745700733,0.014351252543162225,DUSP5/LDHA/PTPN14/PERP/SLC2A3/EGLN1,6
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,10/151,466/21728,0.0015923389988912204,0.019820641557870593,0.014570135509176975,STK24/TRIP12/ARIH1/ATP13A3/PTPN12/PKD2/GBE1/NRIP1/SLC4A7/SEC24A,10
REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING,REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING,4/151,72/21728,0.0015982086785324022,0.019820641557870593,0.014570135509176975,CLTC/ACBD3/SORT1/HSPA8,4
REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE,REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE,4/151,72/21728,0.0015982086785324022,0.019820641557870593,0.014570135509176975,ACTB/ACTG1/YWHAZ/PRKAG1,4
LINDGREN_BLADDER_CANCER_CLUSTER_2B,LINDGREN_BLADDER_CANCER_CLUSTER_2B,9/151,389/21728,0.0016334555037592691,0.020167730619747776,0.014825280361604595,PRKAR1A/SSR1/YWHAZ/RALB/DUSP5/AKAP12/BIRC3/MOXD1/TPM1,9
GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,3/151,34/21728,0.0016811422227643563,0.02058203107655342,0.015129832249067348,AKAP12/PPP1R15A/EGLN1,3
WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,4/151,73/21728,0.0016818290332532852,0.02058203107655342,0.015129832249067348,SEC23A/SEC24A/PRKAG1/LDLR,4
WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,5/151,123/21728,0.0016978346269332022,0.020686774533422964,0.01520682906856146,PRKAR1A/MET/ITGB3/CTNNA1/EPHA2,5
JISON_SICKLE_CELL_DISEASE_UP,JISON_SICKLE_CELL_DISEASE_UP,6/151,182/21728,0.0017383112501767684,0.020905232007479253,0.015367416958247032,ITGB3/SLC2A3/PRDX1/JAK2/TPM1/CD151,6
WANG_CLIM2_TARGETS_DN,WANG_CLIM2_TARGETS_DN,6/151,182/21728,0.0017383112501767684,0.020905232007479253,0.015367416958247032,RARS1/SEC23A/DUSP3/ACBD3/CRK/PGM3,6
REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,5/151,124/21728,0.0017594205663200592,0.020905232007479253,0.015367416958247032,HSP90B1/PDIA6/LAMC1/CALU/APLP2,5
REACTOME_RHOC_GTPASE_CYCLE,REACTOME_RHOC_GTPASE_CYCLE,4/151,74/21728,0.0017684411525405413,0.020905232007479253,0.015367416958247032,PKN1/IQGAP1/LMAN1/FLOT2,4
REACTOME_RHOG_GTPASE_CYCLE,REACTOME_RHOG_GTPASE_CYCLE,4/151,74/21728,0.0017684411525405413,0.020905232007479253,0.015367416958247032,LMAN1/STBD1/EPHA2/PGRMC2,4
SESTO_RESPONSE_TO_UV_C1,SESTO_RESPONSE_TO_UV_C1,4/151,74/21728,0.0017684411525405413,0.020905232007479253,0.015367416958247032,ETF1/DUSP5/EIF4H/MAP2K3,4
WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,4/151,74/21728,0.0017684411525405413,0.020905232007479253,0.015367416958247032,ITGB3/ACTN4/LAMA5/CD151,4
LI_AMPLIFIED_IN_LUNG_CANCER,LI_AMPLIFIED_IN_LUNG_CANCER,6/151,183/21728,0.0017871235655901386,0.0210365646830907,0.01546395948815731,HSP90B1/YWHAZ/HSPA5/KDELR1/LDHA/PRDX1,6
WP_MAPK_SIGNALING_PATHWAY,WP_MAPK_SIGNALING_PATHWAY,7/151,249/21728,0.0018194214935872313,0.021264433727721174,0.015631465814777413,ARAF/RPS6KA3/DUSP3/RASA2/CRK/HSPA8/MAP2K3,7
PID_ARF6_PATHWAY,PID_ARF6_PATHWAY,3/151,35/21728,0.0018294455222913463,0.021264433727721174,0.015631465814777413,MET/ITGB3/EPHA2,3
SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES,SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES,3/151,35/21728,0.0018294455222913463,0.021264433727721174,0.015631465814777413,ACTG1/ACTR2/ACTR3,3
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,4/151,75/21728,0.0018581001212272046,0.021418266127672923,0.01574454787150372,WWTR1/ADAM9/MET/SLC4A7,4
REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,4/151,75/21728,0.0018581001212272046,0.021418266127672923,0.01574454787150372,UBC/WWTR1/PPP1R15A/FURIN,4
REACTOME_RHO_GTPASE_EFFECTORS,REACTOME_RHO_GTPASE_EFFECTORS,8/151,322/21728,0.0018984662406180148,0.021762324990620384,0.01599746522746525,ACTB/ACTG1/PKN1/YWHAZ/IQGAP1/ACTR2/ACTR3/CTNNA1,8
DANG_REGULATED_BY_MYC_DN,DANG_REGULATED_BY_MYC_DN,7/151,251/21728,0.0019036159009073988,0.021762324990620384,0.01599746522746525,TRIP12/LAMC1/AKAP12/PPP1R15A/PERP/TPM1/CD151,7
LEI_MYB_TARGETS,LEI_MYB_TARGETS,8/151,323/21728,0.0019354563919030479,0.02203564695371585,0.01619838395294182,RARS1/UBC/ACTR2/HSPA4/ACBD3/SLC2A3/TPM1/LAMA5,8
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP,4/151,76/21728,0.0019508608328191043,0.022066094209102077,0.0162207657025721,ATP6V1C1/CALU/ATP1A1/MAP2K3,4
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,5/151,127/21728,0.001954016981799536,0.022066094209102077,0.0162207657025721,APLP2/PKD2/NRIP1/DNAJC10/ACTN4,5
GUTIERREZ_MULTIPLE_MYELOMA_UP,GUTIERREZ_MULTIPLE_MYELOMA_UP,3/151,36/21728,0.0019856637837202045,0.022242637061188418,0.016350542191923587,YWHAZ/ETF1/VDAC1,3
MMS_MOUSE_LYMPH_HIGH_4HRS_UP,MMS_MOUSE_LYMPH_HIGH_4HRS_UP,3/151,36/21728,0.0019856637837202045,0.022242637061188418,0.016350542191923587,PRKAR1A/ACTG1/ATP6V1A,3
KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,4/151,77/21728,0.002046777975347346,0.02274379686205971,0.0167189443038899,CSNK1A1/RPS6KA3/TPM1/ACTN4,4
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP,4/151,77/21728,0.002046777975347346,0.02274379686205971,0.0167189443038899,ACTB/LDHA/SLC2A3/ZNF330,4
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP,2/151,10/21728,0.0020814688010234784,0.022855021064202462,0.0168007051133162,TM9SF2/STK24,2
REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES,REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES,2/151,10/21728,0.0020814688010234784,0.022855021064202462,0.0168007051133162,HSP90B1/HSPA5,2
REACTOME_MET_RECEPTOR_RECYCLING,REACTOME_MET_RECEPTOR_RECYCLING,2/151,10/21728,0.0020814688010234784,0.022855021064202462,0.0168007051133162,MET/CRK,2
KEGG_AXON_GUIDANCE,KEGG_AXON_GUIDANCE,5/151,129/21728,0.002092201911705562,0.02288242878235453,0.016820852501901327,MET/EFNB2/UNC5C/EPHA2/EPHB4,5
GUO_HEX_TARGETS_UP,GUO_HEX_TARGETS_UP,4/151,78/21728,0.002145906017579589,0.023149384244716627,0.017017091218502617,WWTR1/IQGAP1/ATP6V1A/AKAP12,4
REACTOME_RHOV_GTPASE_CYCLE,REACTOME_RHOV_GTPASE_CYCLE,3/151,37/21728,0.0021499428132242225,0.023149384244716627,0.017017091218502617,CLTC/IQGAP1/EPHA2,3
WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,3/151,37/21728,0.0021499428132242225,0.023149384244716627,0.017017091218502617,LDHA/SLC2A3/EGLN1,3
WP_PRION_DISEASE_PATHWAY,WP_PRION_DISEASE_PATHWAY,3/151,37/21728,0.0021499428132242225,0.023149384244716627,0.017017091218502617,HSP90B1/PDIA3/HSPA5,3
DANG_MYC_TARGETS_UP,DANG_MYC_TARGETS_UP,5/151,130/21728,0.002163907390466026,0.023209786605075753,0.01706149293844377,HSPA9/HSPA4/LDHA/PRPS2/HSPA8,5
APPIERTO_RESPONSE_TO_FENRETINIDE_UP,APPIERTO_RESPONSE_TO_FENRETINIDE_UP,3/151,38/21728,0.0023224242715069723,0.024531158274701023,0.01803283204612178,HSPA4/HSPA8/SDC4,3
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR,HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR,3/151,38/21728,0.0023224242715069723,0.024531158274701023,0.01803283204612178,UBC/ACTB/LOXL1,3
REACTOME_DNA_DAMAGE_RECOGNITION_IN_GG_NER,REACTOME_DNA_DAMAGE_RECOGNITION_IN_GG_NER,3/151,38/21728,0.0023224242715069723,0.024531158274701023,0.01803283204612178,UBC/ACTB/COPS2,3
WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,3/151,38/21728,0.0023224242715069723,0.024531158274701023,0.01803283204612178,ACTG1/TPM1/ACTN4,3
ELVIDGE_HYPOXIA_BY_DMOG_UP,ELVIDGE_HYPOXIA_BY_DMOG_UP,5/151,133/21728,0.002389784325758822,0.025110934392416066,0.018459024940808297,STBD1/GBE1/AKAP12/MET/EGLN1,5
ALONSO_METASTASIS_UP,ALONSO_METASTASIS_UP,6/151,194/21728,0.0023953915097157156,0.025110934392416066,0.018459024940808297,STK24/PRKAR1A/VDAC1/APLP2/CBFB/HSPA8,6
AMIT_SERUM_RESPONSE_480_MCF10A,AMIT_SERUM_RESPONSE_480_MCF10A,3/151,39/21728,0.002503245735346454,0.025864368355271367,0.019012873558874786,TPM1/ACTN4/PVR,3
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN,2/151,11/21728,0.0025324363544398172,0.025864368355271367,0.019012873558874786,EFNB2/SLC35D1,2
PID_INTEGRIN4_PATHWAY,PID_INTEGRIN4_PATHWAY,2/151,11/21728,0.0025324363544398172,0.025864368355271367,0.019012873558874786,LAMC1/LAMA5,2
PID_P38_GAMMA_DELTA_PATHWAY,PID_P38_GAMMA_DELTA_PATHWAY,2/151,11/21728,0.0025324363544398172,0.025864368355271367,0.019012873558874786,PKN1/MAP2K3,2
REACTOME_MET_ACTIVATES_RAP1_AND_RAC1,REACTOME_MET_ACTIVATES_RAP1_AND_RAC1,2/151,11/21728,0.0025324363544398172,0.025864368355271367,0.019012873558874786,MET/CRK,2
REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,2/151,11/21728,0.0025324363544398172,0.025864368355271367,0.019012873558874786,NCSTN/YWHAZ,2
REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS,REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS,2/151,11/21728,0.0025324363544398172,0.025864368355271367,0.019012873558874786,MAP2K3/FURIN,2
REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,4/151,82/21728,0.0025756081419730415,0.02611328254890916,0.019195850155311948,HSPA9/HSPA5/HSPA4/HSPA8,4
REACTOME_SELECTIVE_AUTOPHAGY,REACTOME_SELECTIVE_AUTOPHAGY,4/151,82/21728,0.0025756081419730415,0.02611328254890916,0.019195850155311948,UBC/VDAC1/HSPA8/PRKAG1,4
KEGG_MAPK_SIGNALING_PATHWAY,KEGG_MAPK_SIGNALING_PATHWAY,7/151,267/21728,0.00269100246438034,0.026906036787360983,0.019778603072062563,RPS6KA3/DUSP5/DUSP3/RASA2/CRK/HSPA8/MAP2K3,7
NGUYEN_NOTCH1_TARGETS_DN,NGUYEN_NOTCH1_TARGETS_DN,4/151,83/21728,0.0026915991188336793,0.026906036787360983,0.019778603072062563,TRIP12/LAMA5/SLC12A4/GARS1,4
PID_EPHB_FWD_PATHWAY,PID_EPHB_FWD_PATHWAY,3/151,40/21728,0.002692540758418414,0.026906036787360983,0.019778603072062563,EFNB2/CRK/EPHB4,3
REACTOME_RHOU_GTPASE_CYCLE,REACTOME_RHOU_GTPASE_CYCLE,3/151,40/21728,0.002692540758418414,0.026906036787360983,0.019778603072062563,CLTC/IQGAP1/EPHA2,3
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,8/151,341/21728,0.0027041942179454772,0.026925632750725934,0.0197930080468373,ATP6V1C1/DUSP5/BIRC3/PRDX1/PVR/TRIP10/LDLR/SDC4,8
PID_P53_DOWNSTREAM_PATHWAY,PID_P53_DOWNSTREAM_PATHWAY,5/151,137/21728,0.0027170240635497845,0.02695676017336179,0.019815889786791663,DUSP5/MET/PERP/PML/EPHA2,5
WANG_CLIM2_TARGETS_UP,WANG_CLIM2_TARGETS_UP,7/151,268/21728,0.002747427803256095,0.02716140369197663,0.01996632305044699,PTPN12/LMAN1/ITPRID2/MET/NRIP1/DNAJC10/CTNNA1,7
MOOTHA_PGC,MOOTHA_PGC,9/151,421/21728,0.0027812586973993206,0.027258742870188056,0.02003787699146104,UBC/HSPA9/ARIH1/ATP1A1/HSPA5/ACTR2/LDHA/EGLN1/MAP2K3,9
GRUETZMANN_PANCREATIC_CANCER_DN,GRUETZMANN_PANCREATIC_CANCER_DN,6/151,200/21728,0.002786710934173293,0.027258742870188056,0.02003787699146104,SSR1/SEL1L/LMAN1/ITPRID2/SLC33A1/LOXL1,6
JIANG_HYPOXIA_NORMAL,JIANG_HYPOXIA_NORMAL,6/151,200/21728,0.002786710934173293,0.027258742870188056,0.02003787699146104,LAMC1/HSPA5/PTPN12/STBD1/AKAP12/PPP1R15A,6
KEGG_ECM_RECEPTOR_INTERACTION,KEGG_ECM_RECEPTOR_INTERACTION,4/151,84/21728,0.0028111224750970477,0.027401046441472274,0.020142484216761857,LAMC1/ITGB3/LAMA5/SDC4,4
RUTELLA_RESPONSE_TO_HGF_UP,RUTELLA_RESPONSE_TO_HGF_UP,9/151,422/21728,0.0028253744981449934,0.02744367257289088,0.02017381864704191,ATP6V1C1/ATP13A3/DUSP5/BIRC3/PRDX1/PVR/TRIP10/LDLR/SDC4,9
KEGG_AMINOACYL_TRNA_BIOSYNTHESIS,KEGG_AMINOACYL_TRNA_BIOSYNTHESIS,3/151,41/21728,0.002890438931406148,0.027977837461485293,0.02056648276885358,RARS1/IARS2/GARS1,3
WP_PI3KAKT_SIGNALING_PATHWAY,WP_PI3KAKT_SIGNALING_PATHWAY,8/151,345/21728,0.002903641210822706,0.02800803917939402,0.020588684024108368,HSP90B1/PKN1/LAMC1/MET/ITGB3/JAK2/LAMA5/EPHA2,8
REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,5/151,140/21728,0.002982911368397919,0.02843872383516176,0.02090527992126627,NCSTN/LAMC1/ADAM9/LAMA5/FURIN,5
BIOCARTA_PRION_PATHWAY,BIOCARTA_PRION_PATHWAY,2/151,12/21728,0.003025097173673229,0.02843872383516176,0.02090527992126627,LAMC1/HSPA5,2
ITO_PTTG1_TARGETS_UP,ITO_PTTG1_TARGETS_UP,2/151,12/21728,0.003025097173673229,0.02843872383516176,0.02090527992126627,CALU/SLC2A3,2
REACTOME_ALK_MUTANTS_BIND_TKIS,REACTOME_ALK_MUTANTS_BIND_TKIS,2/151,12/21728,0.003025097173673229,0.02843872383516176,0.02090527992126627,PRKAR1A/CLTC,2
REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONES,REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONES,2/151,12/21728,0.003025097173673229,0.02843872383516176,0.02090527992126627,HSP90B1/HSPA5,2
SASSON_RESPONSE_TO_GONADOTROPHINS_UP,SASSON_RESPONSE_TO_GONADOTROPHINS_UP,4/151,86/21728,0.0030609763157321015,0.02843872383516176,0.02090527992126627,PRKAR1A/ACTB/ACTR2/DUSP3,4
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,6/151,204/21728,0.003072995413902851,0.02843872383516176,0.02090527992126627,HSPA5/DUSP5/BIRC3/PPP1R15A/EFNB2/JAK2,6
WELCSH_BRCA1_TARGETS_DN,WELCSH_BRCA1_TARGETS_DN,5/151,141/21728,0.0030755751713685163,0.02843872383516176,0.02090527992126627,HSP90B1/RARS1/PKN1/VDAC1/EIF4H,5
ELLWOOD_MYC_TARGETS_DN,ELLWOOD_MYC_TARGETS_DN,3/151,42/21728,0.003097065941404216,0.02843872383516176,0.02090527992126627,PDIA6/MCFD2/DNAJC10,3
REACTOME_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION,REACTOME_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION,3/151,42/21728,0.003097065941404216,0.02843872383516176,0.02090527992126627,FURIN/ARSJ/ICMT,3
REACTOME_RHOF_GTPASE_CYCLE,REACTOME_RHOF_GTPASE_CYCLE,3/151,42/21728,0.003097065941404216,0.02843872383516176,0.02090527992126627,ACTB/AKAP12/SLC4A7,3
REACTOME_TRNA_AMINOACYLATION,REACTOME_TRNA_AMINOACYLATION,3/151,42/21728,0.003097065941404216,0.02843872383516176,0.02090527992126627,RARS1/IARS2/GARS1,3
WIERENGA_PML_INTERACTOME,WIERENGA_PML_INTERACTOME,3/151,42/21728,0.003097065941404216,0.02843872383516176,0.02090527992126627,ACTG1/CALU/HSPA5,3
WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,3/151,42/21728,0.003097065941404216,0.02843872383516176,0.02090527992126627,ARAF/ACTB/ACTG1,3
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,9/151,428/21728,0.0031018478481115957,0.02843872383516176,0.02090527992126627,SEPTIN11/CALU/MCFD2/PPP1R15A/MET/NRIP1/MOXD1/SLC2A3/PGM3,9
SHEPARD_CRASH_AND_BURN_MUTANT_UP,SHEPARD_CRASH_AND_BURN_MUTANT_UP,6/151,205/21728,0.003147878892808005,0.02876581435598894,0.021145723864430505,SSR1/HSPA9/ETF1/DUSP5/HSPA4/ZNF330,6
ALCALA_APOPTOSIS,ALCALA_APOPTOSIS,4/151,87/21728,0.0031914109909437368,0.02906799912407115,0.0213678596114956,VDAC1/ATP1A1/RALB/HSPA8,4
REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,5/151,143/21728,0.00326711015411858,0.02966023532072358,0.02180321189883057,ACTB/ACTG1/ACTR2/ACTR3/CRK,5
REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY,REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY,3/151,43/21728,0.0033125436306233047,0.029974743341601107,0.022034406457772028,ARAF/UBC/DUSP5,3
KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,4/151,88/21728,0.0033255864059314457,0.029995061804147908,0.02204934254103556,PDIA3/HSPA5/HSPA4/HSPA8,4
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,8/151,353/21728,0.0033368904130510672,0.02999961672315814,0.022052690857840472,SEPTIN11/LAMC1/WWTR1/SEC23A/PKD2/EML1/SLC2A3/LOXL1,8
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,8/151,354/21728,0.0033943985859481883,0.030418191199238925,0.022360384572969388,ACTG1/HSPA5/PPP1R15A/ZNF330/PAFAH2/LDLR/SDC4/PGRMC2,8
SEIDEN_ONCOGENESIS_BY_MET,SEIDEN_ONCOGENESIS_BY_MET,4/151,89/21728,0.0034635538045946507,0.030938110833324563,0.02274257702120028,SEC23A/ADAM9/HSPA4/ACTR3,4
HASINA_NOL7_TARGETS_DN,HASINA_NOL7_TARGETS_DN,2/151,13/21728,0.0035588577467776223,0.0315862837717196,0.023219048356309356,EML1/MET,2
VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN,VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN,2/151,13/21728,0.0035588577467776223,0.0315862837717196,0.023219048356309356,HSPA8/PTGES3,2
BROCKE_APOPTOSIS_REVERSED_BY_IL6,BROCKE_APOPTOSIS_REVERSED_BY_IL6,5/151,146/21728,0.0035703191235790938,0.03158709084491313,0.023219641635076907,DUSP5/DUSP3/SLC2A3/LDLR/SBNO2,5
KEGG_DILATED_CARDIOMYOPATHY,KEGG_DILATED_CARDIOMYOPATHY,4/151,90/21728,0.0036053640720994894,0.03169525757054551,0.02329915489631249,ACTB/ACTG1/ITGB3/TPM1,4
TIEN_INTESTINE_PROBIOTICS_2HR_DN,TIEN_INTESTINE_PROBIOTICS_2HR_DN,4/151,90/21728,0.0036053640720994894,0.03169525757054551,0.02329915489631249,WWTR1/FNDC3B/SEC23A/RECQL,4
KAAB_FAILED_HEART_ATRIUM_DN,KAAB_FAILED_HEART_ATRIUM_DN,5/151,147/21728,0.003675733886052347,0.03221195184685622,0.023678976386988394,ACTB/YWHAZ/LDHA/PRDX1/CTNNA1,5
FAELT_B_CLL_WITH_VH3_21_UP,FAELT_B_CLL_WITH_VH3_21_UP,3/151,45/21728,0.0037705195385428912,0.032835433473580415,0.0241372971614361,VDAC1/ACTN4/SBNO2,3
REACTOME_ELASTIC_FIBRE_FORMATION,REACTOME_ELASTIC_FIBRE_FORMATION,3/151,45/21728,0.0037705195385428912,0.032835433473580415,0.0241372971614361,ITGB3/FURIN/LOXL1,3
WANG_LMO4_TARGETS_DN,WANG_LMO4_TARGETS_DN,8/151,361/21728,0.0038188347328317923,0.033152259024395996,0.024370195334518674,CTNND1/TRIP12/ATP6V1C1/IQGAP1/ACTR2/DUSP3/ACBD3/SCFD1,8
ELVIDGE_HIF1A_TARGETS_DN,ELVIDGE_HIF1A_TARGETS_DN,4/151,92/21728,0.003900714903232606,0.033652751556460185,0.024738106937794234,STBD1/GBE1/EGLN1/LOXL1,4
REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,4/151,92/21728,0.003900714903232606,0.033652751556460185,0.024738106937794234,HSP90B1/PDIA6/SSR1/HSPA5,4
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,7/151,286/21728,0.003927177435318797,0.03377615763255609,0.024828822631639127,HIVEP3/BIRC3/PPP1R15A/ITGB3/EFNB2/LDLR/SDC4,7
DE_YY1_TARGETS_DN,DE_YY1_TARGETS_DN,4/151,93/21728,0.004054355358423118,0.03476234316573896,0.025553766716506984,HSP90B1/ARIH1/WDR1/MET,4
REACTOME_AUTOPHAGY,REACTOME_AUTOPHAGY,5/151,151/21728,0.00411980605699845,0.03511265165454457,0.02581127816672975,UBC/VDAC1/BECN1/HSPA8/PRKAG1,5
BIOCARTA_AKAPCENTROSOME_PATHWAY,BIOCARTA_AKAPCENTROSOME_PATHWAY,2/151,14/21728,0.004133130702316802,0.03511265165454457,0.02581127816672975,PKN1/PRKAG1,2
BIOCARTA_GATA3_PATHWAY,BIOCARTA_GATA3_PATHWAY,2/151,14/21728,0.004133130702316802,0.03511265165454457,0.02581127816672975,PRKAR1A/MAP2K3,2
GENTILE_UV_HIGH_DOSE_DN,GENTILE_UV_HIGH_DOSE_DN,7/151,289/21728,0.004156293368100473,0.03520177736763144,0.02587679439703119,RARS1/ATP13A3/DUSP5/MET/NRIP1/TRIP10/PGRMC2,7
REACTOME_RAC3_GTPASE_CYCLE,REACTOME_RAC3_GTPASE_CYCLE,4/151,94/21728,0.004212038447761608,0.03545770547842953,0.026064926917567847,LMAN1/STBD1/EPHA2/PGRMC2,4
REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,4/151,94/21728,0.004212038447761608,0.03545770547842953,0.026064926917567847,UBC/RPS6KA3/DUSP3/MAP2K3,4
VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,6/151,220/21728,0.004442216626145512,0.037282410233934235,0.027406265717037026,HSP90B1/MFSD5/ATP6V1A/TMCO3/LDLR/FLII,6
REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS,REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS,3/151,48/21728,0.004526694852960507,0.037876982835916534,0.0278433354937964,LRP12/LDLR/SDC4,3
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,9/151,454/21728,0.004556120872595143,0.0380087200722802,0.02794017541594619,FNDC3B/DUSP5/STBD1/AKAP12/PPP1R15A/MAP2K3/TRIP10/LDLR/SDC4,9
CHEN_HOXA5_TARGETS_9HR_UP,CHEN_HOXA5_TARGETS_9HR_UP,6/151,223/21728,0.0047421847341440745,0.038631328700661494,0.02839785445010924,ARIH1/DUSP5/FEM1C/NRBF2/BIRC3/SEC24A,6
FINETTI_BREAST_CANCERS_KINOME_GRAY,FINETTI_BREAST_CANCERS_KINOME_GRAY,2/151,15/21728,0.004747334753608897,0.038631328700661494,0.02839785445010924,CSNK1A1/SCYL2,2
REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL,REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL,2/151,15/21728,0.004747334753608897,0.038631328700661494,0.02839785445010924,UBC/MET,2
REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,2/151,15/21728,0.004747334753608897,0.038631328700661494,0.02839785445010924,ITGB3/CRK,2
VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP,VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP,2/151,15/21728,0.004747334753608897,0.038631328700661494,0.02839785445010924,PRKAR1A/SLC12A4,2
WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,2/151,15/21728,0.004747334753608897,0.038631328700661494,0.02839785445010924,SEL1L/LDLR,2
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP,JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP,3/151,49/21728,0.004797627214445001,0.038631328700661494,0.02839785445010924,NCSTN/CALU/MAP2K3,3
JIANG_AGING_CEREBRAL_CORTEX_DN,JIANG_AGING_CEREBRAL_CORTEX_DN,3/151,49/21728,0.004797627214445001,0.038631328700661494,0.02839785445010924,CSNK1A1/ATP1A1/ACTR3,3
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN,PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN,3/151,49/21728,0.004797627214445001,0.038631328700661494,0.02839785445010924,PDIA6/PDIA3/KDELR1,3
PID_ARF6_TRAFFICKING_PATHWAY,PID_ARF6_TRAFFICKING_PATHWAY,3/151,49/21728,0.004797627214445001,0.038631328700661494,0.02839785445010924,CTNND1/CLTC/CTNNA1,3
PID_FOXO_PATHWAY,PID_FOXO_PATHWAY,3/151,49/21728,0.004797627214445001,0.038631328700661494,0.02839785445010924,YWHAZ/CSNK1A1/RALB,3
REACTOME_TRANSLATION_OF_SARS_COV_2_STRUCTURAL_PROTEINS,REACTOME_TRANSLATION_OF_SARS_COV_2_STRUCTURAL_PROTEINS,3/151,49/21728,0.004797627214445001,0.038631328700661494,0.02839785445010924,UBC/CSNK1A1/MGAT4B,3
WEST_ADRENOCORTICAL_TUMOR_UP,WEST_ADRENOCORTICAL_TUMOR_UP,7/151,298/21728,0.004904733269500103,0.03937962145280719,0.028947923768878007,RARS1/DOLK/VDAC1/ATP1A1/ACTR2/SLC35D1/ICMT,7
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,8/151,378/21728,0.00502093288852032,0.040010813952506004,0.029411912799007862,ATP13A3/FEM1C/STBD1/BIRC3/RASA2/SEC24A/PML/SDC4,8
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,8/151,378/21728,0.00502093288852032,0.040010813952506004,0.029411912799007862,ACTB/API5/DUSP3/HUS1/PML/MAP2K3/FURIN/EPHB4,8
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,9/151,461/21728,0.005026556540469617,0.040010813952506004,0.029411912799007862,APLP2/AKAP12/BIRC3/MET/EFNB2/SORT1/TPM1/RRBP1/SDC4,9
WP_COMPLEMENT_SYSTEM,WP_COMPLEMENT_SYSTEM,4/151,99/21728,0.0050627921659040405,0.04006962004809523,0.029455141106174358,LAMC1/CSNK1A1/ITGB3/LAMA5,4
WP_HIPPO_SIGNALING_REGULATION_PATHWAYS,WP_HIPPO_SIGNALING_REGULATION_PATHWAYS,4/151,99/21728,0.0050627921659040405,0.04006962004809523,0.029455141106174358,PRKAR1A/MET/PRKAG1/EPHA2,4
REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES,REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES,3/151,50/21728,0.005078160281626405,0.04007707176806294,0.029460618858717782,PDIA6/SSR1/HSPA5,3
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,6/151,227/21728,0.005165026763291572,0.04064715112867985,0.029879683676116445,STK24/PRKAR1A/IQGAP1/FLOT2/ACTN4/FLII,6
MENSE_HYPOXIA_UP,MENSE_HYPOXIA_UP,4/151,100/21728,0.005245744370333625,0.04093448837299665,0.0300909050220202,GBE1/PPP1R15A/SLC2A3/EGLN1,4
REACTOME_VISUAL_PHOTOTRANSDUCTION,REACTOME_VISUAL_PHOTOTRANSDUCTION,4/151,100/21728,0.005245744370333625,0.04093448837299665,0.0300909050220202,LRP12/FNTB/LDLR/SDC4,4
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11,4/151,100/21728,0.005245744370333625,0.04093448837299665,0.0300909050220202,HSP90B1/PDIA6/HSPA5/BECN1,4
FRASOR_TAMOXIFEN_RESPONSE_UP,FRASOR_TAMOXIFEN_RESPONSE_UP,3/151,51/21728,0.005368387169505035,0.04121891571285472,0.030299987299813633,YWHAZ/GBE1/EFNB2,3
REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION,REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION,3/151,51/21728,0.005368387169505035,0.04121891571285472,0.030299987299813633,ACTB/ACTG1/CLTC,3
SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES,SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES,3/151,51/21728,0.005368387169505035,0.04121891571285472,0.030299987299813633,YWHAZ/RPS6KA3/FLOT2,3
VERHAAK_GLIOBLASTOMA_CLASSICAL,VERHAAK_GLIOBLASTOMA_CLASSICAL,5/151,161/21728,0.00539584297666831,0.04121891571285472,0.030299987299813633,SEPTIN11/PTPN14/CD151/SLC12A4/EPHB4,5
REACTOME_ASSEMBLY_OF_THE_HIV_VIRION,REACTOME_ASSEMBLY_OF_THE_HIV_VIRION,2/151,16/21728,0.005400894643441007,0.04121891571285472,0.030299987299813633,UBC/FURIN,2
REACTOME_GLYCOGEN_STORAGE_DISEASES,REACTOME_GLYCOGEN_STORAGE_DISEASES,2/151,16/21728,0.005400894643441007,0.04121891571285472,0.030299987299813633,UBC/GBE1,2
REACTOME_GLYCOGEN_SYNTHESIS,REACTOME_GLYCOGEN_SYNTHESIS,2/151,16/21728,0.005400894643441007,0.04121891571285472,0.030299987299813633,UBC/GBE1,2
REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS,REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS,2/151,16/21728,0.005400894643441007,0.04121891571285472,0.030299987299813633,UBC/NCSTN,2
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,8/151,383/21728,0.00542448194726609,0.041285509176726576,0.03034894009429334,RARS1/CSNK1A1/FEM1C/ITPRID2/LDHA/PCYT1A/NRBF2/PERP,8
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,9/151,467/21728,0.0054591358196519404,0.04143573581145653,0.030459371556297854,RARS1/HSPA9/ACTR2/FEM1B/PGM3/RECQL/RRBP1/EPHB4/FLII,9
PID_PTP1B_PATHWAY,PID_PTP1B_PATHWAY,3/151,52/21728,0.005668397646259847,0.04290683558940015,0.03154077565967046,ITGB3/CRK/JAK2,3
REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,4/151,103/21728,0.005821042424513476,0.0439425430850501,0.03230212329392489,UBC/RPS6KA3/DUSP3/MAP2K3,4
REACTOME_LEISHMANIA_INFECTION,REACTOME_LEISHMANIA_INFECTION,7/151,308/21728,0.00585090177091356,0.044048252356633795,0.03237983008293341,PRKAR1A/ACTB/ACTG1/ACTR2/ACTR3/CRK/FURIN,7
TIEN_INTESTINE_PROBIOTICS_6HR_UP,TIEN_INTESTINE_PROBIOTICS_6HR_UP,3/151,53/21728,0.005978278185350124,0.0448855589159531,0.03299533337006897,UBC/ACTB/HSPA8,3
REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,4/151,104/21728,0.006021773737205843,0.0449690522633275,0.033056709253478596,UBC/WWTR1/PPP1R15A/FURIN,4
WP_INTEGRINMEDIATED_CELL_ADHESION,WP_INTEGRINMEDIATED_CELL_ADHESION,4/151,104/21728,0.006021773737205843,0.0449690522633275,0.033056709253478596,ARAF/ITGB3/CRK/MAP2K3,4
KIM_HYPOXIA,KIM_HYPOXIA,2/151,17/21728,0.006093241089250366,0.04513872998916671,0.03318143919479498,LDHA/PDLIM4,2
KORKOLA_TERATOMA_UP,KORKOLA_TERATOMA_UP,2/151,17/21728,0.006093241089250366,0.04513872998916671,0.03318143919479498,SLC2A3/RECQL,2
REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY,REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY,2/151,17/21728,0.006093241089250366,0.04513872998916671,0.03318143919479498,CBFB/PML,2
BROWNE_HCMV_INFECTION_20HR_UP,BROWNE_HCMV_INFECTION_20HR_UP,6/151,236/21728,0.006216838704397449,0.0458853553444565,0.03373028281165761,DUSP3/EFNB2/HUS1/PGM3/PML/FURIN,6
REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,4/151,105/21728,0.006227062262368646,0.0458853553444565,0.03373028281165761,UBC/CLTC/COPS2/LDLR,4
KIM_WT1_TARGETS_8HR_UP,KIM_WT1_TARGETS_8HR_UP,5/151,167/21728,0.006283299283118713,0.045921667147530223,0.033756975584937524,WWTR1/SEL1L/CBFB/PDLIM4/MAP2K3,5
HENDRICKS_SMARCA4_TARGETS_UP,HENDRICKS_SMARCA4_TARGETS_UP,3/151,54/21728,0.006298112016993885,0.045921667147530223,0.033756975584937524,PERP/TPM1/ACTN4,3
PID_TAP63_PATHWAY,PID_TAP63_PATHWAY,3/151,54/21728,0.006298112016993885,0.045921667147530223,0.033756975584937524,PERP/FLOT2/PML,3
WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,3/151,54/21728,0.006298112016993885,0.045921667147530223,0.033756975584937524,PKN1/HSPA5/CTNNA1,3
SASAKI_ADULT_T_CELL_LEUKEMIA,SASAKI_ADULT_T_CELL_LEUKEMIA,5/151,168/21728,0.0064405874245246535,0.04671527902174801,0.03434035894895652,WWTR1/ATP6V1A/PRDX1/RECQL/ICMT,5
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,5/151,168/21728,0.0064405874245246535,0.04671527902174801,0.03434035894895652,ACBD3/EFNB2/DNAJC10/TPM1/SLC12A4,5
DOUGLAS_BMI1_TARGETS_DN,DOUGLAS_BMI1_TARGETS_DN,7/151,314/21728,0.006480598683845726,0.046883081103446425,0.034463710105977825,API5/ATP6V1A/DUSP3/PCYT1A/SLC33A1/BIRC3/PAFAH2,7
WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,3/151,55/21728,0.006627979179029603,0.04774632980368592,0.0350982834372137,ACTB/ACTG1/YWHAZ,3
HELLER_SILENCED_BY_METHYLATION_DN,HELLER_SILENCED_BY_METHYLATION_DN,4/151,107/21728,0.006651486549325576,0.04774632980368592,0.0350982834372137,HSP90B1/PPP1R15A/PGM3/PPFIBP1,4
KIM_MYCN_AMPLIFICATION_TARGETS_DN,KIM_MYCN_AMPLIFICATION_TARGETS_DN,4/151,107/21728,0.006651486549325576,0.04774632980368592,0.0350982834372137,AKAP12/RASA2/DNAJC10/RECQL,4
ONDER_CDH1_TARGETS_1_DN,ONDER_CDH1_TARGETS_1_DN,5/151,170/21728,0.0067634236537785644,0.04799125621397091,0.03527832861774983,SEPTIN11/ATP13A3/CBFB/HSPA8/SCYL2,5
KOBAYASHI_EGFR_SIGNALING_6HR_DN,KOBAYASHI_EGFR_SIGNALING_6HR_DN,2/151,18/21728,0.006823810728768362,0.04799125621397091,0.03527832861774983,DUSP5/EPHA2,2
REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS,REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS,2/151,18/21728,0.006823810728768362,0.04799125621397091,0.03527832861774983,ACTB/ACTG1,2
REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSYLATION_PRECURSOR_BIOSYNTHESIS,REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSYLATION_PRECURSOR_BIOSYNTHESIS,2/151,18/21728,0.006823810728768362,0.04799125621397091,0.03527832861774983,NUS1/DOLK,2
REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS,REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS,2/151,18/21728,0.006823810728768362,0.04799125621397091,0.03527832861774983,MET/SLC2A3,2
REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI,REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI,2/151,18/21728,0.006823810728768362,0.04799125621397091,0.03527832861774983,SEL1L/FURIN,2
TERAMOTO_OPN_TARGETS_CLUSTER_7,TERAMOTO_OPN_TARGETS_CLUSTER_7,2/151,18/21728,0.006823810728768362,0.04799125621397091,0.03527832861774983,PPP1R15A/RRBP1,2
WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,2/151,18/21728,0.006823810728768362,0.04799125621397091,0.03527832861774983,SEL1L/LDLR,2
IWANAGA_CARCINOGENESIS_BY_KRAS_UP,IWANAGA_CARCINOGENESIS_BY_KRAS_UP,5/151,171/21728,0.00692902037037541,0.0484914093097178,0.03564599070169851,ATP6V1C1/CSNK1A1/ATP1A1/LDHA/LDLR,5
KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,3/151,56/21728,0.006967956567167557,0.0484914093097178,0.03564599070169851,ACTB/ACTG1/YWHAZ,3
REACTOME_REGULATED_NECROSIS,REACTOME_REGULATED_NECROSIS,3/151,56/21728,0.006967956567167557,0.0484914093097178,0.03564599070169851,UBC/BIRC3/FLOT2,3
BERENJENO_TRANSFORMED_BY_RHOA_DN,BERENJENO_TRANSFORMED_BY_RHOA_DN,8/151,400/21728,0.006984310611435924,0.0484914093097178,0.03564599070169851,CTNND1/ACTB/SEC23A/SEL1L/APLP2/ATP6V1A/PKD2/AKAP12,8
LU_EZH2_TARGETS_DN,LU_EZH2_TARGETS_DN,8/151,400/21728,0.006984310611435924,0.0484914093097178,0.03564599070169851,LAMC1/PTPN12/CBFB/NRBF2/SEC24A/DIPK2A/CRK/CTNNA1,8
DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,6/151,242/21728,0.006999659875160848,0.0484914093097178,0.03564599070169851,LAMC1/YWHAZ/CALU/ADAM9/PTPN12/SLC4A7,6
WINTER_HYPOXIA_METAGENE,WINTER_HYPOXIA_METAGENE,6/151,243/21728,0.007136762798356355,0.049318226502074514,0.03625378326475865,HSP90B1/HSPA5/LDHA/GBE1/MET/SLC2A3,6
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,5/151,173/21728,0.007268691798515094,0.0500301386624135,0.036777109243712705,YWHAZ/CSNK1A1/CALU/PRKAG1/ZBTB38,5
UDAYAKUMAR_MED1_TARGETS_DN,UDAYAKUMAR_MED1_TARGETS_DN,6/151,244/21728,0.007275801302957183,0.0500301386624135,0.036777109243712705,DUSP5/FEM1C/SLC2A3/TPM1/LAMA5/EPHB4,6
GRESHOCK_CANCER_COPY_NUMBER_UP,GRESHOCK_CANCER_COPY_NUMBER_UP,7/151,323/21728,0.007518141973588822,0.05131558143963762,0.03772203705539653,PRKAR1A/CLTC/CBFB/BIRC3/MET/JAK2/PML,7
REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,4/151,111/21728,0.007556925733499395,0.05131558143963762,0.03772203705539653,HSP90B1/HSPA8/JAK2/LAMA5,4
REACTOME_DISEASES_OF_METABOLISM,REACTOME_DISEASES_OF_METABOLISM,6/151,246/21728,0.007559745599802482,0.05131558143963762,0.03772203705539653,NUS1/UBC/DOLK/GBE1/SLC35D1/SDC4,6
BIOCARTA_CHREBP_PATHWAY,BIOCARTA_CHREBP_PATHWAY,2/151,19/21728,0.007592046066123492,0.05131558143963762,0.03772203705539653,PRKAR1A/PRKAG1,2
REACTOME_EPHRIN_SIGNALING,REACTOME_EPHRIN_SIGNALING,2/151,19/21728,0.007592046066123492,0.05131558143963762,0.03772203705539653,EFNB2/EPHB4,2
REACTOME_LDL_CLEARANCE,REACTOME_LDL_CLEARANCE,2/151,19/21728,0.007592046066123492,0.05131558143963762,0.03772203705539653,CLTC/LDLR,2
REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT,REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT,2/151,19/21728,0.007592046066123492,0.05131558143963762,0.03772203705539653,UBC/BIRC3,2
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,7/151,324/21728,0.0076405896087731965,0.05151834449799015,0.03787108799443025,YWHAZ/WWTR1/CALU/ATP6V1A/PERP/SLC2A3/LRP12,7
REACTOME_IRON_UPTAKE_AND_TRANSPORT,REACTOME_IRON_UPTAKE_AND_TRANSPORT,3/151,58/21728,0.007678534191237081,0.05152407725424302,0.03787530213831664,UBC/ATP6V1C1/ATP6V1A,3
REACTOME_SIGNALING_BY_PDGF,REACTOME_SIGNALING_BY_PDGF,3/151,58/21728,0.007678534191237081,0.05152407725424302,0.03787530213831664,PTPN12/CRK/FURIN,3
MOHANKUMAR_HOXA1_TARGETS_UP,MOHANKUMAR_HOXA1_TARGETS_UP,8/151,410/21728,0.008048139925189858,0.053367255990645665,0.03923022114427365,TM9SF2/HSP90B1/IARS2/LDHA/UNC5C/EIF4H/HSPA8/ICMT,8
ELVIDGE_HYPOXIA_BY_DMOG_DN,ELVIDGE_HYPOXIA_BY_DMOG_DN,3/151,59/21728,0.008049272951792849,0.053367255990645665,0.03923022114427365,DOLK/HSPA4/JAK2,3
HUTTMANN_B_CLL_POOR_SURVIVAL_DN,HUTTMANN_B_CLL_POOR_SURVIVAL_DN,3/151,59/21728,0.008049272951792849,0.053367255990645665,0.03923022114427365,BIRC3/NRIP1/SLC4A7,3
REACTOME_RHOQ_GTPASE_CYCLE,REACTOME_RHOQ_GTPASE_CYCLE,3/151,59/21728,0.008049272951792849,0.053367255990645665,0.03923022114427365,IQGAP1/SLC4A7/TRIP10,3
WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,3/151,59/21728,0.008049272951792849,0.053367255990645665,0.03923022114427365,ARAF/MET/CRK,3
MITSIADES_RESPONSE_TO_APLIDIN_DN,MITSIADES_RESPONSE_TO_APLIDIN_DN,6/151,250/21728,0.008151525644052547,0.05378845187453201,0.03953984185388659,CLTC/EDEM3/ATP13A3/IQGAP1/CBFB/CTNNA1,6
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,6/151,250/21728,0.008151525644052547,0.05378845187453201,0.03953984185388659,DUSP5/BIRC3/PVR/TRIP10/LDLR/SDC4,6
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,5/151,179/21728,0.00835724746092943,0.05459125560707988,0.04012998214457011,FNDC3B/APLP2/RRBP1/TRIP10/EPHB4,5
BIOCARTA_STATHMIN_PATHWAY,BIOCARTA_STATHMIN_PATHWAY,2/151,20/21728,0.008397395418399687,0.05459125560707988,0.04012998214457011,PRKAR1A/HSPA5,2
KORKOLA_YOLK_SAC_TUMOR_UP,KORKOLA_YOLK_SAC_TUMOR_UP,2/151,20/21728,0.008397395418399687,0.05459125560707988,0.04012998214457011,SLC2A3/RECQL,2
SEIDEN_MET_SIGNALING,SEIDEN_MET_SIGNALING,2/151,20/21728,0.008397395418399687,0.05459125560707988,0.04012998214457011,API5/PRPS2,2
WANG_RECURRENT_LIVER_CANCER_UP,WANG_RECURRENT_LIVER_CANCER_UP,2/151,20/21728,0.008397395418399687,0.05459125560707988,0.04012998214457011,DNAJC10/ZBTB38,2
ZHU_SKIL_TARGETS_UP,ZHU_SKIL_TARGETS_UP,2/151,20/21728,0.008397395418399687,0.05459125560707988,0.04012998214457011,SEL1L/PPP1R15A,2
WP_KIT_RECEPTOR_SIGNALING_PATHWAY,WP_KIT_RECEPTOR_SIGNALING_PATHWAY,3/151,60/21728,0.008430399084030694,0.05459125560707988,0.04012998214457011,RPS6KA3/CRK/JAK2,3
WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,3/151,60/21728,0.008430399084030694,0.05459125560707988,0.04012998214457011,ACTB/CSNK1A1/ICMT,3
LENAOUR_DENDRITIC_CELL_MATURATION_UP,LENAOUR_DENDRITIC_CELL_MATURATION_UP,4/151,116/21728,0.008798247892354224,0.05673019716969933,0.0417023161339914,PKD2/DUSP5/BIRC3/PDLIM4,4
CUI_GLUCOSE_DEPRIVATION,CUI_GLUCOSE_DEPRIVATION,3/151,61/21728,0.00882197450587117,0.05673019716969933,0.0417023161339914,PDIA6/PDIA3/SLC33A1,3
PID_AR_PATHWAY,PID_AR_PATHWAY,3/151,61/21728,0.00882197450587117,0.05673019716969933,0.0417023161339914,RPS6KA3/NRIP1/PRDX1,3
KYNG_DNA_DAMAGE_DN,KYNG_DNA_DAMAGE_DN,5/151,182/21728,0.008941805413851027,0.057367980230203584,0.042171149879350896,CSNK1A1/CALU/AKAP12/TPM1/ACTN4,5
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,5/151,183/21728,0.00914277962307183,0.0584665401649925,0.04297870028422017,ATP1A1/IQGAP1/ITPRID2/PRPS2/PGRMC2,5
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,3/151,62/21728,0.009224058282150267,0.0584665401649925,0.04297870028422017,CTNND1/ATP1A1/ACTN4,3
CHIBA_RESPONSE_TO_TSA_DN,CHIBA_RESPONSE_TO_TSA_DN,2/151,21/21728,0.009239312862646403,0.0584665401649925,0.04297870028422017,ADAM9/BIRC3,2
PID_ECADHERIN_KERATINOCYTE_PATHWAY,PID_ECADHERIN_KERATINOCYTE_PATHWAY,2/151,21/21728,0.009239312862646403,0.0584665401649925,0.04297870028422017,CTNND1/CTNNA1,2
REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION,REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION,2/151,21/21728,0.009239312862646403,0.0584665401649925,0.04297870028422017,IARS2/GARS1,2
REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY,REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY,2/151,21/21728,0.009239312862646403,0.0584665401649925,0.04297870028422017,UBC/MET,2
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,3/151,63/21728,0.009636706670773272,0.060704696443102384,0.044623966920396586,PRKAR1A/ACTR2/PPP1R15A,3
REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS,REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS,3/151,63/21728,0.009636706670773272,0.060704696443102384,0.044623966920396586,NUS1/DOLK/PGM3,3
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,4/151,120/21728,0.009882002045274245,0.061906923421386394,0.045507722874271385,UBC/WWTR1/CBFB/HIVEP3,4
KIM_GERMINAL_CENTER_T_HELPER_UP,KIM_GERMINAL_CENTER_T_HELPER_UP,3/151,64/21728,0.01005997316830769,0.061906923421386394,0.045507722874271385,IQGAP1/ACTR3/PTPN14,3
JOHNSTONE_PARVB_TARGETS_2_DN,JOHNSTONE_PARVB_TARGETS_2_DN,7/151,342/21728,0.01010619253365735,0.061906923421386394,0.045507722874271385,SSR1/CSNK1A1/HSPA4/HIVEP3/GBE1/RASA2/ZNF654,7
FOURNIER_ACINAR_DEVELOPMENT_LATE_DN,FOURNIER_ACINAR_DEVELOPMENT_LATE_DN,2/151,22/21728,0.010117258183336725,0.061906923421386394,0.045507722874271385,ACTB/EPHA2,2
LANDIS_ERBB2_BREAST_TUMORS_65_UP,LANDIS_ERBB2_BREAST_TUMORS_65_UP,2/151,22/21728,0.010117258183336725,0.061906923421386394,0.045507722874271385,ATP6V1A/PERP,2
MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP,MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP,2/151,22/21728,0.010117258183336725,0.061906923421386394,0.045507722874271385,STBD1/PPP1R15A,2
REACTOME_CHAPERONE_MEDIATED_AUTOPHAGY,REACTOME_CHAPERONE_MEDIATED_AUTOPHAGY,2/151,22/21728,0.010117258183336725,0.061906923421386394,0.045507722874271385,UBC/HSPA8,2
REACTOME_ERK_MAPK_TARGETS,REACTOME_ERK_MAPK_TARGETS,2/151,22/21728,0.010117258183336725,0.061906923421386394,0.045507722874271385,RPS6KA3/DUSP3,2
REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,2/151,22/21728,0.010117258183336725,0.061906923421386394,0.045507722874271385,UBC/NCSTN,2
REACTOME_PINK1_PRKN_MEDIATED_MITOPHAGY,REACTOME_PINK1_PRKN_MEDIATED_MITOPHAGY,2/151,22/21728,0.010117258183336725,0.061906923421386394,0.045507722874271385,UBC/VDAC1,2
REACTOME_REGULATION_OF_SIGNALING_BY_CBL,REACTOME_REGULATION_OF_SIGNALING_BY_CBL,2/151,22/21728,0.010117258183336725,0.061906923421386394,0.045507722874271385,UBC/CRK,2
WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,2/151,22/21728,0.010117258183336725,0.061906923421386394,0.045507722874271385,SEL1L/LDLR,2
WP_PI3KAKTMTOR_VITD3_SIGNALING,WP_PI3KAKTMTOR_VITD3_SIGNALING,2/151,22/21728,0.010117258183336725,0.061906923421386394,0.045507722874271385,LDHA/SLC2A3,2
WP_FRAGILE_X_SYNDROME,WP_FRAGILE_X_SYNDROME,4/151,122/21728,0.010454935574553218,0.06383255170573371,0.046923250467630406,ARAF/PRKAR1A/CLTC/DUSP3,4
RHODES_CANCER_META_SIGNATURE,RHODES_CANCER_META_SIGNATURE,3/151,65/21728,0.010493908555020921,0.06392999553914061,0.04699488134058307,HSP90B1/SSR1/LDHA,3
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,5/151,190/21728,0.010637615491604534,0.0646636670364932,0.047534202588305416,PRKAR1A/DUSP3/DNAJC10/LRP12/PTGES3,5
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP,4/151,123/21728,0.010749291908927006,0.06491637591956353,0.04771996865747916,HSP90B1/ATP13A3/EFNB2/LOXL1,4
KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,4/151,123/21728,0.010749291908927006,0.06491637591956353,0.04771996865747916,PPP1R15A/EFNB2/SLC2A3/LDLR,4
KARLSSON_TGFB1_TARGETS_UP,KARLSSON_TGFB1_TARGETS_UP,4/151,123/21728,0.010749291908927006,0.06491637591956353,0.04771996865747916,HSPA9/ACTR3/TPM1/GARS1,4
WP_ALZHEIMERS_DISEASE,WP_ALZHEIMERS_DISEASE,6/151,266/21728,0.010854671212330871,0.06516771764187809,0.047904729728029824,ARAF/NCSTN/CSNK1A1/VDAC1/NRBF2/BECN1,6
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,3/151,66/21728,0.01093856093936859,0.06516771764187809,0.047904729728029824,SLC2A3/SDC4/FLII,3
PID_HIF1_TFPATHWAY,PID_HIF1_TFPATHWAY,3/151,66/21728,0.01093856093936859,0.06516771764187809,0.047904729728029824,LDHA/EGLN1/FURIN,3
OZEN_MIR125B1_TARGETS,OZEN_MIR125B1_TARGETS,2/151,23/21728,0.011030696820269817,0.06516771764187809,0.047904729728029824,SEL1L/CBFB,2
REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION,REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION,2/151,23/21728,0.011030696820269817,0.06516771764187809,0.047904729728029824,UBC/MAP2K3,2
REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1,REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1,2/151,23/21728,0.011030696820269817,0.06516771764187809,0.047904729728029824,UBC/BIRC3,2
REACTOME_NEPHRIN_FAMILY_INTERACTIONS,REACTOME_NEPHRIN_FAMILY_INTERACTIONS,2/151,23/21728,0.011030696820269817,0.06516771764187809,0.047904729728029824,IQGAP1/ACTN4,2
REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION,REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION,2/151,23/21728,0.011030696820269817,0.06516771764187809,0.047904729728029824,DUSP5/JAK2,2
WP_PROGERIAASSOCIATED_LIPODYSTROPHY,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,2/151,23/21728,0.011030696820269817,0.06516771764187809,0.047904729728029824,RECQL/ICMT,2
WU_HBX_TARGETS_1_DN,WU_HBX_TARGETS_1_DN,2/151,23/21728,0.011030696820269817,0.06516771764187809,0.047904729728029824,PTPN14/MAP2K3,2
KAYO_AGING_MUSCLE_DN,KAYO_AGING_MUSCLE_DN,4/151,124/21728,0.011048954287013888,0.06516771764187809,0.047904729728029824,RARS1/LAMC1/SLC2A3/TPM1,4
SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,3/151,67/21728,0.011393975801939342,0.06706030673260062,0.04929597024032632,YWHAZ/RPS6KA3/MET,3
KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,4/151,126/21728,0.011664332847813536,0.06850637769815222,0.05035897568656562,YWHAZ/RPS6KA3/CRK/SORT1,4
PLASARI_TGFB1_TARGETS_10HR_UP,PLASARI_TGFB1_TARGETS_10HR_UP,5/151,195/21728,0.011802513623343992,0.06907258825148414,0.05077519654726203,DUSP5/HIVEP3/PPP1R15A/ITGB3/PVR,5
AMIT_EGF_RESPONSE_120_HELA,AMIT_EGF_RESPONSE_120_HELA,3/151,68/21728,0.011860196038861747,0.06907258825148414,0.05077519654726203,EPHA2/MAP2K3/EPHB4,3
KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION,KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION,3/151,68/21728,0.011860196038861747,0.06907258825148414,0.05077519654726203,ATP6V1C1/ATP6V1A/MET,3
LEE_CALORIE_RESTRICTION_NEOCORTEX_DN,LEE_CALORIE_RESTRICTION_NEOCORTEX_DN,3/151,68/21728,0.011860196038861747,0.06907258825148414,0.05077519654726203,SEC23A/PTPN14/PML,3
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP,BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP,2/151,24/21728,0.011979099816914461,0.06932904019039245,0.05096371413336416,HSPA8/JAK2,2
REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION,REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION,2/151,24/21728,0.011979099816914461,0.06932904019039245,0.05096371413336416,RARS1/GARS1,2
REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION,REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION,2/151,24/21728,0.011979099816914461,0.06932904019039245,0.05096371413336416,WWTR1/CBFB,2
MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,6/151,272/21728,0.012015316873556522,0.06939407541525991,0.05101152146777472,ITPRID2/CRK/HSPA8/PTGES3/PAFAH2/NPAS2,6
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,6/151,274/21728,0.012420926238303306,0.07158782798756554,0.05262414698036343,SDF4/SEPTIN11/MOXD1/PDLIM4/UNC5C/EPHA2,6
BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2,BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2,3/151,70/21728,0.012825211554697702,0.07300909364538978,0.053668918067544306,VDAC1/KDELR1/HSPA8,3
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN,HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN,3/151,70/21728,0.012825211554697702,0.07300909364538978,0.053668918067544306,CTNND1/ITPRID2/SLC35D1,3
MAHAJAN_RESPONSE_TO_IL1A_DN,MAHAJAN_RESPONSE_TO_IL1A_DN,3/151,70/21728,0.012825211554697702,0.07300909364538978,0.053668918067544306,SLC2A3/EPHA2/EPHB4,3
NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,3/151,70/21728,0.012825211554697702,0.07300909364538978,0.053668918067544306,HSP90B1/HSPA9/HSPA4,3
REACTOME_CIRCADIAN_CLOCK,REACTOME_CIRCADIAN_CLOCK,3/151,70/21728,0.012825211554697702,0.07300909364538978,0.053668918067544306,UBC/NRIP1/NPAS2,3
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10,3/151,70/21728,0.012825211554697702,0.07300909364538978,0.053668918067544306,LDHA/PRDX1/RRBP1,3
REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING,REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING,2/151,25/21728,0.012961943769189752,0.07318756055042507,0.05380010892646153,UBC/JAK2,2
REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,2/151,25/21728,0.012961943769189752,0.07318756055042507,0.05380010892646153,UBC/NCSTN,2
WANG_BARRETTS_ESOPHAGUS_DN,WANG_BARRETTS_ESOPHAGUS_DN,2/151,25/21728,0.012961943769189752,0.07318756055042507,0.05380010892646153,STK24/ACTR3,2
WP_UNFOLDED_PROTEIN_RESPONSE,WP_UNFOLDED_PROTEIN_RESPONSE,2/151,25/21728,0.012961943769189752,0.07318756055042507,0.05380010892646153,HSPA5/PPP1R15A,2
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,4/151,131/21728,0.013297950787870499,0.07462559371203466,0.054857205790363094,PCYT1A/NRIP1/EGLN1/SDC4,4
XU_GH1_AUTOCRINE_TARGETS_DN,XU_GH1_AUTOCRINE_TARGETS_DN,4/151,131/21728,0.013297950787870499,0.07462559371203466,0.054857205790363094,EFNB2/UNC5C/TPM1/LAMA5,4
RAGHAVACHARI_PLATELET_SPECIFIC_GENES,RAGHAVACHARI_PLATELET_SPECIFIC_GENES,3/151,71/21728,0.013324080086813963,0.07462559371203466,0.054857205790363094,PTPN12/ITGB3/TPM1,3
REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,3/151,71/21728,0.013324080086813963,0.07462559371203466,0.054857205790363094,CLTC/FURIN/LDLR,3
IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,8/151,449/21728,0.013390768955698573,0.07484820152702341,0.055020844591878074,SEPTIN11/HSPA9/CBFB/NRBF2/LRP12/PRDX1/PGM3/PPFIBP1,8
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,6/151,279/21728,0.013476967632620823,0.07517874715546315,0.05526382838149312,ARIH1/VDAC1/STBD1/DNAJC10/LAMA5/TRIP10,6
KEGG_TIGHT_JUNCTION,KEGG_TIGHT_JUNCTION,4/151,132/21728,0.013641240723497287,0.0759426186971452,0.055825349654223685,ACTB/ACTG1/CTNNA1/ACTN4,4
MULLIGHAN_MLL_SIGNATURE_2_DN,MULLIGHAN_MLL_SIGNATURE_2_DN,6/151,280/21728,0.013695488182191023,0.07609213234025332,0.055935256996738084,SEPTIN11/PTPN14/PML/LAMA5/SLC12A4/LOXL1,6
PID_IL3_PATHWAY,PID_IL3_PATHWAY,2/151,26/21728,0.013978710774679675,0.07680743468525933,0.05646107509734498,YWHAZ/JAK2,2
PID_INSULIN_GLUCOSE_PATHWAY,PID_INSULIN_GLUCOSE_PATHWAY,2/151,26/21728,0.013978710774679675,0.07680743468525933,0.05646107509734498,YWHAZ/TRIP10,2
REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING,REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING,2/151,26/21728,0.013978710774679675,0.07680743468525933,0.05646107509734498,UBC/PPP1R15A,2
REACTOME_INSULIN_RECEPTOR_RECYCLING,REACTOME_INSULIN_RECEPTOR_RECYCLING,2/151,26/21728,0.013978710774679675,0.07680743468525933,0.05646107509734498,ATP6V1C1/ATP6V1A,2
WP_WNTBETACATENIN_SIGNALING_PATHWAY_IN_LEUKEMIA,WP_WNTBETACATENIN_SIGNALING_PATHWAY_IN_LEUKEMIA,2/151,26/21728,0.013978710774679675,0.07680743468525933,0.05646107509734498,CSNK1A1/PML,2
WP_TGFBETA_SIGNALING_PATHWAY,WP_TGFBETA_SIGNALING_PATHWAY,4/151,133/21728,0.013990123092419447,0.07680743468525933,0.05646107509734498,MET/ITGB3/PML/MAP2K3,4
PROVENZANI_METASTASIS_UP,PROVENZANI_METASTASIS_UP,5/151,204/21728,0.014112666646468323,0.07732739239425838,0.05684329553440994,CBFB/MET/EFNB2/SLC35D1/HUS1,5
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,7/151,366/21728,0.014238233349247006,0.07786183512639407,0.057236163898755056,UBC/YWHAZ/PERP/HUS1/PRDX1/PRKAG1/PML,7
HOSHIDA_LIVER_CANCER_SURVIVAL_UP,HOSHIDA_LIVER_CANCER_SURVIVAL_UP,3/151,73/21728,0.014354703649236463,0.07788548190933378,0.05725354662730004,IQGAP1/ACTR2/DUSP5,3
HUANG_GATA2_TARGETS_DN,HUANG_GATA2_TARGETS_DN,3/151,73/21728,0.014354703649236463,0.07788548190933378,0.05725354662730004,ACTB/ETF1/SLC2A3,3
REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,3/151,73/21728,0.014354703649236463,0.07788548190933378,0.05725354662730004,UBC/CBFB/HIVEP3,3
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7,3/151,73/21728,0.014354703649236463,0.07788548190933378,0.05725354662730004,ETF1/ATP1A1/HSPA4,3
KYNG_DNA_DAMAGE_UP,KYNG_DNA_DAMAGE_UP,5/151,205/21728,0.014386786340309852,0.07790739269664868,0.057269653227046496,CTNND1/RPS6KA3/SEC23A/DUSP5/MET,5
MARTENS_BOUND_BY_PML_RARA_FUSION,MARTENS_BOUND_BY_PML_RARA_FUSION,8/151,456/21728,0.014573392815791474,0.07872470587058297,0.05787045939484332,STK24/APLP2/DUSP5/TMEM115/HIVEP3/GBE1/PAFAH2/MAP2K3,8
REACTOME_SENSORY_PERCEPTION,REACTOME_SENSORY_PERCEPTION,6/151,284/21728,0.014594392916972726,0.07872470587058297,0.05787045939484332,ACTB/ACTG1/LRP12/FNTB/LDLR/SDC4,6
WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,3/151,74/21728,0.014886517557547545,0.07967605329383211,0.0585697940169127,ARAF/CSNK1A1/RALB,3
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,5/151,207/21728,0.014945720583811446,0.07967605329383211,0.0585697940169127,YWHAZ/VDAC1/SEC23A/ATP6V1A/SDC4,5
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP,2/151,27/21728,0.015028888382277908,0.07967605329383211,0.0585697940169127,SLC4A7/LDLR,2
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN,2/151,27/21728,0.015028888382277908,0.07967605329383211,0.0585697940169127,CSNK1A1/SCFD1,2
NICK_RESPONSE_TO_PROC_TREATMENT_DN,NICK_RESPONSE_TO_PROC_TREATMENT_DN,2/151,27/21728,0.015028888382277908,0.07967605329383211,0.0585697940169127,ATP6V1A/ITPRID2,2
REACTOME_GLYCOGEN_METABOLISM,REACTOME_GLYCOGEN_METABOLISM,2/151,27/21728,0.015028888382277908,0.07967605329383211,0.0585697940169127,UBC/GBE1,2
REACTOME_INTEGRIN_SIGNALING,REACTOME_INTEGRIN_SIGNALING,2/151,27/21728,0.015028888382277908,0.07967605329383211,0.0585697940169127,ITGB3/CRK,2
REACTOME_SYNDECAN_INTERACTIONS,REACTOME_SYNDECAN_INTERACTIONS,2/151,27/21728,0.015028888382277908,0.07967605329383211,0.0585697940169127,ITGB3/SDC4,2
REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY,REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY,2/151,27/21728,0.015028888382277908,0.07967605329383211,0.0585697940169127,CTNND1/CTNNA1,2
HUTTMANN_B_CLL_POOR_SURVIVAL_UP,HUTTMANN_B_CLL_POOR_SURVIVAL_UP,6/151,286/21728,0.01505892417647294,0.0796832216423654,0.05857506346337345,DUSP5/AKAP12/PPP1R15A/LAMA5/RRBP1/MGAT4B,6
REACTOME_PROGRAMMED_CELL_DEATH,REACTOME_PROGRAMMED_CELL_DEATH,5/151,208/21728,0.015230572825391179,0.08029267267651181,0.05902307036202983,STK24/UBC/YWHAZ/BIRC3/FLOT2,5
YAGI_AML_WITH_T_8_21_TRANSLOCATION,YAGI_AML_WITH_T_8_21_TRANSLOCATION,7/151,371/21728,0.015231907307603213,0.08029267267651181,0.05902307036202983,SSR1/SEPTIN11/PTPN12/RALB/LAMA5/BCAM/FURIN,7
ODONNELL_METASTASIS_UP,ODONNELL_METASTASIS_UP,3/151,75/21728,0.015429368284060909,0.08117951722182047,0.05967498897742855,ATP6V1C1/PVR/SBNO2,3
GROSS_HYPOXIA_VIA_ELK3_UP,GROSS_HYPOXIA_VIA_ELK3_UP,5/151,209/21728,0.015519039964212592,0.0814969622317251,0.05990834251432182,CBFB/EGLN1/LAMA5/MAP2K3/MGAT4B,5
HADDAD_B_LYMPHOCYTE_PROGENITOR,HADDAD_B_LYMPHOCYTE_PROGENITOR,6/151,289/21728,0.015774863519325416,0.08268409595601132,0.06078100343096586,VDAC1/PKD2/AKAP12/EFNB2/SLC35D1/PPFIBP1,6
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN,3/151,76/21728,0.01598327954918044,0.08330497295989354,0.06123740954954093,WDR1/LDHA/LDLR,3
REACTOME_ECM_PROTEOGLYCANS,REACTOME_ECM_PROTEOGLYCANS,3/151,76/21728,0.01598327954918044,0.08330497295989354,0.06123740954954093,LAMC1/ITGB3/LAMA5,3
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6,3/151,76/21728,0.01598327954918044,0.08330497295989354,0.06123740954954093,PERP/EFNB2/SDC4,3
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP,2/151,28/21728,0.016111969542259626,0.08350569288880082,0.061384958585985215,PPP1R15A/HSPA8,2
REACTOME_ATTENUATION_PHASE,REACTOME_ATTENUATION_PHASE,2/151,28/21728,0.016111969542259626,0.08350569288880082,0.061384958585985215,HSPA8/PTGES3,2
REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY,REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY,2/151,28/21728,0.016111969542259626,0.08350569288880082,0.061384958585985215,UBC/WWTR1,2
SHEPARD_BMYB_MORPHOLINO_UP,SHEPARD_BMYB_MORPHOLINO_UP,5/151,212/21728,0.016406313590191898,0.0848728848297078,0.0623899801332398,ATP1A1/DNAJC10/ZNF330/PRDX1/FNTB,5
MUNSHI_MULTIPLE_MYELOMA_UP,MUNSHI_MULTIPLE_MYELOMA_UP,3/151,77/21728,0.016548272856227744,0.08535277787631176,0.06274274907356478,HSP90B1/UBC/HSPA5,3
HOLLERN_EMT_BREAST_TUMOR_UP,HOLLERN_EMT_BREAST_TUMOR_UP,4/151,140/21728,0.01659125271893749,0.08535277787631176,0.06274274907356478,CALU/SEC23A/PVR/LOXL1,4
REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,4/151,140/21728,0.01659125271893749,0.08535277787631176,0.06274274907356478,UBC/PTPN12/PTPN14/PTPN9,4
REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN,REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN,3/151,78/21728,0.017124367529773643,0.0871727927189894,0.06408064032239758,NUS1/DOLK/PGM3,3
PAL_PRMT5_TARGETS_DN,PAL_PRMT5_TARGETS_DN,2/151,29/21728,0.01722745255677652,0.0871727927189894,0.06408064032239758,PDIA6/SEL1L,2
PID_IGF1_PATHWAY,PID_IGF1_PATHWAY,2/151,29/21728,0.01722745255677652,0.0871727927189894,0.06408064032239758,YWHAZ/CRK,2
PID_S1P_S1P3_PATHWAY,PID_S1P_S1P3_PATHWAY,2/151,29/21728,0.01722745255677652,0.0871727927189894,0.06408064032239758,ITGB3/JAK2,2
REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING,REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING,2/151,29/21728,0.01722745255677652,0.0871727927189894,0.06408064032239758,UBC/PTPN12,2
REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION,REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION,2/151,29/21728,0.01722745255677652,0.0871727927189894,0.06408064032239758,LAMC1/WWTR1,2
REACTOME_MITOPHAGY,REACTOME_MITOPHAGY,2/151,29/21728,0.01722745255677652,0.0871727927189894,0.06408064032239758,UBC/VDAC1,2
REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS,REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS,2/151,29/21728,0.01722745255677652,0.0871727927189894,0.06408064032239758,MAP2K3/FURIN,2
WP_LIPID_METABOLISM_PATHWAY,WP_LIPID_METABOLISM_PATHWAY,2/151,29/21728,0.01722745255677652,0.0871727927189894,0.06408064032239758,PRKAR1A/PRKAG1,2
REACTOME_TRANSLATION,REACTOME_TRANSLATION,6/151,295/21728,0.017276919841340086,0.08726415148953229,0.06414779807119572,RARS1/SSR1/ETF1/IARS2/EIF4H/GARS1,6
VERHAAK_GLIOBLASTOMA_MESENCHYMAL,VERHAAK_GLIOBLASTOMA_MESENCHYMAL,5/151,216/21728,0.017641046667763522,0.08894161096741754,0.06538089700154978,WWTR1/FNDC3B/IQGAP1/FURIN/ARSJ,5
PID_MET_PATHWAY,PID_MET_PATHWAY,3/151,79/21728,0.01771158075349166,0.0891354553137678,0.06552339180353513,MET/CRK/CTNNA1,3
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,4/151,143/21728,0.017792630657132828,0.08938142489243217,0.06570420381619432,RARS1/GBE1/ZNF330/SDC4,4
WANG_SMARCE1_TARGETS_DN,WANG_SMARCE1_TARGETS_DN,7/151,385/21728,0.018276151595478525,0.09082795086029247,0.06676754373421522,HSPA9/HSPA4/SLC4A7/TPM1/EPHA2/ARSJ/LOXL1,7
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN,2/151,30/21728,0.01837484103077191,0.09082795086029247,0.06676754373421522,AKAP12/EPHA2,2
BIOCARTA_GPCR_PATHWAY,BIOCARTA_GPCR_PATHWAY,2/151,30/21728,0.01837484103077191,0.09082795086029247,0.06676754373421522,PRKAR1A/RPS6KA3,2
PID_P38_ALPHA_BETA_PATHWAY,PID_P38_ALPHA_BETA_PATHWAY,2/151,30/21728,0.01837484103077191,0.09082795086029247,0.06676754373421522,RALB/MAP2K3,2
REACTOME_LAMININ_INTERACTIONS,REACTOME_LAMININ_INTERACTIONS,2/151,30/21728,0.01837484103077191,0.09082795086029247,0.06676754373421522,LAMC1/LAMA5,2
REACTOME_SIGNALING_BY_CSF3_G_CSF,REACTOME_SIGNALING_BY_CSF3_G_CSF,2/151,30/21728,0.01837484103077191,0.09082795086029247,0.06676754373421522,UBC/JAK2,2
REACTOME_TNFR1_INDUCED_NFKAPPAB_SIGNALING_PATHWAY,REACTOME_TNFR1_INDUCED_NFKAPPAB_SIGNALING_PATHWAY,2/151,30/21728,0.01837484103077191,0.09082795086029247,0.06676754373421522,UBC/BIRC3,2
VALK_AML_CLUSTER_12,VALK_AML_CLUSTER_12,2/151,30/21728,0.01837484103077191,0.09082795086029247,0.06676754373421522,LAMC1/NRIP1,2
WP_AUTOPHAGY,WP_AUTOPHAGY,2/151,30/21728,0.01837484103077191,0.09082795086029247,0.06676754373421522,BECN1/PRKAG1,2
MULLIGHAN_MLL_SIGNATURE_1_UP,MULLIGHAN_MLL_SIGNATURE_1_UP,7/151,386/21728,0.018508830591528205,0.09124240878971036,0.06707221137965144,SDF4/ACTR2/CBFB/PCYT1A/PTPN9/PRDX1/RRBP1,7
AMUNDSON_RESPONSE_TO_ARSENITE,AMUNDSON_RESPONSE_TO_ARSENITE,5/151,219/21728,0.018606478626303876,0.09124240878971036,0.06707221137965144,HSPA9/ARIH1/ATP6V1C1/HSPA4/GARS1,5
WP_CILIARY_LANDSCAPE,WP_CILIARY_LANDSCAPE,5/151,219/21728,0.018606478626303876,0.09124240878971036,0.06707221137965144,RAB21/IQGAP1/RALB/COPS2/PGRMC2,5
GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB,GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB,4/151,145/21728,0.018622910649303735,0.09124240878971036,0.06707221137965144,CLTC/SEL1L/API5/TPM1,4
SMITH_TERT_TARGETS_UP,SMITH_TERT_TARGETS_UP,4/151,145/21728,0.018622910649303735,0.09124240878971036,0.06707221137965144,HSPA5/SLC33A1/MCFD2/EPHA2,4
GRABARCZYK_BCL11B_TARGETS_UP,GRABARCZYK_BCL11B_TARGETS_UP,3/151,81/21728,0.01891942110546202,0.09228749970065042,0.06784045675391681,NUS1/RPS6KA3/RECQL,3
WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,3/151,81/21728,0.01891942110546202,0.09228749970065042,0.06784045675391681,HUS1/RECQL/PML,3
BIDUS_METASTASIS_UP,BIDUS_METASTASIS_UP,5/151,220/21728,0.018935880068168015,0.09228749970065042,0.06784045675391681,STK24/VDAC1/SEC23A/CBFB/PTGES3,5
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,6/151,303/21728,0.019429148821627232,0.09285473938660176,0.06825743412906196,KDELR1/DUSP3/BECN1/SCFD1/LAMA5/GARS1,6
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,7/151,390/21728,0.019460426206911546,0.09285473938660176,0.06825743412906196,LAMC1/WWTR1/ITPRID2/MET/PGM3/PML/FLII,7
LEE_NEURAL_CREST_STEM_CELL_UP,LEE_NEURAL_CREST_STEM_CELL_UP,4/151,147/21728,0.019476890764474262,0.09285473938660176,0.06825743412906196,NRIP1/MOXD1/PCDH8/RRBP1,4
PID_SMAD2_3NUCLEAR_PATHWAY,PID_SMAD2_3NUCLEAR_PATHWAY,3/151,82/21728,0.01954007223065781,0.09285473938660176,0.06825743412906196,LAMC1/CBFB/HSPA8,3
REACTOME_SIGNALING_BY_NOTCH4,REACTOME_SIGNALING_BY_NOTCH4,3/151,82/21728,0.01954007223065781,0.09285473938660176,0.06825743412906196,UBC/NCSTN/YWHAZ,3
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP,2/151,31/21728,0.019553643823312466,0.09285473938660176,0.06825743412906196,PRDX1/FURIN,2
REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS,REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS,2/151,31/21728,0.019553643823312466,0.09285473938660176,0.06825743412906196,UBC/NCSTN,2
REACTOME_EGFR_DOWNREGULATION,REACTOME_EGFR_DOWNREGULATION,2/151,31/21728,0.019553643823312466,0.09285473938660176,0.06825743412906196,UBC/PTPN12,2
REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS,REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS,2/151,31/21728,0.019553643823312466,0.09285473938660176,0.06825743412906196,ACTB/ACTG1,2
REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES,REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES,2/151,31/21728,0.019553643823312466,0.09285473938660176,0.06825743412906196,RPS6KA3/DUSP3,2
REACTOME_PYRUVATE_METABOLISM,REACTOME_PYRUVATE_METABOLISM,2/151,31/21728,0.019553643823312466,0.09285473938660176,0.06825743412906196,VDAC1/LDHA,2
REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT,REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT,2/151,31/21728,0.019553643823312466,0.09285473938660176,0.06825743412906196,WWTR1/CBFB,2
REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING,REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING,2/151,31/21728,0.019553643823312466,0.09285473938660176,0.06825743412906196,ATP6V1C1/ATP6V1A,2
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP,WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP,2/151,31/21728,0.019553643823312466,0.09285473938660176,0.06825743412906196,CTNND1/SORT1,2
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,2/151,31/21728,0.019553643823312466,0.09285473938660176,0.06825743412906196,VDAC1/ATP13A3,2
PODAR_RESPONSE_TO_ADAPHOSTIN_UP,PODAR_RESPONSE_TO_ADAPHOSTIN_UP,4/151,148/21728,0.019912822057602614,0.09439900968604105,0.06939262581596743,DUSP5/TMCO3/PPP1R15A/GARS1,4
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,8/151,484/21728,0.02007306155987624,0.09479301708400419,0.06968226029440647,ACTG1/PKN1/HSPA9/ATP1A1/PKD2/SLC4A7/ZNF330/ICMT,8
KESHELAVA_MULTIPLE_DRUG_RESISTANCE,KESHELAVA_MULTIPLE_DRUG_RESISTANCE,3/151,83/21728,0.02017188997235123,0.09479301708400419,0.06968226029440647,IQGAP1/CD151/SBNO2,3
NELSON_RESPONSE_TO_ANDROGEN_UP,NELSON_RESPONSE_TO_ANDROGEN_UP,3/151,83/21728,0.02017188997235123,0.09479301708400419,0.06968226029440647,LMAN1/AKAP12/PGM3,3
WP_GLIOBLASTOMA_SIGNALING_PATHWAYS,WP_GLIOBLASTOMA_SIGNALING_PATHWAYS,3/151,83/21728,0.02017188997235123,0.09479301708400419,0.06968226029440647,ARAF/MET/MAP2K3,3
THUM_SYSTOLIC_HEART_FAILURE_DN,THUM_SYSTOLIC_HEART_FAILURE_DN,5/151,224/21728,0.020291870745957827,0.09479301708400419,0.06968226029440647,HSP90B1/YWHAZ/CSNK1A1/EGLN1/PPFIBP1,5
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,5/151,225/21728,0.0206405431420899,0.09479301708400419,0.06968226029440647,PTPN12/DUSP5/PPP1R15A/SEC24A/CRK,5
CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN,CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN,2/151,32/21728,0.020763374999333107,0.09479301708400419,0.06968226029440647,ACTB/PRDX1,2
CHO_NR4A1_TARGETS,CHO_NR4A1_TARGETS,2/151,32/21728,0.020763374999333107,0.09479301708400419,0.06968226029440647,BIRC3/PPP1R15A,2
FARDIN_HYPOXIA_11,FARDIN_HYPOXIA_11,2/151,32/21728,0.020763374999333107,0.09479301708400419,0.06968226029440647,SLC2A3/EGLN1,2
FIRESTEIN_CTNNB1_PATHWAY,FIRESTEIN_CTNNB1_PATHWAY,2/151,32/21728,0.020763374999333107,0.09479301708400419,0.06968226029440647,PKN1/EPHA2,2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP,2/151,32/21728,0.020763374999333107,0.09479301708400419,0.06968226029440647,DIPK2A/LDLR,2
JIANG_AGING_CEREBRAL_CORTEX_UP,JIANG_AGING_CEREBRAL_CORTEX_UP,2/151,32/21728,0.020763374999333107,0.09479301708400419,0.06968226029440647,ACTB/PRDX1,2
POS_HISTAMINE_RESPONSE_NETWORK,POS_HISTAMINE_RESPONSE_NETWORK,2/151,32/21728,0.020763374999333107,0.09479301708400419,0.06968226029440647,GARS1/LOXL1,2
REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION,REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION,2/151,32/21728,0.020763374999333107,0.09479301708400419,0.06968226029440647,UBC/WWTR1,2
WP_OVARIAN_INFERTILITY,WP_OVARIAN_INFERTILITY,2/151,32/21728,0.020763374999333107,0.09479301708400419,0.06968226029440647,ESR2/NRIP1,2
REACTOME_SIGNALING_BY_HEDGEHOG,REACTOME_SIGNALING_BY_HEDGEHOG,4/151,150/21728,0.02080266954226929,0.09479301708400419,0.06968226029440647,PRKAR1A/UBC/CSNK1A1/SEL1L,4
WP_REGULATION_OF_ACTIN_CYTOSKELETON,WP_REGULATION_OF_ACTIN_CYTOSKELETON,4/151,150/21728,0.02080266954226929,0.09479301708400419,0.06968226029440647,ACTB/ACTG1/IQGAP1/CRK,4
GHANDHI_BYSTANDER_IRRADIATION_UP,GHANDHI_BYSTANDER_IRRADIATION_UP,3/151,84/21728,0.02081488136113843,0.09479301708400419,0.06968226029440647,ATP6V1C1/DUSP5/BIRC3,3
JACKSON_DNMT1_TARGETS_UP,JACKSON_DNMT1_TARGETS_UP,3/151,84/21728,0.02081488136113843,0.09479301708400419,0.06968226029440647,JAK2/EPHA2/MAP2K3,3
KEGG_SMALL_CELL_LUNG_CANCER,KEGG_SMALL_CELL_LUNG_CANCER,3/151,84/21728,0.02081488136113843,0.09479301708400419,0.06968226029440647,LAMC1/BIRC3/LAMA5,3
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,3/151,84/21728,0.02081488136113843,0.09479301708400419,0.06968226029440647,ETF1/PML/FURIN,3
PID_CMYB_PATHWAY,PID_CMYB_PATHWAY,3/151,84/21728,0.02081488136113843,0.09479301708400419,0.06968226029440647,IQGAP1/BIRC3/HSPA8,3
REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,3/151,84/21728,0.02081488136113843,0.09479301708400419,0.06968226029440647,UBC/ACTB/COPS2,3
WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,3/151,84/21728,0.02081488136113843,0.09479301708400419,0.06968226029440647,ARAF/MET/JAK2,3
LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,5/151,226/21728,0.02099311610348519,0.09544824310226162,0.0701639163420816,TRIP12/ARIH1/PML/NPAS2/SNX19,5
HORIUCHI_WTAP_TARGETS_UP,HORIUCHI_WTAP_TARGETS_UP,6/151,309/21728,0.021158770805374615,0.09604422434204359,0.07060202160720117,FNDC3B/SEL1L/DUSP5/BIRC3/SLC2A3/SDC4,6
BURTON_ADIPOGENESIS_9,BURTON_ADIPOGENESIS_9,3/151,85/21728,0.0214690515040739,0.09729367875745072,0.07152049440697753,CTNND1/AKAP12/TPM1,3
LANDIS_ERBB2_BREAST_TUMORS_324_DN,LANDIS_ERBB2_BREAST_TUMORS_324_DN,4/151,152/21728,0.021716626877845653,0.09764516358756785,0.07177887058462416,SEC23A/APLP2/GBE1/CD151,4
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,7/151,399/21728,0.02172603316433021,0.09764516358756785,0.07177887058462416,LAMC1/WWTR1/FNDC3B/ADAM9/MET/SLC4A7/LDLR,7
BIOCARTA_MET_PATHWAY,BIOCARTA_MET_PATHWAY,2/151,33/21728,0.022003553781791748,0.09764516358756785,0.07177887058462416,MET/CRK,2
DOANE_BREAST_CANCER_CLASSES_DN,DOANE_BREAST_CANCER_CLASSES_DN,2/151,33/21728,0.022003553781791748,0.09764516358756785,0.07177887058462416,WWTR1/CALU,2
KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN,KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN,2/151,33/21728,0.022003553781791748,0.09764516358756785,0.07177887058462416,ZBTB38/EPHA2,2
PID_NCADHERIN_PATHWAY,PID_NCADHERIN_PATHWAY,2/151,33/21728,0.022003553781791748,0.09764516358756785,0.07177887058462416,CTNND1/CTNNA1,2
REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE,REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE,2/151,33/21728,0.022003553781791748,0.09764516358756785,0.07177887058462416,CLTC/LDLR,2
REACTOME_SIGNALING_BY_NOTCH2,REACTOME_SIGNALING_BY_NOTCH2,2/151,33/21728,0.022003553781791748,0.09764516358756785,0.07177887058462416,UBC/NCSTN,2
WP_INFLAMMATORY_RESPONSE_PATHWAY,WP_INFLAMMATORY_RESPONSE_PATHWAY,2/151,33/21728,0.022003553781791748,0.09764516358756785,0.07177887058462416,LAMC1/LAMA5,2
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,2/151,33/21728,0.022003553781791748,0.09764516358756785,0.07177887058462416,ESR2/JAK2,2
WP_MAPK_CASCADE,WP_MAPK_CASCADE,2/151,33/21728,0.022003553781791748,0.09764516358756785,0.07177887058462416,ARAF/MAP2K3,2
ZHAN_LATE_DIFFERENTIATION_GENES_UP,ZHAN_LATE_DIFFERENTIATION_GENES_UP,2/151,33/21728,0.022003553781791748,0.09764516358756785,0.07177887058462416,DUSP5/MCFD2,2
ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP,ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP,2/151,33/21728,0.022003553781791748,0.09764516358756785,0.07177887058462416,APLP2/BIRC3,2
WP_HEPATITIS_B_INFECTION,WP_HEPATITIS_B_INFECTION,4/151,154/21728,0.022654842174468538,0.1003750423615209,0.07378560197845876,ARAF/YWHAZ/JAK2/MAP2K3,4
HUMMERICH_SKIN_CANCER_PROGRESSION_UP,HUMMERICH_SKIN_CANCER_PROGRESSION_UP,3/151,87/21728,0.022810939070328447,0.10058537894821021,0.07394022021125679,HSPA5/PERP/HSPA8,3
REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,3/151,87/21728,0.022810939070328447,0.10058537894821021,0.07394022021125679,UBC/YWHAZ/HSPA8,3
REACTOME_TP53_REGULATES_METABOLIC_GENES,REACTOME_TP53_REGULATES_METABOLIC_GENES,3/151,87/21728,0.022810939070328447,0.10058537894821021,0.07394022021125679,YWHAZ/PRDX1/PRKAG1,3
LUI_TARGETS_OF_PAX8_PPARG_FUSION,LUI_TARGETS_OF_PAX8_PPARG_FUSION,2/151,34/21728,0.02327370450423099,0.10131803010226446,0.0744787914055523,HSPA8/SDC4,2
PETRETTO_CARDIAC_HYPERTROPHY,PETRETTO_CARDIAC_HYPERTROPHY,2/151,34/21728,0.02327370450423099,0.10131803010226446,0.0744787914055523,ACTB/LOXL1,2
PID_EPHA_FWDPATHWAY,PID_EPHA_FWDPATHWAY,2/151,34/21728,0.02327370450423099,0.10131803010226446,0.0744787914055523,CRK/EPHA2,2
REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM,REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM,2/151,34/21728,0.02327370450423099,0.10131803010226446,0.0744787914055523,UBC/GBE1,2
REACTOME_LATE_ENDOSOMAL_MICROAUTOPHAGY,REACTOME_LATE_ENDOSOMAL_MICROAUTOPHAGY,2/151,34/21728,0.02327370450423099,0.10131803010226446,0.0744787914055523,UBC/HSPA8,2
REACTOME_RAF_ACTIVATION,REACTOME_RAF_ACTIVATION,2/151,34/21728,0.02327370450423099,0.10131803010226446,0.0744787914055523,ARAF/JAK2,2
REACTOME_SIGNALLING_TO_ERKS,REACTOME_SIGNALLING_TO_ERKS,2/151,34/21728,0.02327370450423099,0.10131803010226446,0.0744787914055523,RALB/CRK,2
WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,2/151,34/21728,0.02327370450423099,0.10131803010226446,0.0744787914055523,MET/CRK,2
PASINI_SUZ12_TARGETS_DN,PASINI_SUZ12_TARGETS_DN,6/151,316/21728,0.023305335217907484,0.10131803010226446,0.0744787914055523,WWTR1/RPS6KA3/PTPN12/PERP/TPM1/CD151,6
SASSON_RESPONSE_TO_FORSKOLIN_UP,SASSON_RESPONSE_TO_FORSKOLIN_UP,3/151,88/21728,0.023498657399660124,0.10199885977539973,0.07497926867654711,PRKAR1A/DUSP3/BECN1,3
HELLER_HDAC_TARGETS_UP,HELLER_HDAC_TARGETS_UP,6/151,317/21728,0.023623500521296217,0.1023807869706098,0.07526002300897391,CLTC/APLP2/AKAP12/BIRC3/CRK/SDC4,6
KUMAR_TARGETS_OF_MLL_AF9_FUSION,KUMAR_TARGETS_OF_MLL_AF9_FUSION,7/151,407/21728,0.023888655814219346,0.1033686695512482,0.0759862145918766,CSNK1A1/HSPA4/IARS2/PERP/PML/SDC4/PGRMC2,7
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP,3/151,89/21728,0.02419755636227865,0.10403586456357826,0.07647666903616453,VDAC1/NRIP1/PRDX1,3
LI_DCP2_BOUND_MRNA,LI_DCP2_BOUND_MRNA,3/151,89/21728,0.02419755636227865,0.10403586456357826,0.07647666903616453,HSP90B1/ACBD3/FLII,3
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,5/151,235/21728,0.024344198790100545,0.10403586456357826,0.07647666903616453,NRIP1/SLC4A7/PDLIM4/SLC2A3/DIPK2A,5
ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,7/151,409/21728,0.024451702499841792,0.10403586456357826,0.07647666903616453,DUSP5/STBD1/PPP1R15A/PML/MAP2K3/TRIP10/SDC4,7
KEGG_PRION_DISEASES,KEGG_PRION_DISEASES,2/151,35/21728,0.02457335656374249,0.10403586456357826,0.07647666903616453,LAMC1/HSPA5,2
QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2,QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2,2/151,35/21728,0.02457335656374249,0.10403586456357826,0.07647666903616453,CTNND1/ACTN4,2
REACTOME_LYSOSOME_VESICLE_BIOGENESIS,REACTOME_LYSOSOME_VESICLE_BIOGENESIS,2/151,35/21728,0.02457335656374249,0.10403586456357826,0.07647666903616453,CLTC/HSPA8,2
REACTOME_REGULATION_OF_TNFR1_SIGNALING,REACTOME_REGULATION_OF_TNFR1_SIGNALING,2/151,35/21728,0.02457335656374249,0.10403586456357826,0.07647666903616453,UBC/BIRC3,2
REACTOME_RHOBTB_GTPASE_CYCLE,REACTOME_RHOBTB_GTPASE_CYCLE,2/151,35/21728,0.02457335656374249,0.10403586456357826,0.07647666903616453,ACTG1/COPS2,2
WANG_METHYLATED_IN_BREAST_CANCER,WANG_METHYLATED_IN_BREAST_CANCER,2/151,35/21728,0.02457335656374249,0.10403586456357826,0.07647666903616453,CTNNA1/EPHA2,2
WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2,WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2,2/151,35/21728,0.02457335656374249,0.10403586456357826,0.07647666903616453,ACTB/CTNNA1,2
WP_ALPHA_6_BETA_4_SIGNALING_PATHWAY,WP_ALPHA_6_BETA_4_SIGNALING_PATHWAY,2/151,35/21728,0.02457335656374249,0.10403586456357826,0.07647666903616453,LAMC1/LAMA5,2
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP,XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP,2/151,35/21728,0.02457335656374249,0.10403586456357826,0.07647666903616453,AKAP12/SLC4A7,2
YAGI_AML_RELAPSE_PROGNOSIS,YAGI_AML_RELAPSE_PROGNOSIS,2/151,35/21728,0.02457335656374249,0.10403586456357826,0.07647666903616453,VDAC1/APLP2,2
WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,4/151,158/21728,0.024604594319032006,0.10403586456357826,0.07647666903616453,PRKAR1A/ACTB/ACTG1/YWHAZ,4
UEDA_CENTRAL_CLOCK,UEDA_CENTRAL_CLOCK,3/151,90/21728,0.024907631958491726,0.10507230189438756,0.07723855317157814,PDIA6/STK24/HSPA5,3
WP_NUCLEAR_RECEPTORS_METAPATHWAY,WP_NUCLEAR_RECEPTORS_METAPATHWAY,6/151,321/21728,0.024925358872714687,0.10507230189438756,0.07723855317157814,BIRC3/NRIP1/SLC2A3/PTGES3/PRDX1/EPHA2,6
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,6/151,322/21728,0.02525817287068601,0.10631394581025111,0.0781512844802725,SEPTIN11/RALB/ITPRID2/PTPN14/ITGB3/SLC4A7,6
MULLIGHAN_MLL_SIGNATURE_1_DN,MULLIGHAN_MLL_SIGNATURE_1_DN,5/151,238/21728,0.025533473377636035,0.10731011958104827,0.07888357090948946,SEPTIN11/PTPN14/LAMA5/SLC12A4/LOXL1,5
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,4/151,160/21728,0.02561638275168316,0.10733380284189416,0.07890098045290994,PCYT1A/BECN1/CD151/LOXL1,4
REACTOME_REGULATION_OF_TP53_ACTIVITY,REACTOME_REGULATION_OF_TP53_ACTIVITY,4/151,160/21728,0.02561638275168316,0.10733380284189416,0.07890098045290994,UBC/HUS1/PRKAG1/PML,4
HOUSTIS_ROS,HOUSTIS_ROS,2/151,36/21728,0.02590204437433203,0.10739683473417072,0.07894731513936235,PRDX1/SDC4,2
PID_GMCSF_PATHWAY,PID_GMCSF_PATHWAY,2/151,36/21728,0.02590204437433203,0.10739683473417072,0.07894731513936235,YWHAZ/JAK2,2
REACTOME_NOD1_2_SIGNALING_PATHWAY,REACTOME_NOD1_2_SIGNALING_PATHWAY,2/151,36/21728,0.02590204437433203,0.10739683473417072,0.07894731513936235,UBC/BIRC3,2
REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES,REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES,2/151,36/21728,0.02590204437433203,0.10739683473417072,0.07894731513936235,ATP6V1C1/ATP6V1A,2
SEMENZA_HIF1_TARGETS,SEMENZA_HIF1_TARGETS,2/151,36/21728,0.02590204437433203,0.10739683473417072,0.07894731513936235,LDHA/SLC2A3,2
SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES,SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES,2/151,36/21728,0.02590204437433203,0.10739683473417072,0.07894731513936235,RPS6KA3/FLOT2,2
WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,2/151,36/21728,0.02590204437433203,0.10739683473417072,0.07894731513936235,RPS6KA3/MAP2K3,2
WP_INSULIN_SIGNALING,WP_INSULIN_SIGNALING,4/151,161/21728,0.026131555739581657,0.10818697741364806,0.07952814830149565,RPS6KA3/CRK/FLOT2/MAP2K3,4
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,6/151,325/21728,0.02627441017215134,0.10861653490808991,0.07984391562339223,SEC23A/DUSP5/BIRC3/ZBTB38/RECQL/PGRMC2,6
REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,3/151,92/21728,0.026361288474191297,0.10881375836746424,0.07998889440827578,UBC/HUS1/PRKAG1,3
WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,4/151,162/21728,0.026652932417830264,0.10985437130079001,0.08075384802528612,HSP90B1/PRKAR1A/YWHAZ/ESR2,4
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,6/151,327/21728,0.026966826493766208,0.11098347259212227,0.08158384935346034,ATP6V1C1/STBD1/PRPS2/AKAP12/PRDX1/PGM3,6
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,5/151,242/21728,0.02717632705172614,0.11168023158238938,0.08209603625093227,SLC33A1/SLC2A3/EGLN1/EPHA2/SBNO2,5
SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS,SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS,2/151,37/21728,0.027259307320681065,0.11185576918294238,0.0822250737807996,ADAM9/BIRC3,2
AMIT_EGF_RESPONSE_480_HELA,AMIT_EGF_RESPONSE_480_HELA,4/151,164/21728,0.02771434710065488,0.1135552452000284,0.08347435704901485,EGLN1/PVR/RRBP1/MAP2K3,4
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,3/151,94/21728,0.027859561080513996,0.11381450100245276,0.08366493575262718,BIRC3/NRIP1/PPFIBP1,3
REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS,REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS,3/151,94/21728,0.027859561080513996,0.11381450100245276,0.08366493575262718,PRKAR1A/RPS6KA3/PRKAG1,3
GAVIN_FOXP3_TARGETS_CLUSTER_P3,GAVIN_FOXP3_TARGETS_CLUSTER_P3,4/151,165/21728,0.028254408876340717,0.11518336860398176,0.0846711890764748,LAMC1/SLC35D1/SLC2A3/SDC4,4
REACTOME_SIGNALING_BY_NOTCH,REACTOME_SIGNALING_BY_NOTCH,5/151,245/21728,0.02845174764605505,0.11518336860398176,0.0846711890764748,UBC/NCSTN/YWHAZ/SEL1L/FURIN,5
WINTER_HYPOXIA_UP,WINTER_HYPOXIA_UP,3/151,95/21728,0.028625400687785744,0.11518336860398176,0.0846711890764748,LDHA/PVR/LDLR,3
BERNARD_PPAPDC1B_TARGETS_UP,BERNARD_PPAPDC1B_TARGETS_UP,2/151,38/21728,0.02864468971230183,0.11518336860398176,0.0846711890764748,SCFD1/ZBTB38,2
DORN_ADENOVIRUS_INFECTION_32HR_DN,DORN_ADENOVIRUS_INFECTION_32HR_DN,2/151,38/21728,0.02864468971230183,0.11518336860398176,0.0846711890764748,EPHA2/MAP2K3,2
GENTILE_UV_RESPONSE_CLUSTER_D2,GENTILE_UV_RESPONSE_CLUSTER_D2,2/151,38/21728,0.02864468971230183,0.11518336860398176,0.0846711890764748,DUSP5/NRIP1,2
LEE_AGING_MUSCLE_UP,LEE_AGING_MUSCLE_UP,2/151,38/21728,0.02864468971230183,0.11518336860398176,0.0846711890764748,RAB21/HSPA8,2
PID_FAS_PATHWAY,PID_FAS_PATHWAY,2/151,38/21728,0.02864468971230183,0.11518336860398176,0.0846711890764748,CLTC/BIRC3,2
REACTOME_HSF1_DEPENDENT_TRANSACTIVATION,REACTOME_HSF1_DEPENDENT_TRANSACTIVATION,2/151,38/21728,0.02864468971230183,0.11518336860398176,0.0846711890764748,HSPA8/PTGES3,2
WEINMANN_ADAPTATION_TO_HYPOXIA_DN,WEINMANN_ADAPTATION_TO_HYPOXIA_DN,2/151,38/21728,0.02864468971230183,0.11518336860398176,0.0846711890764748,TPM1/SDC4,2
MULLIGHAN_MLL_SIGNATURE_2_UP,MULLIGHAN_MLL_SIGNATURE_2_UP,7/151,423/21728,0.028650722716109217,0.11518336860398176,0.0846711890764748,SDF4/IQGAP1/ACTR2/CBFB/PCYT1A/PTPN9/RRBP1,7
CAIRO_LIVER_DEVELOPMENT_UP,CAIRO_LIVER_DEVELOPMENT_UP,4/151,166/21728,0.028800721888809618,0.11561908295825594,0.0849914823004117,CBFB/EFNB2/LRP12/NPAS2,4
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,3/151,96/21728,0.029402357873572763,0.11786399736332633,0.08664171682954531,UBC/WWTR1/CBFB,3
DORN_ADENOVIRUS_INFECTION_48HR_DN,DORN_ADENOVIRUS_INFECTION_48HR_DN,2/151,39/21728,0.030057740738083222,0.11945694387753246,0.08781269035747527,EPHA2/MAP2K3,2
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP,GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP,2/151,39/21728,0.030057740738083222,0.11945694387753246,0.08781269035747527,RAB21/SLC2A3,2
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP,HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP,2/151,39/21728,0.030057740738083222,0.11945694387753246,0.08781269035747527,CALU/EFNB2,2
LEE_CALORIE_RESTRICTION_MUSCLE_UP,LEE_CALORIE_RESTRICTION_MUSCLE_UP,2/151,39/21728,0.030057740738083222,0.11945694387753246,0.08781269035747527,ACTB/CTNNA1,2
PID_ATR_PATHWAY,PID_ATR_PATHWAY,2/151,39/21728,0.030057740738083222,0.11945694387753246,0.08781269035747527,YWHAZ/HUS1,2
REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION,REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION,2/151,39/21728,0.030057740738083222,0.11945694387753246,0.08781269035747527,ITGB3/CRK,2
REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,5/151,249/21728,0.030210584076371113,0.11980894492099368,0.08807144600307974,SLC33A1/SLC4A7/SLC35D1/SLC2A3/SLC12A4,5
WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,6/151,336/21728,0.030232566734923173,0.11980894492099368,0.08807144600307974,ARAF/NCSTN/CSNK1A1/VDAC1/NRBF2/BECN1,6
WP_SMALL_CELL_LUNG_CANCER,WP_SMALL_CELL_LUNG_CANCER,3/151,98/21728,0.030989561893061675,0.12251883272788593,0.0900634820552835,LAMC1/BIRC3/LAMA5,3
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,4/151,170/21728,0.031048689071429696,0.12251883272788593,0.0900634820552835,DUSP5/MOXD1/FURIN/LOXL1,4
TIEN_INTESTINE_PROBIOTICS_6HR_DN,TIEN_INTESTINE_PROBIOTICS_6HR_DN,4/151,170/21728,0.031048689071429696,0.12251883272788593,0.0900634820552835,ETF1/WWTR1/FNDC3B/RECQL,4
BALDWIN_PRKCI_TARGETS_UP,BALDWIN_PRKCI_TARGETS_UP,2/151,40/21728,0.031498014421223436,0.12272297904931095,0.09021354982973864,SEPTIN11/SLC4A7,2
BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN,BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN,2/151,40/21728,0.031498014421223436,0.12272297904931095,0.09021354982973864,GBE1/ZNF330,2
FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,2/151,40/21728,0.031498014421223436,0.12272297904931095,0.09021354982973864,PPP1R15A/EPHA2,2
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP,2/151,40/21728,0.031498014421223436,0.12272297904931095,0.09021354982973864,APLP2/SLC35D1,2
NABA_BASEMENT_MEMBRANES,NABA_BASEMENT_MEMBRANES,2/151,40/21728,0.031498014421223436,0.12272297904931095,0.09021354982973864,LAMC1/LAMA5,2
TOMLINS_PROSTATE_CANCER_DN,TOMLINS_PROSTATE_CANCER_DN,2/151,40/21728,0.031498014421223436,0.12272297904931095,0.09021354982973864,SEC23A/AKAP12,2
TRAYNOR_RETT_SYNDROM_UP,TRAYNOR_RETT_SYNDROM_UP,2/151,40/21728,0.031498014421223436,0.12272297904931095,0.09021354982973864,AKAP12/MOXD1,2
WP_G13_SIGNALING_PATHWAY,WP_G13_SIGNALING_PATHWAY,2/151,40/21728,0.031498014421223436,0.12272297904931095,0.09021354982973864,PKN1/IQGAP1,2
WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,2/151,40/21728,0.031498014421223436,0.12272297904931095,0.09021354982973864,CSNK1A1/ICMT,2
ZHANG_BREAST_CANCER_PROGENITORS_UP,ZHANG_BREAST_CANCER_PROGENITORS_UP,7/151,432/21728,0.031594486291902174,0.12287853845951359,0.0903279014101233,VDAC1/PRPS2/PTPN14/MET/MOXD1/HUS1/EIF4H,7
UEDA_PERIFERAL_CLOCK,UEDA_PERIFERAL_CLOCK,4/151,171/21728,0.03162640568702384,0.12287853845951359,0.0903279014101233,HSPA4/STBD1/HSPA8/MAP2K3,4
PID_CXCR4_PATHWAY,PID_CXCR4_PATHWAY,3/151,100/21728,0.03262103207827358,0.12656595965564807,0.09303852136408518,RALB/CRK/JAK2,3
LI_LUNG_CANCER,LI_LUNG_CANCER,2/151,41/21728,0.03296506957454741,0.12754451710040768,0.09375785804811902,YWHAZ/PRDX1,2
MARTIN_INTERACT_WITH_HDAC,MARTIN_INTERACT_WITH_HDAC,2/151,41/21728,0.03296506957454741,0.12754451710040768,0.09375785804811902,NRIP1/ACTN4,2
BROWNE_HCMV_INFECTION_20HR_DN,BROWNE_HCMV_INFECTION_20HR_DN,3/151,102/21728,0.034296604199457015,0.13113099860648814,0.09639427732809935,SEPTIN11/ATP13A3/GBE1,3
CHEN_HOXA5_TARGETS_9HR_DN,CHEN_HOXA5_TARGETS_9HR_DN,2/151,42/21728,0.034458469756204584,0.13113099860648814,0.09639427732809935,KDELR1/LOXL1,2
CHESLER_BRAIN_HIGHEST_EXPRESSION,CHESLER_BRAIN_HIGHEST_EXPRESSION,2/151,42/21728,0.034458469756204584,0.13113099860648814,0.09639427732809935,ACTB/ATP13A3,2
DORN_ADENOVIRUS_INFECTION_24HR_DN,DORN_ADENOVIRUS_INFECTION_24HR_DN,2/151,42/21728,0.034458469756204584,0.13113099860648814,0.09639427732809935,EPHA2/MAP2K3,2
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,2/151,42/21728,0.034458469756204584,0.13113099860648814,0.09639427732809935,PTPN12/SLC2A3,2
KORKOLA_EMBRYONAL_CARCINOMA_UP,KORKOLA_EMBRYONAL_CARCINOMA_UP,2/151,42/21728,0.034458469756204584,0.13113099860648814,0.09639427732809935,SLC2A3/RECQL,2
PID_TCPTP_PATHWAY,PID_TCPTP_PATHWAY,2/151,42/21728,0.034458469756204584,0.13113099860648814,0.09639427732809935,LMAN1/MET,2
PID_UPA_UPAR_PATHWAY,PID_UPA_UPAR_PATHWAY,2/151,42/21728,0.034458469756204584,0.13113099860648814,0.09639427732809935,ITGB3/CRK,2
REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX,REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX,2/151,42/21728,0.034458469756204584,0.13113099860648814,0.09639427732809935,UBC/YWHAZ,2
REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION,REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION,2/151,42/21728,0.034458469756204584,0.13113099860648814,0.09639427732809935,PRKAR1A/IQGAP1,2
REACTOME_RND1_GTPASE_CYCLE,REACTOME_RND1_GTPASE_CYCLE,2/151,42/21728,0.034458469756204584,0.13113099860648814,0.09639427732809935,FLOT2/EPHA2,2
REACTOME_RND3_GTPASE_CYCLE,REACTOME_RND3_GTPASE_CYCLE,2/151,42/21728,0.034458469756204584,0.13113099860648814,0.09639427732809935,FLOT2/EPHA2,2
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN,4/151,176/21728,0.03460972571745803,0.13152642687154367,0.0966849562846405,FEM1B/SLC33A1/MET/SNX19,4
GRYDER_PAX3FOXO1_TOP_ENHANCERS,GRYDER_PAX3FOXO1_TOP_ENHANCERS,7/151,441/21728,0.034735346698704525,0.13182348788114914,0.09690332556152831,STK24/ACTB/ACTG1/YWHAZ/PTPN12/MCFD2/ZNF330,7
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,5/151,259/21728,0.034902983127896636,0.13227897289126447,0.09723815217651968,SLC2A3/CD151/PVR/RRBP1/LOXL1,5
DER_IFN_BETA_RESPONSE_UP,DER_IFN_BETA_RESPONSE_UP,3/151,103/21728,0.03515087105270532,0.13303694793517082,0.09779533893911993,ADAM9/IQGAP1/PML,3
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,4/151,177/21728,0.03522538143014974,0.13313756409925984,0.0978693017894601,SEPTIN11/WWTR1/MOXD1/SLC2A3,4
REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES,REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES,2/151,43/21728,0.03597778322574513,0.13561232266094975,0.09968849454823331,SLC33A1/SLC35D1,2
ULE_SPLICING_VIA_NOVA2,ULE_SPLICING_VIA_NOVA2,2/151,43/21728,0.03597778322574513,0.13561232266094975,0.09968849454823331,APLP2/LRP12,2
RIZKI_TUMOR_INVASIVENESS_3D_DN,RIZKI_TUMOR_INVASIVENESS_3D_DN,5/151,262/21728,0.036393938385087074,0.1369950688804497,0.10070495003147759,VDAC1/ZNF330/LAMA5/SLC12A4/ICMT,5
XU_GH1_EXOGENOUS_TARGETS_DN,XU_GH1_EXOGENOUS_TARGETS_DN,3/151,105/21728,0.03689223969159628,0.13868287126286125,0.10194565202150385,ITGB3/SLC4A7/ZNF654,3
GNATENKO_PLATELET_SIGNATURE,GNATENKO_PLATELET_SIGNATURE,2/151,44/21728,0.03752258290057091,0.13991642321850467,0.1028524349376299,UBC/ACTB,2
KORKOLA_SEMINOMA_UP,KORKOLA_SEMINOMA_UP,2/151,44/21728,0.03752258290057091,0.13991642321850467,0.1028524349376299,SLC2A3/RECQL,2
PID_INSULIN_PATHWAY,PID_INSULIN_PATHWAY,2/151,44/21728,0.03752258290057091,0.13991642321850467,0.1028524349376299,CRK/TRIP10,2
REACTOME_TNF_SIGNALING,REACTOME_TNF_SIGNALING,2/151,44/21728,0.03752258290057091,0.13991642321850467,0.1028524349376299,UBC/BIRC3,2
WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,2/151,44/21728,0.03752258290057091,0.13991642321850467,0.1028524349376299,ACTB/ACTG1,2
WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,2/151,44/21728,0.03752258290057091,0.13991642321850467,0.1028524349376299,SORT1/EPHB4,2
KEGG_ENDOCYTOSIS,KEGG_ENDOCYTOSIS,4/151,181/21728,0.03775147408071003,0.14030863505735194,0.10314074950220256,CLTC/MET/HSPA8/LDLR,4
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN,3/151,106/21728,0.03777928690529131,0.14030863505735194,0.10314074950220256,HSP90B1/UBC/NCSTN,3
WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,3/151,106/21728,0.03777928690529131,0.14030863505735194,0.10314074950220256,CLTC/EIF4H/BECN1,3
OKUMURA_INFLAMMATORY_RESPONSE_LPS,OKUMURA_INFLAMMATORY_RESPONSE_LPS,4/151,182/21728,0.038398882365358565,0.14241935275162362,0.10469233615177516,BIRC3/SLC4A7/JAK2/SDC4,4
ZHU_CMV_ALL_UP,ZHU_CMV_ALL_UP,3/151,107/21728,0.038677204223251875,0.14251813104572505,0.10476494798556575,SSR1/ATP6V1C1/PML,3
REACTOME_ION_CHANNEL_TRANSPORT,REACTOME_ION_CHANNEL_TRANSPORT,4/151,183/21728,0.03905265002440411,0.14251813104572505,0.10476494798556575,UBC/ATP6V1C1/ATP1A1/ATP6V1A,4
WU_CELL_MIGRATION,WU_CELL_MIGRATION,4/151,183/21728,0.03905265002440411,0.14251813104572505,0.10476494798556575,WWTR1/AKAP12/PERP/EFNB2,4
BURTON_ADIPOGENESIS_4,BURTON_ADIPOGENESIS_4,2/151,45/21728,0.039092446312758274,0.14251813104572505,0.10476494798556575,LDHA/EPHB4,2
CHIBA_RESPONSE_TO_TSA,CHIBA_RESPONSE_TO_TSA,2/151,45/21728,0.039092446312758274,0.14251813104572505,0.10476494798556575,PRDX1/SDC4,2
NAKAMURA_METASTASIS_MODEL_UP,NAKAMURA_METASTASIS_MODEL_UP,2/151,45/21728,0.039092446312758274,0.14251813104572505,0.10476494798556575,DUSP5/DUSP3,2
PID_RHOA_PATHWAY,PID_RHOA_PATHWAY,2/151,45/21728,0.039092446312758274,0.14251813104572505,0.10476494798556575,PKN1/MAP2K3,2
ROVERSI_GLIOMA_LOH_REGIONS,ROVERSI_GLIOMA_LOH_REGIONS,2/151,45/21728,0.039092446312758274,0.14251813104572505,0.10476494798556575,PPFIBP1/PVR,2
SAGIV_CD24_TARGETS_DN,SAGIV_CD24_TARGETS_DN,2/151,45/21728,0.039092446312758274,0.14251813104572505,0.10476494798556575,DUSP5/PPP1R15A,2
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP,SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP,2/151,45/21728,0.039092446312758274,0.14251813104572505,0.10476494798556575,LDHA/PRDX1,2
SIG_CHEMOTAXIS,SIG_CHEMOTAXIS,2/151,45/21728,0.039092446312758274,0.14251813104572505,0.10476494798556575,ACTR2/ACTR3,2
WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,2/151,45/21728,0.039092446312758274,0.14251813104572505,0.10476494798556575,LDHA/SLC2A3,2
WP_NEPHROTIC_SYNDROME,WP_NEPHROTIC_SYNDROME,2/151,45/21728,0.039092446312758274,0.14251813104572505,0.10476494798556575,ACTN4/CD151,2
REACTOME_AMYLOID_FIBER_FORMATION,REACTOME_AMYLOID_FIBER_FORMATION,3/151,108/21728,0.039585961232789166,0.1440961680519344,0.10592496154778248,UBC/NCSTN/FURIN,3
TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,7/151,454/21728,0.039629039737825014,0.1440961680519344,0.10592496154778248,ARAF/YWHAZ/API5/LDHA/MET/DIPK2A/PRKAG1,7
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,4/151,184/21728,0.03971277885743849,0.1442118949881884,0.1060100323129421,PRKAR1A/SLC2A3/SORT1/PPFIBP1,4
MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,5/151,269/21728,0.04002396800978314,0.1447226153175945,0.10638546236070379,ATP1A1/PERP/PDLIM4/BECN1/SDC4,5
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,4/151,185/21728,0.040379270175691616,0.1447226153175945,0.10638546236070379,CRK/FLOT2/MAP2K3/FLII,4
WP_RAS_SIGNALING,WP_RAS_SIGNALING,4/151,185/21728,0.040379270175691616,0.1447226153175945,0.10638546236070379,RALB/RASA2/MET/EPHA2,4
SESTO_RESPONSE_TO_UV_C0,SESTO_RESPONSE_TO_UV_C0,3/151,109/21728,0.040505526317070356,0.1447226153175945,0.10638546236070379,RAB21/MCFD2/COPS2,3
VANTVEER_BREAST_CANCER_METASTASIS_DN,VANTVEER_BREAST_CANCER_METASTASIS_DN,3/151,109/21728,0.040505526317070356,0.1447226153175945,0.10638546236070379,GBE1/SLC2A3/LRP12,3
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,2/151,46/21728,0.04068695556624957,0.1447226153175945,0.10638546236070379,PDLIM4/EPHA2,2
BURTON_ADIPOGENESIS_PEAK_AT_2HR,BURTON_ADIPOGENESIS_PEAK_AT_2HR,2/151,46/21728,0.04068695556624957,0.1447226153175945,0.10638546236070379,PPP1R15A/MAP2K3,2
IRITANI_MAD1_TARGETS_DN,IRITANI_MAD1_TARGETS_DN,2/151,46/21728,0.04068695556624957,0.1447226153175945,0.10638546236070379,RARS1/HSPA9,2
LUI_THYROID_CANCER_PAX8_PPARG_DN,LUI_THYROID_CANCER_PAX8_PPARG_DN,2/151,46/21728,0.04068695556624957,0.1447226153175945,0.10638546236070379,YWHAZ/HSPA8,2
LUI_THYROID_CANCER_PAX8_PPARG_UP,LUI_THYROID_CANCER_PAX8_PPARG_UP,2/151,46/21728,0.04068695556624957,0.1447226153175945,0.10638546236070379,ATP13A3/APLP2,2
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1,2/151,46/21728,0.04068695556624957,0.1447226153175945,0.10638546236070379,DUSP5/EPHA2,2
PID_PS1_PATHWAY,PID_PS1_PATHWAY,2/151,46/21728,0.04068695556624957,0.1447226153175945,0.10638546236070379,NCSTN/CSNK1A1,2
PID_SYNDECAN_1_PATHWAY,PID_SYNDECAN_1_PATHWAY,2/151,46/21728,0.04068695556624957,0.1447226153175945,0.10638546236070379,MET/LAMA5,2
PID_TNF_PATHWAY,PID_TNF_PATHWAY,2/151,46/21728,0.04068695556624957,0.1447226153175945,0.10638546236070379,BIRC3/MAP2K3,2
REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,2/151,46/21728,0.04068695556624957,0.1447226153175945,0.10638546236070379,UBC/WWTR1,2
STOSSI_RESPONSE_TO_ESTRADIOL,STOSSI_RESPONSE_TO_ESTRADIOL,2/151,46/21728,0.04068695556624957,0.1447226153175945,0.10638546236070379,BIRC3/NRIP1,2
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,4/151,186/21728,0.041052124805146896,0.14583478607250394,0.10720301806701438,PDIA3/MCFD2/BECN1/SDC4,4
CHENG_IMPRINTED_BY_ESTRADIOL,CHENG_IMPRINTED_BY_ESTRADIOL,3/151,110/21728,0.04143586668044119,0.14663546195957405,0.10779159418043033,WDR1/RECQL/LAMA5,3
GROSS_HYPOXIA_VIA_HIF1A_DN,GROSS_HYPOXIA_VIA_HIF1A_DN,3/151,110/21728,0.04143586668044119,0.14663546195957405,0.10779159418043033,DUSP3/GBE1/PDLIM4,3
REACTOME_NUCLEOTIDE_EXCISION_REPAIR,REACTOME_NUCLEOTIDE_EXCISION_REPAIR,3/151,110/21728,0.04143586668044119,0.14663546195957405,0.10779159418043033,UBC/ACTB/COPS2,3
AMIT_EGF_RESPONSE_60_HELA,AMIT_EGF_RESPONSE_60_HELA,2/151,47/21728,0.042305697294410936,0.14807944978784665,0.10885306831435812,SLC2A3/LDLR,2
MCDOWELL_ACUTE_LUNG_INJURY_UP,MCDOWELL_ACUTE_LUNG_INJURY_UP,2/151,47/21728,0.042305697294410936,0.14807944978784665,0.10885306831435812,AKAP12/TPM1,2
NAKAMURA_METASTASIS,NAKAMURA_METASTASIS,2/151,47/21728,0.042305697294410936,0.14807944978784665,0.10885306831435812,DUSP3/PCDH8,2
PID_IL6_7_PATHWAY,PID_IL6_7_PATHWAY,2/151,47/21728,0.042305697294410936,0.14807944978784665,0.10885306831435812,HSP90B1/JAK2,2
PID_LKB1_PATHWAY,PID_LKB1_PATHWAY,2/151,47/21728,0.042305697294410936,0.14807944978784665,0.10885306831435812,YWHAZ/PRKAG1,2
REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,2/151,47/21728,0.042305697294410936,0.14807944978784665,0.10885306831435812,UBC/JAK2,2
REACTOME_INTERLEUKIN_12_SIGNALING,REACTOME_INTERLEUKIN_12_SIGNALING,2/151,47/21728,0.042305697294410936,0.14807944978784665,0.10885306831435812,HSPA9/JAK2,2
WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,2/151,47/21728,0.042305697294410936,0.14807944978784665,0.10885306831435812,HSPA5/PPP1R15A,2
LIM_MAMMARY_LUMINAL_MATURE_UP,LIM_MAMMARY_LUMINAL_MATURE_UP,3/151,111/21728,0.04237694837341184,0.14807944978784665,0.10885306831435812,TMCO3/SORT1/LAMA5,3
ZWANG_EGF_INTERVAL_UP,ZWANG_EGF_INTERVAL_UP,3/151,111/21728,0.04237694837341184,0.14807944978784665,0.10885306831435812,ATP13A3/SLC33A1/SH2D4A,3
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,5/151,274/21728,0.042747296312226644,0.14918591602432868,0.10966643063438204,DUSP5/PPP1R15A/SH2D4A/PVR/EPHA2,5
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,4/151,189/21728,0.04310886960826378,0.15025902104360953,0.11045526915410651,SLC2A3/LRP12/LDLR/SDC4,4
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,7/151,463/21728,0.04326957169012365,0.15063016310170865,0.11072809534209192,HSP90B1/CSNK1A1/CLTC/NRIP1/HSPA8/PTGES3/FURIN,7
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,6/151,367/21728,0.04342694335620091,0.1509887968004082,0.1109917266465052,PPP1R15A/SORT1/CTNNA1/PML/TRIP10/EPHB4,6
APRELIKOVA_BRCA1_TARGETS,APRELIKOVA_BRCA1_TARGETS,2/151,48/21728,0.04394826261795223,0.15166245161822522,0.1114869296879076,PDIA3/TPM1,2
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,2/151,48/21728,0.04394826261795223,0.15166245161822522,0.1114869296879076,HSPA5/TPM1,2
REACTOME_HEME_SIGNALING,REACTOME_HEME_SIGNALING,2/151,48/21728,0.04394826261795223,0.15166245161822522,0.1114869296879076,NRIP1/NPAS2,2
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN,SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN,2/151,48/21728,0.04394826261795223,0.15166245161822522,0.1114869296879076,HSPA9/LDHA,2
SU_PANCREAS,SU_PANCREAS,2/151,48/21728,0.04394826261795223,0.15166245161822522,0.1114869296879076,SEL1L/PML,2
ZHAN_MULTIPLE_MYELOMA_CD2_UP,ZHAN_MULTIPLE_MYELOMA_CD2_UP,2/151,48/21728,0.04394826261795223,0.15166245161822522,0.1114869296879076,APLP2/SORT1,2
DITTMER_PTHLH_TARGETS_UP,DITTMER_PTHLH_TARGETS_UP,3/151,113/21728,0.04429119432859183,0.15246708530957637,0.11207841517963628,ATP1A1/DUSP5/LAMA5,3
REACTOME_HEDGEHOG_OFF_STATE,REACTOME_HEDGEHOG_OFF_STATE,3/151,113/21728,0.04429119432859183,0.15246708530957637,0.11207841517963628,PRKAR1A/UBC/CSNK1A1,3
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,4/151,191/21728,0.04451184296239992,0.15303700464052844,0.11249736235937448,ARIH1/ATP6V1C1/PGM3/RECQL,4
SMIRNOV_RESPONSE_TO_IR_6HR_DN,SMIRNOV_RESPONSE_TO_IR_6HR_DN,3/151,114/21728,0.04526428514285808,0.1552397334899503,0.11411658632507432,SLC2A3/EGLN1/LDLR,3
WP_GASTRIN_SIGNALING_PATHWAY,WP_GASTRIN_SIGNALING_PATHWAY,3/151,114/21728,0.04526428514285808,0.1552397334899503,0.11411658632507432,BIRC3/CRK/JAK2,3
FAELT_B_CLL_WITH_VH3_21_DN,FAELT_B_CLL_WITH_VH3_21_DN,2/151,49/21728,0.04561424710320788,0.15528967947636213,0.11415330157407545,ACBD3/CTNNA1,2
GUILLAUMOND_KLF10_TARGETS_UP,GUILLAUMOND_KLF10_TARGETS_UP,2/151,49/21728,0.04561424710320788,0.15528967947636213,0.11415330157407545,YWHAZ/MOXD1,2
JIANG_AGING_HYPOTHALAMUS_UP,JIANG_AGING_HYPOTHALAMUS_UP,2/151,49/21728,0.04561424710320788,0.15528967947636213,0.11415330157407545,ACTB/PRDX1,2
LINDSTEDT_DENDRITIC_CELL_MATURATION_B,LINDSTEDT_DENDRITIC_CELL_MATURATION_B,2/151,49/21728,0.04561424710320788,0.15528967947636213,0.11415330157407545,BIRC3/SDC4,2
REACTOME_SIGNALING_BY_NOTCH3,REACTOME_SIGNALING_BY_NOTCH3,2/151,49/21728,0.04561424710320788,0.15528967947636213,0.11415330157407545,UBC/NCSTN,2
WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,2/151,49/21728,0.04561424710320788,0.15528967947636213,0.11415330157407545,STBD1/HSPA8,2
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,4/151,193/21728,0.04594024887662826,0.15620809226349242,0.11482842597520947,PTPN12/BIRC3/FLOT2/TPM1,4
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN,CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN,4/151,194/21728,0.04666398255625667,0.15847499210425556,0.11649482197804394,TM9SF2/PDIA6/ATP1A1/HSPA8,4
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,5/151,281/21728,0.046743867326482426,0.15855245840411256,0.11655176738432738,ACTR2/FEM1C/SLC2A3/PGM3/SNX19,5
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP,2/151,50/21728,0.04730325072077377,0.1591880962171306,0.1170190241602188,HSPA8/GARS1,2
NOUSHMEHR_GBM_SILENCED_BY_METHYLATION,NOUSHMEHR_GBM_SILENCED_BY_METHYLATION,2/151,50/21728,0.04730325072077377,0.1591880962171306,0.1170190241602188,LDHA/BIRC3,2
REACTOME_SARS_COV_1_INFECTION,REACTOME_SARS_COV_1_INFECTION,2/151,50/21728,0.04730325072077377,0.1591880962171306,0.1170190241602188,UBC/BECN1,2
REACTOME_SIGNALING_BY_EGFR,REACTOME_SIGNALING_BY_EGFR,2/151,50/21728,0.04730325072077377,0.1591880962171306,0.1170190241602188,UBC/PTPN12,2
REACTOME_SIGNALING_BY_ERBB2,REACTOME_SIGNALING_BY_ERBB2,2/151,50/21728,0.04730325072077377,0.1591880962171306,0.1170190241602188,UBC/PTPN12,2
ZHAN_MULTIPLE_MYELOMA_MS_UP,ZHAN_MULTIPLE_MYELOMA_MS_UP,2/151,50/21728,0.04730325072077377,0.1591880962171306,0.1170190241602188,NRIP1/LRP12,2
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,5/151,282/21728,0.04733238570026994,0.1591880962171306,0.1170190241602188,HSP90B1/PDIA6/HSPA9/PPP1R15A/ZBTB38,5
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,4/151,195/21728,0.04739406567527064,0.15920279860447623,0.11702983187173045,APLP2/PCYT1A/NRIP1/EGLN1,4
HELLER_SILENCED_BY_METHYLATION_UP,HELLER_SILENCED_BY_METHYLATION_UP,5/151,283/21728,0.047925307803432855,0.16079288052890878,0.11819869964233376,AKAP12/BIRC3/PML/LDLR/SBNO2,5
GLASS_IGF2BP1_CLIP_TARGETS_KNOCKDOWN_DN,GLASS_IGF2BP1_CLIP_TARGETS_KNOCKDOWN_DN,3/151,117/21728,0.04824696604134139,0.16167680538340937,0.11884847199568574,YWHAZ/PTPN9/PTGES3,3
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,6/151,377/21728,0.04834846844629547,0.16182174137808292,0.11895501431301612,UBC/TRIP12/PDIA3/SEC23A/HSPA5/SEC24A,6
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,6/151,378/21728,0.048858849174467305,0.1628747972977252,0.11972911475790492,SSR1/VDAC1/AKAP12/BIRC3/SEC24A/SBNO2,6
APPIERTO_RESPONSE_TO_FENRETINIDE_DN,APPIERTO_RESPONSE_TO_FENRETINIDE_DN,2/151,51/21728,0.049014877804499014,0.1628747972977252,0.11972911475790492,IARS2/LDHA,2
BIOCARTA_NFAT_PATHWAY,BIOCARTA_NFAT_PATHWAY,2/151,51/21728,0.049014877804499014,0.1628747972977252,0.11972911475790492,PRKAR1A/CSNK1A1,2
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,2/151,51/21728,0.049014877804499014,0.1628747972977252,0.11972911475790492,HSPA9/PPP1R15A,2
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR,HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR,2/151,51/21728,0.049014877804499014,0.1628747972977252,0.11972911475790492,NUS1/API5,2
MORI_IMMATURE_B_LYMPHOCYTE_UP,MORI_IMMATURE_B_LYMPHOCYTE_UP,2/151,51/21728,0.049014877804499014,0.1628747972977252,0.11972911475790492,BIRC3/PML,2
WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,3/151,118/21728,0.04926219462794091,0.16350104740313004,0.12018947063850263,ARAF/ACTR2/MAP2K3,3
WHITFIELD_CELL_CYCLE_G2_M,WHITFIELD_CELL_CYCLE_G2_M,4/151,198/21728,0.049622370947186925,0.16449993614711847,0.1209237528420332,CTNND1/PTPN9/HSPA8/CTNNA1,4
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,4/151,199/21728,0.050377808871526,0.16680518837318142,0.12261834164827859,PRKAR1A/PTPN12/PKD2/ZNF330,4
BIOCARTA_PPARA_PATHWAY,BIOCARTA_PPARA_PATHWAY,2/151,52/21728,0.050748737010828604,0.16743466914023974,0.12308107238530754,PRKAR1A/NRIP1,2
KEGG_ENDOMETRIAL_CANCER,KEGG_ENDOMETRIAL_CANCER,2/151,52/21728,0.050748737010828604,0.16743466914023974,0.12308107238530754,ARAF/CTNNA1,2
LUI_THYROID_CANCER_CLUSTER_1,LUI_THYROID_CANCER_CLUSTER_1,2/151,52/21728,0.050748737010828604,0.16743466914023974,0.12308107238530754,ATP13A3/APLP2,2
GABRIELY_MIR21_TARGETS,GABRIELY_MIR21_TARGETS,5/151,289/21728,0.05157543743407317,0.16996033830587812,0.12493768948255224,RPS6KA3/PKD2/ACTR2/TPM1/ZBTB38,5
KRIEG_HYPOXIA_VIA_KDM3A,KRIEG_HYPOXIA_VIA_KDM3A,2/151,53/21728,0.0525044412784944,0.17139522664119558,0.12599247458751825,BIRC3/PPP1R15A,2
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,2/151,53/21728,0.0525044412784944,0.17139522664119558,0.12599247458751825,CALU/AKAP12,2
PID_NFAT_3PATHWAY,PID_NFAT_3PATHWAY,2/151,53/21728,0.0525044412784944,0.17139522664119558,0.12599247458751825,YWHAZ/CSNK1A1,2
REACTOME_FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX,REACTOME_FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX,2/151,53/21728,0.0525044412784944,0.17139522664119558,0.12599247458751825,UBC/COPS2,2
REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY,REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY,2/151,53/21728,0.0525044412784944,0.17139522664119558,0.12599247458751825,NRBF2/ESR2,2
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN,2/151,53/21728,0.0525044412784944,0.17139522664119558,0.12599247458751825,PCDH8/HSPA8,2
WP_TRANSLATION_FACTORS,WP_TRANSLATION_FACTORS,2/151,53/21728,0.0525044412784944,0.17139522664119558,0.12599247458751825,ETF1/EIF4H,2
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN,ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN,2/151,53/21728,0.0525044412784944,0.17139522664119558,0.12599247458751825,SORT1/LAMA5,2
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP,3/151,122/21728,0.05342698260482307,0.1739104615664089,0.12784142148415492,WWTR1/HSPA5/API5,3
REACTOME_INTERFERON_SIGNALING,REACTOME_INTERFERON_SIGNALING,4/151,203/21728,0.05346275528355408,0.1739104615664089,0.12784142148415492,UBC/ARIH1/JAK2/PML,4
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,4/151,203/21728,0.05346275528355408,0.1739104615664089,0.12784142148415492,CALU/HSPA5/APLP2/PPFIBP1,4
PAL_PRMT5_TARGETS_UP,PAL_PRMT5_TARGETS_UP,4/151,204/21728,0.05424975705629577,0.17513856728989285,0.128744200879994,PKD2/HSPA4/MET/LOXL1,4
LEE_LIVER_CANCER_MYC_UP,LEE_LIVER_CANCER_MYC_UP,2/151,54/21728,0.0542816077885521,0.17513856728989285,0.128744200879994,ACTG1/RALB,2
MARSON_FOXP3_TARGETS_DN,MARSON_FOXP3_TARGETS_DN,2/151,54/21728,0.0542816077885521,0.17513856728989285,0.128744200879994,ETF1/JAK2,2
MORI_PLASMA_CELL_UP,MORI_PLASMA_CELL_UP,2/151,54/21728,0.0542816077885521,0.17513856728989285,0.128744200879994,LMAN1/RRBP1,2
PID_TGFBR_PATHWAY,PID_TGFBR_PATHWAY,2/151,54/21728,0.0542816077885521,0.17513856728989285,0.128744200879994,PPP1R15A/PML,2
REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING,REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING,2/151,54/21728,0.0542816077885521,0.17513856728989285,0.128744200879994,UBC/YWHAZ,2
REACTOME_SIGNALING_BY_PTK6,REACTOME_SIGNALING_BY_PTK6,2/151,54/21728,0.0542816077885521,0.17513856728989285,0.128744200879994,UBC/CRK,2
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,5/151,296/21728,0.05603482692565762,0.17886319783580343,0.13148217339299711,LAMC1/ITPRID2/GBE1/COPS2/CTNNA1,5
MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER,MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER,2/151,55/21728,0.05607985792476054,0.17886319783580343,0.13148217339299711,SSR1/MET,2
PID_FGF_PATHWAY,PID_FGF_PATHWAY,2/151,55/21728,0.05607985792476054,0.17886319783580343,0.13148217339299711,CTNND1/MET,2
REACTOME_AMINO_ACIDS_REGULATE_MTORC1,REACTOME_AMINO_ACIDS_REGULATE_MTORC1,2/151,55/21728,0.05607985792476054,0.17886319783580343,0.13148217339299711,ATP6V1C1/ATP6V1A,2
REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,2/151,55/21728,0.05607985792476054,0.17886319783580343,0.13148217339299711,UBC/HSPA8,2
REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE,REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE,2/151,55/21728,0.05607985792476054,0.17886319783580343,0.13148217339299711,VDAC1/LDHA,2
REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2/151,55/21728,0.05607985792476054,0.17886319783580343,0.13148217339299711,SEC23A/SEC24A,2
REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY,REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY,2/151,55/21728,0.05607985792476054,0.17886319783580343,0.13148217339299711,UBC/CBFB,2
REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA,REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA,2/151,55/21728,0.05607985792476054,0.17886319783580343,0.13148217339299711,ACTB/ACTG1,2
WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,2/151,55/21728,0.05607985792476054,0.17886319783580343,0.13148217339299711,CRK/MAP2K3,2
WP_CIRCADIAN_RHYTHM_GENES,WP_CIRCADIAN_RHYTHM_GENES,4/151,207/21728,0.05664847630515233,0.17998123543649827,0.132304041812287,UBC/NRIP1/PML/NPAS2,4
RASHI_RESPONSE_TO_IONIZING_RADIATION_2,RASHI_RESPONSE_TO_IONIZING_RADIATION_2,3/151,125/21728,0.056658379037782376,0.17998123543649827,0.132304041812287,WWTR1/BIRC3/PVR,3
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP,RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP,3/151,125/21728,0.056658379037782376,0.17998123543649827,0.132304041812287,DUSP3/PAFAH2/SNX19,3
REACTOME_DEUBIQUITINATION,REACTOME_DEUBIQUITINATION,5/151,297/21728,0.0566895539981771,0.17998123543649827,0.132304041812287,UBC/ACTB/VDAC1/BIRC3/BECN1,5
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,3/151,126/21728,0.057755794798513276,0.18236158081279835,0.13405383152469735,CALU/WDR1/SLC4A7,3
CHEBOTAEV_GR_TARGETS_DN,CHEBOTAEV_GR_TARGETS_DN,3/151,126/21728,0.057755794798513276,0.18236158081279835,0.13405383152469735,STBD1/PTPN14/LOXL1,3
REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,3/151,126/21728,0.057755794798513276,0.18236158081279835,0.13405383152469735,CLTC/SEC23A/SEC24A,3
BIOCARTA_HIVNEF_PATHWAY,BIOCARTA_HIVNEF_PATHWAY,2/151,56/21728,0.05789881723430099,0.18236158081279835,0.13405383152469735,ACTG1/BIRC3,2
LEE_LIVER_CANCER_MYC_E2F1_UP,LEE_LIVER_CANCER_MYC_E2F1_UP,2/151,56/21728,0.05789881723430099,0.18236158081279835,0.13405383152469735,ACTG1/LAMA5,2
MODY_HIPPOCAMPUS_POSTNATAL,MODY_HIPPOCAMPUS_POSTNATAL,2/151,56/21728,0.05789881723430099,0.18236158081279835,0.13405383152469735,ATP6V1C1/VDAC1,2
REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,2/151,56/21728,0.05789881723430099,0.18236158081279835,0.13405383152469735,UBC/BIRC3,2
BASAKI_YBX1_TARGETS_DN,BASAKI_YBX1_TARGETS_DN,6/151,395/21728,0.05804692191289196,0.1826210068788379,0.13424453538893769,LMAN1/PKD2/DUSP5/GBE1/MET/FLOT2,6
DAZARD_RESPONSE_TO_UV_NHEK_DN,DAZARD_RESPONSE_TO_UV_NHEK_DN,5/151,300/21728,0.05868023371359906,0.18440462585563144,0.13555567206999544,ATP13A3/FEM1B/NRIP1/EFNB2/NPAS2,5
PILON_KLF1_TARGETS_UP,PILON_KLF1_TARGETS_UP,7/151,497/21728,0.0589458480846063,0.18503001805540825,0.1360153973049494,RARS1/ACTB/HSPA9/ARIH1/CSNK1A1/RPS6KA3/PKD2,7
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,4/151,210/21728,0.05910358173853748,0.18531574499961304,0.13622543492071132,LAMC1/WWTR1/TPM1/LOXL1,4
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP,JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP,2/151,57/21728,0.05973811538883419,0.1858370487684002,0.13660864484509733,TPM1/PPFIBP1,2
KEGG_ACUTE_MYELOID_LEUKEMIA,KEGG_ACUTE_MYELOID_LEUKEMIA,2/151,57/21728,0.05973811538883419,0.1858370487684002,0.13660864484509733,ARAF/PML,2
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN,LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN,2/151,57/21728,0.05973811538883419,0.1858370487684002,0.13660864484509733,APLP2/GBE1,2
NAGASHIMA_EGF_SIGNALING_UP,NAGASHIMA_EGF_SIGNALING_UP,2/151,57/21728,0.05973811538883419,0.1858370487684002,0.13660864484509733,DUSP5/EPHA2,2
REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND,REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND,2/151,57/21728,0.05973811538883419,0.1858370487684002,0.13660864484509733,HSPA8/PTGES3,2
REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING,2/151,57/21728,0.05973811538883419,0.1858370487684002,0.13660864484509733,HSPA9/JAK2,2
SMIRNOV_RESPONSE_TO_IR_2HR_DN,SMIRNOV_RESPONSE_TO_IR_2HR_DN,2/151,57/21728,0.05973811538883419,0.1858370487684002,0.13660864484509733,SLC2A3/JAK2,2
AMIT_SERUM_RESPONSE_60_MCF10A,AMIT_SERUM_RESPONSE_60_MCF10A,2/151,58/21728,0.06159738614589125,0.19013059857031764,0.13976482938365967,DUSP5/SLC35D1,2
JIANG_HYPOXIA_CANCER,JIANG_HYPOXIA_CANCER,2/151,58/21728,0.06159738614589125,0.19013059857031764,0.13976482938365967,ATP6V1A/PGM3,2
KANNAN_TP53_TARGETS_UP,KANNAN_TP53_TARGETS_UP,2/151,58/21728,0.06159738614589125,0.19013059857031764,0.13976482938365967,PDLIM4/LOXL1,2
LUCAS_HNF4A_TARGETS_UP,LUCAS_HNF4A_TARGETS_UP,2/151,58/21728,0.06159738614589125,0.19013059857031764,0.13976482938365967,SLC35D1/SDC4,2
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP,PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP,2/151,58/21728,0.06159738614589125,0.19013059857031764,0.13976482938365967,PERP/UNC5C,2
REACTOME_SIGNALING_BY_ERBB4,REACTOME_SIGNALING_BY_ERBB4,2/151,58/21728,0.06159738614589125,0.19013059857031764,0.13976482938365967,UBC/NCSTN,2
REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER,REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER,2/151,58/21728,0.06159738614589125,0.19013059857031764,0.13976482938365967,UBC/NCSTN,2
BROWN_MYELOID_CELL_DEVELOPMENT_DN,BROWN_MYELOID_CELL_DEVELOPMENT_DN,3/151,131/21728,0.06339276659687164,0.19421388656495284,0.14276645065969779,NRIP1/PTPN9/LAMA5,3
GERY_CEBP_TARGETS,GERY_CEBP_TARGETS,3/151,131/21728,0.06339276659687164,0.19421388656495284,0.14276645065969779,NUS1/SSR1/PPP1R15A,3
AMIT_EGF_RESPONSE_240_HELA,AMIT_EGF_RESPONSE_240_HELA,2/151,59/21728,0.06347626731059651,0.19421388656495284,0.14276645065969779,AKAP12/SDC4,2
BARIS_THYROID_CANCER_DN,BARIS_THYROID_CANCER_DN,2/151,59/21728,0.06347626731059651,0.19421388656495284,0.14276645065969779,CTNNA1/RECQL,2
PID_ATF2_PATHWAY,PID_ATF2_PATHWAY,2/151,59/21728,0.06347626731059651,0.19421388656495284,0.14276645065969779,DUSP5/CBFB,2
PID_NOTCH_PATHWAY,PID_NOTCH_PATHWAY,2/151,59/21728,0.06347626731059651,0.19421388656495284,0.14276645065969779,NCSTN/FURIN,2
WP_COMPLEMENT_AND_COAGULATION_CASCADES,WP_COMPLEMENT_AND_COAGULATION_CASCADES,2/151,59/21728,0.06347626731059651,0.19421388656495284,0.14276645065969779,CLTC/LMAN1,2
REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,5/151,307/21728,0.06347955687580172,0.19421388656495284,0.14276645065969779,PRKAR1A/UBC/ESR2/MET/PML,5
LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,4/151,216/21728,0.06418185993532731,0.19614654224459765,0.1441871440849227,ATP6V1C1/SEC23A/PCYT1A/MET,4
SENESE_HDAC2_TARGETS_DN,SENESE_HDAC2_TARGETS_DN,3/151,133/21728,0.06571654011265578,0.1986935234713633,0.14605942765884006,TPM1/BCAM/LOXL1,3
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,6/151,408/21728,0.06572904595659984,0.1986935234713633,0.14605942765884006,NUS1/AKAP12/MCFD2/MET/PPFIBP1/ICMT,6
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,6/151,408/21728,0.06572904595659984,0.1986935234713633,0.14605942765884006,ETF1/ATP1A1/HSPA4/PCYT1A/TPM1/MAP2K3,6
FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,5/151,311/21728,0.06631886562062407,0.1986935234713633,0.14605942765884006,GBE1/PPFIBP1/PML/SLC12A4/EPHA2,5
REACTOME_ESR_MEDIATED_SIGNALING,REACTOME_ESR_MEDIATED_SIGNALING,4/151,219/21728,0.06680440796682062,0.1986935234713633,0.14605942765884006,CBFB/ESR2/NRIP1/PTGES3,4
REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,4/151,219/21728,0.06680440796682062,0.1986935234713633,0.14605942765884006,UBC/VDAC1/BIRC3/BECN1,4
WANG_CISPLATIN_RESPONSE_AND_XPC_DN,WANG_CISPLATIN_RESPONSE_AND_XPC_DN,4/151,219/21728,0.06680440796682062,0.1986935234713633,0.14605942765884006,ATP6V1C1/TMEM115/SLC12A4/TRIP10,4
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,3/151,134/21728,0.06689299614043255,0.1986935234713633,0.14605942765884006,LAMA5/EPHA2/EPHB4,3
LEE_LIVER_CANCER_MYC_TGFA_UP,LEE_LIVER_CANCER_MYC_TGFA_UP,2/151,61/21728,0.06729143209405328,0.1986935234713633,0.14605942765884006,ACTG1/RALB,2
REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,2/151,61/21728,0.06729143209405328,0.1986935234713633,0.14605942765884006,CD151/LOXL1,2
REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS,REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS,2/151,61/21728,0.06729143209405328,0.1986935234713633,0.14605942765884006,UBC/SEL1L,2
REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,2/151,61/21728,0.06729143209405328,0.1986935234713633,0.14605942765884006,RPS6KA3/DUSP3,2
BIOCARTA_SODD_PATHWAY,BIOCARTA_SODD_PATHWAY,1/151,10/21728,0.06737555763499792,0.1986935234713633,0.14605942765884006,BIRC3,1
GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP,GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP,1/151,10/21728,0.06737555763499792,0.1986935234713633,0.14605942765884006,APLP2,1
HOLLEMAN_DAUNORUBICIN_B_ALL_UP,HOLLEMAN_DAUNORUBICIN_B_ALL_UP,1/151,10/21728,0.06737555763499792,0.1986935234713633,0.14605942765884006,ATP1A1,1
MATZUK_PREOVULATORY_FOLLICLE,MATZUK_PREOVULATORY_FOLLICLE,1/151,10/21728,0.06737555763499792,0.1986935234713633,0.14605942765884006,ESR2,1
MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY,MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY,1/151,10/21728,0.06737555763499792,0.1986935234713633,0.14605942765884006,PERP,1
RADAEVA_RESPONSE_TO_IFNA1_DN,RADAEVA_RESPONSE_TO_IFNA1_DN,1/151,10/21728,0.06737555763499792,0.1986935234713633,0.14605942765884006,MET,1
REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION,REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION,1/151,10/21728,0.06737555763499792,0.1986935234713633,0.14605942765884006,PRKAG1,1
REACTOME_BICARBONATE_TRANSPORTERS,REACTOME_BICARBONATE_TRANSPORTERS,1/151,10/21728,0.06737555763499792,0.1986935234713633,0.14605942765884006,SLC4A7,1
REACTOME_FOLDING_OF_ACTIN_BY_CCT_TRIC,REACTOME_FOLDING_OF_ACTIN_BY_CCT_TRIC,1/151,10/21728,0.06737555763499792,0.1986935234713633,0.14605942765884006,ACTB,1
REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX,REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX,1/151,10/21728,0.06737555763499792,0.1986935234713633,0.14605942765884006,UBC,1
REACTOME_MAPK3_ERK1_ACTIVATION,REACTOME_MAPK3_ERK1_ACTIVATION,1/151,10/21728,0.06737555763499792,0.1986935234713633,0.14605942765884006,JAK2,1
REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS,REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS,1/151,10/21728,0.06737555763499792,0.1986935234713633,0.14605942765884006,FURIN,1
REACTOME_RUNX1_AND_FOXP3_CONTROL_THE_DEVELOPMENT_OF_REGULATORY_T_LYMPHOCYTES_TREGS,REACTOME_RUNX1_AND_FOXP3_CONTROL_THE_DEVELOPMENT_OF_REGULATORY_T_LYMPHOCYTES_TREGS,1/151,10/21728,0.06737555763499792,0.1986935234713633,0.14605942765884006,CBFB,1
REACTOME_RUNX3_REGULATES_P14_ARF,REACTOME_RUNX3_REGULATES_P14_ARF,1/151,10/21728,0.06737555763499792,0.1986935234713633,0.14605942765884006,CBFB,1
SHIRAISHI_PLZF_TARGETS_UP,SHIRAISHI_PLZF_TARGETS_UP,1/151,10/21728,0.06737555763499792,0.1986935234713633,0.14605942765884006,PNKP,1
TAKAYAMA_BOUND_BY_AR,TAKAYAMA_BOUND_BY_AR,1/151,10/21728,0.06737555763499792,0.1986935234713633,0.14605942765884006,MET,1
TSUDA_ALVEOLAR_SOFT_PART_SARCOMA,TSUDA_ALVEOLAR_SOFT_PART_SARCOMA,1/151,10/21728,0.06737555763499792,0.1986935234713633,0.14605942765884006,MET,1
WP_LEPTIN_AND_ADIPONECTIN,WP_LEPTIN_AND_ADIPONECTIN,1/151,10/21728,0.06737555763499792,0.1986935234713633,0.14605942765884006,PRKAG1,1
WP_LIPID_PARTICLES_COMPOSITION,WP_LIPID_PARTICLES_COMPOSITION,1/151,10/21728,0.06737555763499792,0.1986935234713633,0.14605942765884006,LDLR,1
WP_SARSCOV2_AND_COVID19_PATHWAY,WP_SARSCOV2_AND_COVID19_PATHWAY,1/151,10/21728,0.06737555763499792,0.1986935234713633,0.14605942765884006,FURIN,1
XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP,XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP,1/151,10/21728,0.06737555763499792,0.1986935234713633,0.14605942765884006,LRP12,1
REACTOME_NEURONAL_SYSTEM,REACTOME_NEURONAL_SYSTEM,6/151,411/21728,0.06758282137901919,0.1990934016870788,0.1463533777700477,PRKAR1A/RPS6KA3/FLOT2/HSPA8/PRKAG1/PPFIBP1,6
KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS,KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS,3/151,135/21728,0.06807909194854418,0.20034292100959292,0.14727189828297918,TRIP12/BIRC3/PML,3
WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING_PATHWAY,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING_PATHWAY,4/151,221/21728,0.06858342915660481,0.2016135092032256,0.14820590650382995,ACTB/ACTG1/HSPA8/JAK2,4
KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,2/151,62/21728,0.06922701122111667,0.2027874778387182,0.14906888977572405,HSP90B1/BIRC3,2
PID_IL12_2PATHWAY,PID_IL12_2PATHWAY,2/151,62/21728,0.06922701122111667,0.2027874778387182,0.14906888977572405,JAK2/MAP2K3,2
TENEDINI_MEGAKARYOCYTE_MARKERS,TENEDINI_MEGAKARYOCYTE_MARKERS,2/151,62/21728,0.06922701122111667,0.2027874778387182,0.14906888977572405,ITGB3/JAK2,2
UDAYAKUMAR_MED1_TARGETS_UP,UDAYAKUMAR_MED1_TARGETS_UP,3/151,136/21728,0.06927477194706391,0.2027874778387182,0.14906888977572405,CTNND1/FEM1B/GARS1,3
RODWELL_AGING_KIDNEY_NO_BLOOD_UP,RODWELL_AGING_KIDNEY_NO_BLOOD_UP,4/151,223/21728,0.0703868435779922,0.2045690111682584,0.15037849329939043,CALU/MOXD1/TPM1/LOXL1,4
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,3/151,137/21728,0.07047997993482162,0.2045690111682584,0.15037849329939043,SEL1L/BIRC3/SEC24A,3
ZHANG_BREAST_CANCER_PROGENITORS_DN,ZHANG_BREAST_CANCER_PROGENITORS_DN,3/151,137/21728,0.07047997993482162,0.2045690111682584,0.15037849329939043,HSP90B1/MFSD5/LAMA5,3
ANDERSEN_CHOLANGIOCARCINOMA_CLASS1,ANDERSEN_CHOLANGIOCARCINOMA_CLASS1,2/151,63/21728,0.07118079169817712,0.2045690111682584,0.15037849329939043,ATP1A1/PTPN14,2
GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,2/151,63/21728,0.07118079169817712,0.2045690111682584,0.15037849329939043,HSPA5/SLC33A1,2
LINDSTEDT_DENDRITIC_CELL_MATURATION_C,LINDSTEDT_DENDRITIC_CELL_MATURATION_C,2/151,63/21728,0.07118079169817712,0.2045690111682584,0.15037849329939043,CTNNA1/TRIP10,2
LINDSTEDT_DENDRITIC_CELL_MATURATION_D,LINDSTEDT_DENDRITIC_CELL_MATURATION_D,2/151,63/21728,0.07118079169817712,0.2045690111682584,0.15037849329939043,CTNND1/ATP6V1A,2
PID_ENDOTHELIN_PATHWAY,PID_ENDOTHELIN_PATHWAY,2/151,63/21728,0.07118079169817712,0.2045690111682584,0.15037849329939043,CRK/JAK2,2
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP,POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP,2/151,63/21728,0.07118079169817712,0.2045690111682584,0.15037849329939043,LDHA/PRDX1,2
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2,2/151,63/21728,0.07118079169817712,0.2045690111682584,0.15037849329939043,MET/SLC2A3,2
RIZKI_TUMOR_INVASIVENESS_2D_DN,RIZKI_TUMOR_INVASIVENESS_2D_DN,2/151,63/21728,0.07118079169817712,0.2045690111682584,0.15037849329939043,COPS2/FLOT2,2
WP_ENDOMETRIAL_CANCER,WP_ENDOMETRIAL_CANCER,2/151,63/21728,0.07118079169817712,0.2045690111682584,0.15037849329939043,ARAF/CTNNA1,2
WP_NOTCH_SIGNALING_PATHWAY,WP_NOTCH_SIGNALING_PATHWAY,2/151,63/21728,0.07118079169817712,0.2045690111682584,0.15037849329939043,NCSTN/JAK2,2
BROWNE_HCMV_INFECTION_16HR_UP,BROWNE_HCMV_INFECTION_16HR_UP,4/151,224/21728,0.07129766126584733,0.2045690111682584,0.15037849329939043,SSR1/STBD1/PGM3/EPHA2,4
HORIUCHI_WTAP_TARGETS_DN,HORIUCHI_WTAP_TARGETS_DN,5/151,318/21728,0.07145639433747034,0.2045690111682584,0.15037849329939043,WWTR1/ITPRID2/LDHA/DNAJC10/PGRMC2,5
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,3/151,138/21728,0.07169465911656706,0.2045690111682584,0.15037849329939043,CTNND1/DUSP3/LDLR,3
RIEGE_DELTANP63_DIRECT_TARGETS_UP,RIEGE_DELTANP63_DIRECT_TARGETS_UP,3/151,138/21728,0.07169465911656706,0.2045690111682584,0.15037849329939043,FLOT2/PPFIBP1/LDLR,3
LIU_SOX4_TARGETS_UP,LIU_SOX4_TARGETS_UP,3/151,139/21728,0.072918752119887,0.2045690111682584,0.15037849329939043,WWTR1/DUSP5/SLC33A1,3
BILBAN_B_CLL_LPL_UP,BILBAN_B_CLL_LPL_UP,2/151,64/21728,0.07315243100559232,0.2045690111682584,0.15037849329939043,AKAP12/RRBP1,2
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,2/151,64/21728,0.07315243100559232,0.2045690111682584,0.15037849329939043,NRIP1/PPFIBP1,2
PID_ERA_GENOMIC_PATHWAY,PID_ERA_GENOMIC_PATHWAY,2/151,64/21728,0.07315243100559232,0.2045690111682584,0.15037849329939043,ESR2/NRIP1,2
PID_IL4_2PATHWAY,PID_IL4_2PATHWAY,2/151,64/21728,0.07315243100559232,0.2045690111682584,0.15037849329939043,ITGB3/JAK2,2
REACTOME_COLLAGEN_DEGRADATION,REACTOME_COLLAGEN_DEGRADATION,2/151,64/21728,0.07315243100559232,0.2045690111682584,0.15037849329939043,ADAM9/FURIN,2
BIOCARTA_AGPCR_PATHWAY,BIOCARTA_AGPCR_PATHWAY,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,PRKAR1A,1
BIOCARTA_AKAP13_PATHWAY,BIOCARTA_AKAP13_PATHWAY,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,PRKAG1,1
BIOCARTA_AKAP95_PATHWAY,BIOCARTA_AKAP95_PATHWAY,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,PRKAG1,1
BIOCARTA_CFTR_PATHWAY,BIOCARTA_CFTR_PATHWAY,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,PRKAR1A,1
BIOCARTA_EPONFKB_PATHWAY,BIOCARTA_EPONFKB_PATHWAY,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,JAK2,1
BIOCARTA_LEPTIN_PATHWAY,BIOCARTA_LEPTIN_PATHWAY,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,PRKAG1,1
BIOCARTA_MYOSIN_PATHWAY,BIOCARTA_MYOSIN_PATHWAY,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,PKN1,1
BIOCARTA_PLCE_PATHWAY,BIOCARTA_PLCE_PATHWAY,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,PRKAR1A,1
BIOCARTA_VITCB_PATHWAY,BIOCARTA_VITCB_PATHWAY,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,SLC2A3,1
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS,KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,IARS2,1
MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN,MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,APLP2,1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,CLTC,1
REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY,REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,UBC,1
REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2,REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,PTPN12,1
REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS,REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,FURIN,1
REACTOME_INTERLEUKIN_27_SIGNALING,REACTOME_INTERLEUKIN_27_SIGNALING,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,JAK2,1
REACTOME_INTERLEUKIN_6_SIGNALING,REACTOME_INTERLEUKIN_6_SIGNALING,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,JAK2,1
REACTOME_MET_ACTIVATES_RAS_SIGNALING,REACTOME_MET_ACTIVATES_RAS_SIGNALING,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,MET,1
REACTOME_PEXOPHAGY,REACTOME_PEXOPHAGY,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,UBC,1
REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR,REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,NCSTN,1
REACTOME_REGULATION_OF_BACH1_ACTIVITY,REACTOME_REGULATION_OF_BACH1_ACTIVITY,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,UBC,1
REACTOME_SIGNALING_BY_LEPTIN,REACTOME_SIGNALING_BY_LEPTIN,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,JAK2,1
REACTOME_TICAM1_TRAF6_DEPENDENT_INDUCTION_OF_TAK1_COMPLEX,REACTOME_TICAM1_TRAF6_DEPENDENT_INDUCTION_OF_TAK1_COMPLEX,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,UBC,1
REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY,REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,CD151,1
TAGHAVI_NEOPLASTIC_TRANSFORMATION,TAGHAVI_NEOPLASTIC_TRANSFORMATION,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,ACTN4,1
WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,ICMT,1
WP_GLYCOLYSIS_IN_SENESCENCE,WP_GLYCOLYSIS_IN_SENESCENCE,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,LDHA,1
WP_INCLUSION_BODY_MYOSITIS,WP_INCLUSION_BODY_MYOSITIS,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,NCSTN,1
WP_SEROTONIN_TRANSPORTER_ACTIVITY,WP_SEROTONIN_TRANSPORTER_ACTIVITY,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,ITGB3,1
YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP,YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,SLC2A3,1
YIH_RESPONSE_TO_ARSENITE_C5,YIH_RESPONSE_TO_ARSENITE_C5,1/151,11/21728,0.0738598697630537,0.2045690111682584,0.15037849329939043,PML,1
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP,ALCALAY_AML_BY_NPM1_LOCALIZATION_UP,3/151,140/21728,0.07415220101187854,0.20496996458805827,0.15067323379213865,CTNND1/CTNNA1/RRBP1,3
HOELZEL_NF1_TARGETS_UP,HOELZEL_NF1_TARGETS_UP,3/151,140/21728,0.07415220101187854,0.20496996458805827,0.15067323379213865,RPS6KA3/MET/NRIP1,3
REACTOME_HEDGEHOG_LIGAND_BIOGENESIS,REACTOME_HEDGEHOG_LIGAND_BIOGENESIS,2/151,65/21728,0.0751415904484676,0.20729229222030088,0.15238037471387356,UBC/SEL1L,2
REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT,REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT,2/151,65/21728,0.0751415904484676,0.20729229222030088,0.15238037471387356,HSPA9/VDAC1,2
SWEET_LUNG_CANCER_KRAS_DN,SWEET_LUNG_CANCER_KRAS_DN,6/151,423/21728,0.07530125634922062,0.20737342934919642,0.15244001854323105,WWTR1/PKD2/AKAP12/EFNB2/DIPK2A/LOXL1,6
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,3/151,141/21728,0.07539494731558258,0.20737342934919642,0.15244001854323105,AKAP12/DIPK2A/CD151,3
REACTOME_DEATH_RECEPTOR_SIGNALLING,REACTOME_DEATH_RECEPTOR_SIGNALLING,3/151,141/21728,0.07539494731558258,0.20737342934919642,0.15244001854323105,UBC/NCSTN/BIRC3,3
HAN_SATB1_TARGETS_UP,HAN_SATB1_TARGETS_UP,6/151,425/21728,0.07663474704441214,0.2105750022644678,0.15479349186960234,FNDC3B/ATP13A3/SLC33A1/SLC2A3/TPM1/LAMA5,6
BENPORATH_MYC_TARGETS_WITH_EBOX,BENPORATH_MYC_TARGETS_WITH_EBOX,4/151,230/21728,0.07688912225722126,0.21073447764513428,0.1549107220762989,ACTB/ACTG1/MET/HSPA8,4
MARKEY_RB1_ACUTE_LOF_DN,MARKEY_RB1_ACUTE_LOF_DN,4/151,230/21728,0.07688912225722126,0.21073447764513428,0.1549107220762989,IQGAP1/PCYT1A/EGLN1/LDLR,4
GAJATE_RESPONSE_TO_TRABECTEDIN_UP,GAJATE_RESPONSE_TO_TRABECTEDIN_UP,2/151,66/21728,0.07714793512062691,0.21073447764513428,0.1549107220762989,DUSP5/GARS1,2
KYNG_RESPONSE_TO_H2O2,KYNG_RESPONSE_TO_H2O2,2/151,66/21728,0.07714793512062691,0.21073447764513428,0.1549107220762989,PDIA3/FLOT2,2
PID_INTEGRIN1_PATHWAY,PID_INTEGRIN1_PATHWAY,2/151,66/21728,0.07714793512062691,0.21073447764513428,0.1549107220762989,LAMC1/LAMA5,2
WP_ONCOSTATIN_M_SIGNALING_PATHWAY,WP_ONCOSTATIN_M_SIGNALING_PATHWAY,2/151,66/21728,0.07714793512062691,0.21073447764513428,0.1549107220762989,JAK2/LDLR,2
REACTOME_DISEASES_OF_GLYCOSYLATION,REACTOME_DISEASES_OF_GLYCOSYLATION,3/151,143/21728,0.07790809562694354,0.21260185623934102,0.15628343037562864,NUS1/DOLK/SDC4,3
KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY,KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY,2/151,67/21728,0.07917113386889414,0.21286813646624136,0.15647917272725864,PRKAG1/JAK2,2
MARSON_FOXP3_TARGETS_UP,MARSON_FOXP3_TARGETS_UP,2/151,67/21728,0.07917113386889414,0.21286813646624136,0.15647917272725864,NRIP1/SLC2A3,2
PID_TELOMERASE_PATHWAY,PID_TELOMERASE_PATHWAY,2/151,67/21728,0.07917113386889414,0.21286813646624136,0.15647917272725864,HUS1/PTGES3,2
REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,2/151,67/21728,0.07917113386889414,0.21286813646624136,0.15647917272725864,UBC/HUS1,2
VANHARANTA_UTERINE_FIBROID_DN,VANHARANTA_UTERINE_FIBROID_DN,2/151,67/21728,0.07917113386889414,0.21286813646624136,0.15647917272725864,BIRC3/MOXD1,2
WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING_PATHWAY,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING_PATHWAY,3/151,144/21728,0.07917837810498227,0.21286813646624136,0.15647917272725864,RPS6KA3/SORT1/JAK2,3
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14,3/151,144/21728,0.07917837810498227,0.21286813646624136,0.15647917272725864,RARS1/SSR1/PDIA3,3
AMIT_EGF_RESPONSE_20_HELA,AMIT_EGF_RESPONSE_20_HELA,1/151,12/21728,0.08029939454390611,0.21286813646624136,0.15647917272725864,PPP1R15A,1
BIOCARTA_CARM1_PATHWAY,BIOCARTA_CARM1_PATHWAY,1/151,12/21728,0.08029939454390611,0.21286813646624136,0.15647917272725864,PRKAR1A,1
BIOCARTA_CBL_PATHWAY,BIOCARTA_CBL_PATHWAY,1/151,12/21728,0.08029939454390611,0.21286813646624136,0.15647917272725864,MET,1
BIOCARTA_CELL2CELL_PATHWAY,BIOCARTA_CELL2CELL_PATHWAY,1/151,12/21728,0.08029939454390611,0.21286813646624136,0.15647917272725864,CTNNA1,1
BIOCARTA_HSWI_SNF_PATHWAY,BIOCARTA_HSWI_SNF_PATHWAY,1/151,12/21728,0.08029939454390611,0.21286813646624136,0.15647917272725864,ACTB,1
CAFFAREL_RESPONSE_TO_THC_8HR_5_DN,CAFFAREL_RESPONSE_TO_THC_8HR_5_DN,1/151,12/21728,0.08029939454390611,0.21286813646624136,0.15647917272725864,HSPA8,1
HOEGERKORP_CD44_TARGETS_TEMPORAL_UP,HOEGERKORP_CD44_TARGETS_TEMPORAL_UP,1/151,12/21728,0.08029939454390611,0.21286813646624136,0.15647917272725864,KDELR1,1
HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN,HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN,1/151,12/21728,0.08029939454390611,0.21286813646624136,0.15647917272725864,SLC2A3,1
NEBEN_AML_WITH_FLT3_OR_NRAS_DN,NEBEN_AML_WITH_FLT3_OR_NRAS_DN,1/151,12/21728,0.08029939454390611,0.21286813646624136,0.15647917272725864,HSPA5,1
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,1/151,12/21728,0.08029939454390611,0.21286813646624136,0.15647917272725864,ITGB3,1
REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE,REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE,1/151,12/21728,0.08029939454390611,0.21286813646624136,0.15647917272725864,PRKAR1A,1
REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K,REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K,1/151,12/21728,0.08029939454390611,0.21286813646624136,0.15647917272725864,JAK2,1
REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING,REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING,1/151,12/21728,0.08029939454390611,0.21286813646624136,0.15647917272725864,YWHAZ,1
REACTOME_INTERLEUKIN_35_SIGNALLING,REACTOME_INTERLEUKIN_35_SIGNALLING,1/151,12/21728,0.08029939454390611,0.21286813646624136,0.15647917272725864,JAK2,1
REACTOME_JOSEPHIN_DOMAIN_DUBS,REACTOME_JOSEPHIN_DOMAIN_DUBS,1/151,12/21728,0.08029939454390611,0.21286813646624136,0.15647917272725864,UBC,1
REACTOME_PECAM1_INTERACTIONS,REACTOME_PECAM1_INTERACTIONS,1/151,12/21728,0.08029939454390611,0.21286813646624136,0.15647917272725864,ITGB3,1
REACTOME_PHYSIOLOGICAL_FACTORS,REACTOME_PHYSIOLOGICAL_FACTORS,1/151,12/21728,0.08029939454390611,0.21286813646624136,0.15647917272725864,WWTR1,1
REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS,REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS,1/151,12/21728,0.08029939454390611,0.21286813646624136,0.15647917272725864,YWHAZ,1
REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7,REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7,1/151,12/21728,0.08029939454390611,0.21286813646624136,0.15647917272725864,UBC,1
REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION,REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION,1/151,12/21728,0.08029939454390611,0.21286813646624136,0.15647917272725864,CLTC,1
WP_AEROBIC_GLYCOLYSIS,WP_AEROBIC_GLYCOLYSIS,1/151,12/21728,0.08029939454390611,0.21286813646624136,0.15647917272725864,LDHA,1
XU_RESPONSE_TO_TRETINOIN_DN,XU_RESPONSE_TO_TRETINOIN_DN,1/151,12/21728,0.08029939454390611,0.21286813646624136,0.15647917272725864,GARS1,1
IGLESIAS_E2F_TARGETS_UP,IGLESIAS_E2F_TARGETS_UP,3/151,145/21728,0.0804577189667219,0.21286813646624136,0.15647917272725864,ACTG1/APLP2/PKD2,3
WP_ENDODERM_DIFFERENTIATION,WP_ENDODERM_DIFFERENTIATION,3/151,145/21728,0.0804577189667219,0.21286813646624136,0.15647917272725864,LAMC1/DUSP5/MAP2K3,3
WP_NRF2_PATHWAY,WP_NRF2_PATHWAY,3/151,145/21728,0.0804577189667219,0.21286813646624136,0.15647917272725864,SLC2A3/PRDX1/EPHA2,3
REACTOME_NEDDYLATION,REACTOME_NEDDYLATION,4/151,234/21728,0.08073605728221474,0.21325953774952627,0.1567668914531776,UBC/FEM1C/FEM1B/COPS2,4
REACTOME_DNA_REPAIR,REACTOME_DNA_REPAIR,5/151,330/21728,0.0807591914011885,0.21325953774952627,0.1567668914531776,UBC/ACTB/HUS1/COPS2/PNKP,5
DANG_REGULATED_BY_MYC_UP,DANG_REGULATED_BY_MYC_UP,2/151,68/21728,0.0812108592576831,0.21343781174819643,0.15689794050680198,VDAC1/ZNF330,2
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP,2/151,68/21728,0.0812108592576831,0.21343781174819643,0.15689794050680198,ATP6V1A/ZBTB38,2
REACTOME_REGULATION_OF_RAS_BY_GAPS,REACTOME_REGULATION_OF_RAS_BY_GAPS,2/151,68/21728,0.0812108592576831,0.21343781174819643,0.15689794050680198,UBC/RASA2,2
WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,2/151,68/21728,0.0812108592576831,0.21343781174819643,0.15689794050680198,ACTR2/ACTR3,2
WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING_PATHWAY,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING_PATHWAY,2/151,68/21728,0.0812108592576831,0.21343781174819643,0.15689794050680198,JAK2/MAP2K3,2
BASSO_B_LYMPHOCYTE_NETWORK,BASSO_B_LYMPHOCYTE_NETWORK,3/151,146/21728,0.08174605725318454,0.21464134881790797,0.1577826595076888,HSPA9/CTNNA1/GARS1,3
FISCHER_G2_M_CELL_CYCLE,FISCHER_G2_M_CELL_CYCLE,4/151,236/21728,0.08269488405601601,0.21692765619226861,0.15946332197074803,CTNND1/LAMC1/BIRC3/LDLR,4
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN,3/151,147/21728,0.08304333155503267,0.21740144339206036,0.15981160250865717,ATP1A1/DNAJC10/LDLR,3
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN,2/151,69/21728,0.08326678753389209,0.21740144339206036,0.15981160250865717,BIRC3/CD151,2
LEE_AGING_NEOCORTEX_DN,LEE_AGING_NEOCORTEX_DN,2/151,69/21728,0.08326678753389209,0.21740144339206036,0.15981160250865717,FEM1B/HSPA8,2
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,2/151,69/21728,0.08326678753389209,0.21740144339206036,0.15981160250865717,BIRC3/FLII,2
PID_MTOR_4PATHWAY,PID_MTOR_4PATHWAY,2/151,69/21728,0.08326678753389209,0.21740144339206036,0.15981160250865717,YWHAZ/PML,2
MARKEY_RB1_ACUTE_LOF_UP,MARKEY_RB1_ACUTE_LOF_UP,4/151,237/21728,0.08368307113768172,0.21828316584082613,0.16045975587556466,PDIA3/WWTR1/PERP/PTGES3,4
REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION,REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION,3/151,148/21728,0.08434948002739329,0.21981506145975474,0.16158585094612718,CBFB/NRIP1/PTGES3,3
DITTMER_PTHLH_TARGETS_DN,DITTMER_PTHLH_TARGETS_DN,2/151,70/21728,0.0853385985921038,0.2199426048506911,0.1616796079763331,ACTG1/SEC24A,2
KEGG_LONG_TERM_POTENTIATION,KEGG_LONG_TERM_POTENTIATION,2/151,70/21728,0.0853385985921038,0.2199426048506911,0.1616796079763331,ARAF/RPS6KA3,2
KEGG_PANCREATIC_CANCER,KEGG_PANCREATIC_CANCER,2/151,70/21728,0.0853385985921038,0.2199426048506911,0.1616796079763331,ARAF/RALB,2
KEGG_VIRAL_MYOCARDITIS,KEGG_VIRAL_MYOCARDITIS,2/151,70/21728,0.0853385985921038,0.2199426048506911,0.1616796079763331,ACTB/ACTG1,2
REACTOME_RHOB_GTPASE_CYCLE,REACTOME_RHOB_GTPASE_CYCLE,2/151,70/21728,0.0853385985921038,0.2199426048506911,0.1616796079763331,PKN1/FLOT2,2
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,4/151,239/21728,0.08567689484655235,0.2199426048506911,0.1616796079763331,GBE1/PTPN14/PERP/EGLN1,4
BIOCARTA_DREAM_PATHWAY,BIOCARTA_DREAM_PATHWAY,1/151,13/21728,0.08669443927700027,0.2199426048506911,0.1616796079763331,PRKAR1A,1
CHIN_BREAST_CANCER_COPY_NUMBER_DN,CHIN_BREAST_CANCER_COPY_NUMBER_DN,1/151,13/21728,0.08669443927700027,0.2199426048506911,0.1616796079763331,PDIA3,1
IVANOV_MUTATED_IN_COLON_CANCER,IVANOV_MUTATED_IN_COLON_CANCER,1/151,13/21728,0.08669443927700027,0.2199426048506911,0.1616796079763331,CTNND1,1
KEGG_CIRCADIAN_RHYTHM_MAMMAL,KEGG_CIRCADIAN_RHYTHM_MAMMAL,1/151,13/21728,0.08669443927700027,0.2199426048506911,0.1616796079763331,NPAS2,1
REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX,REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX,1/151,13/21728,0.08669443927700027,0.2199426048506911,0.1616796079763331,YWHAZ,1
REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING,REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING,1/151,13/21728,0.08669443927700027,0.2199426048506911,0.1616796079763331,UBC,1
REACTOME_ERKS_ARE_INACTIVATED,REACTOME_ERKS_ARE_INACTIVATED,1/151,13/21728,0.08669443927700027,0.2199426048506911,0.1616796079763331,DUSP3,1
REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL,REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL,1/151,13/21728,0.08669443927700027,0.2199426048506911,0.1616796079763331,UBC,1
REACTOME_P38MAPK_EVENTS,REACTOME_P38MAPK_EVENTS,1/151,13/21728,0.08669443927700027,0.2199426048506911,0.1616796079763331,RALB,1
REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES,REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES,1/151,13/21728,0.08669443927700027,0.2199426048506911,0.1616796079763331,UBC,1
REACTOME_SUPPRESSION_OF_PHAGOSOMAL_MATURATION,REACTOME_SUPPRESSION_OF_PHAGOSOMAL_MATURATION,1/151,13/21728,0.08669443927700027,0.2199426048506911,0.1616796079763331,UBC,1
REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES,REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES,1/151,13/21728,0.08669443927700027,0.2199426048506911,0.1616796079763331,ARSJ,1
REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING,REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING,1/151,13/21728,0.08669443927700027,0.2199426048506911,0.1616796079763331,UBC,1
REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR,REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR,1/151,13/21728,0.08669443927700027,0.2199426048506911,0.1616796079763331,HSP90B1,1
REACTOME_TRANSLATION_OF_REPLICASE_AND_ASSEMBLY_OF_THE_REPLICATION_TRANSCRIPTION_COMPLEX,REACTOME_TRANSLATION_OF_REPLICASE_AND_ASSEMBLY_OF_THE_REPLICATION_TRANSCRIPTION_COMPLEX,1/151,13/21728,0.08669443927700027,0.2199426048506911,0.1616796079763331,BECN1,1
REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2,REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2,1/151,13/21728,0.08669443927700027,0.2199426048506911,0.1616796079763331,CLTC,1
WHITESIDE_CISPLATIN_RESISTANCE_DN,WHITESIDE_CISPLATIN_RESISTANCE_DN,1/151,13/21728,0.08669443927700027,0.2199426048506911,0.1616796079763331,ACTB,1
WP_BILE_ACIDS_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,WP_BILE_ACIDS_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,1/151,13/21728,0.08669443927700027,0.2199426048506911,0.1616796079763331,LDLR,1
WP_GANGLIO_SPHINGOLIPID_METABOLISM,WP_GANGLIO_SPHINGOLIPID_METABOLISM,1/151,13/21728,0.08669443927700027,0.2199426048506911,0.1616796079763331,SLC33A1,1
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PUBERTY_STAGE_2_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PUBERTY_STAGE_2_OF_4,1/151,13/21728,0.08669443927700027,0.2199426048506911,0.1616796079763331,NRIP1,1
WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,1/151,13/21728,0.08669443927700027,0.2199426048506911,0.1616796079763331,ITGB3,1
WP_OSTEOPONTIN_SIGNALING,WP_OSTEOPONTIN_SIGNALING,1/151,13/21728,0.08669443927700027,0.2199426048506911,0.1616796079763331,ITGB3,1
YAGUE_PRETUMOR_DRUG_RESISTANCE_DN,YAGUE_PRETUMOR_DRUG_RESISTANCE_DN,1/151,13/21728,0.08669443927700027,0.2199426048506911,0.1616796079763331,SEPTIN11,1
GOLDRATH_HOMEOSTATIC_PROLIFERATION,GOLDRATH_HOMEOSTATIC_PROLIFERATION,3/151,150/21728,0.08698815001389544,0.2203896199288123,0.16200820835205026,SEL1L/PRPS2/PTGES3,3
BOYLAN_MULTIPLE_MYELOMA_PCA3_DN,BOYLAN_MULTIPLE_MYELOMA_PCA3_DN,2/151,71/21728,0.08742597594008321,0.2203896199288123,0.16200820835205026,FLOT2/CTNNA1,2
KEGG_MELANOMA,KEGG_MELANOMA,2/151,71/21728,0.08742597594008321,0.2203896199288123,0.16200820835205026,ARAF/MET,2
LIN_APC_TARGETS,LIN_APC_TARGETS,2/151,71/21728,0.08742597594008321,0.2203896199288123,0.16200820835205026,FLOT2/ACTN4,2
MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP,MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP,2/151,71/21728,0.08742597594008321,0.2203896199288123,0.16200820835205026,PDIA3/ADAM9,2
SATOH_COLORECTAL_CANCER_MYC_DN,SATOH_COLORECTAL_CANCER_MYC_DN,2/151,71/21728,0.08742597594008321,0.2203896199288123,0.16200820835205026,SLC35D1/PAFAH2,2
WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,2/151,71/21728,0.08742597594008321,0.2203896199288123,0.16200820835205026,BIRC3/PTGES3,2
KAYO_AGING_MUSCLE_UP,KAYO_AGING_MUSCLE_UP,4/151,242/21728,0.08871095197996925,0.22342613291056626,0.164240346272024,UBC/ACTB/RALB/ITGB3,4
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN,2/151,72/21728,0.08952860666457627,0.22498233270407797,0.1653843073191282,BIRC3/MET,2
WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,2/151,72/21728,0.08952860666457627,0.22498233270407797,0.1653843073191282,PERP/PML,2
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,3/151,152/21728,0.08966156429258261,0.22498233270407797,0.1653843073191282,AKAP12/DIPK2A/CD151,3
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,3/151,152/21728,0.08966156429258261,0.22498233270407797,0.1653843073191282,LDHA/ACTN4/FLII,3
CHYLA_CBFA2T3_TARGETS_DN,CHYLA_CBFA2T3_TARGETS_DN,4/151,243/21728,0.08973377416706925,0.22498233270407797,0.1653843073191282,CHURC1-FNTB/SH2D4A/SLC12A4/BCAM,4
BLUM_RESPONSE_TO_SALIRASIB_DN,BLUM_RESPONSE_TO_SALIRASIB_DN,5/151,341/21728,0.08982885113948913,0.22501762711046058,0.16541025220502958,WWTR1/CBFB/LDHA/NRIP1/FNTB,5
KEGG_CHRONIC_MYELOID_LEUKEMIA,KEGG_CHRONIC_MYELOID_LEUKEMIA,2/151,73/21728,0.09164618139740267,0.22773556728363636,0.167408207544335,ARAF/CRK,2
WP_OREXIN_RECEPTOR_PATHWAY,WP_OREXIN_RECEPTOR_PATHWAY,3/151,154/21728,0.09236921388716036,0.22773556728363636,0.167408207544335,HSPA5/LDHA/LDLR,3
BIOCARTA_UCALPAIN_PATHWAY,BIOCARTA_UCALPAIN_PATHWAY,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,ITGB3,1
CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB,CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,CSNK1A1,1
CASTELLANO_NRAS_TARGETS_DN,CASTELLANO_NRAS_TARGETS_DN,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,AKAP12,1
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN,DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,MOXD1,1
DAZARD_UV_RESPONSE_CLUSTER_G3,DAZARD_UV_RESPONSE_CLUSTER_G3,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,PPP1R15A,1
GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION,GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,VDAC1,1
HOEGERKORP_CD44_TARGETS_DIRECT_DN,HOEGERKORP_CD44_TARGETS_DIRECT_DN,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,BCAM,1
MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_UP,MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_UP,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,KDELR1,1
PID_IL5_PATHWAY,PID_IL5_PATHWAY,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,JAK2,1
PID_TCR_JNK_PATHWAY,PID_TCR_JNK_PATHWAY,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,CRK,1
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,HSPA5,1
REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2,REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,SDC4,1
REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS,REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,JAK2,1
REACTOME_IRAK1_RECRUITS_IKK_COMPLEX,REACTOME_IRAK1_RECRUITS_IKK_COMPLEX,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,UBC,1
REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS,REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,CRK,1
REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES,REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,CRK,1
REACTOME_REGULATION_OF_IFNG_SIGNALING,REACTOME_REGULATION_OF_IFNG_SIGNALING,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,JAK2,1
REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING,REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,CLTC,1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_SEVERAL_ADDITIONAL_CELL_DEATH_GENES_WHOSE_SPECIFIC_ROLES_IN_P53_DEPENDENT_APOPTOSIS_REMAIN_UNCERTAIN,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_SEVERAL_ADDITIONAL_CELL_DEATH_GENES_WHOSE_SPECIFIC_ROLES_IN_P53_DEPENDENT_APOPTOSIS_REMAIN_UNCERTAIN,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,PERP,1
ROETH_TERT_TARGETS_UP,ROETH_TERT_TARGETS_UP,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,NRIP1,1
SINGH_NFE2L2_TARGETS,SINGH_NFE2L2_TARGETS,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,PRDX1,1
STEINER_ERYTHROCYTE_MEMBRANE_GENES,STEINER_ERYTHROCYTE_MEMBRANE_GENES,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,ACTB,1
WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,LDLR,1
WP_OSTEOBLAST_SIGNALING,WP_OSTEOBLAST_SIGNALING,1/151,14/21728,0.09304530916736042,0.22773556728363636,0.167408207544335,ITGB3,1
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP,LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP,2/151,74/21728,0.09377839428184309,0.22912610317938445,0.1684303892114758,MET/SH2D4A,2
REACTOME_SIGNALING_BY_NOTCH1,REACTOME_SIGNALING_BY_NOTCH1,2/151,74/21728,0.09377839428184309,0.22912610317938445,0.1684303892114758,UBC/NCSTN,2
WP_BREAST_CANCER_PATHWAY,WP_BREAST_CANCER_PATHWAY,3/151,156/21728,0.09511058420195768,0.23217680396576312,0.170672956573673,ARAF/CSNK1A1/ESR2,3
MCCLUNG_COCAINE_REWARD_5D,MCCLUNG_COCAINE_REWARD_5D,2/151,75/21728,0.09592494293931657,0.23375393989949245,0.17183230775833255,HSPA5/ACTR2,2
REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA,REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA,2/151,75/21728,0.09592494293931657,0.23375393989949245,0.17183230775833255,UBC/EGLN1,2
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_DN,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_DN,2/151,76/21728,0.09808552843634735,0.23469448111384827,0.1725236987461126,APLP2/PRDX1,2
MORI_SMALL_PRE_BII_LYMPHOCYTE_DN,MORI_SMALL_PRE_BII_LYMPHOCYTE_DN,2/151,76/21728,0.09808552843634735,0.23469448111384827,0.1725236987461126,ATP1A1/ACTN4,2
REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE,REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE,2/151,76/21728,0.09808552843634735,0.23469448111384827,0.1725236987461126,UBC/NCSTN,2
RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,2/151,76/21728,0.09808552843634735,0.23469448111384827,0.1725236987461126,DUSP5/BIRC3,2
WP_PROLACTIN_SIGNALING_PATHWAY,WP_PROLACTIN_SIGNALING_PATHWAY,2/151,76/21728,0.09808552843634735,0.23469448111384827,0.1725236987461126,YWHAZ/JAK2,2
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,3/151,159/21728,0.09928472766173732,0.23469448111384827,0.1725236987461126,LAMC1/FNDC3B/NRIP1,3
BIOCARTA_HIF_PATHWAY,BIOCARTA_HIF_PATHWAY,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,LDHA,1
BIOCARTA_IL3_PATHWAY,BIOCARTA_IL3_PATHWAY,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,JAK2,1
BIOCARTA_NO2IL12_PATHWAY,BIOCARTA_NO2IL12_PATHWAY,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,JAK2,1
BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER,BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,MET,1
CAFFAREL_RESPONSE_TO_THC_8HR_5_UP,CAFFAREL_RESPONSE_TO_THC_8HR_5_UP,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,GARS1,1
FIGUEROA_AML_METHYLATION_CLUSTER_4_DN,FIGUEROA_AML_METHYLATION_CLUSTER_4_DN,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,EPHA2,1
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,SLC33A1,1
LI_CYTIDINE_ANALOGS_CYCTOTOXICITY,LI_CYTIDINE_ANALOGS_CYCTOTOXICITY,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,ESR2,1
LUND_SILENCED_BY_METHYLATION,LUND_SILENCED_BY_METHYLATION,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,SDC4,1
MATZUK_OVULATION,MATZUK_OVULATION,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,NRIP1,1
NGO_MALIGNANT_GLIOMA_1P_LOH,NGO_MALIGNANT_GLIOMA_1P_LOH,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,HSPA5,1
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN,PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,PTPN12,1
PID_ERB_GENOMIC_PATHWAY,PID_ERB_GENOMIC_PATHWAY,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,ESR2,1
REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA,REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,YWHAZ,1
REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,ITGB3,1
REACTOME_MATURATION_OF_SARS_COV_2_NUCLEOPROTEIN,REACTOME_MATURATION_OF_SARS_COV_2_NUCLEOPROTEIN,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,CSNK1A1,1
REACTOME_N_GLYCAN_ANTENNAE_ELONGATION,REACTOME_N_GLYCAN_ANTENNAE_ELONGATION,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,MGAT4B,1
REACTOME_NEGATIVE_REGULATION_OF_FLT3,REACTOME_NEGATIVE_REGULATION_OF_FLT3,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,UBC,1
REACTOME_PENTOSE_PHOSPHATE_PATHWAY,REACTOME_PENTOSE_PHOSPHATE_PATHWAY,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,PRPS2,1
REACTOME_PROLACTIN_RECEPTOR_SIGNALING,REACTOME_PROLACTIN_RECEPTOR_SIGNALING,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,JAK2,1
REACTOME_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA,REACTOME_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,UBC,1
REACTOME_RESPONSE_OF_EIF2AK1_HRI_TO_HEME_DEFICIENCY,REACTOME_RESPONSE_OF_EIF2AK1_HRI_TO_HEME_DEFICIENCY,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,PPP1R15A,1
REACTOME_SIGNALING_BY_CTNNB1_PHOSPHO_SITE_MUTANTS,REACTOME_SIGNALING_BY_CTNNB1_PHOSPHO_SITE_MUTANTS,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,CSNK1A1,1
REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER,REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,UBC,1
REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX,REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,PTGES3,1
REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4,REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,CLTC,1
REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION,REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,WWTR1,1
SCHAVOLT_TARGETS_OF_TP53_AND_TP63,SCHAVOLT_TARGETS_OF_TP53_AND_TP63,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,EPHA2,1
TERAMOTO_OPN_TARGETS_CLUSTER_4,TERAMOTO_OPN_TARGETS_CLUSTER_4,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,LDHA,1
WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,1/151,15/21728,0.09935230733977163,0.23469448111384827,0.1725236987461126,PCYT1A,1
MALONEY_RESPONSE_TO_17AAG_DN,MALONEY_RESPONSE_TO_17AAG_DN,2/151,77/21728,0.10025985525181724,0.2364362291082753,0.17380405610626884,LDHA/PTGES3,2
REACTOME_SENSORY_PROCESSING_OF_SOUND,REACTOME_SENSORY_PROCESSING_OF_SOUND,2/151,77/21728,0.10025985525181724,0.2364362291082753,0.17380405610626884,ACTB/ACTG1,2
RODRIGUES_NTN1_TARGETS_DN,RODRIGUES_NTN1_TARGETS_DN,3/151,160/21728,0.10069240304218433,0.23725487332585923,0.174405840723037,MET/RRBP1/BCAM,3
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,6/151,459/21728,0.1013360067068619,0.23856900562005282,0.1753718581724461,SEC23A/ACTR3/PGM3/RECQL/PVR/PNKP,6
MULLIGHAN_NPM1_SIGNATURE_3_DN,MULLIGHAN_NPM1_SIGNATURE_3_DN,3/151,161/21728,0.10210811533274003,0.23976370648460651,0.1762500816869905,DUSP5/LDHA/LDLR,3
REACTOME_ABC_TRANSPORTER_DISORDERS,REACTOME_ABC_TRANSPORTER_DISORDERS,2/151,78/21728,0.10244763124450249,0.23976370648460651,0.1762500816869905,UBC/SEL1L,2
REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,2/151,78/21728,0.10244763124450249,0.23976370648460651,0.1762500816869905,ESR2/MET,2
REACTOME_REGULATION_OF_INSULIN_SECRETION,REACTOME_REGULATION_OF_INSULIN_SECRETION,2/151,78/21728,0.10244763124450249,0.23976370648460651,0.1762500816869905,PRKAR1A/IQGAP1,2
REACTOME_SIGNALING_BY_INSULIN_RECEPTOR,REACTOME_SIGNALING_BY_INSULIN_RECEPTOR,2/151,78/21728,0.10244763124450249,0.23976370648460651,0.1762500816869905,ATP6V1C1/ATP6V1A,2
REACTOME_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,REACTOME_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,2/151,78/21728,0.10244763124450249,0.23976370648460651,0.1762500816869905,UBC/COPS2,2
SEKI_INFLAMMATORY_RESPONSE_LPS_UP,SEKI_INFLAMMATORY_RESPONSE_LPS_UP,2/151,78/21728,0.10244763124450249,0.23976370648460651,0.1762500816869905,BIRC3/SLC4A7,2
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,3/151,162/21728,0.10353179802924775,0.24128331531352373,0.17736714474943582,PDLIM4/TPM1/LAMA5,3
ONDER_CDH1_TARGETS_2_UP,ONDER_CDH1_TARGETS_2_UP,4/151,257/21728,0.10464158841201397,0.24128331531352373,0.17736714474943582,SEPTIN11/EML1/MOXD1/TPM1,4
BASSO_HAIRY_CELL_LEUKEMIA_UP,BASSO_HAIRY_CELL_LEUKEMIA_UP,2/151,79/21728,0.10464856762089245,0.24128331531352373,0.17736714474943582,ACTB/WWTR1,2
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,2/151,79/21728,0.10464856762089245,0.24128331531352373,0.17736714474943582,UBC/ACTG1,2
KEGG_CARDIAC_MUSCLE_CONTRACTION,KEGG_CARDIAC_MUSCLE_CONTRACTION,2/151,79/21728,0.10464856762089245,0.24128331531352373,0.17736714474943582,ATP1A1/TPM1,2
PID_MYC_ACTIV_PATHWAY,PID_MYC_ACTIV_PATHWAY,2/151,79/21728,0.10464856762089245,0.24128331531352373,0.17736714474943582,HSPA4/LDHA,2
PID_P73PATHWAY,PID_P73PATHWAY,2/151,79/21728,0.10464856762089245,0.24128331531352373,0.17736714474943582,FLOT2/PML,2
BIOCARTA_CK1_PATHWAY,BIOCARTA_CK1_PATHWAY,1/151,16/21728,0.10561573485285991,0.24128331531352373,0.17736714474943582,PRKAR1A,1
BIOCARTA_SHH_PATHWAY,BIOCARTA_SHH_PATHWAY,1/151,16/21728,0.10561573485285991,0.24128331531352373,0.17736714474943582,PRKAR1A,1
DASU_IL6_SIGNALING_SCAR_DN,DASU_IL6_SIGNALING_SCAR_DN,1/151,16/21728,0.10561573485285991,0.24128331531352373,0.17736714474943582,TPM1,1
GHO_ATF5_TARGETS_DN,GHO_ATF5_TARGETS_DN,1/151,16/21728,0.10561573485285991,0.24128331531352373,0.17736714474943582,ACTN4,1
KANG_FLUOROURACIL_RESISTANCE_DN,KANG_FLUOROURACIL_RESISTANCE_DN,1/151,16/21728,0.10561573485285991,0.24128331531352373,0.17736714474943582,LDLR,1
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL,1/151,16/21728,0.10561573485285991,0.24128331531352373,0.17736714474943582,APLP2,1
MACLACHLAN_BRCA1_TARGETS_DN,MACLACHLAN_BRCA1_TARGETS_DN,1/151,16/21728,0.10561573485285991,0.24128331531352373,0.17736714474943582,ACTB,1
MAINA_VHL_TARGETS_DN,MAINA_VHL_TARGETS_DN,1/151,16/21728,0.10561573485285991,0.24128331531352373,0.17736714474943582,GBE1,1
PID_CIRCADIAN_PATHWAY,PID_CIRCADIAN_PATHWAY,1/151,16/21728,0.10561573485285991,0.24128331531352373,0.17736714474943582,NPAS2,1
PID_DNA_PK_PATHWAY,PID_DNA_PK_PATHWAY,1/151,16/21728,0.10561573485285991,0.24128331531352373,0.17736714474943582,PNKP,1
RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP,RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP,1/151,16/21728,0.10561573485285991,0.24128331531352373,0.17736714474943582,CTNNA1,1
REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION,REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION,1/151,16/21728,0.10561573485285991,0.24128331531352373,0.17736714474943582,UBC,1
REACTOME_P75NTR_SIGNALS_VIA_NF_KB,REACTOME_P75NTR_SIGNALS_VIA_NF_KB,1/151,16/21728,0.10561573485285991,0.24128331531352373,0.17736714474943582,UBC,1
REACTOME_RAP1_SIGNALLING,REACTOME_RAP1_SIGNALLING,1/151,16/21728,0.10561573485285991,0.24128331531352373,0.17736714474943582,YWHAZ,1
REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING,REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING,1/151,16/21728,0.10561573485285991,0.24128331531352373,0.17736714474943582,UBC,1
REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,1/151,16/21728,0.10561573485285991,0.24128331531352373,0.17736714474943582,UBC,1
REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX_WITHIN_TLR4_COMPLEX,REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX_WITHIN_TLR4_COMPLEX,1/151,16/21728,0.10561573485285991,0.24128331531352373,0.17736714474943582,UBC,1
VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN,VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN,1/151,16/21728,0.10561573485285991,0.24128331531352373,0.17736714474943582,PVR,1
VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP,VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP,1/151,16/21728,0.10561573485285991,0.24128331531352373,0.17736714474943582,PML,1
WP_OSTEOCLAST_SIGNALING,WP_OSTEOCLAST_SIGNALING,1/151,16/21728,0.10561573485285991,0.24128331531352373,0.17736714474943582,ITGB3,1
WU_HBX_TARGETS_2_DN,WU_HBX_TARGETS_2_DN,1/151,16/21728,0.10561573485285991,0.24128331531352373,0.17736714474943582,PTPN14,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4,1/151,16/21728,0.10561573485285991,0.24128331531352373,0.17736714474943582,LDLR,1
REACTOME_PROTEIN_LOCALIZATION,REACTOME_PROTEIN_LOCALIZATION,3/151,164/21728,0.10640280744450202,0.24288167549780332,0.17854209786129302,UBC/HSPA9/VDAC1,3
BOYLAN_MULTIPLE_MYELOMA_D_DN,BOYLAN_MULTIPLE_MYELOMA_D_DN,2/151,80/21728,0.1068623789032861,0.24313160408954038,0.17872582014084662,FLOT2/CTNNA1,2
HUANG_DASATINIB_SENSITIVITY_UP,HUANG_DASATINIB_SENSITIVITY_UP,2/151,80/21728,0.1068623789032861,0.24313160408954038,0.17872582014084662,MET/EPHA2,2
ROSS_AML_WITH_PML_RARA_FUSION,ROSS_AML_WITH_PML_RARA_FUSION,2/151,80/21728,0.1068623789032861,0.24313160408954038,0.17872582014084662,FNDC3B/HSPA5,2
SCHUHMACHER_MYC_TARGETS_UP,SCHUHMACHER_MYC_TARGETS_UP,2/151,80/21728,0.1068623789032861,0.24313160408954038,0.17872582014084662,LDHA/PRPS2,2
BIOCARTA_MAPK_PATHWAY,BIOCARTA_MAPK_PATHWAY,2/151,81/21728,0.1090887828981678,0.24637597494127805,0.18111075419123165,RPS6KA3/MAP2K3,2
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP,HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP,2/151,81/21728,0.1090887828981678,0.24637597494127805,0.18111075419123165,HSPA5/TPM1,2
HARRIS_HYPOXIA,HARRIS_HYPOXIA,2/151,81/21728,0.1090887828981678,0.24637597494127805,0.18111075419123165,LDHA/SLC2A3,2
HINATA_NFKB_TARGETS_FIBROBLAST_UP,HINATA_NFKB_TARGETS_FIBROBLAST_UP,2/151,81/21728,0.1090887828981678,0.24637597494127805,0.18111075419123165,SEC24A/NPAS2,2
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN,SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN,2/151,81/21728,0.1090887828981678,0.24637597494127805,0.18111075419123165,NRIP1/PGRMC2,2
FIRESTEIN_PROLIFERATION,FIRESTEIN_PROLIFERATION,3/151,166/21728,0.10930489469993679,0.24637597494127805,0.18111075419123165,STK24/PKN1/EPHB4,3
RICKMAN_METASTASIS_DN,RICKMAN_METASTASIS_DN,4/151,262/21728,0.1102245193006146,0.24637597494127805,0.18111075419123165,ACTR3/PERP/FLOT2/PML,4
FOSTER_TOLERANT_MACROPHAGE_UP,FOSTER_TOLERANT_MACROPHAGE_UP,3/151,167/21728,0.11076742393206951,0.24637597494127805,0.18111075419123165,ETF1/MET/PVR,3
BHAT_ESR1_TARGETS_VIA_AKT1_DN,BHAT_ESR1_TARGETS_VIA_AKT1_DN,2/151,82/21728,0.11132750066485557,0.24637597494127805,0.18111075419123165,PTPN14/EFNB2,2
FOROUTAN_PRODRANK_TGFB_EMT_DN,FOROUTAN_PRODRANK_TGFB_EMT_DN,2/151,82/21728,0.11132750066485557,0.24637597494127805,0.18111075419123165,BIRC3/LAMA5,2
REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,2/151,82/21728,0.11132750066485557,0.24637597494127805,0.18111075419123165,UBC/ARIH1,2
ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,2/151,82/21728,0.11132750066485557,0.24637597494127805,0.18111075419123165,CBFB/EGLN1,2
ZHU_CMV_24_HR_UP,ZHU_CMV_24_HR_UP,2/151,82/21728,0.11132750066485557,0.24637597494127805,0.18111075419123165,SSR1/ATP6V1C1,2
KIM_WT1_TARGETS_DN,KIM_WT1_TARGETS_DN,6/151,472/21728,0.11177330978114773,0.24637597494127805,0.18111075419123165,SDF4/HSPA5/ACTR2/SLC33A1/PERP/BECN1,6
BIOCARTA_HCMV_PATHWAY,BIOCARTA_HCMV_PATHWAY,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,MAP2K3,1
BIOCARTA_PML_PATHWAY,BIOCARTA_PML_PATHWAY,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,PML,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BROWN_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BROWN_UP,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,SLC2A3,1
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN,JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,LOXL1,1
KASLER_HDAC7_TARGETS_1_DN,KASLER_HDAC7_TARGETS_1_DN,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,TRIP10,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,CTNND1,1
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,FLOT2,1
LIU_VAV3_PROSTATE_CARCINOGENESIS_DN,LIU_VAV3_PROSTATE_CARCINOGENESIS_DN,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,HSPA5,1
NELSON_RESPONSE_TO_ANDROGEN_DN,NELSON_RESPONSE_TO_ANDROGEN_DN,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,SDC4,1
PID_SYNDECAN_3_PATHWAY,PID_SYNDECAN_3_PATHWAY,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,NCSTN,1
REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON,REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,UBC,1
REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE,REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,CSNK1A1,1
REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS,REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,JAK2,1
REACTOME_KSRP_KHSRP_BINDS_AND_DESTABILIZES_MRNA,REACTOME_KSRP_KHSRP_BINDS_AND_DESTABILIZES_MRNA,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,YWHAZ,1
REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING,REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,PRKAR1A,1
REACTOME_PROTEIN_METHYLATION,REACTOME_PROTEIN_METHYLATION,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,HSPA8,1
REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY,REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,BIRC3,1
REACTOME_TRANSLESION_SYNTHESIS_BY_POLK,REACTOME_TRANSLESION_SYNTHESIS_BY_POLK,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,UBC,1
RUAN_RESPONSE_TO_TROGLITAZONE_DN,RUAN_RESPONSE_TO_TROGLITAZONE_DN,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,NRIP1,1
VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP,VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,SLC2A3,1
WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,LOXL1,1
WP_CORI_CYCLE,WP_CORI_CYCLE,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,LDHA,1
WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,LDLR,1
WP_LEPTININSULIN_SIGNALING_OVERLAP,WP_LEPTININSULIN_SIGNALING_OVERLAP,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,JAK2,1
WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,LDLR,1
WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,1/151,17/21728,0.11183589071308553,0.24637597494127805,0.18111075419123165,JAK2,1
REACTOME_G2_M_CHECKPOINTS,REACTOME_G2_M_CHECKPOINTS,3/151,168/21728,0.1122375199445834,0.2470246659562998,0.1815876063639959,UBC/YWHAZ/HUS1,3
GOLDRATH_ANTIGEN_RESPONSE,GOLDRATH_ANTIGEN_RESPONSE,5/151,366/21728,0.11230819046177344,0.2470246659562998,0.1815876063639959,PERP/SLC4A7/SLC2A3/CTNNA1/MAP2K3,5
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,2/151,83/21728,0.11357825648442348,0.24942323835077349,0.18335079474082094,DUSP3/SLC4A7,2
SANA_TNF_SIGNALING_UP,SANA_TNF_SIGNALING_UP,2/151,83/21728,0.11357825648442348,0.24942323835077349,0.18335079474082094,ATP13A3/BIRC3,2
SENESE_HDAC1_TARGETS_DN,SENESE_HDAC1_TARGETS_DN,4/151,266/21728,0.1147854734686382,0.25187523325108757,0.18515325395290436,PKD2/LAMA5/BCAM/PGRMC2,4
REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,3/151,170/21728,0.11520014041587519,0.2520145172263254,0.1852556414759089,PRKAR1A/ACTB/JAK2,3
BHATTACHARYA_EMBRYONIC_STEM_CELL,BHATTACHARYA_EMBRYONIC_STEM_CELL,2/151,84/21728,0.11584077782889388,0.2520145172263254,0.1852556414759089,CALU/HSPA4,2
BROWNE_HCMV_INFECTION_16HR_DN,BROWNE_HCMV_INFECTION_16HR_DN,2/151,84/21728,0.11584077782889388,0.2520145172263254,0.1852556414759089,ATP13A3/TPM1,2
HILLION_HMGA1_TARGETS,HILLION_HMGA1_TARGETS,2/151,84/21728,0.11584077782889388,0.2520145172263254,0.1852556414759089,ARAF/ESR2,2
ONDER_CDH1_SIGNALING_VIA_CTNNB1,ONDER_CDH1_SIGNALING_VIA_CTNNB1,2/151,84/21728,0.11584077782889388,0.2520145172263254,0.1852556414759089,BIRC3/TPM1,2
ZHU_CMV_24_HR_DN,ZHU_CMV_24_HR_DN,2/151,84/21728,0.11584077782889388,0.2520145172263254,0.1852556414759089,ACTG1/CD151,2
HOLLMANN_APOPTOSIS_VIA_CD40_DN,HOLLMANN_APOPTOSIS_VIA_CD40_DN,4/151,268/21728,0.11709691100245412,0.2520145172263254,0.1852556414759089,SEPTIN11/FNDC3B/CTNNA1/RRBP1,4
REACTOME_NEUTROPHIL_DEGRANULATION,REACTOME_NEUTROPHIL_DEGRANULATION,6/151,479/21728,0.11761361524970171,0.2520145172263254,0.1852556414759089,NCSTN/IQGAP1/ACTR2/STBD1/SLC2A3/HSPA8,6
ALONSO_METASTASIS_NEURAL_UP,ALONSO_METASTASIS_NEURAL_UP,1/151,18/21728,0.11801307188863397,0.2520145172263254,0.1852556414759089,APLP2,1
AMIT_EGF_RESPONSE_40_MCF10A,AMIT_EGF_RESPONSE_40_MCF10A,1/151,18/21728,0.11801307188863397,0.2520145172263254,0.1852556414759089,DUSP5,1
CHEN_PDGF_TARGETS,CHEN_PDGF_TARGETS,1/151,18/21728,0.11801307188863397,0.2520145172263254,0.1852556414759089,EPHA2,1
DORMOY_ELAVL1_TARGETS,DORMOY_ELAVL1_TARGETS,1/151,18/21728,0.11801307188863397,0.2520145172263254,0.1852556414759089,ACTB,1
GRANDVAUX_IRF3_TARGETS_DN,GRANDVAUX_IRF3_TARGETS_DN,1/151,18/21728,0.11801307188863397,0.2520145172263254,0.1852556414759089,ADAM9,1
HASLINGER_B_CLL_WITH_MUTATED_VH_GENES,HASLINGER_B_CLL_WITH_MUTATED_VH_GENES,1/151,18/21728,0.11801307188863397,0.2520145172263254,0.1852556414759089,NRIP1,1
HOWLIN_CITED1_TARGETS_2_UP,HOWLIN_CITED1_TARGETS_2_UP,1/151,18/21728,0.11801307188863397,0.2520145172263254,0.1852556414759089,IQGAP1,1
PID_ANTHRAX_PATHWAY,PID_ANTHRAX_PATHWAY,1/151,18/21728,0.11801307188863397,0.2520145172263254,0.1852556414759089,MAP2K3,1
PID_BETA_CATENIN_DEG_PATHWAY,PID_BETA_CATENIN_DEG_PATHWAY,1/151,18/21728,0.11801307188863397,0.2520145172263254,0.1852556414759089,CSNK1A1,1
PODAR_RESPONSE_TO_ADAPHOSTIN_DN,PODAR_RESPONSE_TO_ADAPHOSTIN_DN,1/151,18/21728,0.11801307188863397,0.2520145172263254,0.1852556414759089,ACTG1,1
REACTOME_ACTIVATION_OF_SMO,REACTOME_ACTIVATION_OF_SMO,1/151,18/21728,0.11801307188863397,0.2520145172263254,0.1852556414759089,CSNK1A1,1
REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS,REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS,1/151,18/21728,0.11801307188863397,0.2520145172263254,0.1852556414759089,LOXL1,1
REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK,REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK,1/151,18/21728,0.11801307188863397,0.2520145172263254,0.1852556414759089,RPS6KA3,1
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP,SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP,1/151,18/21728,0.11801307188863397,0.2520145172263254,0.1852556414759089,PKD2,1
TOMIDA_METASTASIS_DN,TOMIDA_METASTASIS_DN,1/151,18/21728,0.11801307188863397,0.2520145172263254,0.1852556414759089,GARS1,1
WEBER_METHYLATED_IN_COLON_CANCER,WEBER_METHYLATED_IN_COLON_CANCER,1/151,18/21728,0.11801307188863397,0.2520145172263254,0.1852556414759089,WWTR1,1
WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,1/151,18/21728,0.11801307188863397,0.2520145172263254,0.1852556414759089,MAP2K3,1
WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,1/151,18/21728,0.11801307188863397,0.2520145172263254,0.1852556414759089,ARAF,1
WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,1/151,18/21728,0.11801307188863397,0.2520145172263254,0.1852556414759089,ITGB3,1
WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,1/151,18/21728,0.11801307188863397,0.2520145172263254,0.1852556414759089,CALU,1
WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,1/151,18/21728,0.11801307188863397,0.2520145172263254,0.1852556414759089,CSNK1A1,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,2/151,85/21728,0.11811479533069677,0.2520145172263254,0.1852556414759089,RPS6KA3/DUSP5,2
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN,2/151,85/21728,0.11811479533069677,0.2520145172263254,0.1852556414759089,GBE1/PVR,2
KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION,KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION,2/151,85/21728,0.11811479533069677,0.2520145172263254,0.1852556414759089,ARAF/RPS6KA3,2
MILI_PSEUDOPODIA_CHEMOTAXIS_UP,MILI_PSEUDOPODIA_CHEMOTAXIS_UP,2/151,85/21728,0.11811479533069677,0.2520145172263254,0.1852556414759089,PKN1/AKAP12,2
REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,2/151,85/21728,0.11811479533069677,0.2520145172263254,0.1852556414759089,UBC/CSNK1A1,2
SANA_TNF_SIGNALING_DN,SANA_TNF_SIGNALING_DN,2/151,85/21728,0.11811479533069677,0.2520145172263254,0.1852556414759089,ITPRID2/PDLIM4,2
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN,2/151,85/21728,0.11811479533069677,0.2520145172263254,0.1852556414759089,PERP/SORT1,2
LIM_MAMMARY_STEM_CELL_UP,LIM_MAMMARY_STEM_CELL_UP,6/151,480/21728,0.11846033070533114,0.2525577887178894,0.18565499985324752,LAMC1/CALU/PDLIM4/SLC2A3/DIPK2A/SLC12A4,6
REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,4/151,270/21728,0.11942870276813411,0.25442709838180716,0.18702912768015834,PRKAR1A/RPS6KA3/HSPA8/PRKAG1,4
BROWNE_HCMV_INFECTION_18HR_UP,BROWNE_HCMV_INFECTION_18HR_UP,3/151,173/21728,0.11969911863308415,0.25480777897525503,0.18730896563676808,MET/SEC24A/LAMA5,3
REACTOME_HEDGEHOG_ON_STATE,REACTOME_HEDGEHOG_ON_STATE,2/151,86/21728,0.12040004275239642,0.2561036131440714,0.18826153215092212,UBC/CSNK1A1,2
KEGG_APOPTOSIS,KEGG_APOPTOSIS,2/151,87/21728,0.12269625695668031,0.25679967140126414,0.188773203940151,PRKAR1A/BIRC3,2
KEGG_ERBB_SIGNALING_PATHWAY,KEGG_ERBB_SIGNALING_PATHWAY,2/151,87/21728,0.12269625695668031,0.25679967140126414,0.188773203940151,ARAF/CRK,2
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN,KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN,2/151,87/21728,0.12269625695668031,0.25679967140126414,0.188773203940151,EPHA2/SBNO2,2
REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,2/151,87/21728,0.12269625695668031,0.25679967140126414,0.188773203940151,FLOT2/PPFIBP1,2
ABE_VEGFA_TARGETS,ABE_VEGFA_TARGETS,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,SLC4A7,1
BIOCARTA_CXCR4_PATHWAY,BIOCARTA_CXCR4_PATHWAY,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,CRK,1
BIOCARTA_EPO_PATHWAY,BIOCARTA_EPO_PATHWAY,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,JAK2,1
BIOCARTA_IL12_PATHWAY,BIOCARTA_IL12_PATHWAY,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,JAK2,1
BIOCARTA_MCALPAIN_PATHWAY,BIOCARTA_MCALPAIN_PATHWAY,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,PRKAR1A,1
BIOCARTA_MITOCHONDRIA_PATHWAY,BIOCARTA_MITOCHONDRIA_PATHWAY,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,BIRC3,1
BIOCARTA_TID_PATHWAY,BIOCARTA_TID_PATHWAY,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,JAK2,1
CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP,CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,PDIA3,1
CHOI_ATL_CHRONIC_VS_ACUTE_DN,CHOI_ATL_CHRONIC_VS_ACUTE_DN,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,ATP6V1A,1
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN,DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,SLC2A3,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,DUSP5,1
KAMIKUBO_MYELOID_MN1_NETWORK,KAMIKUBO_MYELOID_MN1_NETWORK,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,RECQL,1
KOBAYASHI_RESPONSE_TO_ROMIDEPSIN,KOBAYASHI_RESPONSE_TO_ROMIDEPSIN,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,EFNB2,1
MARSON_FOXP3_CORE_DIRECT_TARGETS,MARSON_FOXP3_CORE_DIRECT_TARGETS,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,JAK2,1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,BIRC3,1
PID_ARF_3PATHWAY,PID_ARF_3PATHWAY,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,KDELR1,1
PID_EPHA2_FWD_PATHWAY,PID_EPHA2_FWD_PATHWAY,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,EPHA2,1
PID_HIF1A_PATHWAY,PID_HIF1A_PATHWAY,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,EGLN1,1
RASHI_NFKB1_TARGETS,RASHI_NFKB1_TARGETS,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,BIRC3,1
REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES,REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,FURIN,1
REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS,REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,UBC,1
REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION,REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,HSPA8,1
REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER,REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,CLTC,1
REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,UBC,1
REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS,REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,HSP90B1,1
REACTOME_TRANSLESION_SYNTHESIS_BY_POLH,REACTOME_TRANSLESION_SYNTHESIS_BY_POLH,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,UBC,1
SA_CASPASE_CASCADE,SA_CASPASE_CASCADE,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,BIRC3,1
VERNOCHET_ADIPOGENESIS,VERNOCHET_ADIPOGENESIS,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,SORT1,1
VERRECCHIA_RESPONSE_TO_TGFB1_C1,VERRECCHIA_RESPONSE_TO_TGFB1_C1,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,ADAM9,1
VISALA_AGING_LYMPHOCYTE_DN,VISALA_AGING_LYMPHOCYTE_DN,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,SDC4,1
WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,BECN1,1
WP_NUCLEOTIDE_METABOLISM,WP_NUCLEOTIDE_METABOLISM,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,PRPS2,1
WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,1/151,19/21728,0.12414757332321735,0.25679967140126414,0.188773203940151,LDLR,1
HOEBEKE_LYMPHOID_STEM_CELL_DN,HOEBEKE_LYMPHOID_STEM_CELL_DN,2/151,88/21728,0.12500317787661094,0.2578016541508724,0.18950976054438734,HSP90B1/ACTR2,2
JIANG_VHL_TARGETS,JIANG_VHL_TARGETS,2/151,88/21728,0.12500317787661094,0.2578016541508724,0.18950976054438734,STK24/TRIP10,2
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP,MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP,2/151,88/21728,0.12500317787661094,0.2578016541508724,0.18950976054438734,MAP2K3/EPHB4,2
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS,2/151,88/21728,0.12500317787661094,0.2578016541508724,0.18950976054438734,CBFB/PML,2
BAKKER_FOXO3_TARGETS_DN,BAKKER_FOXO3_TARGETS_DN,3/151,177/21728,0.12579763184868833,0.2590554642517837,0.19043143520460018,CALU/SEL1L/PRKAG1,3
REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,3/151,177/21728,0.12579763184868833,0.2590554642517837,0.19043143520460018,UBC/SEL1L/SLC33A1,3
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,4/151,276/21728,0.12654400679136396,0.260399445086229,0.1914193942886909,LAMA5/RRBP1/MAP2K3/EPHB4,4
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN,2/151,89/21728,0.1273205484861359,0.2606458980799451,0.19160056165931322,TRIP12/APLP2,2
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,2/151,89/21728,0.1273205484861359,0.2606458980799451,0.19160056165931322,UBC/MOXD1,2
KEGG_PROSTATE_CANCER,KEGG_PROSTATE_CANCER,2/151,89/21728,0.1273205484861359,0.2606458980799451,0.19160056165931322,HSP90B1/ARAF,2
SAFFORD_T_LYMPHOCYTE_ANERGY,SAFFORD_T_LYMPHOCYTE_ANERGY,2/151,89/21728,0.1273205484861359,0.2606458980799451,0.19160056165931322,ACTN4/FURIN,2
SWEET_KRAS_ONCOGENIC_SIGNATURE,SWEET_KRAS_ONCOGENIC_SIGNATURE,2/151,89/21728,0.1273205484861359,0.2606458980799451,0.19160056165931322,LAMC1/KDELR1,2
WNT_SIGNALING,WNT_SIGNALING,2/151,89/21728,0.1273205484861359,0.2606458980799451,0.19160056165931322,ACTB/CSNK1A1,2
WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,2/151,89/21728,0.1273205484861359,0.2606458980799451,0.19160056165931322,ARAF/RALB,2
LIU_PROSTATE_CANCER_DN,LIU_PROSTATE_CANCER_DN,6/151,491/21728,0.12797532005448195,0.26163525736706666,0.1923278387678032,PKD2/AKAP12/MET/PDLIM4/TPM1/EPHA2,6
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,5/151,382/21728,0.1279921939387486,0.26163525736706666,0.1923278387678032,PDIA6/UBC/FEM1C/PPP1R15A/PNKP,5
REACTOME_APOPTOSIS,REACTOME_APOPTOSIS,3/151,179/21728,0.12888845281553876,0.26255867425581175,0.19300664167946455,STK24/UBC/YWHAZ,3
REACTOME_COLLAGEN_FORMATION,REACTOME_COLLAGEN_FORMATION,2/151,90/21728,0.12964811477085494,0.26255867425581175,0.19300664167946455,CD151/LOXL1,2
WP_IL18_SIGNALING_PATHWAY,WP_IL18_SIGNALING_PATHWAY,4/151,279/21728,0.13016773194678977,0.26255867425581175,0.19300664167946455,PKN1/BIRC3/SLC4A7/SDC4,4
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN,1/151,20/21728,0.13023968794978713,0.26255867425581175,0.19300664167946455,MOXD1,1
MARCHINI_TRABECTEDIN_RESISTANCE_UP,MARCHINI_TRABECTEDIN_RESISTANCE_UP,1/151,20/21728,0.13023968794978713,0.26255867425581175,0.19300664167946455,AKAP12,1
MCCABE_HOXC6_TARGETS_CANCER_DN,MCCABE_HOXC6_TARGETS_CANCER_DN,1/151,20/21728,0.13023968794978713,0.26255867425581175,0.19300664167946455,ARIH1,1
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP,PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP,1/151,20/21728,0.13023968794978713,0.26255867425581175,0.19300664167946455,PRKAR1A,1
RAHMAN_TP53_TARGETS_PHOSPHORYLATED,RAHMAN_TP53_TARGETS_PHOSPHORYLATED,1/151,20/21728,0.13023968794978713,0.26255867425581175,0.19300664167946455,ACTB,1
REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE,REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE,1/151,20/21728,0.13023968794978713,0.26255867425581175,0.19300664167946455,SDC4,1
REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB,REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB,1/151,20/21728,0.13023968794978713,0.26255867425581175,0.19300664167946455,PRKAR1A,1
REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES,REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES,1/151,20/21728,0.13023968794978713,0.26255867425581175,0.19300664167946455,PPFIBP1,1
REACTOME_SIGNALING_BY_HIPPO,REACTOME_SIGNALING_BY_HIPPO,1/151,20/21728,0.13023968794978713,0.26255867425581175,0.19300664167946455,WWTR1,1
REACTOME_SIGNALING_BY_KIT_IN_DISEASE,REACTOME_SIGNALING_BY_KIT_IN_DISEASE,1/151,20/21728,0.13023968794978713,0.26255867425581175,0.19300664167946455,JAK2,1
REACTOME_SIGNALLING_TO_RAS,REACTOME_SIGNALLING_TO_RAS,1/151,20/21728,0.13023968794978713,0.26255867425581175,0.19300664167946455,RALB,1
TOMLINS_METASTASIS_DN,TOMLINS_METASTASIS_DN,1/151,20/21728,0.13023968794978713,0.26255867425581175,0.19300664167946455,TM9SF2,1
WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION,WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION,1/151,20/21728,0.13023968794978713,0.26255867425581175,0.19300664167946455,ICMT,1
WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP,WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP,1/151,20/21728,0.13023968794978713,0.26255867425581175,0.19300664167946455,ADAM9,1
WP_HYPERTROPHY_MODEL,WP_HYPERTROPHY_MODEL,1/151,20/21728,0.13023968794978713,0.26255867425581175,0.19300664167946455,WDR1,1
ZIRN_TRETINOIN_RESPONSE_UP,ZIRN_TRETINOIN_RESPONSE_UP,1/151,20/21728,0.13023968794978713,0.26255867425581175,0.19300664167946455,AKAP12,1
BROWNE_HCMV_INFECTION_48HR_UP,BROWNE_HCMV_INFECTION_48HR_UP,3/151,180/21728,0.13044401264496447,0.26277988914264777,0.19316925654076644,PRPS2/ZNF330/LAMA5,3
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN,2/151,91/21728,0.1319856256990441,0.2649662952406599,0.1947764816668107,APLP2/PERP,2
WP_AMINO_ACID_METABOLISM,WP_AMINO_ACID_METABOLISM,2/151,91/21728,0.1319856256990441,0.2649662952406599,0.1947764816668107,RARS1/LDHA,2
WP_ERBB_SIGNALING_PATHWAY,WP_ERBB_SIGNALING_PATHWAY,2/151,91/21728,0.1319856256990441,0.2649662952406599,0.1947764816668107,ARAF/CRK,2
WP_SELENIUM_MICRONUTRIENT_NETWORK,WP_SELENIUM_MICRONUTRIENT_NETWORK,2/151,91/21728,0.1319856256990441,0.2649662952406599,0.1947764816668107,PRDX1/LDLR,2
FERNANDEZ_BOUND_BY_MYC,FERNANDEZ_BOUND_BY_MYC,3/151,181/21728,0.1320062464409911,0.2649662952406599,0.1947764816668107,ACTG1/MET/HSPA8,3
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,3/151,182/21728,0.13357508494505207,0.2679217227273319,0.19694901371339618,PTPN14/PERP/SORT1,3
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C,2/151,92/21728,0.13433283319292968,0.2682502303914666,0.19719049939731167,ETF1/SDC4,2
REACTOME_PCP_CE_PATHWAY,REACTOME_PCP_CE_PATHWAY,2/151,92/21728,0.13433283319292968,0.2682502303914666,0.19719049939731167,UBC/CLTC,2
REACTOME_RHO_GTPASES_ACTIVATE_PKNS,REACTOME_RHO_GTPASES_ACTIVATE_PKNS,2/151,92/21728,0.13433283319292968,0.2682502303914666,0.19719049939731167,PKN1/YWHAZ,2
RODWELL_AGING_KIDNEY_UP,RODWELL_AGING_KIDNEY_UP,6/151,500/21728,0.1360292921608581,0.2682502303914666,0.19719049939731167,NUS1/CALU/BIRC3/MOXD1/TPM1/LOXL1,6
AMIT_EGF_RESPONSE_240_MCF10A,AMIT_EGF_RESPONSE_240_MCF10A,1/151,21/21728,0.13628970670414398,0.2682502303914666,0.19719049939731167,AKAP12,1
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP,1/151,21/21728,0.13628970670414398,0.2682502303914666,0.19719049939731167,GBE1,1
BIOCARTA_IL6_PATHWAY,BIOCARTA_IL6_PATHWAY,1/151,21/21728,0.13628970670414398,0.2682502303914666,0.19719049939731167,JAK2,1
BIOCARTA_MPR_PATHWAY,BIOCARTA_MPR_PATHWAY,1/151,21/21728,0.13628970670414398,0.2682502303914666,0.19719049939731167,PRKAR1A,1
BIOCARTA_NOS1_PATHWAY,BIOCARTA_NOS1_PATHWAY,1/151,21/21728,0.13628970670414398,0.2682502303914666,0.19719049939731167,PRKAR1A,1
DELLA_RESPONSE_TO_TSA_AND_BUTYRATE,DELLA_RESPONSE_TO_TSA_AND_BUTYRATE,1/151,21/21728,0.13628970670414398,0.2682502303914666,0.19719049939731167,PRDX1,1
JACKSON_DNMT1_TARGETS_DN,JACKSON_DNMT1_TARGETS_DN,1/151,21/21728,0.13628970670414398,0.2682502303914666,0.19719049939731167,LDLR,1
LEE_INTRATHYMIC_T_PROGENITOR,LEE_INTRATHYMIC_T_PROGENITOR,1/151,21/21728,0.13628970670414398,0.2682502303914666,0.19719049939731167,HIVEP3,1
MACLACHLAN_BRCA1_TARGETS_UP,MACLACHLAN_BRCA1_TARGETS_UP,1/151,21/21728,0.13628970670414398,0.2682502303914666,0.19719049939731167,MET,1
MOOTHA_GLYCOGEN_METABOLISM,MOOTHA_GLYCOGEN_METABOLISM,1/151,21/21728,0.13628970670414398,0.2682502303914666,0.19719049939731167,GBE1,1
OUYANG_PROSTATE_CANCER_MARKERS,OUYANG_PROSTATE_CANCER_MARKERS,1/151,21/21728,0.13628970670414398,0.2682502303914666,0.19719049939731167,MET,1
OUYANG_PROSTATE_CANCER_PROGRESSION_DN,OUYANG_PROSTATE_CANCER_PROGRESSION_DN,1/151,21/21728,0.13628970670414398,0.2682502303914666,0.19719049939731167,MAP2K3,1
PID_P38_MK2_PATHWAY,PID_P38_MK2_PATHWAY,1/151,21/21728,0.13628970670414398,0.2682502303914666,0.19719049939731167,YWHAZ,1
PID_S1P_S1P1_PATHWAY,PID_S1P_S1P1_PATHWAY,1/151,21/21728,0.13628970670414398,0.2682502303914666,0.19719049939731167,ITGB3,1
REACTOME_CELLULAR_HEXOSE_TRANSPORT,REACTOME_CELLULAR_HEXOSE_TRANSPORT,1/151,21/21728,0.13628970670414398,0.2682502303914666,0.19719049939731167,SLC2A3,1
REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION,REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION,1/151,21/21728,0.13628970670414398,0.2682502303914666,0.19719049939731167,UBC,1
REACTOME_SIGNAL_TRANSDUCTION_BY_L1,REACTOME_SIGNAL_TRANSDUCTION_BY_L1,1/151,21/21728,0.13628970670414398,0.2682502303914666,0.19719049939731167,ITGB3,1
REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES,REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES,1/151,21/21728,0.13628970670414398,0.2682502303914666,0.19719049939731167,FLOT2,1
REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM,REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM,1/151,21/21728,0.13628970670414398,0.2682502303914666,0.19719049939731167,PKD2,1
SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A,SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A,1/151,21/21728,0.13628970670414398,0.2682502303914666,0.19719049939731167,PCDH8,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP,1/151,21/21728,0.13628970670414398,0.2682502303914666,0.19719049939731167,PPFIBP1,1
MORI_MATURE_B_LYMPHOCYTE_UP,MORI_MATURE_B_LYMPHOCYTE_UP,2/151,93/21728,0.13668949210021647,0.2682502303914666,0.19719049939731167,SLC4A7/JAK2,2
REACTOME_INTERFERON_GAMMA_SIGNALING,REACTOME_INTERFERON_GAMMA_SIGNALING,2/151,93/21728,0.13668949210021647,0.2682502303914666,0.19719049939731167,JAK2/PML,2
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN,2/151,93/21728,0.13668949210021647,0.2682502303914666,0.19719049939731167,ARIH1/SEC23A,2
DOANE_RESPONSE_TO_ANDROGEN_UP,DOANE_RESPONSE_TO_ANDROGEN_UP,3/151,184/21728,0.1367322988604452,0.2682502303914666,0.19719049939731167,HSPA4/RRBP1/BCAM,3
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,3/151,184/21728,0.1367322988604452,0.2682502303914666,0.19719049939731167,PML/FURIN/SBNO2,3
REACTOME_RAC1_GTPASE_CYCLE,REACTOME_RAC1_GTPASE_CYCLE,3/151,184/21728,0.1367322988604452,0.2682502303914666,0.19719049939731167,PKN1/IQGAP1/EPHA2,3
FOROUTAN_PRODRANK_TGFB_EMT_UP,FOROUTAN_PRODRANK_TGFB_EMT_UP,3/151,185/21728,0.13832053559700722,0.2711746280088116,0.199340221415291,EML1/ITGB3/TPM1,3
KAYO_CALORIE_RESTRICTION_MUSCLE_UP,KAYO_CALORIE_RESTRICTION_MUSCLE_UP,2/151,94/21728,0.13905536016586223,0.2718478469674632,0.19983510405701893,ACTB/RASA2,2
REACTOME_MITOCHONDRIAL_BIOGENESIS,REACTOME_MITOCHONDRIAL_BIOGENESIS,2/151,94/21728,0.13905536016586223,0.2718478469674632,0.19983510405701893,HSPA9/PRKAG1,2
WP_TNFALPHA_SIGNALING_PATHWAY,WP_TNFALPHA_SIGNALING_PATHWAY,2/151,94/21728,0.13905536016586223,0.2718478469674632,0.19983510405701893,BIRC3/MAP2K3,2
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP,ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP,2/151,94/21728,0.13905536016586223,0.2718478469674632,0.19983510405701893,ACTR3/PGM3,2
WP_VITAMIN_D_RECEPTOR_PATHWAY,WP_VITAMIN_D_RECEPTOR_PATHWAY,3/151,186/21728,0.13991509970834917,0.2722476705921937,0.20012901403844333,NRIP1/TPM1/EPHB4,3
CHEN_LIVER_METABOLISM_QTL_CIS,CHEN_LIVER_METABOLISM_QTL_CIS,2/151,95/21728,0.1414301980041004,0.2722476705921937,0.20012901403844333,IARS2/ACTR3,2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,2/151,95/21728,0.1414301980041004,0.2722476705921937,0.20012901403844333,SLC2A3/LAMA5,2
REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT,REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT,2/151,95/21728,0.1414301980041004,0.2722476705921937,0.20012901403844333,YWHAZ/HUS1,2
BIOCARTA_ATRBRCA_PATHWAY,BIOCARTA_ATRBRCA_PATHWAY,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,HUS1,1
BIOCARTA_CASPASE_PATHWAY,BIOCARTA_CASPASE_PATHWAY,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,BIRC3,1
BIOCARTA_CREB_PATHWAY,BIOCARTA_CREB_PATHWAY,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,PRKAR1A,1
BIOCARTA_CSK_PATHWAY,BIOCARTA_CSK_PATHWAY,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,PRKAR1A,1
BIOCARTA_EDG1_PATHWAY,BIOCARTA_EDG1_PATHWAY,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,ITGB3,1
CAIRO_PML_TARGETS_BOUND_BY_MYC_UP,CAIRO_PML_TARGETS_BOUND_BY_MYC_UP,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,LDHA,1
DESERT_EXTRACELLULAR_MATRIX_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_EXTRACELLULAR_MATRIX_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,HSPA5,1
FERRARI_RESPONSE_TO_FENRETINIDE_UP,FERRARI_RESPONSE_TO_FENRETINIDE_UP,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,NRIP1,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN,GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,STBD1,1
GAVIN_PDE3B_TARGETS,GAVIN_PDE3B_TARGETS,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,LAMC1,1
HASLINGER_B_CLL_WITH_17P13_DELETION,HASLINGER_B_CLL_WITH_17P13_DELETION,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,VDAC1,1
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,HSPA8,1
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN,JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,CTNND1,1
KANNAN_TP53_TARGETS_DN,KANNAN_TP53_TARGETS_DN,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,BIRC3,1
KIM_LIVER_CANCER_POOR_SURVIVAL_UP,KIM_LIVER_CANCER_POOR_SURVIVAL_UP,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,IQGAP1,1
MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP,MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,HSPA4,1
OKAWA_NEUROBLASTOMA_1P36_31_DELETION,OKAWA_NEUROBLASTOMA_1P36_31_DELETION,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,ICMT,1
PID_PDGFRA_PATHWAY,PID_PDGFRA_PATHWAY,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,CRK,1
REACTOME_HS_GAG_DEGRADATION,REACTOME_HS_GAG_DEGRADATION,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,SDC4,1
REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1,REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,UBC,1
REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING,REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,PTPN12,1
SAGIV_CD24_TARGETS_UP,SAGIV_CD24_TARGETS_UP,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,EDEM3,1
TIAN_TNF_SIGNALING_NOT_VIA_NFKB,TIAN_TNF_SIGNALING_NOT_VIA_NFKB,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,PPP1R15A,1
WENG_POR_DOSAGE,WENG_POR_DOSAGE,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,ACTG1,1
WENG_POR_TARGETS_LIVER_DN,WENG_POR_TARGETS_LIVER_DN,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,SDC4,1
WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,NRIP1,1
WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,1/151,22/21728,0.1422979185384684,0.2722476705921937,0.20012901403844333,MAP2K3,1
XIE_ST_HSC_S1PR3_OE_UP,XIE_ST_HSC_S1PR3_OE_UP,3/151,188/21728,0.14312293258820438,0.27363765088095787,0.20115078727939764,MOXD1/PDLIM4/EPHA2,3
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP,2/151,96/21728,0.14381376907070734,0.27458051579273196,0.20184388641502785,APLP2/PERP,2
WP_G_PROTEIN_SIGNALING_PATHWAYS,WP_G_PROTEIN_SIGNALING_PATHWAYS,2/151,96/21728,0.14381376907070734,0.27458051579273196,0.20184388641502785,PRKAR1A/AKAP12,2
BROWNE_HCMV_INFECTION_14HR_DN,BROWNE_HCMV_INFECTION_14HR_DN,4/151,291/21728,0.14508490802540336,0.2768172214935237,0.20348808673314236,HSPA4/RASA2/MET/LDLR,4
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,2/151,97/21728,0.14620583963551187,0.27857326646601643,0.20477895378881888,PPP1R15A/SBNO2,2
REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,2/151,97/21728,0.14620583963551187,0.27857326646601643,0.20477895378881888,UBC/NCSTN,2
IVANOVA_HEMATOPOIESIS_STEM_CELL,IVANOVA_HEMATOPOIESIS_STEM_CELL,3/151,190/21728,0.14635524263339927,0.2786668019435114,0.2048477116329098,RPS6KA3/PKD2/DUSP5,3
REACTOME_METABOLISM_OF_CARBOHYDRATES,REACTOME_METABOLISM_OF_CARBOHYDRATES,4/151,293/21728,0.14763443431495724,0.2789378139066192,0.20504693227950485,UBC/PRPS2/GBE1/SDC4,4
BIOCARTA_GLEEVEC_PATHWAY,BIOCARTA_GLEEVEC_PATHWAY,1/151,23/21728,0.14826461043475003,0.2789378139066192,0.20504693227950485,JAK2,1
BIOCARTA_IGF1R_PATHWAY,BIOCARTA_IGF1R_PATHWAY,1/151,23/21728,0.14826461043475003,0.2789378139066192,0.20504693227950485,PRKAR1A,1
BIOCARTA_NTHI_PATHWAY,BIOCARTA_NTHI_PATHWAY,1/151,23/21728,0.14826461043475003,0.2789378139066192,0.20504693227950485,MAP2K3,1
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP,FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP,1/151,23/21728,0.14826461043475003,0.2789378139066192,0.20504693227950485,ATP6V1A,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN,1/151,23/21728,0.14826461043475003,0.2789378139066192,0.20504693227950485,PML,1
HASLINGER_B_CLL_WITH_11Q23_DELETION,HASLINGER_B_CLL_WITH_11Q23_DELETION,1/151,23/21728,0.14826461043475003,0.2789378139066192,0.20504693227950485,SLC4A7,1
KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION,KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION,1/151,23/21728,0.14826461043475003,0.2789378139066192,0.20504693227950485,ATP1A1,1
REACTOME_MITOCHONDRIAL_CALCIUM_ION_TRANSPORT,REACTOME_MITOCHONDRIAL_CALCIUM_ION_TRANSPORT,1/151,23/21728,0.14826461043475003,0.2789378139066192,0.20504693227950485,VDAC1,1
REACTOME_RESPONSE_OF_MTB_TO_PHAGOCYTOSIS,REACTOME_RESPONSE_OF_MTB_TO_PHAGOCYTOSIS,1/151,23/21728,0.14826461043475003,0.2789378139066192,0.20504693227950485,UBC,1
REACTOME_RHOBTB1_GTPASE_CYCLE,REACTOME_RHOBTB1_GTPASE_CYCLE,1/151,23/21728,0.14826461043475003,0.2789378139066192,0.20504693227950485,COPS2,1
REACTOME_RHOBTB2_GTPASE_CYCLE,REACTOME_RHOBTB2_GTPASE_CYCLE,1/151,23/21728,0.14826461043475003,0.2789378139066192,0.20504693227950485,ACTG1,1
REACTOME_SIGNALING_BY_NODAL,REACTOME_SIGNALING_BY_NODAL,1/151,23/21728,0.14826461043475003,0.2789378139066192,0.20504693227950485,FURIN,1
VERNELL_RETINOBLASTOMA_PATHWAY_DN,VERNELL_RETINOBLASTOMA_PATHWAY_DN,1/151,23/21728,0.14826461043475003,0.2789378139066192,0.20504693227950485,PPFIBP1,1
WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,1/151,23/21728,0.14826461043475003,0.2789378139066192,0.20504693227950485,JAK2,1
WU_HBX_TARGETS_2_UP,WU_HBX_TARGETS_2_UP,1/151,23/21728,0.14826461043475003,0.2789378139066192,0.20504693227950485,MAP2K3,1
ZIRN_TRETINOIN_RESPONSE_WT1_UP,ZIRN_TRETINOIN_RESPONSE_WT1_UP,1/151,23/21728,0.14826461043475003,0.2789378139066192,0.20504693227950485,AKAP12,1
IGARASHI_ATF4_TARGETS_DN,IGARASHI_ATF4_TARGETS_DN,2/151,98/21728,0.14860617875514628,0.2789378139066192,0.20504693227950485,TRIP12/RPS6KA3,2
QI_PLASMACYTOMA_DN,QI_PLASMACYTOMA_DN,2/151,98/21728,0.14860617875514628,0.2789378139066192,0.20504693227950485,CALU/PVR,2
REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,2/151,98/21728,0.14860617875514628,0.2789378139066192,0.20504693227950485,UBC/HUS1,2
TAKAO_RESPONSE_TO_UVB_RADIATION_DN,TAKAO_RESPONSE_TO_UVB_RADIATION_DN,2/151,98/21728,0.14860617875514628,0.2789378139066192,0.20504693227950485,CBFB/EIF4H,2
FOROUTAN_TGFB_EMT_UP,FOROUTAN_TGFB_EMT_UP,3/151,192/21728,0.1496114752542949,0.28044580179246376,0.20615545279730957,EML1/ITGB3/TPM1,3
KASLER_HDAC7_TARGETS_1_UP,KASLER_HDAC7_TARGETS_1_UP,3/151,192/21728,0.1496114752542949,0.28044580179246376,0.20615545279730957,PCYT1A/AKAP12/ITGB3,3
REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,4/151,295/21728,0.15020140857039604,0.2811721785771969,0.20668941170844682,CBFB/ESR2/NRIP1/PTGES3,4
WANG_SMARCE1_TARGETS_UP,WANG_SMARCE1_TARGETS_UP,4/151,295/21728,0.15020140857039604,0.2811721785771969,0.20668941170844682,NRIP1/PERP/ITGB3/BCAM,4
HAHTOLA_SEZARY_SYNDROM_UP,HAHTOLA_SEZARY_SYNDROM_UP,2/151,99/21728,0.15101455824603524,0.282313891525899,0.20752868385443674,IQGAP1/RECQL,2
LIU_PROSTATE_CANCER_UP,LIU_PROSTATE_CANCER_UP,2/151,99/21728,0.15101455824603524,0.282313891525899,0.20752868385443674,SEL1L/BCAM,2
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,5/151,405/21728,0.15218093771176228,0.2834811431420097,0.2083867294515171,HSP90B1/FNDC3B/IQGAP1/HSPA4/LRP12,5
YAGI_AML_FAB_MARKERS,YAGI_AML_FAB_MARKERS,3/151,194/21728,0.15289107637277619,0.2834811431420097,0.2083867294515171,ITGB3/TPM1/LAMA5,3
BENPORATH_ES_CORE_NINE_CORRELATED,BENPORATH_ES_CORE_NINE_CORRELATED,2/151,100/21728,0.15343075265762215,0.2834811431420097,0.2083867294515171,WWTR1/CBFB,2
REACTOME_UCH_PROTEINASES,REACTOME_UCH_PROTEINASES,2/151,100/21728,0.15343075265762215,0.2834811431420097,0.2083867294515171,UBC/ACTB,2
WINZEN_DEGRADED_VIA_KHSRP,WINZEN_DEGRADED_VIA_KHSRP,2/151,100/21728,0.15343075265762215,0.2834811431420097,0.2083867294515171,DUSP5/SDC4,2
BIOCARTA_STRESS_PATHWAY,BIOCARTA_STRESS_PATHWAY,1/151,24/21728,0.15419006741813412,0.2834811431420097,0.2083867294515171,MAP2K3,1
BIOCARTA_TPO_PATHWAY,BIOCARTA_TPO_PATHWAY,1/151,24/21728,0.15419006741813412,0.2834811431420097,0.2083867294515171,JAK2,1
BIOCARTA_VDR_PATHWAY,BIOCARTA_VDR_PATHWAY,1/151,24/21728,0.15419006741813412,0.2834811431420097,0.2083867294515171,COPS2,1
DAZARD_UV_RESPONSE_CLUSTER_G24,DAZARD_UV_RESPONSE_CLUSTER_G24,1/151,24/21728,0.15419006741813412,0.2834811431420097,0.2083867294515171,PDLIM4,1
HANSON_HRAS_SIGNALING_VIA_NFKB,HANSON_HRAS_SIGNALING_VIA_NFKB,1/151,24/21728,0.15419006741813412,0.2834811431420097,0.2083867294515171,PVR,1
HASLINGER_B_CLL_WITH_13Q14_DELETION,HASLINGER_B_CLL_WITH_13Q14_DELETION,1/151,24/21728,0.15419006741813412,0.2834811431420097,0.2083867294515171,LDLR,1
HORTON_SREBF_TARGETS,HORTON_SREBF_TARGETS,1/151,24/21728,0.15419006741813412,0.2834811431420097,0.2083867294515171,LDLR,1
KEGG_PROTEIN_EXPORT,KEGG_PROTEIN_EXPORT,1/151,24/21728,0.15419006741813412,0.2834811431420097,0.2083867294515171,HSPA5,1
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN,MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN,1/151,24/21728,0.15419006741813412,0.2834811431420097,0.2083867294515171,MET,1
OSADA_ASCL1_TARGETS_DN,OSADA_ASCL1_TARGETS_DN,1/151,24/21728,0.15419006741813412,0.2834811431420097,0.2083867294515171,BIRC3,1
REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B,REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B,1/151,24/21728,0.15419006741813412,0.2834811431420097,0.2083867294515171,UBC,1
REACTOME_DARPP_32_EVENTS,REACTOME_DARPP_32_EVENTS,1/151,24/21728,0.15419006741813412,0.2834811431420097,0.2083867294515171,PRKAR1A,1
REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING,REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING,1/151,24/21728,0.15419006741813412,0.2834811431420097,0.2083867294515171,JAK2,1
REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING,1/151,24/21728,0.15419006741813412,0.2834811431420097,0.2083867294515171,JAK2,1
REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING,REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING,1/151,24/21728,0.15419006741813412,0.2834811431420097,0.2083867294515171,MET,1
SA_B_CELL_RECEPTOR_COMPLEXES,SA_B_CELL_RECEPTOR_COMPLEXES,1/151,24/21728,0.15419006741813412,0.2834811431420097,0.2083867294515171,RPS6KA3,1
SHI_SPARC_TARGETS_UP,SHI_SPARC_TARGETS_UP,1/151,24/21728,0.15419006741813412,0.2834811431420097,0.2083867294515171,PPP1R15A,1
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN,WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN,1/151,24/21728,0.15419006741813412,0.2834811431420097,0.2083867294515171,NRIP1,1
WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,1/151,24/21728,0.15419006741813412,0.2834811431420097,0.2083867294515171,PCYT1A,1
WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,1/151,24/21728,0.15419006741813412,0.2834811431420097,0.2083867294515171,BECN1,1
KARLSSON_TGFB1_TARGETS_DN,KARLSSON_TGFB1_TARGETS_DN,3/151,195/21728,0.15453946716492467,0.28374794433850675,0.2085828547674219,WWTR1/MET/LAMA5,3
REACTOME_MUSCLE_CONTRACTION,REACTOME_MUSCLE_CONTRACTION,3/151,195/21728,0.15453946716492467,0.28374794433850675,0.2085828547674219,WWTR1/ATP1A1/TPM1,3
PUJANA_BREAST_CANCER_LIT_INT_NETWORK,PUJANA_BREAST_CANCER_LIT_INT_NETWORK,2/151,101/21728,0.15585453924583073,0.28578475909235496,0.21008011543297664,JAK2/MAP2K3,2
REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY,REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY,2/151,101/21728,0.15585453924583073,0.28578475909235496,0.21008011543297664,UBC/BIRC3,2
REACTOME_CELLULAR_SENESCENCE,REACTOME_CELLULAR_SENESCENCE,3/151,196/21728,0.1561934926485403,0.28621736317786606,0.21039812230118607,UBC/RPS6KA3/MAP2K3,3
REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT,REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT,2/151,102/21728,0.15828569794675826,0.28986003223209916,0.2130758449965035,KDELR1/TMEM115,2
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,5/151,412/21728,0.15990207051194458,0.29007642700583286,0.2132349165970656,ATP6V1C1/ATP13A3/APLP2/SLC2A3/PRDX1,5
BIOCARTA_BAD_PATHWAY,BIOCARTA_BAD_PATHWAY,1/151,25/21728,0.16007457257017343,0.29007642700583286,0.2132349165970656,PRKAR1A,1
BIOCARTA_TOLL_PATHWAY,BIOCARTA_TOLL_PATHWAY,1/151,25/21728,0.16007457257017343,0.29007642700583286,0.2132349165970656,MAP2K3,1
HOEGERKORP_CD44_TARGETS_TEMPORAL_DN,HOEGERKORP_CD44_TARGETS_TEMPORAL_DN,1/151,25/21728,0.16007457257017343,0.29007642700583286,0.2132349165970656,PAFAH2,1
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN,IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN,1/151,25/21728,0.16007457257017343,0.29007642700583286,0.2132349165970656,ACTB,1
OLSSON_E2F3_TARGETS_UP,OLSSON_E2F3_TARGETS_UP,1/151,25/21728,0.16007457257017343,0.29007642700583286,0.2132349165970656,TM9SF2,1
PID_LYMPH_ANGIOGENESIS_PATHWAY,PID_LYMPH_ANGIOGENESIS_PATHWAY,1/151,25/21728,0.16007457257017343,0.29007642700583286,0.2132349165970656,CRK,1
PID_MYC_PATHWAY,PID_MYC_PATHWAY,1/151,25/21728,0.16007457257017343,0.29007642700583286,0.2132349165970656,PML,1
REACTOME_DEFECTIVE_INTRINSIC_PATHWAY_FOR_APOPTOSIS,REACTOME_DEFECTIVE_INTRINSIC_PATHWAY_FOR_APOPTOSIS,1/151,25/21728,0.16007457257017343,0.29007642700583286,0.2132349165970656,PRDX1,1
REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER,REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER,1/151,25/21728,0.16007457257017343,0.29007642700583286,0.2132349165970656,UBC,1
REACTOME_GLUCURONIDATION,REACTOME_GLUCURONIDATION,1/151,25/21728,0.16007457257017343,0.29007642700583286,0.2132349165970656,SLC35D1,1
REACTOME_SIGNALING_BY_EGFR_IN_CANCER,REACTOME_SIGNALING_BY_EGFR_IN_CANCER,1/151,25/21728,0.16007457257017343,0.29007642700583286,0.2132349165970656,UBC,1
REACTOME_SIGNALING_BY_ERYTHROPOIETIN,REACTOME_SIGNALING_BY_ERYTHROPOIETIN,1/151,25/21728,0.16007457257017343,0.29007642700583286,0.2132349165970656,JAK2,1
VALK_AML_CLUSTER_8,VALK_AML_CLUSTER_8,1/151,25/21728,0.16007457257017343,0.29007642700583286,0.2132349165970656,BCAM,1
WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,1/151,25/21728,0.16007457257017343,0.29007642700583286,0.2132349165970656,DOLK,1
WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,1/151,25/21728,0.16007457257017343,0.29007642700583286,0.2132349165970656,MAP2K3,1
BASSO_CD40_SIGNALING_UP,BASSO_CD40_SIGNALING_UP,2/151,103/21728,0.16072401135060072,0.2908738133758754,0.21382107458951852,HSP90B1/TRIP10,2
REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,2/151,103/21728,0.16072401135060072,0.2908738133758754,0.21382107458951852,UBC/SEL1L,2
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,3/151,199/21728,0.1611886874548624,0.2915248527015675,0.2142996530033121,RPS6KA3/APLP2/PTPN14,3
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,3/151,200/21728,0.1628645623012733,0.2943641861242272,0.21638684440945807,WWTR1/HIVEP3/TPM1,3
WIERENGA_STAT5A_TARGETS_UP,WIERENGA_STAT5A_TARGETS_UP,3/151,201/21728,0.16454572754983213,0.2952731164398829,0.21705499825447042,FNDC3B/DUSP5/DIPK2A,3
REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,2/151,105/21728,0.16562124574346226,0.2952731164398829,0.21705499825447042,ESR2/MET,2
BIOCARTA_CARM_ER_PATHWAY,BIOCARTA_CARM_ER_PATHWAY,1/151,26/21728,0.16591840704199323,0.2952731164398829,0.21705499825447042,NRIP1,1
BIOCARTA_VIP_PATHWAY,BIOCARTA_VIP_PATHWAY,1/151,26/21728,0.16591840704199323,0.2952731164398829,0.21705499825447042,PRKAR1A,1
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP,CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP,1/151,26/21728,0.16591840704199323,0.2952731164398829,0.21705499825447042,MOXD1,1
DALESSIO_TSA_RESPONSE,DALESSIO_TSA_RESPONSE,1/151,26/21728,0.16591840704199323,0.2952731164398829,0.21705499825447042,PPP1R15A,1
GROSS_HIF1A_TARGETS_DN,GROSS_HIF1A_TARGETS_DN,1/151,26/21728,0.16591840704199323,0.2952731164398829,0.21705499825447042,GBE1,1
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN,GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN,1/151,26/21728,0.16591840704199323,0.2952731164398829,0.21705499825447042,MET,1
HAHTOLA_CTCL_CUTANEOUS,HAHTOLA_CTCL_CUTANEOUS,1/151,26/21728,0.16591840704199323,0.2952731164398829,0.21705499825447042,RECQL,1
NOJIMA_SFRP2_TARGETS_DN,NOJIMA_SFRP2_TARGETS_DN,1/151,26/21728,0.16591840704199323,0.2952731164398829,0.21705499825447042,MET,1
PID_IL27_PATHWAY,PID_IL27_PATHWAY,1/151,26/21728,0.16591840704199323,0.2952731164398829,0.21705499825447042,JAK2,1
PID_INTEGRIN_CS_PATHWAY,PID_INTEGRIN_CS_PATHWAY,1/151,26/21728,0.16591840704199323,0.2952731164398829,0.21705499825447042,ITGB3,1
PID_P38_MKK3_6PATHWAY,PID_P38_MKK3_6PATHWAY,1/151,26/21728,0.16591840704199323,0.2952731164398829,0.21705499825447042,MAP2K3,1
REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS,REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS,1/151,26/21728,0.16591840704199323,0.2952731164398829,0.21705499825447042,SDC4,1
REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A,REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A,1/151,26/21728,0.16591840704199323,0.2952731164398829,0.21705499825447042,UBC,1
REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING,1/151,26/21728,0.16591840704199323,0.2952731164398829,0.21705499825447042,JAK2,1
REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI,REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI,1/151,26/21728,0.16591840704199323,0.2952731164398829,0.21705499825447042,MGAT4B,1
REACTOME_SIGNALING_BY_ERBB2_IN_CANCER,REACTOME_SIGNALING_BY_ERBB2_IN_CANCER,1/151,26/21728,0.16591840704199323,0.2952731164398829,0.21705499825447042,PTPN12,1
SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP,SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP,1/151,26/21728,0.16591840704199323,0.2952731164398829,0.21705499825447042,LDLR,1
TERAMOTO_OPN_TARGETS_CLUSTER_6,TERAMOTO_OPN_TARGETS_CLUSTER_6,1/151,26/21728,0.16591840704199323,0.2952731164398829,0.21705499825447042,ACTN4,1
TIAN_TNF_SIGNALING_VIA_NFKB,TIAN_TNF_SIGNALING_VIA_NFKB,1/151,26/21728,0.16591840704199323,0.2952731164398829,0.21705499825447042,SDC4,1
WEINMANN_ADAPTATION_TO_HYPOXIA_UP,WEINMANN_ADAPTATION_TO_HYPOXIA_UP,1/151,26/21728,0.16591840704199323,0.2952731164398829,0.21705499825447042,TPM1,1
WP_EPO_RECEPTOR_SIGNALING,WP_EPO_RECEPTOR_SIGNALING,1/151,26/21728,0.16591840704199323,0.2952731164398829,0.21705499825447042,JAK2,1
WP_GLUCURONIDATION,WP_GLUCURONIDATION,1/151,26/21728,0.16591840704199323,0.2952731164398829,0.21705499825447042,PGM3,1
HOLLMANN_APOPTOSIS_VIA_CD40_UP,HOLLMANN_APOPTOSIS_VIA_CD40_UP,3/151,203/21728,0.16792365500156356,0.2981644517728907,0.21918041621742562,COPS2/SNX19/FLII,3
BROWNE_HCMV_INFECTION_8HR_UP,BROWNE_HCMV_INFECTION_8HR_UP,2/151,106/21728,0.1680797449518887,0.2981644517728907,0.21918041621742562,EFNB2/SEC24A,2
REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,2/151,106/21728,0.1680797449518887,0.2981644517728907,0.21918041621742562,UBC/PDIA3,2
REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,2/151,106/21728,0.1680797449518887,0.2981644517728907,0.21918041621742562,SLC4A7/SLC12A4,2
WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY,WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY,2/151,106/21728,0.1680797449518887,0.2981644517728907,0.21918041621742562,CTNND1/LDLR,2
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,2/151,107/21728,0.1705445552514819,0.30097369052816725,0.2212454850610604,AKAP12/NRIP1,2
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP,JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP,2/151,107/21728,0.1705445552514819,0.30097369052816725,0.2212454850610604,ACTB/PGRMC2,2
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,2/151,107/21728,0.1705445552514819,0.30097369052816725,0.2212454850610604,PERP/TPM1,2
REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,3/151,205/21728,0.1713219223787552,0.30097369052816725,0.2212454850610604,PRKAR1A/RPS6KA3/PRKAG1,3
AKL_HTLV1_INFECTION_UP,AKL_HTLV1_INFECTION_UP,1/151,27/21728,0.17172185006736684,0.30097369052816725,0.2212454850610604,CTNNA1,1
BIOCARTA_GH_PATHWAY,BIOCARTA_GH_PATHWAY,1/151,27/21728,0.17172185006736684,0.30097369052816725,0.2212454850610604,JAK2,1
BIOCARTA_PYK2_PATHWAY,BIOCARTA_PYK2_PATHWAY,1/151,27/21728,0.17172185006736684,0.30097369052816725,0.2212454850610604,MAP2K3,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP,1/151,27/21728,0.17172185006736684,0.30097369052816725,0.2212454850610604,NUS1,1
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP,HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP,1/151,27/21728,0.17172185006736684,0.30097369052816725,0.2212454850610604,CALU,1
KEGG_PENTOSE_PHOSPHATE_PATHWAY,KEGG_PENTOSE_PHOSPHATE_PATHWAY,1/151,27/21728,0.17172185006736684,0.30097369052816725,0.2212454850610604,PRPS2,1
REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION,REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION,1/151,27/21728,0.17172185006736684,0.30097369052816725,0.2212454850610604,NPAS2,1
REACTOME_INFECTION_WITH_MYCOBACTERIUM_TUBERCULOSIS,REACTOME_INFECTION_WITH_MYCOBACTERIUM_TUBERCULOSIS,1/151,27/21728,0.17172185006736684,0.30097369052816725,0.2212454850610604,UBC,1
REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING,REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING,1/151,27/21728,0.17172185006736684,0.30097369052816725,0.2212454850610604,JAK2,1
SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP,SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP,1/151,27/21728,0.17172185006736684,0.30097369052816725,0.2212454850610604,ITGB3,1
SHIN_B_CELL_LYMPHOMA_CLUSTER_7,SHIN_B_CELL_LYMPHOMA_CLUSTER_7,1/151,27/21728,0.17172185006736684,0.30097369052816725,0.2212454850610604,PML,1
VALK_AML_CLUSTER_7,VALK_AML_CLUSTER_7,1/151,27/21728,0.17172185006736684,0.30097369052816725,0.2212454850610604,TPM1,1
WESTON_VEGFA_TARGETS_12HR,WESTON_VEGFA_TARGETS_12HR,1/151,27/21728,0.17172185006736684,0.30097369052816725,0.2212454850610604,SDC4,1
WP_MTHFR_DEFICIENCY,WP_MTHFR_DEFICIENCY,1/151,27/21728,0.17172185006736684,0.30097369052816725,0.2212454850610604,PCYT1A,1
XU_AKT1_TARGETS_6HR,XU_AKT1_TARGETS_6HR,1/151,27/21728,0.17172185006736684,0.30097369052816725,0.2212454850610604,PRKAR1A,1
BOUDOUKHA_BOUND_BY_IGF2BP2,BOUDOUKHA_BOUND_BY_IGF2BP2,2/151,108/21728,0.17301547211975896,0.30266812440093854,0.2224910618535943,IQGAP1/PTPN12,2
FOROUTAN_TGFB_EMT_DN,FOROUTAN_TGFB_EMT_DN,2/151,108/21728,0.17301547211975896,0.30266812440093854,0.2224910618535943,BIRC3/LAMA5,2
REACTOME_INTEGRATION_OF_ENERGY_METABOLISM,REACTOME_INTEGRATION_OF_ENERGY_METABOLISM,2/151,108/21728,0.17301547211975896,0.30266812440093854,0.2224910618535943,PRKAR1A/IQGAP1,2
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,3/151,207/21728,0.17473998409369748,0.3054925587239091,0.22456730094516453,RARS1/HSPA4/BIRC3,3
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,2/151,109/21728,0.17549229353663176,0.3066148373866434,0.22539228696528674,IQGAP1/HSPA4,2
LI_INDUCED_T_TO_NATURAL_KILLER_UP,LI_INDUCED_T_TO_NATURAL_KILLER_UP,4/151,315/21728,0.17677585696998735,0.30662551442444375,0.2254001356460236,DUSP5/LRP12/CTNNA1/FURIN,4
BIOCARTA_NO1_PATHWAY,BIOCARTA_NO1_PATHWAY,1/151,28/21728,0.17748517897570393,0.30662551442444375,0.2254001356460236,PRKAR1A,1
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN,COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN,1/151,28/21728,0.17748517897570393,0.30662551442444375,0.2254001356460236,CSNK1A1,1
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP,DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP,1/151,28/21728,0.17748517897570393,0.30662551442444375,0.2254001356460236,EFNB2,1
DORN_ADENOVIRUS_INFECTION_12HR_UP,DORN_ADENOVIRUS_INFECTION_12HR_UP,1/151,28/21728,0.17748517897570393,0.30662551442444375,0.2254001356460236,EPHA2,1
LEE_DOUBLE_POLAR_THYMOCYTE,LEE_DOUBLE_POLAR_THYMOCYTE,1/151,28/21728,0.17748517897570393,0.30662551442444375,0.2254001356460236,EFNB2,1
LOPES_METHYLATED_IN_COLON_CANCER_UP,LOPES_METHYLATED_IN_COLON_CANCER_UP,1/151,28/21728,0.17748517897570393,0.30662551442444375,0.2254001356460236,ESR2,1
LUI_THYROID_CANCER_CLUSTER_3,LUI_THYROID_CANCER_CLUSTER_3,1/151,28/21728,0.17748517897570393,0.30662551442444375,0.2254001356460236,HSPA8,1
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN,MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN,1/151,28/21728,0.17748517897570393,0.30662551442444375,0.2254001356460236,ACTB,1
PID_LIS1_PATHWAY,PID_LIS1_PATHWAY,1/151,28/21728,0.17748517897570393,0.30662551442444375,0.2254001356460236,IQGAP1,1
PLASARI_NFIC_TARGETS_BASAL_UP,PLASARI_NFIC_TARGETS_BASAL_UP,1/151,28/21728,0.17748517897570393,0.30662551442444375,0.2254001356460236,PERP,1
REACTOME_BUDDING_AND_MATURATION_OF_HIV_VIRION,REACTOME_BUDDING_AND_MATURATION_OF_HIV_VIRION,1/151,28/21728,0.17748517897570393,0.30662551442444375,0.2254001356460236,UBC,1
REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING,REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING,1/151,28/21728,0.17748517897570393,0.30662551442444375,0.2254001356460236,RPS6KA3,1
REACTOME_FLT3_SIGNALING_IN_DISEASE,REACTOME_FLT3_SIGNALING_IN_DISEASE,1/151,28/21728,0.17748517897570393,0.30662551442444375,0.2254001356460236,UBC,1
REACTOME_SYNTHESIS_OF_PC,REACTOME_SYNTHESIS_OF_PC,1/151,28/21728,0.17748517897570393,0.30662551442444375,0.2254001356460236,PCYT1A,1
SHIN_B_CELL_LYMPHOMA_CLUSTER_3,SHIN_B_CELL_LYMPHOMA_CLUSTER_3,1/151,28/21728,0.17748517897570393,0.30662551442444375,0.2254001356460236,JAK2,1
WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,1/151,28/21728,0.17748517897570393,0.30662551442444375,0.2254001356460236,PRKAG1,1
WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,1/151,28/21728,0.17748517897570393,0.30662551442444375,0.2254001356460236,PVR,1
REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP,REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP,2/151,110/21728,0.17797481995989453,0.30708947195564407,0.22574119040352758,UBC/RPS6KA3,2
SUNG_METASTASIS_STROMA_UP,SUNG_METASTASIS_STROMA_UP,2/151,110/21728,0.17797481995989453,0.30708947195564407,0.22574119040352758,FURIN/SDC4,2
MARKEY_RB1_CHRONIC_LOF_UP,MARKEY_RB1_CHRONIC_LOF_UP,2/151,112/21728,0.1829562019006331,0.3109063427314325,0.22854696862528098,CBFB/PML,2
ROPERO_HDAC2_TARGETS,ROPERO_HDAC2_TARGETS,2/151,112/21728,0.1829562019006331,0.3109063427314325,0.22854696862528098,SEL1L/EPHA2,2
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,2/151,112/21728,0.1829562019006331,0.3109063427314325,0.22854696862528098,FNDC3B/ATP1A1,2
ABE_VEGFA_TARGETS_30MIN,ABE_VEGFA_TARGETS_30MIN,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,DUSP5,1
BIOCARTA_BIOPEPTIDES_PATHWAY,BIOCARTA_BIOPEPTIDES_PATHWAY,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,JAK2,1
BIOCARTA_DEATH_PATHWAY,BIOCARTA_DEATH_PATHWAY,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,BIRC3,1
GENTLES_LEUKEMIC_STEM_CELL_UP,GENTLES_LEUKEMIC_STEM_CELL_UP,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,BIRC3,1
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP,HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,ATP6V1A,1
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN,HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,HSPA4,1
KRIGE_AMINO_ACID_DEPRIVATION,KRIGE_AMINO_ACID_DEPRIVATION,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,PPP1R15A,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,CTNND1,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,LOXL1,1
REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS,REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,PRKAG1,1
REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION,REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,CRK,1
REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK,REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,PRKAG1,1
REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE,REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,EPHA2,1
REACTOME_MATURATION_OF_SARS_COV_2_SPIKE_PROTEIN,REACTOME_MATURATION_OF_SARS_COV_2_SPIKE_PROTEIN,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,MGAT4B,1
REACTOME_MYOGENESIS,REACTOME_MYOGENESIS,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,CTNNA1,1
REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING,REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,UBC,1
REACTOME_TRANSLATION_OF_SARS_COV_1_STRUCTURAL_PROTEINS,REACTOME_TRANSLATION_OF_SARS_COV_1_STRUCTURAL_PROTEINS,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,UBC,1
STANELLE_E2F1_TARGETS,STANELLE_E2F1_TARGETS,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,HSP90B1,1
VALK_AML_CLUSTER_1,VALK_AML_CLUSTER_1,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,SLC2A3,1
WP_CANNABINOID_RECEPTOR_SIGNALING,WP_CANNABINOID_RECEPTOR_SIGNALING,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,PRKAR1A,1
WP_PDGFRBETA_PATHWAY,WP_PDGFRBETA_PATHWAY,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,JAK2,1
WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,CSNK1A1,1
XIE_LT_HSC_S1PR3_OE_UP,XIE_LT_HSC_S1PR3_OE_UP,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,AKAP12,1
YANAGIHARA_ESX1_TARGETS,YANAGIHARA_ESX1_TARGETS,1/151,29/21728,0.18320866920495138,0.3109063427314325,0.22854696862528098,ACTR2,1
MCBRYAN_PUBERTAL_BREAST_3_4WK_UP,MCBRYAN_PUBERTAL_BREAST_3_4WK_UP,3/151,212/21728,0.183368176885454,0.3109870545713011,0.2286062998250632,PTPN14/PERP/COPS2,3
CAIRO_HEPATOBLASTOMA_UP,CAIRO_HEPATOBLASTOMA_UP,3/151,213/21728,0.1851075107187824,0.31374537204196307,0.23063393647887853,LAMC1/ZBTB38/BCAM,3
KEGG_OOCYTE_MEIOSIS,KEGG_OOCYTE_MEIOSIS,2/151,113/21728,0.18545467050553477,0.3137594851792787,0.23064431103323124,YWHAZ/RPS6KA3,2
REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,2/151,113/21728,0.18545467050553477,0.3137594851792787,0.23064431103323124,ESR2/MET,2
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN,2/151,113/21728,0.18545467050553477,0.3137594851792787,0.23064431103323124,NRBF2/PERP,2
BAE_BRCA1_TARGETS_DN,BAE_BRCA1_TARGETS_DN,1/151,30/21728,0.18889259431440608,0.31649193426141137,0.23265293185826155,LAMC1,1
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,1/151,30/21728,0.18889259431440608,0.31649193426141137,0.23265293185826155,ACTN4,1
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN,CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN,1/151,30/21728,0.18889259431440608,0.31649193426141137,0.23265293185826155,MCFD2,1
DIRMEIER_LMP1_RESPONSE_LATE_DN,DIRMEIER_LMP1_RESPONSE_LATE_DN,1/151,30/21728,0.18889259431440608,0.31649193426141137,0.23265293185826155,UBC,1
MARSON_FOXP3_TARGETS_STIMULATED_UP,MARSON_FOXP3_TARGETS_STIMULATED_UP,1/151,30/21728,0.18889259431440608,0.31649193426141137,0.23265293185826155,JAK2,1
PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION,PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION,1/151,30/21728,0.18889259431440608,0.31649193426141137,0.23265293185826155,PKN1,1
PID_RAS_PATHWAY,PID_RAS_PATHWAY,1/151,30/21728,0.18889259431440608,0.31649193426141137,0.23265293185826155,RASA2,1
PID_RETINOIC_ACID_PATHWAY,PID_RETINOIC_ACID_PATHWAY,1/151,30/21728,0.18889259431440608,0.31649193426141137,0.23265293185826155,NRIP1,1
REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS,REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS,1/151,30/21728,0.18889259431440608,0.31649193426141137,0.23265293185826155,YWHAZ,1
REACTOME_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX,REACTOME_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX,1/151,30/21728,0.18889259431440608,0.31649193426141137,0.23265293185826155,UBC,1
REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION,1/151,30/21728,0.18889259431440608,0.31649193426141137,0.23265293185826155,PML,1
REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES,REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES,1/151,30/21728,0.18889259431440608,0.31649193426141137,0.23265293185826155,UBC,1
SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN,SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN,1/151,30/21728,0.18889259431440608,0.31649193426141137,0.23265293185826155,ETF1,1
VALK_AML_CLUSTER_4,VALK_AML_CLUSTER_4,1/151,30/21728,0.18889259431440608,0.31649193426141137,0.23265293185826155,CTNNA1,1
WANG_RESPONSE_TO_BEXAROTENE_DN,WANG_RESPONSE_TO_BEXAROTENE_DN,1/151,30/21728,0.18889259431440608,0.31649193426141137,0.23265293185826155,PCYT1A,1
WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,1/151,30/21728,0.18889259431440608,0.31649193426141137,0.23265293185826155,MET,1
DAZARD_RESPONSE_TO_UV_SCC_DN,DAZARD_RESPONSE_TO_UV_SCC_DN,2/151,115/21728,0.19046621360354596,0.31893619131443685,0.23444970298586923,ATP13A3/PGRMC2,2
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,2/151,116/21728,0.19297891540606288,0.31996708929597134,0.2352075151506894,SLC2A3/BCAM,2
BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,2/151,116/21728,0.19297891540606288,0.31996708929597134,0.2352075151506894,EDEM3/EPHB4,2
BOQUEST_STEM_CELL_DN,BOQUEST_STEM_CELL_DN,3/151,218/21728,0.19386897251971688,0.31996708929597134,0.2352075151506894,MET/EFNB2/EPHB4,3
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN,BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,PPP1R15A,1
BILANGES_SERUM_SENSITIVE_VIA_TSC2,BILANGES_SERUM_SENSITIVE_VIA_TSC2,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,ATP1A1,1
BIOCARTA_IL1R_PATHWAY,BIOCARTA_IL1R_PATHWAY,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,MAP2K3,1
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN,BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,NRIP1,1
BURTON_ADIPOGENESIS_10,BURTON_ADIPOGENESIS_10,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,ATP6V1C1,1
DANG_MYC_TARGETS_DN,DANG_MYC_TARGETS_DN,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,LAMC1,1
DASU_IL6_SIGNALING_SCAR_UP,DASU_IL6_SIGNALING_SCAR_UP,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,MOXD1,1
HUNSBERGER_EXERCISE_REGULATED_GENES,HUNSBERGER_EXERCISE_REGULATED_GENES,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,LDHA,1
KIM_TIAL1_TARGETS,KIM_TIAL1_TARGETS,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,LAMA5,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,CTNND1,1
MOOTHA_GLUCONEOGENESIS,MOOTHA_GLUCONEOGENESIS,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,LDHA,1
PID_AVB3_OPN_PATHWAY,PID_AVB3_OPN_PATHWAY,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,ITGB3,1
PID_CD40_PATHWAY,PID_CD40_PATHWAY,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,BIRC3,1
REACTOME_CRISTAE_FORMATION,REACTOME_CRISTAE_FORMATION,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,HSPA9,1
REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE,REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,CSNK1A1,1
REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT,REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,UBC,1
REACTOME_HS_GAG_BIOSYNTHESIS,REACTOME_HS_GAG_BIOSYNTHESIS,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,SDC4,1
REACTOME_HSF1_ACTIVATION,REACTOME_HSF1_ACTIVATION,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,PTGES3,1
REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING,REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,UBC,1
SHIN_B_CELL_LYMPHOMA_CLUSTER_2,SHIN_B_CELL_LYMPHOMA_CLUSTER_2,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,NCSTN,1
SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN,SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,PRKAR1A,1
TSENG_ADIPOGENIC_POTENTIAL_UP,TSENG_ADIPOGENIC_POTENTIAL_UP,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,EFNB2,1
URS_ADIPOCYTE_DIFFERENTIATION_DN,URS_ADIPOCYTE_DIFFERENTIATION_DN,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,LOXL1,1
VALK_AML_CLUSTER_15,VALK_AML_CLUSTER_15,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,CTNNA1,1
WP_BASE_EXCISION_REPAIR,WP_BASE_EXCISION_REPAIR,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,PNKP,1
WP_CELL_MIGRATION_AND_INVASION_THROUGH_P75NTR,WP_CELL_MIGRATION_AND_INVASION_THROUGH_P75NTR,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,EFNB2,1
WP_FAMILIAL_PARTIAL_LIPODYSTROPHY_FPLD,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY_FPLD,1/151,31/21728,0.1945372259974426,0.31996708929597134,0.2352075151506894,ICMT,1
REACTOME_SIGNALING_BY_WNT,REACTOME_SIGNALING_BY_WNT,4/151,329/21728,0.1962655577371988,0.32261876887215285,0.2371567623856529,UBC/YWHAZ/CSNK1A1/CLTC,4
BURTON_ADIPOGENESIS_5,BURTON_ADIPOGENESIS_5,2/151,118/21728,0.19801726516836002,0.3245380310546927,0.23856761026338671,PDIA6/NRIP1,2
DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2,DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2,2/151,118/21728,0.19801726516836002,0.3245380310546927,0.23856761026338671,APLP2/TPM1,2
FOROUTAN_INTEGRATED_TGFB_EMT_UP,FOROUTAN_INTEGRATED_TGFB_EMT_UP,2/151,118/21728,0.19801726516836002,0.3245380310546927,0.23856761026338671,ITGB3/TPM1,2
PUJANA_BRCA_CENTERED_NETWORK,PUJANA_BRCA_CENTERED_NETWORK,2/151,118/21728,0.19801726516836002,0.3245380310546927,0.23856761026338671,ZNF330/RECQL,2
REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING,REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING,2/151,118/21728,0.19801726516836002,0.3245380310546927,0.23856761026338671,SEL1L/FURIN,2
RATTENBACHER_BOUND_BY_CELF1,RATTENBACHER_BOUND_BY_CELF1,5/151,445/21728,0.19831820824865168,0.32457489381994387,0.2385947080484601,SSR1/ATP6V1C1/FNDC3B/APLP2/HUS1,5
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN,1/151,32/21728,0.20014283409415545,0.32457489381994387,0.2385947080484601,LOXL1,1
CAFFAREL_RESPONSE_TO_THC_DN,CAFFAREL_RESPONSE_TO_THC_DN,1/151,32/21728,0.20014283409415545,0.32457489381994387,0.2385947080484601,HSPA8,1
DORSAM_HOXA9_TARGETS_DN,DORSAM_HOXA9_TARGETS_DN,1/151,32/21728,0.20014283409415545,0.32457489381994387,0.2385947080484601,SDC4,1
LI_PROSTATE_CANCER_EPIGENETIC,LI_PROSTATE_CANCER_EPIGENETIC,1/151,32/21728,0.20014283409415545,0.32457489381994387,0.2385947080484601,ESR2,1
LIU_BREAST_CANCER,LIU_BREAST_CANCER,1/151,32/21728,0.20014283409415545,0.32457489381994387,0.2385947080484601,PCYT1A,1
MAYBURD_RESPONSE_TO_L663536_UP,MAYBURD_RESPONSE_TO_L663536_UP,1/151,32/21728,0.20014283409415545,0.32457489381994387,0.2385947080484601,GARS1,1
MODY_HIPPOCAMPUS_NEONATAL,MODY_HIPPOCAMPUS_NEONATAL,1/151,32/21728,0.20014283409415545,0.32457489381994387,0.2385947080484601,ACTG1,1
PID_NETRIN_PATHWAY,PID_NETRIN_PATHWAY,1/151,32/21728,0.20014283409415545,0.32457489381994387,0.2385947080484601,UNC5C,1
PID_SYNDECAN_4_PATHWAY,PID_SYNDECAN_4_PATHWAY,1/151,32/21728,0.20014283409415545,0.32457489381994387,0.2385947080484601,SDC4,1
PID_WNT_NONCANONICAL_PATHWAY,PID_WNT_NONCANONICAL_PATHWAY,1/151,32/21728,0.20014283409415545,0.32457489381994387,0.2385947080484601,CSNK1A1,1
REACTOME_NUCLEAR_SIGNALING_BY_ERBB4,REACTOME_NUCLEAR_SIGNALING_BY_ERBB4,1/151,32/21728,0.20014283409415545,0.32457489381994387,0.2385947080484601,NCSTN,1
REACTOME_PERK_REGULATES_GENE_EXPRESSION,REACTOME_PERK_REGULATES_GENE_EXPRESSION,1/151,32/21728,0.20014283409415545,0.32457489381994387,0.2385947080484601,HSPA5,1
REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX,REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX,1/151,32/21728,0.20014283409415545,0.32457489381994387,0.2385947080484601,UBC,1
REACTOME_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS,REACTOME_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS,1/151,32/21728,0.20014283409415545,0.32457489381994387,0.2385947080484601,UBC,1
STAEGE_EWING_FAMILY_TUMOR,STAEGE_EWING_FAMILY_TUMOR,1/151,32/21728,0.20014283409415545,0.32457489381994387,0.2385947080484601,PCDH8,1
WP_IL17_SIGNALING_PATHWAY,WP_IL17_SIGNALING_PATHWAY,1/151,32/21728,0.20014283409415545,0.32457489381994387,0.2385947080484601,JAK2,1
WP_MONOAMINE_TRANSPORT,WP_MONOAMINE_TRANSPORT,1/151,32/21728,0.20014283409415545,0.32457489381994387,0.2385947080484601,ITGB3,1
ZHU_CMV_ALL_DN,ZHU_CMV_ALL_DN,2/151,119/21728,0.2005425542430349,0.32503338138106824,0.23893174183595636,ACTG1/CD151,2
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,3/151,222/21728,0.20095191335776402,0.325506947701381,0.23927986000556223,EDEM3/BIRC3/PPP1R15A,3
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,3/151,223/21728,0.2027323461274882,0.3274851056651464,0.24073400211829185,BIRC3/MAP2K3/SDC4,3
DAZARD_RESPONSE_TO_UV_NHEK_UP,DAZARD_RESPONSE_TO_UV_NHEK_UP,3/151,224/21728,0.20451652736995388,0.3274851056651464,0.24073400211829185,API5/PPP1R15A/ZNF330,3
VANTVEER_BREAST_CANCER_ESR1_DN,VANTVEER_BREAST_CANCER_ESR1_DN,3/151,224/21728,0.20451652736995388,0.3274851056651464,0.24073400211829185,PDIA6/FNDC3B/EPHA2,3
WONG_EMBRYONIC_STEM_CELL_CORE,WONG_EMBRYONIC_STEM_CELL_CORE,4/151,335/21728,0.2048160892171385,0.3274851056651464,0.24073400211829185,HSPA9/PRDX1/CTNNA1/GARS1,4
KEGG_LYSOSOME,KEGG_LYSOSOME,2/151,121/21728,0.2056044804333296,0.3274851056651464,0.24073400211829185,CLTC/SORT1,2
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,2/151,121/21728,0.2056044804333296,0.3274851056651464,0.24073400211829185,CALU/SDC4,2
AMIT_SERUM_RESPONSE_40_MCF10A,AMIT_SERUM_RESPONSE_40_MCF10A,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,PVR,1
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP,BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,PRKAG1,1
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN,BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,SEC24A,1
BURTON_ADIPOGENESIS_12,BURTON_ADIPOGENESIS_12,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,DIPK2A,1
CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN,CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,TPM1,1
DORN_ADENOVIRUS_INFECTION_12HR_DN,DORN_ADENOVIRUS_INFECTION_12HR_DN,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,MAP2K3,1
DUTTA_APOPTOSIS_VIA_NFKB,DUTTA_APOPTOSIS_VIA_NFKB,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,BIRC3,1
FRIDMAN_IMMORTALIZATION_DN,FRIDMAN_IMMORTALIZATION_DN,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,MAP2K3,1
GROSS_ELK3_TARGETS_DN,GROSS_ELK3_TARGETS_DN,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,GBE1,1
JEPSEN_SMRT_TARGETS,JEPSEN_SMRT_TARGETS,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,PDLIM4,1
KEGG_ETHER_LIPID_METABOLISM,KEGG_ETHER_LIPID_METABOLISM,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,PAFAH2,1
KEGG_PROPANOATE_METABOLISM,KEGG_PROPANOATE_METABOLISM,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,LDHA,1
LIEN_BREAST_CARCINOMA_METAPLASTIC,LIEN_BREAST_CARCINOMA_METAPLASTIC,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,PKD2,1
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN,MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,SDC4,1
PID_EPO_PATHWAY,PID_EPO_PATHWAY,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,JAK2,1
REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES,REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,FURIN,1
REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING,REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,ACTB,1
REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION,REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,PRKAR1A,1
REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING,REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,UBC,1
SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY,SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,SEPTIN11,1
WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_PART_2_OF_3,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_PART_2_OF_3,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,LAMA5,1
WP_PREGNANE_X_RECEPTOR_PATHWAY,WP_PREGNANE_X_RECEPTOR_PATHWAY,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,NRIP1,1
WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,LDLR,1
WP_WHITE_FAT_CELL_DIFFERENTIATION,WP_WHITE_FAT_CELL_DIFFERENTIATION,1/151,33/21728,0.20570968660391664,0.3274851056651464,0.24073400211829185,CTNNA1,1
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,5/151,453/21728,0.20808327721841427,0.331074080247855,0.24337225405662488,PDIA6/HSPA5/NRIP1/LRP12/SORT1,5
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,4/151,339/21728,0.21057713501034075,0.33285269543994217,0.24467971246011436,AKAP12/BIRC3/PPP1R15A/PML,4
BIOCARTA_FMLP_PATHWAY,BIOCARTA_FMLP_PATHWAY,1/151,34/21728,0.21123804969784665,0.33285269543994217,0.24467971246011436,MAP2K3,1
KEGG_CYSTEINE_AND_METHIONINE_METABOLISM,KEGG_CYSTEINE_AND_METHIONINE_METABOLISM,1/151,34/21728,0.21123804969784665,0.33285269543994217,0.24467971246011436,LDHA,1
MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3,MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3,1/151,34/21728,0.21123804969784665,0.33285269543994217,0.24467971246011436,ESR2,1
PID_HIF2PATHWAY,PID_HIF2PATHWAY,1/151,34/21728,0.21123804969784665,0.33285269543994217,0.24467971246011436,EGLN1,1
PID_MAPK_TRK_PATHWAY,PID_MAPK_TRK_PATHWAY,1/151,34/21728,0.21123804969784665,0.33285269543994217,0.24467971246011436,MAP2K3,1
REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES,REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES,1/151,34/21728,0.21123804969784665,0.33285269543994217,0.24467971246011436,SLC35D1,1
REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING,REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING,1/151,34/21728,0.21123804969784665,0.33285269543994217,0.24467971246011436,UBC,1
REACTOME_PLASMA_LIPOPROTEIN_REMODELING,REACTOME_PLASMA_LIPOPROTEIN_REMODELING,1/151,34/21728,0.21123804969784665,0.33285269543994217,0.24467971246011436,FURIN,1
REACTOME_SIGNALING_BY_WNT_IN_CANCER,REACTOME_SIGNALING_BY_WNT_IN_CANCER,1/151,34/21728,0.21123804969784665,0.33285269543994217,0.24467971246011436,CSNK1A1,1
REACTOME_THE_PHOTOTRANSDUCTION_CASCADE,REACTOME_THE_PHOTOTRANSDUCTION_CASCADE,1/151,34/21728,0.21123804969784665,0.33285269543994217,0.24467971246011436,FNTB,1
SCHOEN_NFKB_SIGNALING,SCHOEN_NFKB_SIGNALING,1/151,34/21728,0.21123804969784665,0.33285269543994217,0.24467971246011436,BIRC3,1
WANG_RESPONSE_TO_BEXAROTENE_UP,WANG_RESPONSE_TO_BEXAROTENE_UP,1/151,34/21728,0.21123804969784665,0.33285269543994217,0.24467971246011436,RASA2,1
WP_16P112_DISTAL_DELETION_SYNDROME,WP_16P112_DISTAL_DELETION_SYNDROME,1/151,34/21728,0.21123804969784665,0.33285269543994217,0.24467971246011436,JAK2,1
WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,1/151,34/21728,0.21123804969784665,0.33285269543994217,0.24467971246011436,PERP,1
WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,1/151,34/21728,0.21123804969784665,0.33285269543994217,0.24467971246011436,MAP2K3,1
ZWANG_EGF_PERSISTENTLY_UP,ZWANG_EGF_PERSISTENTLY_UP,1/151,34/21728,0.21123804969784665,0.33285269543994217,0.24467971246011436,CALU,1
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,3/151,228/21728,0.2116894419589173,0.33337486947951944,0.24506356211976346,NRIP1/JAK2/TPM1,3
REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE,REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE,2/151,124/21728,0.21322316505258426,0.3354099391370776,0.246559539966629,UBC/MAP2K3,2
YAGI_AML_SURVIVAL,YAGI_AML_SURVIVAL,2/151,124/21728,0.21322316505258426,0.3354099391370776,0.246559539966629,VDAC1/APLP2,2
KONDO_EZH2_TARGETS,KONDO_EZH2_TARGETS,3/151,229/21728,0.21349139612480164,0.33564182141182736,0.24672999641504492,WWTR1/LMAN1/NPAS2,3
MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD,MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD,2/151,125/21728,0.21576893393087385,0.33635246118283896,0.24725238706176636,SEPTIN11/MOXD1,2
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,2/151,125/21728,0.21576893393087385,0.33635246118283896,0.24725238706176636,DUSP5/LDLR,2
ABE_VEGFA_TARGETS_2HR,ABE_VEGFA_TARGETS_2HR,1/151,35/21728,0.21672818773120295,0.33635246118283896,0.24725238706176636,LDLR,1
ALONSO_METASTASIS_EMT_UP,ALONSO_METASTASIS_EMT_UP,1/151,35/21728,0.21672818773120295,0.33635246118283896,0.24725238706176636,APLP2,1
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN,CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN,1/151,35/21728,0.21672818773120295,0.33635246118283896,0.24725238706176636,LOXL1,1
FRASOR_RESPONSE_TO_ESTRADIOL_UP,FRASOR_RESPONSE_TO_ESTRADIOL_UP,1/151,35/21728,0.21672818773120295,0.33635246118283896,0.24725238706176636,NRIP1,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP,1/151,35/21728,0.21672818773120295,0.33635246118283896,0.24725238706176636,ZNF654,1
GYORFFY_MITOXANTRONE_RESISTANCE,GYORFFY_MITOXANTRONE_RESISTANCE,1/151,35/21728,0.21672818773120295,0.33635246118283896,0.24725238706176636,SLC33A1,1
HONMA_DOCETAXEL_RESISTANCE,HONMA_DOCETAXEL_RESISTANCE,1/151,35/21728,0.21672818773120295,0.33635246118283896,0.24725238706176636,HSPA5,1
JIANG_AGING_HYPOTHALAMUS_DN,JIANG_AGING_HYPOTHALAMUS_DN,1/151,35/21728,0.21672818773120295,0.33635246118283896,0.24725238706176636,UBC,1
KEGG_REGULATION_OF_AUTOPHAGY,KEGG_REGULATION_OF_AUTOPHAGY,1/151,35/21728,0.21672818773120295,0.33635246118283896,0.24725238706176636,BECN1,1
LOPEZ_TRANSLATION_VIA_FN1_SIGNALING,LOPEZ_TRANSLATION_VIA_FN1_SIGNALING,1/151,35/21728,0.21672818773120295,0.33635246118283896,0.24725238706176636,EFNB2,1
NAKAMURA_ADIPOGENESIS_EARLY_DN,NAKAMURA_ADIPOGENESIS_EARLY_DN,1/151,35/21728,0.21672818773120295,0.33635246118283896,0.24725238706176636,TPM1,1
NAKAMURA_ADIPOGENESIS_LATE_DN,NAKAMURA_ADIPOGENESIS_LATE_DN,1/151,35/21728,0.21672818773120295,0.33635246118283896,0.24725238706176636,TPM1,1
PID_HIV_NEF_PATHWAY,PID_HIV_NEF_PATHWAY,1/151,35/21728,0.21672818773120295,0.33635246118283896,0.24725238706176636,BIRC3,1
PID_PI3KCI_AKT_PATHWAY,PID_PI3KCI_AKT_PATHWAY,1/151,35/21728,0.21672818773120295,0.33635246118283896,0.24725238706176636,YWHAZ,1
REACTOME_METALLOPROTEASE_DUBS,REACTOME_METALLOPROTEASE_DUBS,1/151,35/21728,0.21672818773120295,0.33635246118283896,0.24725238706176636,UBC,1
REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING,REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING,1/151,35/21728,0.21672818773120295,0.33635246118283896,0.24725238706176636,UBC,1
REACTOME_ONCOGENE_INDUCED_SENESCENCE,REACTOME_ONCOGENE_INDUCED_SENESCENCE,1/151,35/21728,0.21672818773120295,0.33635246118283896,0.24725238706176636,UBC,1
ROZANOV_MMP14_TARGETS_DN,ROZANOV_MMP14_TARGETS_DN,1/151,35/21728,0.21672818773120295,0.33635246118283896,0.24725238706176636,SDC4,1
VALK_AML_CLUSTER_9,VALK_AML_CLUSTER_9,1/151,35/21728,0.21672818773120295,0.33635246118283896,0.24725238706176636,CBFB,1
WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,1/151,35/21728,0.21672818773120295,0.33635246118283896,0.24725238706176636,BIRC3,1
WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,1/151,35/21728,0.21672818773120295,0.33635246118283896,0.24725238706176636,MAP2K3,1
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN,2/151,126/21728,0.21831753294913767,0.3384409076633395,0.24878760216243365,PRKAG1/GARS1,2
WIERENGA_STAT5A_TARGETS_GROUP1,WIERENGA_STAT5A_TARGETS_GROUP1,2/151,126/21728,0.21831753294913767,0.3384409076633395,0.24878760216243365,FNDC3B/DUSP5,2
REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,3/151,232/21728,0.21891717785972678,0.33918121589198047,0.24933180206526548,UBC/YWHAZ/CSNK1A1,3
YAGI_AML_WITH_11Q23_REARRANGED,YAGI_AML_WITH_11Q23_REARRANGED,4/151,345/21728,0.21930449024907794,0.3395919029609468,0.24963369775462727,RPS6KA3/PRDX1/PRKAG1/PVR,4
KIM_WT1_TARGETS_8HR_DN,KIM_WT1_TARGETS_8HR_DN,2/151,127/21728,0.22086880114174595,0.3410884203855084,0.2507337863468176,ACBD3/HUS1,2
MATTIOLI_MGUS_VS_PCL,MATTIOLI_MGUS_VS_PCL,2/151,127/21728,0.22086880114174595,0.3410884203855084,0.2507337863468176,ACTR3/PPP1R15A,2
REACTOME_CARDIAC_CONDUCTION,REACTOME_CARDIAC_CONDUCTION,2/151,127/21728,0.22086880114174595,0.3410884203855084,0.2507337863468176,WWTR1/ATP1A1,2
SCHLOSSER_SERUM_RESPONSE_UP,SCHLOSSER_SERUM_RESPONSE_UP,2/151,127/21728,0.22086880114174595,0.3410884203855084,0.2507337863468176,PCYT1A/ACTN4,2
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN,BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN,1/151,36/21728,0.2221803632556848,0.3410884203855084,0.2507337863468176,CTNNA1,1
HAN_JNK_SINGALING_UP,HAN_JNK_SINGALING_UP,1/151,36/21728,0.2221803632556848,0.3410884203855084,0.2507337863468176,EFNB2,1
HEIDENBLAD_AMPLICON_12P11_12_UP,HEIDENBLAD_AMPLICON_12P11_12_UP,1/151,36/21728,0.2221803632556848,0.3410884203855084,0.2507337863468176,ACTR3,1
KANG_GLIS3_TARGETS,KANG_GLIS3_TARGETS,1/151,36/21728,0.2221803632556848,0.3410884203855084,0.2507337863468176,LDLR,1
KIM_ALL_DISORDERS_CALB1_CORR_DN,KIM_ALL_DISORDERS_CALB1_CORR_DN,1/151,36/21728,0.2221803632556848,0.3410884203855084,0.2507337863468176,SBNO2,1
MARZEC_IL2_SIGNALING_DN,MARZEC_IL2_SIGNALING_DN,1/151,36/21728,0.2221803632556848,0.3410884203855084,0.2507337863468176,JAK2,1
PACHER_TARGETS_OF_IGF1_AND_IGF2_UP,PACHER_TARGETS_OF_IGF1_AND_IGF2_UP,1/151,36/21728,0.2221803632556848,0.3410884203855084,0.2507337863468176,PCDH8,1
PID_PI3K_PLC_TRK_PATHWAY,PID_PI3K_PLC_TRK_PATHWAY,1/151,36/21728,0.2221803632556848,0.3410884203855084,0.2507337863468176,YWHAZ,1
REACTOME_STRIATED_MUSCLE_CONTRACTION,REACTOME_STRIATED_MUSCLE_CONTRACTION,1/151,36/21728,0.2221803632556848,0.3410884203855084,0.2507337863468176,TPM1,1
SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,1/151,36/21728,0.2221803632556848,0.3410884203855084,0.2507337863468176,DUSP5,1
WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,1/151,36/21728,0.2221803632556848,0.3410884203855084,0.2507337863468176,EGLN1,1
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,4/151,347/21728,0.2222354358883262,0.3410884203855084,0.2507337863468176,ATP13A3/IARS2/DUSP3/CRK,4
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,2/151,128/21728,0.223422579615044,0.3425319680853158,0.25179493694271254,PRKAR1A/EML1,2
REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,2/151,128/21728,0.223422579615044,0.3425319680853158,0.25179493694271254,UBC/CBFB,2
DELACROIX_RAR_BOUND_ES,DELACROIX_RAR_BOUND_ES,5/151,467/21728,0.22554182636335765,0.34474288837183353,0.2534201824263412,FEM1B/HIVEP3/SLC35D1/ACTN4/SBNO2,5
REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE,REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE,2/151,129/21728,0.22597871152665472,0.34474288837183353,0.2534201824263412,PERP/FURIN,2
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,3/151,236/21728,0.22619567296926382,0.34474288837183353,0.2534201824263412,GBE1/EGLN1/PVR,3
GENTILE_UV_RESPONSE_CLUSTER_D8,GENTILE_UV_RESPONSE_CLUSTER_D8,1/151,37/21728,0.22759483703165684,0.34474288837183353,0.2534201824263412,STK24,1
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN,1/151,37/21728,0.22759483703165684,0.34474288837183353,0.2534201824263412,GBE1,1
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN,1/151,37/21728,0.22759483703165684,0.34474288837183353,0.2534201824263412,CD151,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS,1/151,37/21728,0.22759483703165684,0.34474288837183353,0.2534201824263412,CTNND1,1
MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS,MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS,1/151,37/21728,0.22759483703165684,0.34474288837183353,0.2534201824263412,SORT1,1
PID_IL23_PATHWAY,PID_IL23_PATHWAY,1/151,37/21728,0.22759483703165684,0.34474288837183353,0.2534201824263412,JAK2,1
REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,1/151,37/21728,0.22759483703165684,0.34474288837183353,0.2534201824263412,HUS1,1
REACTOME_CA_DEPENDENT_EVENTS,REACTOME_CA_DEPENDENT_EVENTS,1/151,37/21728,0.22759483703165684,0.34474288837183353,0.2534201824263412,PRKAR1A,1
REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES,REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES,1/151,37/21728,0.22759483703165684,0.34474288837183353,0.2534201824263412,PRDX1,1
REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA,REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA,1/151,37/21728,0.22759483703165684,0.34474288837183353,0.2534201824263412,HUS1,1
REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION,REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION,1/151,37/21728,0.22759483703165684,0.34474288837183353,0.2534201824263412,UBC,1
REACTOME_RHOH_GTPASE_CYCLE,REACTOME_RHOH_GTPASE_CYCLE,1/151,37/21728,0.22759483703165684,0.34474288837183353,0.2534201824263412,SLC4A7,1
REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN,REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN,1/151,37/21728,0.22759483703165684,0.34474288837183353,0.2534201824263412,CBFB,1
STEARMAN_TUMOR_FIELD_EFFECT_UP,STEARMAN_TUMOR_FIELD_EFFECT_UP,1/151,37/21728,0.22759483703165684,0.34474288837183353,0.2534201824263412,IQGAP1,1
VALK_AML_WITH_CEBPA,VALK_AML_WITH_CEBPA,1/151,37/21728,0.22759483703165684,0.34474288837183353,0.2534201824263412,CTNNA1,1
WP_NEOVASCULARISATION_PROCESSES,WP_NEOVASCULARISATION_PROCESSES,1/151,37/21728,0.22759483703165684,0.34474288837183353,0.2534201824263412,EPHB4,1
WP_OVERVIEW_OF_INTERFERONSMEDIATED_SIGNALING_PATHWAY,WP_OVERVIEW_OF_INTERFERONSMEDIATED_SIGNALING_PATHWAY,1/151,37/21728,0.22759483703165684,0.34474288837183353,0.2534201824263412,JAK2,1
WP_TARGET_OF_RAPAMYCIN_TOR_SIGNALING,WP_TARGET_OF_RAPAMYCIN_TOR_SIGNALING,1/151,37/21728,0.22759483703165684,0.34474288837183353,0.2534201824263412,PRKAG1,1
WP_TYPE_II_INTERFERON_SIGNALING_IFNG,WP_TYPE_II_INTERFERON_SIGNALING_IFNG,1/151,37/21728,0.22759483703165684,0.34474288837183353,0.2534201824263412,JAK2,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1,3/151,237/21728,0.22802275760813023,0.34520284503290777,0.253758296147869,UBC/CBFB/PML,3
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,2/151,130/21728,0.2285370420649693,0.3457929754120287,0.2541921004506596,BIRC3/PERP,2
NABA_ECM_REGULATORS,NABA_ECM_REGULATORS,3/151,238/21728,0.22985270241135133,0.3475943425687175,0.2555162838025508,ADAM9/EGLN1/LOXL1,3
WP_ADIPOGENESIS,WP_ADIPOGENESIS,2/151,131/21728,0.23109741842881568,0.3492865225218988,0.25676020374085246,WWTR1/NRIP1,2
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN,BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN,1/151,38/21728,0.23297186804028858,0.34973416933443724,0.25708926850396285,MOXD1,1
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP,FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP,1/151,38/21728,0.23297186804028858,0.34973416933443724,0.25708926850396285,CTNNA1,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP,1/151,38/21728,0.23297186804028858,0.34973416933443724,0.25708926850396285,PERP,1
NIKOLSKY_BREAST_CANCER_7P22_AMPLICON,NIKOLSKY_BREAST_CANCER_7P22_AMPLICON,1/151,38/21728,0.23297186804028858,0.34973416933443724,0.25708926850396285,ACTB,1
PID_ERBB4_PATHWAY,PID_ERBB4_PATHWAY,1/151,38/21728,0.23297186804028858,0.34973416933443724,0.25708926850396285,JAK2,1
REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS,REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS,1/151,38/21728,0.23297186804028858,0.34973416933443724,0.25708926850396285,STK24,1
REACTOME_FLT3_SIGNALING,REACTOME_FLT3_SIGNALING,1/151,38/21728,0.23297186804028858,0.34973416933443724,0.25708926850396285,UBC,1
REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION,REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION,1/151,38/21728,0.23297186804028858,0.34973416933443724,0.25708926850396285,HSPA9,1
REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES,REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES,1/151,38/21728,0.23297186804028858,0.34973416933443724,0.25708926850396285,ITGB3,1
REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES,REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES,1/151,38/21728,0.23297186804028858,0.34973416933443724,0.25708926850396285,PNKP,1
REACTOME_SMOOTH_MUSCLE_CONTRACTION,REACTOME_SMOOTH_MUSCLE_CONTRACTION,1/151,38/21728,0.23297186804028858,0.34973416933443724,0.25708926850396285,TPM1,1
WP_SLEEP_REGULATION,WP_SLEEP_REGULATION,1/151,38/21728,0.23297186804028858,0.34973416933443724,0.25708926850396285,NPAS2,1
ONDER_CDH1_TARGETS_2_DN,ONDER_CDH1_TARGETS_2_DN,5/151,473/21728,0.2331569379410257,0.34973416933443724,0.25708926850396285,BIRC3/PERP/SLC2A3/LRP12/SDC4,5
KEGG_OXIDATIVE_PHOSPHORYLATION,KEGG_OXIDATIVE_PHOSPHORYLATION,2/151,132/21728,0.23365968980731303,0.34973416933443724,0.25708926850396285,ATP6V1C1/ATP6V1A,2
NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON,NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON,2/151,132/21728,0.23365968980731303,0.34973416933443724,0.25708926850396285,YWHAZ/ATP6V1C1,2
POOLA_INVASIVE_BREAST_CANCER_DN,POOLA_INVASIVE_BREAST_CANCER_DN,2/151,132/21728,0.23365968980731303,0.34973416933443724,0.25708926850396285,CD151/SDC4,2
RASHI_RESPONSE_TO_IONIZING_RADIATION_5,RASHI_RESPONSE_TO_IONIZING_RADIATION_5,2/151,132/21728,0.23365968980731303,0.34973416933443724,0.25708926850396285,ATP13A3/CRK,2
YAGI_AML_WITH_T_9_11_TRANSLOCATION,YAGI_AML_WITH_T_9_11_TRANSLOCATION,2/151,132/21728,0.23365968980731303,0.34973416933443724,0.25708926850396285,ACTR2/EFNB2,2
KEGG_CELL_ADHESION_MOLECULES_CAMS,KEGG_CELL_ADHESION_MOLECULES_CAMS,2/151,133/21728,0.23622370735990342,0.3530826347150951,0.259550722347499,PVR/SDC4,2
QI_HYPOXIA,QI_HYPOXIA,2/151,133/21728,0.23622370735990342,0.3530826347150951,0.259550722347499,GBE1/EGLN1,2
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,4/151,357/21728,0.23704209924121852,0.3530826347150951,0.259550722347499,PKD2/AKAP12/EFNB2/TPM1,4
AMIT_EGF_RESPONSE_60_MCF10A,AMIT_EGF_RESPONSE_60_MCF10A,1/151,39/21728,0.23831171349560953,0.3530826347150951,0.259550722347499,TPM1,1
CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP,CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP,1/151,39/21728,0.23831171349560953,0.3530826347150951,0.259550722347499,LAMC1,1
CONRAD_STEM_CELL,CONRAD_STEM_CELL,1/151,39/21728,0.23831171349560953,0.3530826347150951,0.259550722347499,HSPA4,1
HEIDENBLAD_AMPLICON_8Q24_DN,HEIDENBLAD_AMPLICON_8Q24_DN,1/151,39/21728,0.23831171349560953,0.3530826347150951,0.259550722347499,HIVEP3,1
LANDIS_ERBB2_BREAST_TUMORS_65_DN,LANDIS_ERBB2_BREAST_TUMORS_65_DN,1/151,39/21728,0.23831171349560953,0.3530826347150951,0.259550722347499,APLP2,1
NEWMAN_ERCC6_TARGETS_DN,NEWMAN_ERCC6_TARGETS_DN,1/151,39/21728,0.23831171349560953,0.3530826347150951,0.259550722347499,SEPTIN11,1
PID_RET_PATHWAY,PID_RET_PATHWAY,1/151,39/21728,0.23831171349560953,0.3530826347150951,0.259550722347499,CRK,1
RASHI_RESPONSE_TO_IONIZING_RADIATION_1,RASHI_RESPONSE_TO_IONIZING_RADIATION_1,1/151,39/21728,0.23831171349560953,0.3530826347150951,0.259550722347499,SEC23A,1
REACTOME_FANCONI_ANEMIA_PATHWAY,REACTOME_FANCONI_ANEMIA_PATHWAY,1/151,39/21728,0.23831171349560953,0.3530826347150951,0.259550722347499,UBC,1
REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES,REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES,1/151,39/21728,0.23831171349560953,0.3530826347150951,0.259550722347499,UBC,1
REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS,REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS,1/151,39/21728,0.23831171349560953,0.3530826347150951,0.259550722347499,PML,1
REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE,REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE,1/151,39/21728,0.23831171349560953,0.3530826347150951,0.259550722347499,UBC,1
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN,RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN,1/151,39/21728,0.23831171349560953,0.3530826347150951,0.259550722347499,NRIP1,1
SPIRA_SMOKERS_LUNG_CANCER_UP,SPIRA_SMOKERS_LUNG_CANCER_UP,1/151,39/21728,0.23831171349560953,0.3530826347150951,0.259550722347499,ACTR2,1
WP_NUCLEAR_RECEPTORS,WP_NUCLEAR_RECEPTORS,1/151,39/21728,0.23831171349560953,0.3530826347150951,0.259550722347499,ESR2,1
ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN,ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN,1/151,39/21728,0.23831171349560953,0.3530826347150951,0.259550722347499,NRIP1,1
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,2/151,134/21728,0.2387893241965619,0.3536016751695357,0.25993226851157564,SEPTIN11/PTPN12,2
DOANE_RESPONSE_TO_ANDROGEN_DN,DOANE_RESPONSE_TO_ANDROGEN_DN,3/151,243/21728,0.2390431800872939,0.35378900068327246,0.26006997132565973,PTPN14/EFNB2/SLC35D1,3
COLINA_TARGETS_OF_4EBP1_AND_4EBP2,COLINA_TARGETS_OF_4EBP1_AND_4EBP2,4/151,359/21728,0.240031995507839,0.35506330325919955,0.2610067099855432,AKAP12/PERP/PAFAH2/SDC4,4
SANSOM_APC_TARGETS_DN,SANSOM_APC_TARGETS_DN,4/151,361/21728,0.2430308076814732,0.3582643933103928,0.26335982835897165,SDF4/MCFD2/PAFAH2/JAK2,4
DELPUECH_FOXO3_TARGETS_DN,DELPUECH_FOXO3_TARGETS_DN,1/151,40/21728,0.243614628856491,0.3582643933103928,0.26335982835897165,EFNB2,1
KEGG_PYRUVATE_METABOLISM,KEGG_PYRUVATE_METABOLISM,1/151,40/21728,0.243614628856491,0.3582643933103928,0.26335982835897165,LDHA,1
MALONEY_RESPONSE_TO_17AAG_UP,MALONEY_RESPONSE_TO_17AAG_UP,1/151,40/21728,0.243614628856491,0.3582643933103928,0.26335982835897165,HSPA8,1
PID_ER_NONGENOMIC_PATHWAY,PID_ER_NONGENOMIC_PATHWAY,1/151,40/21728,0.243614628856491,0.3582643933103928,0.26335982835897165,ESR2,1
PID_IFNG_PATHWAY,PID_IFNG_PATHWAY,1/151,40/21728,0.243614628856491,0.3582643933103928,0.26335982835897165,JAK2,1
REACTOME_SIGNALING_BY_FGFR3,REACTOME_SIGNALING_BY_FGFR3,1/151,40/21728,0.243614628856491,0.3582643933103928,0.26335982835897165,UBC,1
WENG_POR_TARGETS_LIVER_UP,WENG_POR_TARGETS_LIVER_UP,1/151,40/21728,0.243614628856491,0.3582643933103928,0.26335982835897165,ACTG1,1
WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,1/151,40/21728,0.243614628856491,0.3582643933103928,0.26335982835897165,GBE1,1
WP_IL5_SIGNALING_PATHWAY,WP_IL5_SIGNALING_PATHWAY,1/151,40/21728,0.243614628856491,0.3582643933103928,0.26335982835897165,JAK2,1
WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,1/151,40/21728,0.243614628856491,0.3582643933103928,0.26335982835897165,JAK2,1
ZHENG_GLIOBLASTOMA_PLASTICITY_UP,ZHENG_GLIOBLASTOMA_PLASTICITY_UP,3/151,248/21728,0.24829602448368607,0.3607415695629025,0.26518079836005864,UNC5C/FLOT2/SDC4,3
AMIT_EGF_RESPONSE_120_MCF10A,AMIT_EGF_RESPONSE_120_MCF10A,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,EPHA2,1
BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_UP,BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_UP,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,HSPA5,1
CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY,CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,NRIP1,1
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,HSPA4,1
GALLUZZI_PERMEABILIZE_MITOCHONDRIA,GALLUZZI_PERMEABILIZE_MITOCHONDRIA,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,VDAC1,1
HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP,HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,JAK2,1
LEE_AGING_MUSCLE_DN,LEE_AGING_MUSCLE_DN,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,HSPA8,1
LEONARD_HYPOXIA,LEONARD_HYPOXIA,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,SLC2A3,1
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,HSPA4,1
LIAO_HAVE_SOX4_BINDING_SITES,LIAO_HAVE_SOX4_BINDING_SITES,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,PTPN14,1
LIN_MELANOMA_COPY_NUMBER_DN,LIN_MELANOMA_COPY_NUMBER_DN,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,PDIA3,1
MCBRYAN_PUBERTAL_BREAST_3_4WK_DN,MCBRYAN_PUBERTAL_BREAST_3_4WK_DN,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,NRIP1,1
REACTOME_DAG_AND_IP3_SIGNALING,REACTOME_DAG_AND_IP3_SIGNALING,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,PRKAR1A,1
REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM,REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,SDC4,1
REACTOME_DUAL_INCISION_IN_GG_NER,REACTOME_DUAL_INCISION_IN_GG_NER,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,UBC,1
REACTOME_MTOR_SIGNALLING,REACTOME_MTOR_SIGNALLING,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,PRKAG1,1
REACTOME_SIGNALING_BY_FGFR4,REACTOME_SIGNALING_BY_FGFR4,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,UBC,1
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP,SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,WWTR1,1
THILLAINADESAN_ZNF217_TARGETS_UP,THILLAINADESAN_ZNF217_TARGETS_UP,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,ETF1,1
VANTVEER_BREAST_CANCER_BRCA1_DN,VANTVEER_BREAST_CANCER_BRCA1_DN,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,CSNK1A1,1
WP_BLADDER_CANCER,WP_BLADDER_CANCER,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,ARAF,1
WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,EPHB4,1
XU_CREBBP_TARGETS_DN,XU_CREBBP_TARGETS_DN,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,ATP1A1,1
ZHU_CMV_8_HR_UP,ZHU_CMV_8_HR_UP,1/151,41/21728,0.24888086783854002,0.3607415695629025,0.26518079836005864,PML,1
CHUNG_BLISTER_CYTOTOXICITY_UP,CHUNG_BLISTER_CYTOTOXICITY_UP,2/151,138/21728,0.24906491375869222,0.3607415695629025,0.26518079836005864,SDC4/PGRMC2,2
EPPERT_PROGENITOR,EPPERT_PROGENITOR,2/151,138/21728,0.24906491375869222,0.3607415695629025,0.26518079836005864,CALU/TPM1,2
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,2/151,138/21728,0.24906491375869222,0.3607415695629025,0.26518079836005864,PPP1R15A/SLC2A3,2
REACTOME_HOMOLOGY_DIRECTED_REPAIR,REACTOME_HOMOLOGY_DIRECTED_REPAIR,2/151,138/21728,0.24906491375869222,0.3607415695629025,0.26518079836005864,UBC/HUS1,2
PECE_MAMMARY_STEM_CELL_UP,PECE_MAMMARY_STEM_CELL_UP,2/151,139/21728,0.25163639057093756,0.3640864026073253,0.2676395820765455,ACTG1/PERP,2
REACTOME_PTEN_REGULATION,REACTOME_PTEN_REGULATION,2/151,139/21728,0.25163639057093756,0.3640864026073253,0.2676395820765455,UBC/PML,2
BYSTROEM_CORRELATED_WITH_IL5_UP,BYSTROEM_CORRELATED_WITH_IL5_UP,1/151,42/21728,0.25411068242591395,0.36533448567604254,0.26855704680062237,ETF1,1
KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION,KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION,1/151,42/21728,0.25411068242591395,0.36533448567604254,0.26855704680062237,ATP1A1,1
KEGG_BLADDER_CANCER,KEGG_BLADDER_CANCER,1/151,42/21728,0.25411068242591395,0.36533448567604254,0.26855704680062237,ARAF,1
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN,MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN,1/151,42/21728,0.25411068242591395,0.36533448567604254,0.26855704680062237,MET,1
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN,1/151,42/21728,0.25411068242591395,0.36533448567604254,0.26855704680062237,PKD2,1
PID_BMP_PATHWAY,PID_BMP_PATHWAY,1/151,42/21728,0.25411068242591395,0.36533448567604254,0.26855704680062237,PPP1R15A,1
REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE,REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE,1/151,42/21728,0.25411068242591395,0.36533448567604254,0.26855704680062237,HUS1,1
WP_DNA_REPLICATION,WP_DNA_REPLICATION,1/151,42/21728,0.25411068242591395,0.36533448567604254,0.26855704680062237,UBC,1
WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,1/151,42/21728,0.25411068242591395,0.36533448567604254,0.26855704680062237,APLP2,1
WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING_PATHWAY,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING_PATHWAY,1/151,42/21728,0.25411068242591395,0.36533448567604254,0.26855704680062237,BIRC3,1
ZHAN_MULTIPLE_MYELOMA_MF_DN,ZHAN_MULTIPLE_MYELOMA_MF_DN,1/151,42/21728,0.25411068242591395,0.36533448567604254,0.26855704680062237,MOXD1,1
ONDER_CDH1_TARGETS_1_UP,ONDER_CDH1_TARGETS_1_UP,2/151,140/21728,0.2542086252022283,0.36533448567604254,0.26855704680062237,PGM3/PPFIBP1,2
REACTOME_RHO_GTPASES_ACTIVATE_FORMINS,REACTOME_RHO_GTPASES_ACTIVATE_FORMINS,2/151,140/21728,0.2542086252022283,0.36533448567604254,0.26855704680062237,ACTB/ACTG1,2
BOYLAN_MULTIPLE_MYELOMA_C_D_UP,BOYLAN_MULTIPLE_MYELOMA_C_D_UP,2/151,141/21728,0.25678148387685623,0.368650626465068,0.27099473886636805,IQGAP1/AKAP12,2
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,2/151,141/21728,0.25678148387685623,0.368650626465068,0.27099473886636805,RAB21/DNAJC10,2
KOBAYASHI_EGFR_SIGNALING_24HR_DN,KOBAYASHI_EGFR_SIGNALING_24HR_DN,3/151,253/21728,0.25760379355761653,0.36959846535102225,0.2716914943658759,WWTR1/DUSP5/MET,3
AMIT_EGF_RESPONSE_480_MCF10A,AMIT_EGF_RESPONSE_480_MCF10A,1/151,43/21728,0.2593043228830606,0.36959846535102225,0.2716914943658759,EGLN1,1
ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN,ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN,1/151,43/21728,0.2593043228830606,0.36959846535102225,0.2716914943658759,HIVEP3,1
LASTOWSKA_COAMPLIFIED_WITH_MYCN,LASTOWSKA_COAMPLIFIED_WITH_MYCN,1/151,43/21728,0.2593043228830606,0.36959846535102225,0.2716914943658759,PDIA6,1
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN,1/151,43/21728,0.2593043228830606,0.36959846535102225,0.2716914943658759,APLP2,1
PID_CXCR3_PATHWAY,PID_CXCR3_PATHWAY,1/151,43/21728,0.2593043228830606,0.36959846535102225,0.2716914943658759,MAP2K3,1
PID_THROMBIN_PAR1_PATHWAY,PID_THROMBIN_PAR1_PATHWAY,1/151,43/21728,0.2593043228830606,0.36959846535102225,0.2716914943658759,PKN1,1
REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER,REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER,1/151,43/21728,0.2593043228830606,0.36959846535102225,0.2716914943658759,UBC,1
REACTOME_RND2_GTPASE_CYCLE,REACTOME_RND2_GTPASE_CYCLE,1/151,43/21728,0.2593043228830606,0.36959846535102225,0.2716914943658759,EPHA2,1
REACTOME_SIGNALING_BY_SCF_KIT,REACTOME_SIGNALING_BY_SCF_KIT,1/151,43/21728,0.2593043228830606,0.36959846535102225,0.2716914943658759,JAK2,1
REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS,REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS,1/151,43/21728,0.2593043228830606,0.36959846535102225,0.2716914943658759,NRIP1,1
REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS,REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS,1/151,43/21728,0.2593043228830606,0.36959846535102225,0.2716914943658759,PRKAR1A,1
WP_IL6_SIGNALING_PATHWAY,WP_IL6_SIGNALING_PATHWAY,1/151,43/21728,0.2593043228830606,0.36959846535102225,0.2716914943658759,JAK2,1
WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,1/151,43/21728,0.2593043228830606,0.36959846535102225,0.2716914943658759,LAMC1,1
QI_PLASMACYTOMA_UP,QI_PLASMACYTOMA_UP,3/151,254/21728,0.2594712955726603,0.3696467995388976,0.2717270247832448,ACTR2/WDR1/ITGB3,3
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,2/151,143/21728,0.26192854722737646,0.37204451964953,0.2734895866469964,PCDH8/EPHA2,2
RUIZ_TNC_TARGETS_DN,RUIZ_TNC_TARGETS_DN,2/151,143/21728,0.26192854722737646,0.37204451964953,0.2734895866469964,MET/TPM1,2
ZHENG_BOUND_BY_FOXP3,ZHENG_BOUND_BY_FOXP3,5/151,496/21728,0.2629906035666639,0.37204451964953,0.2734895866469964,STK24/NUS1/FEM1C/ACTR3/NRIP1,5
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,3/151,256/21728,0.2632117876912094,0.37204451964953,0.2734895866469964,PDLIM4/PRDX1/PML,3
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,4/151,375/21728,0.2642505525430158,0.37204451964953,0.2734895866469964,BIRC3/PPP1R15A/HSPA8/LDLR,4
CHOI_ATL_STAGE_PREDICTOR,CHOI_ATL_STAGE_PREDICTOR,1/151,44/21728,0.26446203776637456,0.37204451964953,0.2734895866469964,HSPA4,1
GROSS_HYPOXIA_VIA_ELK3_ONLY_DN,GROSS_HYPOXIA_VIA_ELK3_ONLY_DN,1/151,44/21728,0.26446203776637456,0.37204451964953,0.2734895866469964,LAMA5,1
IKEDA_MIR133_TARGETS_UP,IKEDA_MIR133_TARGETS_UP,1/151,44/21728,0.26446203776637456,0.37204451964953,0.2734895866469964,ACTR3,1
KAAB_FAILED_HEART_VENTRICLE_DN,KAAB_FAILED_HEART_VENTRICLE_DN,1/151,44/21728,0.26446203776637456,0.37204451964953,0.2734895866469964,LDHA,1
KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM,KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM,1/151,44/21728,0.26446203776637456,0.37204451964953,0.2734895866469964,PGM3,1
NAKAMURA_METASTASIS_MODEL_DN,NAKAMURA_METASTASIS_MODEL_DN,1/151,44/21728,0.26446203776637456,0.37204451964953,0.2734895866469964,LDLR,1
PARK_HSC_MARKERS,PARK_HSC_MARKERS,1/151,44/21728,0.26446203776637456,0.37204451964953,0.2734895866469964,SDF4,1
PID_CERAMIDE_PATHWAY,PID_CERAMIDE_PATHWAY,1/151,44/21728,0.26446203776637456,0.37204451964953,0.2734895866469964,BIRC3,1
PID_ERBB2_ERBB3_PATHWAY,PID_ERBB2_ERBB3_PATHWAY,1/151,44/21728,0.26446203776637456,0.37204451964953,0.2734895866469964,JAK2,1
PID_HNF3A_PATHWAY,PID_HNF3A_PATHWAY,1/151,44/21728,0.26446203776637456,0.37204451964953,0.2734895866469964,NRIP1,1
REACTOME_AGGREPHAGY,REACTOME_AGGREPHAGY,1/151,44/21728,0.26446203776637456,0.37204451964953,0.2734895866469964,UBC,1
REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING,1/151,44/21728,0.26446203776637456,0.37204451964953,0.2734895866469964,JAK2,1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES,1/151,44/21728,0.26446203776637456,0.37204451964953,0.2734895866469964,PERP,1
VANHARANTA_UTERINE_FIBROID_UP,VANHARANTA_UTERINE_FIBROID_UP,1/151,44/21728,0.26446203776637456,0.37204451964953,0.2734895866469964,EFNB2,1
WP_HEDGEHOG_SIGNALING_PATHWAY_WP4249,WP_HEDGEHOG_SIGNALING_PATHWAY_WP4249,1/151,44/21728,0.26446203776637456,0.37204451964953,0.2734895866469964,CSNK1A1,1
WP_INTERLEUKIN11_SIGNALING_PATHWAY,WP_INTERLEUKIN11_SIGNALING_PATHWAY,1/151,44/21728,0.26446203776637456,0.37204451964953,0.2734895866469964,JAK2,1
WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,1/151,44/21728,0.26446203776637456,0.37204451964953,0.2734895866469964,LDHA,1
WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,1/151,44/21728,0.26446203776637456,0.37204451964953,0.2734895866469964,BECN1,1
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,2/151,144/21728,0.2645024932713541,0.37204451964953,0.2734895866469964,BIRC3/ITGB3,2
PECE_MAMMARY_STEM_CELL_DN,PECE_MAMMARY_STEM_CELL_DN,2/151,144/21728,0.2645024932713541,0.37204451964953,0.2734895866469964,TM9SF2/PDIA3,2
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,3/151,258/21728,0.26695921863196115,0.3750953715629089,0.2757322651025135,AKAP12/MET/SDC4,3
BROWNE_HCMV_INFECTION_24HR_DN,BROWNE_HCMV_INFECTION_24HR_DN,2/151,145/21728,0.26707654605883147,0.3750953715629089,0.2757322651025135,SEPTIN11/LAMC1,2
DAZARD_UV_RESPONSE_CLUSTER_G6,DAZARD_UV_RESPONSE_CLUSTER_G6,2/151,145/21728,0.26707654605883147,0.3750953715629089,0.2757322651025135,ATP13A3/NPAS2,2
CHENG_RESPONSE_TO_NICKEL_ACETATE,CHENG_RESPONSE_TO_NICKEL_ACETATE,1/151,45/21728,0.2695840739357749,0.37642679044113153,0.2767109899040564,ACTR2,1
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN,1/151,45/21728,0.2695840739357749,0.37642679044113153,0.2767109899040564,FLOT2,1
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN,LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN,1/151,45/21728,0.2695840739357749,0.37642679044113153,0.2767109899040564,API5,1
PID_ILK_PATHWAY,PID_ILK_PATHWAY,1/151,45/21728,0.2695840739357749,0.37642679044113153,0.2767109899040564,IQGAP1,1
REACTOME_GLYCOSPHINGOLIPID_METABOLISM,REACTOME_GLYCOSPHINGOLIPID_METABOLISM,1/151,45/21728,0.2695840739357749,0.37642679044113153,0.2767109899040564,ARSJ,1
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN,SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN,1/151,45/21728,0.2695840739357749,0.37642679044113153,0.2767109899040564,YWHAZ,1
WANG_TARGETS_OF_MLL_CBP_FUSION_DN,WANG_TARGETS_OF_MLL_CBP_FUSION_DN,1/151,45/21728,0.2695840739357749,0.37642679044113153,0.2767109899040564,VDAC1,1
WANG_TARGETS_OF_MLL_CBP_FUSION_UP,WANG_TARGETS_OF_MLL_CBP_FUSION_UP,1/151,45/21728,0.2695840739357749,0.37642679044113153,0.2767109899040564,YWHAZ,1
ZHAN_MULTIPLE_MYELOMA_MS_DN,ZHAN_MULTIPLE_MYELOMA_MS_DN,1/151,45/21728,0.2695840739357749,0.37642679044113153,0.2767109899040564,STK24,1
ZHAN_V2_LATE_DIFFERENTIATION_GENES,ZHAN_V2_LATE_DIFFERENTIATION_GENES,1/151,45/21728,0.2695840739357749,0.37642679044113153,0.2767109899040564,NCSTN,1
REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,2/151,146/21728,0.26965058062557656,0.37642679044113153,0.2767109899040564,UBC/CLTC,2
WEI_MIR34A_TARGETS,WEI_MIR34A_TARGETS,2/151,146/21728,0.26965058062557656,0.37642679044113153,0.2767109899040564,ACBD3/FLOT2,2
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP,2/151,147/21728,0.27222447371620473,0.3798290246025197,0.27921196912920626,HSPA9/ATP6V1C1,2
BIOCARTA_KERATINOCYTE_PATHWAY,BIOCARTA_KERATINOCYTE_PATHWAY,1/151,46/21728,0.2746706765662086,0.3807427093586002,0.27988361795903316,MAP2K3,1
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP,BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP,1/151,46/21728,0.2746706765662086,0.3807427093586002,0.27988361795903316,CALU,1
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN,1/151,46/21728,0.2746706765662086,0.3807427093586002,0.27988361795903316,PPFIBP1,1
JAEGER_METASTASIS_UP,JAEGER_METASTASIS_UP,1/151,46/21728,0.2746706765662086,0.3807427093586002,0.27988361795903316,MET,1
KEGG_N_GLYCAN_BIOSYNTHESIS,KEGG_N_GLYCAN_BIOSYNTHESIS,1/151,46/21728,0.2746706765662086,0.3807427093586002,0.27988361795903316,MGAT4B,1
KLEIN_TARGETS_OF_BCR_ABL1_FUSION,KLEIN_TARGETS_OF_BCR_ABL1_FUSION,1/151,46/21728,0.2746706765662086,0.3807427093586002,0.27988361795903316,PML,1
LANDIS_BREAST_CANCER_PROGRESSION_UP,LANDIS_BREAST_CANCER_PROGRESSION_UP,1/151,46/21728,0.2746706765662086,0.3807427093586002,0.27988361795903316,ATP6V1A,1
NAKAJIMA_MAST_CELL,NAKAJIMA_MAST_CELL,1/151,46/21728,0.2746706765662086,0.3807427093586002,0.27988361795903316,PRDX1,1
NUTT_GBM_VS_AO_GLIOMA_DN,NUTT_GBM_VS_AO_GLIOMA_DN,1/151,46/21728,0.2746706765662086,0.3807427093586002,0.27988361795903316,API5,1
NUTT_GBM_VS_AO_GLIOMA_UP,NUTT_GBM_VS_AO_GLIOMA_UP,1/151,46/21728,0.2746706765662086,0.3807427093586002,0.27988361795903316,LDHA,1
RASHI_RESPONSE_TO_IONIZING_RADIATION_3,RASHI_RESPONSE_TO_IONIZING_RADIATION_3,1/151,46/21728,0.2746706765662086,0.3807427093586002,0.27988361795903316,ACTB,1
SIG_BCR_SIGNALING_PATHWAY,SIG_BCR_SIGNALING_PATHWAY,1/151,46/21728,0.2746706765662086,0.3807427093586002,0.27988361795903316,FLOT2,1
WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,1/151,46/21728,0.2746706765662086,0.3807427093586002,0.27988361795903316,ESR2,1
RODWELL_AGING_KIDNEY_NO_BLOOD_DN,RODWELL_AGING_KIDNEY_NO_BLOOD_DN,2/151,148/21728,0.2747981037667363,0.3807427093586002,0.27988361795903316,HSPA9/APLP2,2
LU_AGING_BRAIN_UP,LU_AGING_BRAIN_UP,3/151,263/21728,0.27635521000676894,0.38270925892263413,0.28132922674772093,WWTR1/IQGAP1/ITPRID2,3
NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,2/151,149/21728,0.27737135088731146,0.3837338708988801,0.2820824180757938,LAMA5/SDC4,2
REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2/151,149/21728,0.27737135088731146,0.3837338708988801,0.2820824180757938,UBC/JAK2,2
STEIN_ESRRA_TARGETS_UP,STEIN_ESRRA_TARGETS_UP,4/151,385/21728,0.2796188565310743,0.3840418276718901,0.28230879681841037,RAB21/CALU/EGLN1/PAFAH2,4
KEGG_NOTCH_SIGNALING_PATHWAY,KEGG_NOTCH_SIGNALING_PATHWAY,1/151,47/21728,0.2797220891590738,0.3840418276718901,0.28230879681841037,NCSTN,1
MELLMAN_TUT1_TARGETS_DN,MELLMAN_TUT1_TARGETS_DN,1/151,47/21728,0.2797220891590738,0.3840418276718901,0.28230879681841037,PRDX1,1
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN,ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN,1/151,47/21728,0.2797220891590738,0.3840418276718901,0.28230879681841037,CD151,1
PID_DELTA_NP63_PATHWAY,PID_DELTA_NP63_PATHWAY,1/151,47/21728,0.2797220891590738,0.3840418276718901,0.28230879681841037,PERP,1
PID_FANCONI_PATHWAY,PID_FANCONI_PATHWAY,1/151,47/21728,0.2797220891590738,0.3840418276718901,0.28230879681841037,HUS1,1
REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING,REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING,1/151,47/21728,0.2797220891590738,0.3840418276718901,0.28230879681841037,NRIP1,1
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP,1/151,47/21728,0.2797220891590738,0.3840418276718901,0.28230879681841037,EDEM3,1
WP_NOTCH_SIGNALING,WP_NOTCH_SIGNALING,1/151,47/21728,0.2797220891590738,0.3840418276718901,0.28230879681841037,NCSTN,1
WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING_PATHWAY,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING_PATHWAY,1/151,47/21728,0.2797220891590738,0.3840418276718901,0.28230879681841037,JAK2,1
YAMASHITA_LIVER_CANCER_STEM_CELL_UP,YAMASHITA_LIVER_CANCER_STEM_CELL_UP,1/151,47/21728,0.2797220891590738,0.3840418276718901,0.28230879681841037,YWHAZ,1
YANG_BREAST_CANCER_ESR1_LASER_DN,YANG_BREAST_CANCER_ESR1_LASER_DN,1/151,47/21728,0.2797220891590738,0.3840418276718901,0.28230879681841037,FNDC3B,1
ZHAN_MULTIPLE_MYELOMA_CD2_DN,ZHAN_MULTIPLE_MYELOMA_CD2_DN,1/151,47/21728,0.2797220891590738,0.3840418276718901,0.28230879681841037,LDHA,1
ZHAN_MULTIPLE_MYELOMA_HP_DN,ZHAN_MULTIPLE_MYELOMA_HP_DN,1/151,47/21728,0.2797220891590738,0.3840418276718901,0.28230879681841037,PDIA6,1
BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE,BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE,2/151,150/21728,0.2799440968450603,0.3840418276718901,0.28230879681841037,DUSP5/FURIN,2
TSAI_RESPONSE_TO_IONIZING_RADIATION,TSAI_RESPONSE_TO_IONIZING_RADIATION,2/151,150/21728,0.2799440968450603,0.3840418276718901,0.28230879681841037,BIRC3/JAK2,2
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,2/151,150/21728,0.2799440968450603,0.3840418276718901,0.28230879681841037,HSP90B1/ATP6V1A,2
KOYAMA_SEMA3B_TARGETS_UP,KOYAMA_SEMA3B_TARGETS_UP,3/151,266/21728,0.2820093960026337,0.3866841570065727,0.2842511706993866,ACTN4/NPAS2/LOXL1,3
CHYLA_CBFA2T3_TARGETS_UP,CHYLA_CBFA2T3_TARGETS_UP,4/151,387/21728,0.2827103971330085,0.38717753390690446,0.2846138516082735,FNDC3B/RALB/HIVEP3/LRP12,4
BROWNE_HCMV_INFECTION_8HR_DN,BROWNE_HCMV_INFECTION_8HR_DN,1/151,48/21728,0.2847385535535658,0.38717753390690446,0.2846138516082735,FEM1B,1
DAUER_STAT3_TARGETS_DN,DAUER_STAT3_TARGETS_DN,1/151,48/21728,0.2847385535535658,0.38717753390690446,0.2846138516082735,PGRMC2,1
EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,1/151,48/21728,0.2847385535535658,0.38717753390690446,0.2846138516082735,TPM1,1
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP,1/151,48/21728,0.2847385535535658,0.38717753390690446,0.2846138516082735,JAK2,1
GERHOLD_ADIPOGENESIS_UP,GERHOLD_ADIPOGENESIS_UP,1/151,48/21728,0.2847385535535658,0.38717753390690446,0.2846138516082735,LDHA,1
HALMOS_CEBPA_TARGETS_UP,HALMOS_CEBPA_TARGETS_UP,1/151,48/21728,0.2847385535535658,0.38717753390690446,0.2846138516082735,JAK2,1
HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN,HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN,1/151,48/21728,0.2847385535535658,0.38717753390690446,0.2846138516082735,SDC4,1
PID_HEDGEHOG_GLI_PATHWAY,PID_HEDGEHOG_GLI_PATHWAY,1/151,48/21728,0.2847385535535658,0.38717753390690446,0.2846138516082735,CSNK1A1,1
PID_HES_HEY_PATHWAY,PID_HES_HEY_PATHWAY,1/151,48/21728,0.2847385535535658,0.38717753390690446,0.2846138516082735,JAK2,1
REACTOME_DNA_DAMAGE_BYPASS,REACTOME_DNA_DAMAGE_BYPASS,1/151,48/21728,0.2847385535535658,0.38717753390690446,0.2846138516082735,UBC,1
REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,1/151,48/21728,0.2847385535535658,0.38717753390690446,0.2846138516082735,UBC,1
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP,SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP,1/151,48/21728,0.2847385535535658,0.38717753390690446,0.2846138516082735,VDAC1,1
WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,1/151,48/21728,0.2847385535535658,0.38717753390690446,0.2846138516082735,NRIP1,1
WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,1/151,48/21728,0.2847385535535658,0.38717753390690446,0.2846138516082735,PTGES3,1
WP_ENERGY_METABOLISM,WP_ENERGY_METABOLISM,1/151,48/21728,0.2847385535535658,0.38717753390690446,0.2846138516082735,PRKAG1,1
WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,1/151,48/21728,0.2847385535535658,0.38717753390690446,0.2846138516082735,MAP2K3,1
REACTOME_HIV_LIFE_CYCLE,REACTOME_HIV_LIFE_CYCLE,2/151,152/21728,0.2850876205238557,0.3872730610343625,0.28468407351243347,UBC/FURIN,2
WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,2/151,152/21728,0.2850876205238557,0.3872730610343625,0.28468407351243347,PRKAR1A/YWHAZ,2
REACTOME_METABOLISM_OF_STEROIDS,REACTOME_METABOLISM_OF_STEROIDS,2/151,153/21728,0.2876581699121067,0.39057399609766974,0.28711058786308946,SEC23A/SEC24A,2
WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,3/151,270/21728,0.2895646359860746,0.39089024818242835,0.2873430644817972,ACTB/RRBP1/EPHB4,3
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN,1/151,49/21728,0.2897203099379482,0.39089024818242835,0.2873430644817972,ZNF330,1
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN,1/151,49/21728,0.2897203099379482,0.39089024818242835,0.2873430644817972,HSPA4,1
LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE,LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE,1/151,49/21728,0.2897203099379482,0.39089024818242835,0.2873430644817972,BIRC3,1
MCCLUNG_DELTA_FOSB_TARGETS_2WK,MCCLUNG_DELTA_FOSB_TARGETS_2WK,1/151,49/21728,0.2897203099379482,0.39089024818242835,0.2873430644817972,GARS1,1
MCCLUNG_DELTA_FOSB_TARGETS_8WK,MCCLUNG_DELTA_FOSB_TARGETS_8WK,1/151,49/21728,0.2897203099379482,0.39089024818242835,0.2873430644817972,ACTR2,1
NADLER_OBESITY_DN,NADLER_OBESITY_DN,1/151,49/21728,0.2897203099379482,0.39089024818242835,0.2873430644817972,GBE1,1
PID_ANGIOPOIETIN_RECEPTOR_PATHWAY,PID_ANGIOPOIETIN_RECEPTOR_PATHWAY,1/151,49/21728,0.2897203099379482,0.39089024818242835,0.2873430644817972,CRK,1
PRAMOONJAGO_SOX4_TARGETS_DN,PRAMOONJAGO_SOX4_TARGETS_DN,1/151,49/21728,0.2897203099379482,0.39089024818242835,0.2873430644817972,HSPA8,1
VANTVEER_BREAST_CANCER_POOR_PROGNOSIS,VANTVEER_BREAST_CANCER_POOR_PROGNOSIS,1/151,49/21728,0.2897203099379482,0.39089024818242835,0.2873430644817972,SLC2A3,1
WP_IL3_SIGNALING_PATHWAY,WP_IL3_SIGNALING_PATHWAY,1/151,49/21728,0.2897203099379482,0.39089024818242835,0.2873430644817972,JAK2,1
WP_RETT_SYNDROME_CAUSING_GENES,WP_RETT_SYNDROME_CAUSING_GENES,1/151,49/21728,0.2897203099379482,0.39089024818242835,0.2873430644817972,CRK,1
ZHANG_PROLIFERATING_VS_QUIESCENT,ZHANG_PROLIFERATING_VS_QUIESCENT,1/151,49/21728,0.2897203099379482,0.39089024818242835,0.2873430644817972,ITGB3,1
WP_MESODERMAL_COMMITMENT_PATHWAY,WP_MESODERMAL_COMMITMENT_PATHWAY,2/151,155/21728,0.292796284904295,0.3939300212122991,0.28957759886016454,PRKAR1A/JAK2,2
BROWNE_HCMV_INFECTION_4HR_UP,BROWNE_HCMV_INFECTION_4HR_UP,1/151,50/21728,0.29466759686074784,0.3939300212122991,0.28957759886016454,EFNB2,1
BUFFA_HYPOXIA_METAGENE,BUFFA_HYPOXIA_METAGENE,1/151,50/21728,0.29466759686074784,0.3939300212122991,0.28957759886016454,LDHA,1
CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS,CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS,1/151,50/21728,0.29466759686074784,0.3939300212122991,0.28957759886016454,PDIA6,1
GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP,GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP,1/151,50/21728,0.29466759686074784,0.3939300212122991,0.28957759886016454,PTGES3,1
KENNY_CTNNB1_TARGETS_UP,KENNY_CTNNB1_TARGETS_UP,1/151,50/21728,0.29466759686074784,0.3939300212122991,0.28957759886016454,PKN1,1
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,1/151,50/21728,0.29466759686074784,0.3939300212122991,0.28957759886016454,LDLR,1
LIU_SMARCA4_TARGETS,LIU_SMARCA4_TARGETS,1/151,50/21728,0.29466759686074784,0.3939300212122991,0.28957759886016454,BCAM,1
MARTINEZ_RESPONSE_TO_TRABECTEDIN,MARTINEZ_RESPONSE_TO_TRABECTEDIN,1/151,50/21728,0.29466759686074784,0.3939300212122991,0.28957759886016454,GBE1,1
REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM,REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM,1/151,50/21728,0.29466759686074784,0.3939300212122991,0.28957759886016454,SDC4,1
REACTOME_NETRIN_1_SIGNALING,REACTOME_NETRIN_1_SIGNALING,1/151,50/21728,0.29466759686074784,0.3939300212122991,0.28957759886016454,UNC5C,1
REACTOME_SIGNALING_BY_FGFR1,REACTOME_SIGNALING_BY_FGFR1,1/151,50/21728,0.29466759686074784,0.3939300212122991,0.28957759886016454,UBC,1
WESTON_VEGFA_TARGETS_6HR,WESTON_VEGFA_TARGETS_6HR,1/151,50/21728,0.29466759686074784,0.3939300212122991,0.28957759886016454,SDC4,1
WONG_PROTEASOME_GENE_MODULE,WONG_PROTEASOME_GENE_MODULE,1/151,50/21728,0.29466759686074784,0.3939300212122991,0.28957759886016454,ARIH1,1
WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,1/151,50/21728,0.29466759686074784,0.3939300212122991,0.28957759886016454,BIRC3,1
WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,1/151,50/21728,0.29466759686074784,0.3939300212122991,0.28957759886016454,MAP2K3,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,1/151,50/21728,0.29466759686074784,0.3939300212122991,0.28957759886016454,SLC2A3,1
ZHAN_MULTIPLE_MYELOMA_HP_UP,ZHAN_MULTIPLE_MYELOMA_HP_UP,1/151,50/21728,0.29466759686074784,0.3939300212122991,0.28957759886016454,SCYL2,1
ZHOU_TNF_SIGNALING_4HR,ZHOU_TNF_SIGNALING_4HR,1/151,50/21728,0.29466759686074784,0.3939300212122991,0.28957759886016454,PRDX1,1
RUIZ_TNC_TARGETS_UP,RUIZ_TNC_TARGETS_UP,2/151,156/21728,0.29536363166666313,0.39467059584896114,0.2901219945992894,GBE1/SLC2A3,2
REACTOME_CELLULAR_RESPONSE_TO_STARVATION,REACTOME_CELLULAR_RESPONSE_TO_STARVATION,2/151,157/21728,0.29792969462511965,0.39781790112328974,0.2924355758323603,ATP6V1C1/ATP6V1A,2
BURTON_ADIPOGENESIS_11,BURTON_ADIPOGENESIS_11,1/151,51/21728,0.2995806512418726,0.39781790112328974,0.2924355758323603,PKD2,1
DAIRKEE_CANCER_PRONE_RESPONSE_BPA,DAIRKEE_CANCER_PRONE_RESPONSE_BPA,1/151,51/21728,0.2995806512418726,0.39781790112328974,0.2924355758323603,TRIP12,1
NATSUME_RESPONSE_TO_INTERFERON_BETA_DN,NATSUME_RESPONSE_TO_INTERFERON_BETA_DN,1/151,51/21728,0.2995806512418726,0.39781790112328974,0.2924355758323603,PRDX1,1
PID_CASPASE_PATHWAY,PID_CASPASE_PATHWAY,1/151,51/21728,0.2995806512418726,0.39781790112328974,0.2924355758323603,BIRC3,1
REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE,REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE,1/151,51/21728,0.2995806512418726,0.39781790112328974,0.2924355758323603,PKD2,1
REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE,REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE,1/151,51/21728,0.2995806512418726,0.39781790112328974,0.2924355758323603,HSPA8,1
ROESSLER_LIVER_CANCER_METASTASIS_DN,ROESSLER_LIVER_CANCER_METASTASIS_DN,1/151,51/21728,0.2995806512418726,0.39781790112328974,0.2924355758323603,WWTR1,1
TAVOR_CEBPA_TARGETS_UP,TAVOR_CEBPA_TARGETS_UP,1/151,51/21728,0.2995806512418726,0.39781790112328974,0.2924355758323603,AKAP12,1
VILIMAS_NOTCH1_TARGETS_UP,VILIMAS_NOTCH1_TARGETS_UP,1/151,51/21728,0.2995806512418726,0.39781790112328974,0.2924355758323603,BIRC3,1
WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,1/151,51/21728,0.2995806512418726,0.39781790112328974,0.2924355758323603,MAP2K3,1
WP_SYNAPTIC_SIGNALING_PATHWAYS_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,WP_SYNAPTIC_SIGNALING_PATHWAYS_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,1/151,51/21728,0.2995806512418726,0.39781790112328974,0.2924355758323603,PRKAG1,1
ZHOU_TNF_SIGNALING_30MIN,ZHOU_TNF_SIGNALING_30MIN,1/151,51/21728,0.2995806512418726,0.39781790112328974,0.2924355758323603,COPS2,1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,2/151,159/21728,0.30305754833864396,0.40160924496191897,0.29522258922591893,SSR1/GBE1,2
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,2/151,159/21728,0.30305754833864396,0.40160924496191897,0.29522258922591893,PERP/SLC2A3,2
AUNG_GASTRIC_CANCER,AUNG_GASTRIC_CANCER,1/151,52/21728,0.30445970838365777,0.40160924496191897,0.29522258922591893,PRKAG1,1
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP,BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP,1/151,52/21728,0.30445970838365777,0.40160924496191897,0.29522258922591893,PKD2,1
KEGG_MTOR_SIGNALING_PATHWAY,KEGG_MTOR_SIGNALING_PATHWAY,1/151,52/21728,0.30445970838365777,0.40160924496191897,0.29522258922591893,RPS6KA3,1
KEGG_STARCH_AND_SUCROSE_METABOLISM,KEGG_STARCH_AND_SUCROSE_METABOLISM,1/151,52/21728,0.30445970838365777,0.40160924496191897,0.29522258922591893,GBE1,1
KENNY_CTNNB1_TARGETS_DN,KENNY_CTNNB1_TARGETS_DN,1/151,52/21728,0.30445970838365777,0.40160924496191897,0.29522258922591893,SEL1L,1
PID_KIT_PATHWAY,PID_KIT_PATHWAY,1/151,52/21728,0.30445970838365777,0.40160924496191897,0.29522258922591893,JAK2,1
PRAMOONJAGO_SOX4_TARGETS_UP,PRAMOONJAGO_SOX4_TARGETS_UP,1/151,52/21728,0.30445970838365777,0.40160924496191897,0.29522258922591893,SLC2A3,1
REACTOME_APOPTOTIC_EXECUTION_PHASE,REACTOME_APOPTOTIC_EXECUTION_PHASE,1/151,52/21728,0.30445970838365777,0.40160924496191897,0.29522258922591893,STK24,1
REACTOME_AQUAPORIN_MEDIATED_TRANSPORT,REACTOME_AQUAPORIN_MEDIATED_TRANSPORT,1/151,52/21728,0.30445970838365777,0.40160924496191897,0.29522258922591893,PRKAR1A,1
ROSS_AML_WITH_CBFB_MYH11_FUSION,ROSS_AML_WITH_CBFB_MYH11_FUSION,1/151,52/21728,0.30445970838365777,0.40160924496191897,0.29522258922591893,CBFB,1
WANG_BARRETTS_ESOPHAGUS_UP,WANG_BARRETTS_ESOPHAGUS_UP,1/151,52/21728,0.30445970838365777,0.40160924496191897,0.29522258922591893,RALB,1
WP_SYNAPTIC_VESICLE_PATHWAY,WP_SYNAPTIC_VESICLE_PATHWAY,1/151,52/21728,0.30445970838365777,0.40160924496191897,0.29522258922591893,CLTC,1
REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2/151,160/21728,0.3056191324563211,0.40294729471459895,0.29620618837722024,UBC/PRDX1,2
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,4/151,403/21728,0.3076162705907831,0.4053880453990491,0.2980003819764902,HSP90B1/WWTR1/PCDH8/PRDX1,4
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN,2/151,161/21728,0.3081790194641649,0.4054975438912388,0.2980808742181059,SLC4A7/COPS2,2
BOYLAN_MULTIPLE_MYELOMA_C_D_DN,BOYLAN_MULTIPLE_MYELOMA_C_D_DN,3/151,280/21728,0.308513557611557,0.4054975438912388,0.2980808742181059,FNDC3B/LRP12/PAFAH2,3
JI_RESPONSE_TO_FSH_DN,JI_RESPONSE_TO_FSH_DN,1/151,53/21728,0.3093050019818341,0.4054975438912388,0.2980808742181059,YWHAZ,1
KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,1/151,53/21728,0.3093050019818341,0.4054975438912388,0.2980808742181059,MAP2K3,1
MARTIN_VIRAL_GPCR_SIGNALING_DN,MARTIN_VIRAL_GPCR_SIGNALING_DN,1/151,53/21728,0.3093050019818341,0.4054975438912388,0.2980808742181059,STBD1,1
PEART_HDAC_PROLIFERATION_CLUSTER_UP,PEART_HDAC_PROLIFERATION_CLUSTER_UP,1/151,53/21728,0.3093050019818341,0.4054975438912388,0.2980808742181059,PRDX1,1
PID_AR_TF_PATHWAY,PID_AR_TF_PATHWAY,1/151,53/21728,0.3093050019818341,0.4054975438912388,0.2980808742181059,PKN1,1
SMIRNOV_RESPONSE_TO_IR_2HR_UP,SMIRNOV_RESPONSE_TO_IR_2HR_UP,1/151,53/21728,0.3093050019818341,0.4054975438912388,0.2980808742181059,PPP1R15A,1
WP_VITAMIN_B12_METABOLISM,WP_VITAMIN_B12_METABOLISM,1/151,53/21728,0.3093050019818341,0.4054975438912388,0.2980808742181059,LDLR,1
WP_WNT_SIGNALING_PATHWAY,WP_WNT_SIGNALING_PATHWAY,1/151,53/21728,0.3093050019818341,0.4054975438912388,0.2980808742181059,CSNK1A1,1
YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP,YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP,1/151,53/21728,0.3093050019818341,0.4054975438912388,0.2980808742181059,PTPN12,1
WINNEPENNINCKX_MELANOMA_METASTASIS_UP,WINNEPENNINCKX_MELANOMA_METASTASIS_UP,2/151,162/21728,0.310737109732101,0.4071828730357437,0.29931975813320555,HSPA5/HSPA4,2
BECKER_TAMOXIFEN_RESISTANCE_UP,BECKER_TAMOXIFEN_RESISTANCE_UP,1/151,54/21728,0.31411676413642453,0.408719611602336,0.3004494132501731,NRIP1,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN,1/151,54/21728,0.31411676413642453,0.408719611602336,0.3004494132501731,LOXL1,1
DEMAGALHAES_AGING_UP,DEMAGALHAES_AGING_UP,1/151,54/21728,0.31411676413642453,0.408719611602336,0.3004494132501731,PTGES3,1
GENTILE_UV_RESPONSE_CLUSTER_D4,GENTILE_UV_RESPONSE_CLUSTER_D4,1/151,54/21728,0.31411676413642453,0.408719611602336,0.3004494132501731,ATP13A3,1
KEGG_NON_SMALL_CELL_LUNG_CANCER,KEGG_NON_SMALL_CELL_LUNG_CANCER,1/151,54/21728,0.31411676413642453,0.408719611602336,0.3004494132501731,ARAF,1
KYNG_DNA_DAMAGE_BY_UV,KYNG_DNA_DAMAGE_BY_UV,1/151,54/21728,0.31411676413642453,0.408719611602336,0.3004494132501731,SEC23A,1
REACTOME_G_PROTEIN_MEDIATED_EVENTS,REACTOME_G_PROTEIN_MEDIATED_EVENTS,1/151,54/21728,0.31411676413642453,0.408719611602336,0.3004494132501731,PRKAR1A,1
REACTOME_ION_HOMEOSTASIS,REACTOME_ION_HOMEOSTASIS,1/151,54/21728,0.31411676413642453,0.408719611602336,0.3004494132501731,ATP1A1,1
STARK_HYPPOCAMPUS_22Q11_DELETION_UP,STARK_HYPPOCAMPUS_22Q11_DELETION_UP,1/151,54/21728,0.31411676413642453,0.408719611602336,0.3004494132501731,SORT1,1
SUNG_METASTASIS_STROMA_DN,SUNG_METASTASIS_STROMA_DN,1/151,54/21728,0.31411676413642453,0.408719611602336,0.3004494132501731,EML1,1
VERRECCHIA_EARLY_RESPONSE_TO_TGFB1,VERRECCHIA_EARLY_RESPONSE_TO_TGFB1,1/151,54/21728,0.31411676413642453,0.408719611602336,0.3004494132501731,ADAM9,1
WAKASUGI_HAVE_ZNF143_BINDING_SITES,WAKASUGI_HAVE_ZNF143_BINDING_SITES,1/151,54/21728,0.31411676413642453,0.408719611602336,0.3004494132501731,RECQL,1
WP_COPPER_HOMEOSTASIS,WP_COPPER_HOMEOSTASIS,1/151,54/21728,0.31411676413642453,0.408719611602336,0.3004494132501731,ADAM9,1
WP_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,WP_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,1/151,54/21728,0.31411676413642453,0.408719611602336,0.3004494132501731,PCYT1A,1
ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF,ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF,1/151,54/21728,0.31411676413642453,0.408719611602336,0.3004494132501731,HSPA8,1
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP,2/151,164/21728,0.31584750875246026,0.4103949388748057,0.3016809447982733,API5/ZNF330,2
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN,2/151,164/21728,0.31584750875246026,0.4103949388748057,0.3016809447982733,YWHAZ/GARS1,2
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,2/151,164/21728,0.31584750875246026,0.4103949388748057,0.3016809447982733,ITGB3/EFNB2,2
WP_CHEMOKINE_SIGNALING_PATHWAY,WP_CHEMOKINE_SIGNALING_PATHWAY,2/151,165/21728,0.3183996254241397,0.41261804194560275,0.3033151458355005,CRK/JAK2,2
REACTOME_DEGRADATION_OF_AXIN,REACTOME_DEGRADATION_OF_AXIN,1/151,55/21728,0.3188952253625663,0.41261804194560275,0.3033151458355005,UBC,1
REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM,REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM,1/151,55/21728,0.3188952253625663,0.41261804194560275,0.3033151458355005,SDC4,1
REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS,REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS,1/151,55/21728,0.3188952253625663,0.41261804194560275,0.3033151458355005,YWHAZ,1
REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES,REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES,1/151,55/21728,0.3188952253625663,0.41261804194560275,0.3033151458355005,ATP1A1,1
REACTOME_RHOJ_GTPASE_CYCLE,REACTOME_RHOJ_GTPASE_CYCLE,1/151,55/21728,0.3188952253625663,0.41261804194560275,0.3033151458355005,SLC4A7,1
RICKMAN_HEAD_AND_NECK_CANCER_F,RICKMAN_HEAD_AND_NECK_CANCER_F,1/151,55/21728,0.3188952253625663,0.41261804194560275,0.3033151458355005,TPM1,1
WP_IL4_SIGNALING_PATHWAY,WP_IL4_SIGNALING_PATHWAY,1/151,55/21728,0.3188952253625663,0.41261804194560275,0.3033151458355005,JAK2,1
WP_NRP1TRIGGERED_SIGNALING_PATHWAYS_IN_PANCREATIC_CANCER,WP_NRP1TRIGGERED_SIGNALING_PATHWAYS_IN_PANCREATIC_CANCER,1/151,55/21728,0.3188952253625663,0.41261804194560275,0.3033151458355005,MET,1
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN,2/151,166/21728,0.3209495611646789,0.4148896607331214,0.3049850107317857,PDIA6/HSPA5,2
IBRAHIM_NRF1_DOWN,IBRAHIM_NRF1_DOWN,2/151,166/21728,0.3209495611646789,0.4148896607331214,0.3049850107317857,MOXD1/TPM1,2
PEDRIOLI_MIR31_TARGETS_DN,PEDRIOLI_MIR31_TARGETS_DN,4/151,412/21728,0.32173131797438453,0.4157067913176001,0.30558568267824043,FEM1C/AKAP12/BIRC3/NPAS2,4
REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR,REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR,2/151,167/21728,0.323497223434165,0.4162377904455119,0.3059760196522652,UBC/HUS1,2
CAFFAREL_RESPONSE_TO_THC_24HR_5_DN,CAFFAREL_RESPONSE_TO_THC_24HR_5_DN,1/151,56/21728,0.3236406146012619,0.4162377904455119,0.3059760196522652,GARS1,1
CROONQUIST_STROMAL_STIMULATION_UP,CROONQUIST_STROMAL_STIMULATION_UP,1/151,56/21728,0.3236406146012619,0.4162377904455119,0.3059760196522652,PPP1R15A,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN,1/151,56/21728,0.3236406146012619,0.4162377904455119,0.3059760196522652,PML,1
KEGG_HEDGEHOG_SIGNALING_PATHWAY,KEGG_HEDGEHOG_SIGNALING_PATHWAY,1/151,56/21728,0.3236406146012619,0.4162377904455119,0.3059760196522652,CSNK1A1,1
MAYBURD_RESPONSE_TO_L663536_DN,MAYBURD_RESPONSE_TO_L663536_DN,1/151,56/21728,0.3236406146012619,0.4162377904455119,0.3059760196522652,ACTB,1
MCCLUNG_CREB1_TARGETS_DN,MCCLUNG_CREB1_TARGETS_DN,1/151,56/21728,0.3236406146012619,0.4162377904455119,0.3059760196522652,ACTB,1
OUILLETTE_CLL_13Q14_DELETION_DN,OUILLETTE_CLL_13Q14_DELETION_DN,1/151,56/21728,0.3236406146012619,0.4162377904455119,0.3059760196522652,PKD2,1
PETROVA_PROX1_TARGETS_DN,PETROVA_PROX1_TARGETS_DN,1/151,56/21728,0.3236406146012619,0.4162377904455119,0.3059760196522652,PDLIM4,1
WP_CCL18_SIGNALING_PATHWAY,WP_CCL18_SIGNALING_PATHWAY,1/151,56/21728,0.3236406146012619,0.4162377904455119,0.3059760196522652,LDHA,1
PUJANA_XPRSS_INT_NETWORK,PUJANA_XPRSS_INT_NETWORK,2/151,168/21728,0.3260425210665694,0.4189390025545466,0.30796167820689646,ZNF330/RECQL,2
SMIRNOV_RESPONSE_TO_IR_6HR_UP,SMIRNOV_RESPONSE_TO_IR_6HR_UP,2/151,168/21728,0.3260425210665694,0.4189390025545466,0.30796167820689646,SLC35D1/ZNF654,2
AMIT_SERUM_RESPONSE_240_MCF10A,AMIT_SERUM_RESPONSE_240_MCF10A,1/151,57/21728,0.32835315923005537,0.4199655047610929,0.308716259041537,AKAP12,1
HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER,HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER,1/151,57/21728,0.32835315923005537,0.4199655047610929,0.308716259041537,PPFIBP1,1
NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON,NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON,1/151,57/21728,0.32835315923005537,0.4199655047610929,0.308716259041537,ADAM9,1
PID_SHP2_PATHWAY,PID_SHP2_PATHWAY,1/151,57/21728,0.32835315923005537,0.4199655047610929,0.308716259041537,JAK2,1
REACTOME_DEGRADATION_OF_DVL,REACTOME_DEGRADATION_OF_DVL,1/151,57/21728,0.32835315923005537,0.4199655047610929,0.308716259041537,UBC,1
REACTOME_STABILIZATION_OF_P53,REACTOME_STABILIZATION_OF_P53,1/151,57/21728,0.32835315923005537,0.4199655047610929,0.308716259041537,UBC,1
TONG_INTERACT_WITH_PTTG1,TONG_INTERACT_WITH_PTTG1,1/151,57/21728,0.32835315923005537,0.4199655047610929,0.308716259041537,CTNND1,1
WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,1/151,57/21728,0.32835315923005537,0.4199655047610929,0.308716259041537,TPM1,1
WP_CARDIAC_HYPERTROPHIC_RESPONSE,WP_CARDIAC_HYPERTROPHIC_RESPONSE,1/151,57/21728,0.32835315923005537,0.4199655047610929,0.308716259041537,MAP2K3,1
WP_IL1_SIGNALING_PATHWAY,WP_IL1_SIGNALING_PATHWAY,1/151,57/21728,0.32835315923005537,0.4199655047610929,0.308716259041537,MAP2K3,1
NABA_ECM_AFFILIATED,NABA_ECM_AFFILIATED,2/151,170/21728,0.33112566453914705,0.4231622339669001,0.3110661717615044,LMAN1/SDC4,2
MANALO_HYPOXIA_DN,MANALO_HYPOXIA_DN,3/151,292/21728,0.3313095244341281,0.4231622339669001,0.3110661717615044,ATP13A3/MCFD2/MAP2K3,3
REACTOME_CELL_CYCLE_CHECKPOINTS,REACTOME_CELL_CYCLE_CHECKPOINTS,3/151,292/21728,0.3313095244341281,0.4231622339669001,0.3110661717615044,UBC/YWHAZ/HUS1,3
CROMER_TUMORIGENESIS_UP,CROMER_TUMORIGENESIS_UP,1/151,58/21728,0.33303308507363705,0.42419344811305076,0.31182421633864515,SLC2A3,1
HUPER_BREAST_BASAL_VS_LUMINAL_DN,HUPER_BREAST_BASAL_VS_LUMINAL_DN,1/151,58/21728,0.33303308507363705,0.42419344811305076,0.31182421633864515,LOXL1,1
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN,1/151,58/21728,0.33303308507363705,0.42419344811305076,0.31182421633864515,BIRC3,1
KOHOUTEK_CCNT2_TARGETS,KOHOUTEK_CCNT2_TARGETS,1/151,58/21728,0.33303308507363705,0.42419344811305076,0.31182421633864515,SLC4A7,1
LEE_EARLY_T_LYMPHOCYTE_DN,LEE_EARLY_T_LYMPHOCYTE_DN,1/151,58/21728,0.33303308507363705,0.42419344811305076,0.31182421633864515,SLC2A3,1
LIM_MAMMARY_LUMINAL_PROGENITOR_UP,LIM_MAMMARY_LUMINAL_PROGENITOR_UP,1/151,58/21728,0.33303308507363705,0.42419344811305076,0.31182421633864515,HIVEP3,1
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,4/151,421/21728,0.3358958186918627,0.4269807703227787,0.3138731743496611,DUSP5/BIRC3/PML/SLC12A4,4
REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2/151,172/21728,0.33619828918779626,0.4269807703227787,0.3138731743496611,UBC/ETF1,2
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP,1/151,59/21728,0.33768061641437896,0.4269807703227787,0.3138731743496611,PERP,1
BOYLAN_MULTIPLE_MYELOMA_C_DN,BOYLAN_MULTIPLE_MYELOMA_C_DN,1/151,59/21728,0.33768061641437896,0.4269807703227787,0.3138731743496611,NRIP1,1
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN,BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN,1/151,59/21728,0.33768061641437896,0.4269807703227787,0.3138731743496611,DUSP3,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,1/151,59/21728,0.33768061641437896,0.4269807703227787,0.3138731743496611,WWTR1,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP,1/151,59/21728,0.33768061641437896,0.4269807703227787,0.3138731743496611,PVR,1
GALE_APL_WITH_FLT3_MUTATED_UP,GALE_APL_WITH_FLT3_MUTATED_UP,1/151,59/21728,0.33768061641437896,0.4269807703227787,0.3138731743496611,CSNK1A1,1
KEGG_RNA_DEGRADATION,KEGG_RNA_DEGRADATION,1/151,59/21728,0.33768061641437896,0.4269807703227787,0.3138731743496611,HSPA9,1
MORI_LARGE_PRE_BII_LYMPHOCYTE_DN,MORI_LARGE_PRE_BII_LYMPHOCYTE_DN,1/151,59/21728,0.33768061641437896,0.4269807703227787,0.3138731743496611,BIRC3,1
PID_FAK_PATHWAY,PID_FAK_PATHWAY,1/151,59/21728,0.33768061641437896,0.4269807703227787,0.3138731743496611,CRK,1
PID_P53_REGULATION_PATHWAY,PID_P53_REGULATION_PATHWAY,1/151,59/21728,0.33768061641437896,0.4269807703227787,0.3138731743496611,CSNK1A1,1
REACTOME_ARACHIDONIC_ACID_METABOLISM,REACTOME_ARACHIDONIC_ACID_METABOLISM,1/151,59/21728,0.33768061641437896,0.4269807703227787,0.3138731743496611,PTGES3,1
REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX,REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX,1/151,59/21728,0.33768061641437896,0.4269807703227787,0.3138731743496611,UBC,1
REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS,REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS,1/151,59/21728,0.33768061641437896,0.4269807703227787,0.3138731743496611,UBC,1
ZHENG_IL22_SIGNALING_UP,ZHENG_IL22_SIGNALING_UP,1/151,59/21728,0.33768061641437896,0.4269807703227787,0.3138731743496611,SBNO2,1
REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE,REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE,3/151,296/21728,0.33890879035722277,0.4283387714341969,0.31487143972655146,HSPA9/PKD2/PRKAG1,3
BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,2/151,174/21728,0.3412597136917953,0.43046546914249456,0.31643477326984176,PPP1R15A/ZNF654,2
KATSANOU_ELAVL1_TARGETS_UP,KATSANOU_ELAVL1_TARGETS_UP,2/151,174/21728,0.3412597136917953,0.43046546914249456,0.31643477326984176,SORT1/LAMA5,2
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,1/151,60/21728,0.34229597600279715,0.43046546914249456,0.31643477326984176,MET,1
KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,1/151,60/21728,0.34229597600279715,0.43046546914249456,0.31643477326984176,DUSP5,1
LEE_LIVER_CANCER_DENA_UP,LEE_LIVER_CANCER_DENA_UP,1/151,60/21728,0.34229597600279715,0.43046546914249456,0.31643477326984176,LAMA5,1
NADLER_OBESITY_UP,NADLER_OBESITY_UP,1/151,60/21728,0.34229597600279715,0.43046546914249456,0.31643477326984176,ATP6V1C1,1
REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,1/151,60/21728,0.34229597600279715,0.43046546914249456,0.31643477326984176,EIF4H,1
REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME,REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME,1/151,60/21728,0.34229597600279715,0.43046546914249456,0.31643477326984176,UBC,1
REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,1/151,60/21728,0.34229597600279715,0.43046546914249456,0.31643477326984176,UBC,1
WP_PREIMPLANTATION_EMBRYO,WP_PREIMPLANTATION_EMBRYO,1/151,60/21728,0.34229597600279715,0.43046546914249456,0.31643477326984176,ATP1A1,1
ZHENG_GLIOBLASTOMA_PLASTICITY_DN,ZHENG_GLIOBLASTOMA_PLASTICITY_DN,1/151,60/21728,0.34229597600279715,0.43046546914249456,0.31643477326984176,PDLIM4,1
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,2/151,176/21728,0.3463092773620521,0.4344593921184605,0.31937070240226345,HSPA8/PGM3,2
ISSAEVA_MLL2_TARGETS,ISSAEVA_MLL2_TARGETS,1/151,61/21728,0.3468793850679429,0.4344593921184605,0.31937070240226345,LOXL1,1
KAUFFMANN_MELANOMA_RELAPSE_UP,KAUFFMANN_MELANOMA_RELAPSE_UP,1/151,61/21728,0.3468793850679429,0.4344593921184605,0.31937070240226345,HUS1,1
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN,1/151,61/21728,0.3468793850679429,0.4344593921184605,0.31937070240226345,MET,1
LINDSTEDT_DENDRITIC_CELL_MATURATION_A,LINDSTEDT_DENDRITIC_CELL_MATURATION_A,1/151,61/21728,0.3468793850679429,0.4344593921184605,0.31937070240226345,ATP13A3,1
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP,MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP,1/151,61/21728,0.3468793850679429,0.4344593921184605,0.31937070240226345,CTNND1,1
PID_TRKR_PATHWAY,PID_TRKR_PATHWAY,1/151,61/21728,0.3468793850679429,0.4344593921184605,0.31937070240226345,CRK,1
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN,POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN,1/151,61/21728,0.3468793850679429,0.4344593921184605,0.31937070240226345,LAMC1,1
WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,1/151,61/21728,0.3468793850679429,0.4344593921184605,0.31937070240226345,RASA2,1
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,2/151,177/21728,0.3488294104536337,0.4367048680667843,0.32102134972132984,YWHAZ/RECQL,2
REACTOME_THE_CITRIC_ACID_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT,REACTOME_THE_CITRIC_ACID_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT,2/151,178/21728,0.3513463397069182,0.4377917013114016,0.32182027984696265,VDAC1/LDHA,2
DAZARD_UV_RESPONSE_CLUSTER_G1,DAZARD_UV_RESPONSE_CLUSTER_G1,1/151,62/21728,0.351431063327727,0.4377917013114016,0.32182027984696265,ZNF330,1
GEORGES_CELL_CYCLE_MIR192_TARGETS,GEORGES_CELL_CYCLE_MIR192_TARGETS,1/151,62/21728,0.351431063327727,0.4377917013114016,0.32182027984696265,CRK,1
GERHOLD_ADIPOGENESIS_DN,GERHOLD_ADIPOGENESIS_DN,1/151,62/21728,0.351431063327727,0.4377917013114016,0.32182027984696265,HSPA8,1
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP,HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP,1/151,62/21728,0.351431063327727,0.4377917013114016,0.32182027984696265,ACTR2,1
KEGG_COLORECTAL_CANCER,KEGG_COLORECTAL_CANCER,1/151,62/21728,0.351431063327727,0.4377917013114016,0.32182027984696265,ARAF,1
KEGG_GLYCOLYSIS_GLUCONEOGENESIS,KEGG_GLYCOLYSIS_GLUCONEOGENESIS,1/151,62/21728,0.351431063327727,0.4377917013114016,0.32182027984696265,LDHA,1
MASSARWEH_RESPONSE_TO_ESTRADIOL,MASSARWEH_RESPONSE_TO_ESTRADIOL,1/151,62/21728,0.351431063327727,0.4377917013114016,0.32182027984696265,NRIP1,1
REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING,REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING,1/151,62/21728,0.351431063327727,0.4377917013114016,0.32182027984696265,UBC,1
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN,1/151,62/21728,0.351431063327727,0.4377917013114016,0.32182027984696265,IQGAP1,1
WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,1/151,62/21728,0.351431063327727,0.4377917013114016,0.32182027984696265,ITGB3,1
BOCHKIS_FOXA2_TARGETS,BOCHKIS_FOXA2_TARGETS,4/151,433/21728,0.3548238541661114,0.44182011065596477,0.3247815598774475,NRIP1/SORT1/PRDX1/LDLR,4
BURTON_ADIPOGENESIS_PEAK_AT_0HR,BURTON_ADIPOGENESIS_PEAK_AT_0HR,1/151,63/21728,0.3559512289991713,0.44203509797036117,0.324939596855936,TPM1,1
JOHNSTONE_PARVB_TARGETS_1_DN,JOHNSTONE_PARVB_TARGETS_1_DN,1/151,63/21728,0.3559512289991713,0.44203509797036117,0.324939596855936,SEPTIN11,1
LEE_LIVER_CANCER_E2F1_UP,LEE_LIVER_CANCER_E2F1_UP,1/151,63/21728,0.3559512289991713,0.44203509797036117,0.324939596855936,ACTG1,1
LEE_LIVER_CANCER_MYC_DN,LEE_LIVER_CANCER_MYC_DN,1/151,63/21728,0.3559512289991713,0.44203509797036117,0.324939596855936,HSPA5,1
REACTOME_PEROXISOMAL_PROTEIN_IMPORT,REACTOME_PEROXISOMAL_PROTEIN_IMPORT,1/151,63/21728,0.3559512289991713,0.44203509797036117,0.324939596855936,UBC,1
ZHANG_GATA6_TARGETS_DN,ZHANG_GATA6_TARGETS_DN,1/151,63/21728,0.3559512289991713,0.44203509797036117,0.324939596855936,LDLR,1
RIGGI_EWING_SARCOMA_PROGENITOR_UP,RIGGI_EWING_SARCOMA_PROGENITOR_UP,4/151,434/21728,0.3564020791067667,0.4423972188376219,0.32520579157477414,ATP1A1/DUSP5/HIVEP3/PVR,4
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP,DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP,1/151,64/21728,0.3604400988085932,0.44601451870390724,0.32786486540319815,MET,1
GENTILE_UV_LOW_DOSE_DN,GENTILE_UV_LOW_DOSE_DN,1/151,64/21728,0.3604400988085932,0.44601451870390724,0.32786486540319815,GBE1,1
REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,1/151,64/21728,0.3604400988085932,0.44601451870390724,0.32786486540319815,UBC,1
REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA,REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA,1/151,64/21728,0.3604400988085932,0.44601451870390724,0.32786486540319815,UBC,1
REACTOME_SEMAPHORIN_INTERACTIONS,REACTOME_SEMAPHORIN_INTERACTIONS,1/151,64/21728,0.3604400988085932,0.44601451870390724,0.32786486540319815,MET,1
WP_PROTEASOME_DEGRADATION,WP_PROTEASOME_DEGRADATION,1/151,64/21728,0.3604400988085932,0.44601451870390724,0.32786486540319815,UBC,1
ZHAN_MULTIPLE_MYELOMA_UP,ZHAN_MULTIPLE_MYELOMA_UP,1/151,64/21728,0.3604400988085932,0.44601451870390724,0.32786486540319815,LAMC1,1
KEGG_HUNTINGTONS_DISEASE,KEGG_HUNTINGTONS_DISEASE,2/151,182/21728,0.3613804968913924,0.4469790829760855,0.3285739157188458,CLTC/VDAC1,2
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,3/151,309/21728,0.3635606814937048,0.4485337756056541,0.32971676885111173,RPS6KA3/HSPA4/NRIP1,3
AMIT_SERUM_RESPONSE_120_MCF10A,AMIT_SERUM_RESPONSE_120_MCF10A,1/151,65/21728,0.36489788800172007,0.4485337756056541,0.32971676885111173,FEM1B,1
DELPUECH_FOXO3_TARGETS_UP,DELPUECH_FOXO3_TARGETS_UP,1/151,65/21728,0.36489788800172007,0.4485337756056541,0.32971676885111173,DUSP5,1
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,1/151,65/21728,0.36489788800172007,0.4485337756056541,0.32971676885111173,PTPN12,1
GUO_HEX_TARGETS_DN,GUO_HEX_TARGETS_DN,1/151,65/21728,0.36489788800172007,0.4485337756056541,0.32971676885111173,ACTB,1
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN,JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN,1/151,65/21728,0.36489788800172007,0.4485337756056541,0.32971676885111173,HSPA4,1
KEGG_GLIOMA,KEGG_GLIOMA,1/151,65/21728,0.36489788800172007,0.4485337756056541,0.32971676885111173,ARAF,1
KORKOLA_YOLK_SAC_TUMOR,KORKOLA_YOLK_SAC_TUMOR,1/151,65/21728,0.36489788800172007,0.4485337756056541,0.32971676885111173,SLC2A3,1
PID_LYSOPHOSPHOLIPID_PATHWAY,PID_LYSOPHOSPHOLIPID_PATHWAY,1/151,65/21728,0.36489788800172007,0.4485337756056541,0.32971676885111173,CRK,1
PID_RB_1PATHWAY,PID_RB_1PATHWAY,1/151,65/21728,0.36489788800172007,0.4485337756056541,0.32971676885111173,MET,1
REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3,REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3,1/151,65/21728,0.36489788800172007,0.4485337756056541,0.32971676885111173,PKN1,1
REACTOME_DUAL_INCISION_IN_TC_NER,REACTOME_DUAL_INCISION_IN_TC_NER,1/151,65/21728,0.36489788800172007,0.4485337756056541,0.32971676885111173,UBC,1
REACTOME_RAB_GERANYLGERANYLATION,REACTOME_RAB_GERANYLGERANYLATION,1/151,65/21728,0.36489788800172007,0.4485337756056541,0.32971676885111173,RAB21,1
REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY,REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY,1/151,65/21728,0.36489788800172007,0.4485337756056541,0.32971676885111173,UBC,1
WANG_CISPLATIN_RESPONSE_AND_XPC_UP,WANG_CISPLATIN_RESPONSE_AND_XPC_UP,2/151,185/21728,0.3688688218429138,0.45277331119271036,0.3328332475896548,HSP90B1/HSPA5,2
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN,1/151,66/21728,0.3693248103537371,0.45277331119271036,0.3328332475896548,MOXD1,1
FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP,FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP,1/151,66/21728,0.3693248103537371,0.45277331119271036,0.3328332475896548,CTNNA1,1
REACTOME_FOXO_MEDIATED_TRANSCRIPTION,REACTOME_FOXO_MEDIATED_TRANSCRIPTION,1/151,66/21728,0.3693248103537371,0.45277331119271036,0.3328332475896548,YWHAZ,1
SWEET_KRAS_TARGETS_DN,SWEET_KRAS_TARGETS_DN,1/151,66/21728,0.3693248103537371,0.45277331119271036,0.3328332475896548,CALU,1
WP_AGERAGE_PATHWAY,WP_AGERAGE_PATHWAY,1/151,66/21728,0.3693248103537371,0.45277331119271036,0.3328332475896548,JAK2,1
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,2/151,186/21728,0.37135744925741976,0.45506439966348133,0.33451742463231926,AKAP12/MAP2K3,2
BEIER_GLIOMA_STEM_CELL_DN,BEIER_GLIOMA_STEM_CELL_DN,1/151,67/21728,0.3737210781792648,0.45609736239781706,0.3352767545950381,DUSP3,1
BROWNE_INTERFERON_RESPONSIVE_GENES,BROWNE_INTERFERON_RESPONSIVE_GENES,1/151,67/21728,0.3737210781792648,0.45609736239781706,0.3352767545950381,PML,1
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS,1/151,67/21728,0.3737210781792648,0.45609736239781706,0.3352767545950381,IQGAP1,1
CADWELL_ATG16L1_TARGETS_DN,CADWELL_ATG16L1_TARGETS_DN,1/151,67/21728,0.3737210781792648,0.45609736239781706,0.3352767545950381,PPFIBP1,1
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN,MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN,1/151,67/21728,0.3737210781792648,0.45609736239781706,0.3352767545950381,PERP,1
RIGGINS_TAMOXIFEN_RESISTANCE_UP,RIGGINS_TAMOXIFEN_RESISTANCE_UP,1/151,67/21728,0.3737210781792648,0.45609736239781706,0.3352767545950381,TPM1,1
JISON_SICKLE_CELL_DISEASE_DN,JISON_SICKLE_CELL_DISEASE_DN,2/151,187/21728,0.37384222252693644,0.45609736239781706,0.3352767545950381,SLC4A7/HSPA8,2
RAO_BOUND_BY_SALL4_ISOFORM_A,RAO_BOUND_BY_SALL4_ISOFORM_A,2/151,187/21728,0.37384222252693644,0.45609736239781706,0.3352767545950381,TRIP12/CALU,2
REACTOME_SUMOYLATION,REACTOME_SUMOYLATION,2/151,187/21728,0.37384222252693644,0.45609736239781706,0.3352767545950381,NRIP1/PML,2
VERHAAK_AML_WITH_NPM1_MUTATED_UP,VERHAAK_AML_WITH_NPM1_MUTATED_UP,2/151,187/21728,0.37384222252693644,0.45609736239781706,0.3352767545950381,ITGB3/SORT1,2
CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70,CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70,1/151,68/21728,0.3780869023422735,0.46026530004681676,0.3383406017546984,CTNND1,1
KEGG_P53_SIGNALING_PATHWAY,KEGG_P53_SIGNALING_PATHWAY,1/151,68/21728,0.3780869023422735,0.46026530004681676,0.3383406017546984,PERP,1
REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS,REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS,1/151,68/21728,0.3780869023422735,0.46026530004681676,0.3383406017546984,UBC,1
WP_AMPACTIVATED_PROTEIN_KINASE_AMPK_SIGNALING,WP_AMPACTIVATED_PROTEIN_KINASE_AMPK_SIGNALING,1/151,68/21728,0.3780869023422735,0.46026530004681676,0.3383406017546984,PRKAG1,1
WP_MELANOMA,WP_MELANOMA,1/151,68/21728,0.3780869023422735,0.46026530004681676,0.3383406017546984,ARAF,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,3/151,317/21728,0.37866701319468277,0.46072952610646944,0.33868185390722244,DUSP3/ZNF330/PVR,3
KEGG_CHEMOKINE_SIGNALING_PATHWAY,KEGG_CHEMOKINE_SIGNALING_PATHWAY,2/151,189/21728,0.3787999415504594,0.46072952610646944,0.33868185390722244,CRK/JAK2,2
AKL_HTLV1_INFECTION_DN,AKL_HTLV1_INFECTION_DN,1/151,69/21728,0.3824224922659263,0.4637270437688518,0.34088532640353625,SDF4,1
KEGG_PPAR_SIGNALING_PATHWAY,KEGG_PPAR_SIGNALING_PATHWAY,1/151,69/21728,0.3824224922659263,0.4637270437688518,0.34088532640353625,UBC,1
REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY,REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY,1/151,69/21728,0.3824224922659263,0.4637270437688518,0.34088532640353625,UBC,1
RHODES_UNDIFFERENTIATED_CANCER,RHODES_UNDIFFERENTIATED_CANCER,1/151,69/21728,0.3824224922659263,0.4637270437688518,0.34088532640353625,GARS1,1
WP_DNA_DAMAGE_RESPONSE,WP_DNA_DAMAGE_RESPONSE,1/151,69/21728,0.3824224922659263,0.4637270437688518,0.34088532640353625,PML,1
WP_RAC1PAK1P38MMP2_PATHWAY,WP_RAC1PAK1P38MMP2_PATHWAY,1/151,69/21728,0.3824224922659263,0.4637270437688518,0.34088532640353625,CRK,1
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,3/151,319/21728,0.3824329219850394,0.4637270437688518,0.34088532640353625,SEL1L/TMCO3/SEC24A,3
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,3/151,321/21728,0.386193956157587,0.46689723572701947,0.34321573161699737,ATP13A3/APLP2/SLC2A3,3
CROONQUIST_NRAS_SIGNALING_DN,CROONQUIST_NRAS_SIGNALING_DN,1/151,70/21728,0.3867280559423585,0.46689723572701947,0.34321573161699737,SBNO2,1
FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN,FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN,1/151,70/21728,0.3867280559423585,0.46689723572701947,0.34321573161699737,VDAC1,1
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,1/151,70/21728,0.3867280559423585,0.46689723572701947,0.34321573161699737,FURIN,1
KEGG_LONG_TERM_DEPRESSION,KEGG_LONG_TERM_DEPRESSION,1/151,70/21728,0.3867280559423585,0.46689723572701947,0.34321573161699737,ARAF,1
PID_AP1_PATHWAY,PID_AP1_PATHWAY,1/151,70/21728,0.3867280559423585,0.46689723572701947,0.34321573161699737,CBFB,1
ROSS_AML_OF_FAB_M7_TYPE,ROSS_AML_OF_FAB_M7_TYPE,1/151,70/21728,0.3867280559423585,0.46689723572701947,0.34321573161699737,TPM1,1
SESTO_RESPONSE_TO_UV_C7,SESTO_RESPONSE_TO_UV_C7,1/151,70/21728,0.3867280559423585,0.46689723572701947,0.34321573161699737,HSPA5,1
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,1/151,70/21728,0.3867280559423585,0.46689723572701947,0.34321573161699737,SSR1,1
WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,1/151,70/21728,0.3867280559423585,0.46689723572701947,0.34321573161699737,PCYT1A,1
BURTON_ADIPOGENESIS_6,BURTON_ADIPOGENESIS_6,2/151,193/21728,0.38866627477726845,0.4688297487326321,0.34463632016267143,GBE1/CD151,2
FUJII_YBX1_TARGETS_DN,FUJII_YBX1_TARGETS_DN,2/151,193/21728,0.38866627477726845,0.4688297487326321,0.34463632016267143,SSR1/CALU,2
DER_IFN_GAMMA_RESPONSE_UP,DER_IFN_GAMMA_RESPONSE_UP,1/151,71/21728,0.3910037999423911,0.46995573362244036,0.3454640306269313,PML,1
GU_PDEF_TARGETS_UP,GU_PDEF_TARGETS_UP,1/151,71/21728,0.3910037999423911,0.46995573362244036,0.3454640306269313,LAMC1,1
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,1/151,71/21728,0.3910037999423911,0.46995573362244036,0.3454640306269313,NPAS2,1
LIN_NPAS4_TARGETS_DN,LIN_NPAS4_TARGETS_DN,1/151,71/21728,0.3910037999423911,0.46995573362244036,0.3454640306269313,SLC4A7,1
PEART_HDAC_PROLIFERATION_CLUSTER_DN,PEART_HDAC_PROLIFERATION_CLUSTER_DN,1/151,71/21728,0.3910037999423911,0.46995573362244036,0.3454640306269313,ZNF330,1
REACTOME_ORC1_REMOVAL_FROM_CHROMATIN,REACTOME_ORC1_REMOVAL_FROM_CHROMATIN,1/151,71/21728,0.3910037999423911,0.46995573362244036,0.3454640306269313,UBC,1
SESTO_RESPONSE_TO_UV_C8,SESTO_RESPONSE_TO_UV_C8,1/151,71/21728,0.3910037999423911,0.46995573362244036,0.3454640306269313,CTNNA1,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP,2/151,194/21728,0.3911222664273154,0.46995573362244036,0.3454640306269313,SBNO2/ARSJ,2
REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2/151,194/21728,0.3911222664273154,0.46995573362244036,0.3454640306269313,ITGB3/SDC4,2
CROMER_METASTASIS_UP,CROMER_METASTASIS_UP,1/151,72/21728,0.3952499294251772,0.47327771721687173,0.3479060177335952,SLC2A3,1
KEGG_LEISHMANIA_INFECTION,KEGG_LEISHMANIA_INFECTION,1/151,72/21728,0.3952499294251772,0.47327771721687173,0.3479060177335952,JAK2,1
LIN_MELANOMA_COPY_NUMBER_UP,LIN_MELANOMA_COPY_NUMBER_UP,1/151,72/21728,0.3952499294251772,0.47327771721687173,0.3479060177335952,IQGAP1,1
LIU_NASOPHARYNGEAL_CARCINOMA,LIU_NASOPHARYNGEAL_CARCINOMA,1/151,72/21728,0.3952499294251772,0.47327771721687173,0.3479060177335952,SSR1,1
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN,1/151,72/21728,0.3952499294251772,0.47327771721687173,0.3479060177335952,CSNK1A1,1
WP_NONSMALL_CELL_LUNG_CANCER,WP_NONSMALL_CELL_LUNG_CANCER,1/151,72/21728,0.3952499294251772,0.47327771721687173,0.3479060177335952,ARAF,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,1/151,72/21728,0.3952499294251772,0.47327771721687173,0.3479060177335952,MET,1
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN,YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN,1/151,72/21728,0.3952499294251772,0.47327771721687173,0.3479060177335952,HSPA8,1
NABA_ECM_GLYCOPROTEINS,NABA_ECM_GLYCOPROTEINS,2/151,196/21728,0.3960211223642167,0.473996845294181,0.34843464812652464,LAMC1/LAMA5,2
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,3/151,327/21728,0.3974448967417269,0.47549609093390066,0.3495367422271862,SSR1/ADAM9/APLP2,3
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,2/151,197/21728,0.3984638714776223,0.47627396933671534,0.35010855993074447,APLP2/STBD1,2
CASTELLANO_NRAS_TARGETS_UP,CASTELLANO_NRAS_TARGETS_UP,1/151,73/21728,0.399466648147785,0.47627396933671534,0.35010855993074447,PERP,1
FURUKAWA_DUSP6_TARGETS_PCI35_DN,FURUKAWA_DUSP6_TARGETS_PCI35_DN,1/151,73/21728,0.399466648147785,0.47627396933671534,0.35010855993074447,EPHA2,1
LEE_AGING_CEREBELLUM_DN,LEE_AGING_CEREBELLUM_DN,1/151,73/21728,0.399466648147785,0.47627396933671534,0.35010855993074447,HSPA4,1
LINDVALL_IMMORTALIZED_BY_TERT_DN,LINDVALL_IMMORTALIZED_BY_TERT_DN,1/151,73/21728,0.399466648147785,0.47627396933671534,0.35010855993074447,AKAP12,1
MCCLUNG_COCAIN_REWARD_4WK,MCCLUNG_COCAIN_REWARD_4WK,1/151,73/21728,0.399466648147785,0.47627396933671534,0.35010855993074447,SLC35D1,1
REACTOME_SIGNALING_BY_FGFR2,REACTOME_SIGNALING_BY_FGFR2,1/151,73/21728,0.399466648147785,0.47627396933671534,0.35010855993074447,UBC,1
WP_FOLATE_METABOLISM,WP_FOLATE_METABOLISM,1/151,73/21728,0.399466648147785,0.47627396933671534,0.35010855993074447,LDLR,1
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,2/151,198/21728,0.40090209290395207,0.4777803578237575,0.35121590473195013,ATP6V1A/FEM1C,2
FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,3/151,329/21728,0.4011835425841799,0.4779107552739501,0.3513117597785091,APLP2/FEM1C/PGRMC2,3
XU_GH1_AUTOCRINE_TARGETS_UP,XU_GH1_AUTOCRINE_TARGETS_UP,2/151,199/21728,0.40333573153795277,0.4796198683673052,0.3525681272526892,RPS6KA3/PRDX1,2
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,1/151,74/21728,0.4036541584747154,0.4796198683673052,0.3525681272526892,HSPA5,1
DER_IFN_ALPHA_RESPONSE_UP,DER_IFN_ALPHA_RESPONSE_UP,1/151,74/21728,0.4036541584747154,0.4796198683673052,0.3525681272526892,PML,1
FOROUTAN_INTEGRATED_TGFB_EMT_DN,FOROUTAN_INTEGRATED_TGFB_EMT_DN,1/151,74/21728,0.4036541584747154,0.4796198683673052,0.3525681272526892,BIRC3,1
PID_AVB3_INTEGRIN_PATHWAY,PID_AVB3_INTEGRIN_PATHWAY,1/151,74/21728,0.4036541584747154,0.4796198683673052,0.3525681272526892,ITGB3,1
REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,1/151,74/21728,0.4036541584747154,0.4796198683673052,0.3525681272526892,UBC,1
MEBARKI_HCC_PROGENITOR_WNT_UP,MEBARKI_HCC_PROGENITOR_WNT_UP,2/151,200/21728,0.40576473324741424,0.48192151729855354,0.35426006728020687,SEPTIN11/MOXD1,2
ANDERSEN_LIVER_CANCER_KRT19_DN,ANDERSEN_LIVER_CANCER_KRT19_DN,1/151,75/21728,0.40781266138735617,0.48311453020642875,0.3551370499793383,SEL1L,1
JAIN_NFKB_SIGNALING,JAIN_NFKB_SIGNALING,1/151,75/21728,0.40781266138735617,0.48311453020642875,0.3551370499793383,JAK2,1
REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING,REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING,1/151,75/21728,0.40781266138735617,0.48311453020642875,0.3551370499793383,ESR2,1
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,1/151,75/21728,0.40781266138735617,0.48311453020642875,0.3551370499793383,EFNB2,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3,1/151,75/21728,0.40781266138735617,0.48311453020642875,0.3551370499793383,TPM1,1
TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,1/151,75/21728,0.40781266138735617,0.48311453020642875,0.3551370499793383,MET,1
NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,3/151,334/21728,0.4105020269007841,0.48580525134169367,0.35711499662873164,PRKAR1A/ACTG1/CLTC,3
SHEPARD_BMYB_MORPHOLINO_DN,SHEPARD_BMYB_MORPHOLINO_DN,2/151,202/21728,0.41060861416497363,0.48580525134169367,0.35711499662873164,ATP1A1/MGAT4B,2
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,2/151,202/21728,0.41060861416497363,0.48580525134169367,0.35711499662873164,CSNK1A1/EGLN1,2
BRUECKNER_TARGETS_OF_MIRLET7A3_DN,BRUECKNER_TARGETS_OF_MIRLET7A3_DN,1/151,76/21728,0.41194235649336974,0.4865543649398729,0.3576656693506701,ACTR3,1
SHEPARD_BMYB_TARGETS,SHEPARD_BMYB_TARGETS,1/151,76/21728,0.41194235649336974,0.4865543649398729,0.3576656693506701,ATP1A1,1
WP_16P112_PROXIMAL_DELETION_SYNDROME,WP_16P112_PROXIMAL_DELETION_SYNDROME,1/151,76/21728,0.41194235649336974,0.4865543649398729,0.3576656693506701,MAP2K3,1
WP_LEPTIN_SIGNALING_PATHWAY,WP_LEPTIN_SIGNALING_PATHWAY,1/151,76/21728,0.41194235649336974,0.4865543649398729,0.3576656693506701,JAK2,1
CROMER_METASTASIS_DN,CROMER_METASTASIS_DN,1/151,77/21728,0.41604344203602206,0.48935199290142273,0.35972220311043923,SDC4,1
FRIDMAN_SENESCENCE_UP,FRIDMAN_SENESCENCE_UP,1/151,77/21728,0.41604344203602206,0.48935199290142273,0.35972220311043923,MAP2K3,1
GROSS_HYPOXIA_VIA_HIF1A_UP,GROSS_HYPOXIA_VIA_HIF1A_UP,1/151,77/21728,0.41604344203602206,0.48935199290142273,0.35972220311043923,MGAT4B,1
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,1/151,77/21728,0.41604344203602206,0.48935199290142273,0.35972220311043923,SDC4,1
KEGG_GLYCEROPHOSPHOLIPID_METABOLISM,KEGG_GLYCEROPHOSPHOLIPID_METABOLISM,1/151,77/21728,0.41604344203602206,0.48935199290142273,0.35972220311043923,PCYT1A,1
KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,1/151,77/21728,0.41604344203602206,0.48935199290142273,0.35972220311043923,MET,1
LEE_AGING_NEOCORTEX_UP,LEE_AGING_NEOCORTEX_UP,1/151,77/21728,0.41604344203602206,0.48935199290142273,0.35972220311043923,UBC,1
REACTOME_RMTS_METHYLATE_HISTONE_ARGININES,REACTOME_RMTS_METHYLATE_HISTONE_ARGININES,1/151,77/21728,0.41604344203602206,0.48935199290142273,0.35972220311043923,JAK2,1
REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,1/151,77/21728,0.41604344203602206,0.48935199290142273,0.35972220311043923,PML,1
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,3/151,337/21728,0.4160725008038735,0.48935199290142273,0.35972220311043923,CTNND1/FURIN/SBNO2,3
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE,BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE,1/151,78/21728,0.4201161149034439,0.4923755514420889,0.36194481823259916,PML,1
CHEBOTAEV_GR_TARGETS_UP,CHEBOTAEV_GR_TARGETS_UP,1/151,78/21728,0.4201161149034439,0.4923755514420889,0.36194481823259916,ATP1A1,1
DUAN_PRDM5_TARGETS,DUAN_PRDM5_TARGETS,1/151,78/21728,0.4201161149034439,0.4923755514420889,0.36194481823259916,PML,1
KEGG_PEROXISOME,KEGG_PEROXISOME,1/151,78/21728,0.4201161149034439,0.4923755514420889,0.36194481823259916,PRDX1,1
MORI_PRE_BI_LYMPHOCYTE_DN,MORI_PRE_BI_LYMPHOCYTE_DN,1/151,78/21728,0.4201161149034439,0.4923755514420889,0.36194481823259916,BIRC3,1
REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE,REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE,1/151,78/21728,0.4201161149034439,0.4923755514420889,0.36194481823259916,UBC,1
ROSS_AML_WITH_AML1_ETO_FUSION,ROSS_AML_WITH_AML1_ETO_FUSION,1/151,78/21728,0.4201161149034439,0.4923755514420889,0.36194481823259916,PTPN12,1
WOO_LIVER_CANCER_RECURRENCE_DN,WOO_LIVER_CANCER_RECURRENCE_DN,1/151,78/21728,0.4201161149034439,0.4923755514420889,0.36194481823259916,LDLR,1
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,2/151,206/21728,0.42023845661238035,0.4923755514420889,0.36194481823259916,CSNK1A1/MET,2
PEREZ_TP53_AND_TP63_TARGETS,PEREZ_TP53_AND_TP63_TARGETS,2/151,207/21728,0.4226335636613431,0.49488368972360663,0.3637885483929358,ARIH1/MOXD1,2
BILD_CTNNB1_ONCOGENIC_SIGNATURE,BILD_CTNNB1_ONCOGENIC_SIGNATURE,1/151,79/21728,0.42416057063783563,0.49488368972360663,0.3637885483929358,DUSP5,1
KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY,KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY,1/151,79/21728,0.42416057063783563,0.49488368972360663,0.3637885483929358,MAP2K3,1
MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,1/151,79/21728,0.42416057063783563,0.49488368972360663,0.3637885483929358,PDLIM4,1
PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP,PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP,1/151,79/21728,0.42416057063783563,0.49488368972360663,0.3637885483929358,BCAM,1
REACTOME_PROTEIN_UBIQUITINATION,REACTOME_PROTEIN_UBIQUITINATION,1/151,79/21728,0.42416057063783563,0.49488368972360663,0.3637885483929358,UBC,1
REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,1/151,79/21728,0.42416057063783563,0.49488368972360663,0.3637885483929358,UBC,1
RUAN_RESPONSE_TO_TNF_DN,RUAN_RESPONSE_TO_TNF_DN,1/151,79/21728,0.42416057063783563,0.49488368972360663,0.3637885483929358,NRIP1,1
WP_REGULATORY_CIRCUITS_OF_THE_STAT3_SIGNALING_PATHWAY,WP_REGULATORY_CIRCUITS_OF_THE_STAT3_SIGNALING_PATHWAY,1/151,79/21728,0.42416057063783563,0.49488368972360663,0.3637885483929358,JAK2,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12,1/151,79/21728,0.42416057063783563,0.49488368972360663,0.3637885483929358,IARS2,1
FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN,FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN,1/151,80/21728,0.4281770034446022,0.49831408276879136,0.3663102271878501,TRIP12,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN,1/151,80/21728,0.4281770034446022,0.49831408276879136,0.3663102271878501,PGRMC2,1
PID_BETA_CATENIN_NUC_PATHWAY,PID_BETA_CATENIN_NUC_PATHWAY,1/151,80/21728,0.4281770034446022,0.49831408276879136,0.3663102271878501,YWHAZ,1
SCIBETTA_KDM5B_TARGETS_DN,SCIBETTA_KDM5B_TARGETS_DN,1/151,80/21728,0.4281770034446022,0.49831408276879136,0.3663102271878501,RECQL,1
TOOKER_GEMCITABINE_RESISTANCE_UP,TOOKER_GEMCITABINE_RESISTANCE_UP,1/151,80/21728,0.4281770034446022,0.49831408276879136,0.3663102271878501,HSPA4,1
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,1/151,80/21728,0.4281770034446022,0.49831408276879136,0.3663102271878501,ACTB,1
CHANDRAN_METASTASIS_UP,CHANDRAN_METASTASIS_UP,2/151,210/21728,0.4297884850035516,0.4999800717503628,0.36753489416683865,SEL1L/ESR2,2
BILANGES_SERUM_SENSITIVE_GENES,BILANGES_SERUM_SENSITIVE_GENES,1/151,81/21728,0.4321656062014325,0.5021146189994059,0.3691039979003628,AKAP12,1
MORI_PRE_BI_LYMPHOCYTE_UP,MORI_PRE_BI_LYMPHOCYTE_UP,1/151,81/21728,0.4321656062014325,0.5021146189994059,0.3691039979003628,ACTN4,1
REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,1/151,81/21728,0.4321656062014325,0.5021146189994059,0.3691039979003628,UBC,1
KUNINGER_IGF1_VS_PDGFB_TARGETS_UP,KUNINGER_IGF1_VS_PDGFB_TARGETS_UP,1/151,82/21728,0.4361265704673162,0.5051026182514868,0.37130047342195616,TPM1,1
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,1/151,82/21728,0.4361265704673162,0.5051026182514868,0.37130047342195616,SLC2A3,1
REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,1/151,82/21728,0.4361265704673162,0.5051026182514868,0.37130047342195616,UBC,1
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP,SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP,1/151,82/21728,0.4361265704673162,0.5051026182514868,0.37130047342195616,HSPA4,1
SATOH_COLORECTAL_CANCER_MYC_UP,SATOH_COLORECTAL_CANCER_MYC_UP,1/151,82/21728,0.4361265704673162,0.5051026182514868,0.37130047342195616,PRPS2,1
VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP,VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP,1/151,82/21728,0.4361265704673162,0.5051026182514868,0.37130047342195616,LDHA,1
WARTERS_RESPONSE_TO_IR_SKIN,WARTERS_RESPONSE_TO_IR_SKIN,1/151,82/21728,0.4361265704673162,0.5051026182514868,0.37130047342195616,PPFIBP1,1
BROWNE_HCMV_INFECTION_48HR_DN,BROWNE_HCMV_INFECTION_48HR_DN,4/151,485/21728,0.43637375226910313,0.5051026182514868,0.37130047342195616,ACTG1/HSPA4/MOXD1/CD151,4
MATSUDA_NATURAL_KILLER_DIFFERENTIATION,MATSUDA_NATURAL_KILLER_DIFFERENTIATION,4/151,485/21728,0.43637375226910313,0.5051026182514868,0.37130047342195616,ACTB/WWTR1/PDLIM4/PVR,4
BOYLAN_MULTIPLE_MYELOMA_PCA3_UP,BOYLAN_MULTIPLE_MYELOMA_PCA3_UP,1/151,83/21728,0.44006008649149775,0.5083105697602415,0.3736586356465721,NRIP1,1
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,1/151,83/21728,0.44006008649149775,0.5083105697602415,0.3736586356465721,CALU,1
QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR,QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR,1/151,83/21728,0.44006008649149775,0.5083105697602415,0.3736586356465721,PTPN14,1
STEIN_ESR1_TARGETS,STEIN_ESR1_TARGETS,1/151,83/21728,0.44006008649149775,0.5083105697602415,0.3736586356465721,RECQL,1
SWEET_KRAS_TARGETS_UP,SWEET_KRAS_TARGETS_UP,1/151,83/21728,0.44006008649149775,0.5083105697602415,0.3736586356465721,TPM1,1
IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,2/151,215/21728,0.44160937378189036,0.5098881298279682,0.37481829861174576,MET/EFNB2,2
COATES_MACROPHAGE_M1_VS_M2_DN,COATES_MACROPHAGE_M1_VS_M2_DN,1/151,84/21728,0.4439663432223725,0.511758714303631,0.3761933635516063,ITGB3,1
HINATA_NFKB_TARGETS_KERATINOCYTE_UP,HINATA_NFKB_TARGETS_KERATINOCYTE_UP,1/151,84/21728,0.4439663432223725,0.511758714303631,0.3761933635516063,MAP2K3,1
LEE_AGING_CEREBELLUM_UP,LEE_AGING_CEREBELLUM_UP,1/151,84/21728,0.4439663432223725,0.511758714303631,0.3761933635516063,HSPA8,1
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,1/151,84/21728,0.4439663432223725,0.511758714303631,0.3761933635516063,SLC4A7,1
REACTOME_KERATINIZATION,REACTOME_KERATINIZATION,2/151,217/21728,0.4463003606915783,0.5142357536296991,0.37801423289819114,PERP/FURIN,2
REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1/151,85/21728,0.4478455283163211,0.5155884283724574,0.37900858286634365,UBC,1
REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS,REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS,1/151,85/21728,0.4478455283163211,0.5155884283724574,0.37900858286634365,ITGB3,1
REACTOME_SIGNALING_BY_ROBO_RECEPTORS,REACTOME_SIGNALING_BY_ROBO_RECEPTORS,2/151,218/21728,0.4486376883598364,0.5160726700884578,0.37936454850957074,UBC/ETF1,2
WONG_MITOCHONDRIA_GENE_MODULE,WONG_MITOCHONDRIA_GENE_MODULE,2/151,218/21728,0.4486376883598364,0.5160726700884578,0.37936454850957074,ATP6V1C1/ATP13A3,2
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,2/151,219/21728,0.4509695218180976,0.5185192423929486,0.3811630215764163,ACTB/VDAC1,2
DELASERNA_MYOD_TARGETS_UP,DELASERNA_MYOD_TARGETS_UP,1/151,86/21728,0.45169782814648507,0.5185192423929486,0.3811630215764163,ATP1A1,1
LEIN_CEREBELLUM_MARKERS,LEIN_CEREBELLUM_MARKERS,1/151,86/21728,0.45169782814648507,0.5185192423929486,0.3811630215764163,ICMT,1
REACTOME_PLATELET_HOMEOSTASIS,REACTOME_PLATELET_HOMEOSTASIS,1/151,86/21728,0.45169782814648507,0.5185192423929486,0.3811630215764163,PAFAH2,1
WP_APOPTOSIS,WP_APOPTOSIS,1/151,86/21728,0.45169782814648507,0.5185192423929486,0.3811630215764163,BIRC3,1
KEGG_HEMATOPOIETIC_CELL_LINEAGE,KEGG_HEMATOPOIETIC_CELL_LINEAGE,1/151,87/21728,0.4555234278114825,0.5204370077612637,0.38257276914738036,ITGB3,1
MARTIN_VIRAL_GPCR_SIGNALING_UP,MARTIN_VIRAL_GPCR_SIGNALING_UP,1/151,87/21728,0.4555234278114825,0.5204370077612637,0.38257276914738036,IQGAP1,1
REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1/151,87/21728,0.4555234278114825,0.5204370077612637,0.38257276914738036,UBC,1
REACTOME_SIGNALING_BY_FGFR,REACTOME_SIGNALING_BY_FGFR,1/151,87/21728,0.4555234278114825,0.5204370077612637,0.38257276914738036,UBC,1
SANA_RESPONSE_TO_IFNG_DN,SANA_RESPONSE_TO_IFNG_DN,1/151,87/21728,0.4555234278114825,0.5204370077612637,0.38257276914738036,PRDX1,1
SMITH_TERT_TARGETS_DN,SMITH_TERT_TARGETS_DN,1/151,87/21728,0.4555234278114825,0.5204370077612637,0.38257276914738036,PML,1
TAKAO_RESPONSE_TO_UVB_RADIATION_UP,TAKAO_RESPONSE_TO_UVB_RADIATION_UP,1/151,87/21728,0.4555234278114825,0.5204370077612637,0.38257276914738036,UBC,1
WP_ACUTE_VIRAL_MYOCARDITIS,WP_ACUTE_VIRAL_MYOCARDITIS,1/151,87/21728,0.4555234278114825,0.5204370077612637,0.38257276914738036,ACTB,1
WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,1/151,87/21728,0.4555234278114825,0.5204370077612637,0.38257276914738036,LDHA,1
WP_TCELL_ACTIVATION_SARSCOV2,WP_TCELL_ACTIVATION_SARSCOV2,1/151,87/21728,0.4555234278114825,0.5204370077612637,0.38257276914738036,JAK2,1
ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,1/151,87/21728,0.4555234278114825,0.5204370077612637,0.38257276914738036,ATP1A1,1
RIGGINS_TAMOXIFEN_RESISTANCE_DN,RIGGINS_TAMOXIFEN_RESISTANCE_DN,2/151,221/21728,0.45561655971036474,0.5204370077612637,0.38257276914738036,ADAM9/PTPN12,2
PEREZ_TP63_TARGETS,PEREZ_TP63_TARGETS,3/151,359/21728,0.4563653622628203,0.5210780831755507,0.38304402309899904,ARIH1/STBD1/MOXD1,3
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN,2/151,222/21728,0.4579316928590249,0.5224370606826987,0.38404300622349874,SCFD1/RECQL,2
REACTOME_BIOLOGICAL_OXIDATIONS,REACTOME_BIOLOGICAL_OXIDATIONS,2/151,222/21728,0.4579316928590249,0.5224370606826987,0.38404300622349874,SLC35D1/PTGES3,2
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,1/151,88/21728,0.4593225111440674,0.5235937365442016,0.38489327759302455,EFNB2,1
REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,1/151,88/21728,0.4593225111440674,0.5235937365442016,0.38489327759302455,UBC,1
REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,2/151,223/21728,0.4602411892095364,0.5244257685086514,0.38550490353028827,PRKAR1A/FURIN,2
BAELDE_DIABETIC_NEPHROPATHY_UP,BAELDE_DIABETIC_NEPHROPATHY_UP,1/151,89/21728,0.4630952607197254,0.5263824199179202,0.3869432361944471,EML1,1
IVANOVSKA_MIR106B_TARGETS,IVANOVSKA_MIR106B_TARGETS,1/151,89/21728,0.4630952607197254,0.5263824199179202,0.3869432361944471,PKD2,1
REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION,REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION,1/151,89/21728,0.4630952607197254,0.5263824199179202,0.3869432361944471,ACTB,1
REACTOME_BASE_EXCISION_REPAIR,REACTOME_BASE_EXCISION_REPAIR,1/151,89/21728,0.4630952607197254,0.5263824199179202,0.3869432361944471,PNKP,1
WALLACE_PROSTATE_CANCER_RACE_DN,WALLACE_PROSTATE_CANCER_RACE_DN,1/151,89/21728,0.4630952607197254,0.5263824199179202,0.3869432361944471,ZNF654,1
WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_PART_3_OF_3,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_PART_3_OF_3,1/151,89/21728,0.4630952607197254,0.5263824199179202,0.3869432361944471,PERP,1
KOYAMA_SEMA3B_TARGETS_DN,KOYAMA_SEMA3B_TARGETS_DN,3/151,364/21728,0.46536691276975317,0.5287481732819528,0.38868229933196474,CBFB/BIRC3/PTGES3,3
REACTOME_OPIOID_SIGNALLING,REACTOME_OPIOID_SIGNALLING,1/151,90/21728,0.4668418578652185,0.5293415025100314,0.3891184551057031,PRKAR1A,1
REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1/151,90/21728,0.4668418578652185,0.5293415025100314,0.3891184551057031,RAB21,1
REACTOME_SPHINGOLIPID_METABOLISM,REACTOME_SPHINGOLIPID_METABOLISM,1/151,90/21728,0.4668418578652185,0.5293415025100314,0.3891184551057031,ARSJ,1
WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,1/151,90/21728,0.4668418578652185,0.5293415025100314,0.3891184551057031,RPS6KA3,1
WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,1/151,90/21728,0.4668418578652185,0.5293415025100314,0.3891184551057031,CSNK1A1,1
LU_IL4_SIGNALING,LU_IL4_SIGNALING,1/151,91/21728,0.470562482667065,0.5322567495313952,0.3912614505289329,CLTC,1
MORI_IMMATURE_B_LYMPHOCYTE_DN,MORI_IMMATURE_B_LYMPHOCYTE_DN,1/151,91/21728,0.470562482667065,0.5322567495313952,0.3912614505289329,ACTN4,1
REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1/151,91/21728,0.470562482667065,0.5322567495313952,0.3912614505289329,UBC,1
WP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,WP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,1/151,91/21728,0.470562482667065,0.5322567495313952,0.3912614505289329,PRDX1,1
WP_APOPTOSIS_MODULATION_AND_SIGNALING,WP_APOPTOSIS_MODULATION_AND_SIGNALING,1/151,91/21728,0.470562482667065,0.5322567495313952,0.3912614505289329,BIRC3,1
WP_TCELL_RECEPTOR_TCR_SIGNALING_PATHWAY,WP_TCELL_RECEPTOR_TCR_SIGNALING_PATHWAY,1/151,91/21728,0.470562482667065,0.5322567495313952,0.3912614505289329,CRK,1
BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,1/151,92/21728,0.4742573139799675,0.5355637472505487,0.393692421532365,EFNB2,1
DURCHDEWALD_SKIN_CARCINOGENESIS_UP,DURCHDEWALD_SKIN_CARCINOGENESIS_UP,1/151,92/21728,0.4742573139799675,0.5355637472505487,0.393692421532365,PDLIM4,1
GAVIN_FOXP3_TARGETS_CLUSTER_P7,GAVIN_FOXP3_TARGETS_CLUSTER_P7,1/151,92/21728,0.4742573139799675,0.5355637472505487,0.393692421532365,PDLIM4,1
LEIN_PONS_MARKERS,LEIN_PONS_MARKERS,1/151,92/21728,0.4742573139799675,0.5355637472505487,0.393692421532365,AKAP12,1
KAUFFMANN_DNA_REPAIR_GENES,KAUFFMANN_DNA_REPAIR_GENES,2/151,230/21728,0.47624708801407356,0.5375922025611931,0.3951835371788544,HUS1/PNKP,2
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,3/151,371/21728,0.47785979658399647,0.5383941195340373,0.3957730256132895,SLC2A3/CD151/LDLR,3
CAMPS_COLON_CANCER_COPY_NUMBER_UP,CAMPS_COLON_CANCER_COPY_NUMBER_UP,1/151,93/21728,0.4779265294351821,0.5383941195340373,0.3957730256132895,FLII,1
REACTOME_MAPK6_MAPK4_SIGNALING,REACTOME_MAPK6_MAPK4_SIGNALING,1/151,93/21728,0.4779265294351821,0.5383941195340373,0.3957730256132895,UBC,1
SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,1/151,93/21728,0.4779265294351821,0.5383941195340373,0.3957730256132895,PDLIM4,1
WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,1/151,93/21728,0.4779265294351821,0.5383941195340373,0.3957730256132895,PML,1
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,1/151,94/21728,0.48157030544883084,0.5422790062978727,0.3986288023257448,TPM1,1
DELYS_THYROID_CANCER_DN,DELYS_THYROID_CANCER_DN,2/151,233/21728,0.48301905594878236,0.5436900070606634,0.3996660276979604,AKAP12/EML1,2
CROONQUIST_IL6_DEPRIVATION_DN,CROONQUIST_IL6_DEPRIVATION_DN,1/151,95/21728,0.4851888172301577,0.5448927705251079,0.40055017802232173,SBNO2,1
LIM_MAMMARY_LUMINAL_MATURE_DN,LIM_MAMMARY_LUMINAL_MATURE_DN,1/151,95/21728,0.4851888172301577,0.5448927705251079,0.40055017802232173,MOXD1,1
REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS,REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS,1/151,95/21728,0.4851888172301577,0.5448927705251079,0.40055017802232173,PRKAR1A,1
WESTON_VEGFA_TARGETS,WESTON_VEGFA_TARGETS,1/151,95/21728,0.4851888172301577,0.5448927705251079,0.40055017802232173,SDC4,1
WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,1/151,95/21728,0.4851888172301577,0.5448927705251079,0.40055017802232173,ITGB3,1
REACTOME_HIV_INFECTION,REACTOME_HIV_INFECTION,2/151,234/21728,0.4852644759824034,0.5448927705251079,0.40055017802232173,UBC/FURIN,2
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN,1/151,96/21728,0.48878223878973104,0.5477358045009572,0.40264008970173815,PRDX1,1
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,1/151,96/21728,0.48878223878973104,0.5477358045009572,0.40264008970173815,DOLK,1
GUO_TARGETS_OF_IRS1_AND_IRS2,GUO_TARGETS_OF_IRS1_AND_IRS2,1/151,96/21728,0.48878223878973104,0.5477358045009572,0.40264008970173815,ACTB,1
KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS,KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS,1/151,96/21728,0.48878223878973104,0.5477358045009572,0.40264008970173815,CRK,1
REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION,REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION,1/151,96/21728,0.48878223878973104,0.5477358045009572,0.40264008970173815,CBFB,1
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,2/151,237/21728,0.49196466207811007,0.550845897667498,0.40492631634835596,MFSD5/PRKAG1,2
LEE_RECENT_THYMIC_EMIGRANT,LEE_RECENT_THYMIC_EMIGRANT,2/151,237/21728,0.49196466207811007,0.550845897667498,0.40492631634835596,RASA2/SLC2A3,2
GAVIN_FOXP3_TARGETS_CLUSTER_T4,GAVIN_FOXP3_TARGETS_CLUSTER_T4,1/151,97/21728,0.4923507429475873,0.550845897667498,0.40492631634835596,NRIP1,1
HOEBEKE_LYMPHOID_STEM_CELL_UP,HOEBEKE_LYMPHOID_STEM_CELL_UP,1/151,97/21728,0.4923507429475873,0.550845897667498,0.40492631634835596,SLC33A1,1
SENESE_HDAC1_AND_HDAC2_TARGETS_DN,SENESE_HDAC1_AND_HDAC2_TARGETS_DN,2/151,238/21728,0.49418594987189635,0.5524541524121239,0.40610854294248816,TPM1/LOXL1,2
ZWANG_EGF_INTERVAL_DN,ZWANG_EGF_INTERVAL_DN,2/151,238/21728,0.49418594987189635,0.5524541524121239,0.40610854294248816,PDLIM4/LAMA5,2
BROWNE_HCMV_INFECTION_10HR_UP,BROWNE_HCMV_INFECTION_10HR_UP,1/151,98/21728,0.49589450134132396,0.5532509737856217,0.4066942856064969,ATP6V1C1,1
KIM_MYC_AMPLIFICATION_TARGETS_DN,KIM_MYC_AMPLIFICATION_TARGETS_DN,1/151,98/21728,0.49589450134132396,0.5532509737856217,0.4066942856064969,CTNNA1,1
REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS,REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS,1/151,98/21728,0.49589450134132396,0.5532509737856217,0.4066942856064969,HSP90B1,1
REACTOME_PROTEIN_FOLDING,REACTOME_PROTEIN_FOLDING,1/151,98/21728,0.49589450134132396,0.5532509737856217,0.4066942856064969,ACTB,1
WP_B_CELL_RECEPTOR_SIGNALING_PATHWAY,WP_B_CELL_RECEPTOR_SIGNALING_PATHWAY,1/151,98/21728,0.49589450134132396,0.5532509737856217,0.4066942856064969,CRK,1
RUTELLA_RESPONSE_TO_HGF_DN,RUTELLA_RESPONSE_TO_HGF_DN,2/151,240/21728,0.4986102214605176,0.5560574850330462,0.4087573494616003,APLP2/SLC2A3,2
REACTOME_SLC_TRANSPORTER_DISORDERS,REACTOME_SLC_TRANSPORTER_DISORDERS,1/151,99/21728,0.4994136844341329,0.5565067049169761,0.4090875705880541,SLC33A1,1
ROVERSI_GLIOMA_COPY_NUMBER_UP,ROVERSI_GLIOMA_COPY_NUMBER_UP,1/151,99/21728,0.4994136844341329,0.5565067049169761,0.4090875705880541,BCAM,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,3/151,385/21728,0.5024342784754171,0.5596481257436683,0.41139682616904116,FLOT2/PRKAG1/GARS1,3
REACTOME_CLEC7A_DECTIN_1_SIGNALING,REACTOME_CLEC7A_DECTIN_1_SIGNALING,1/151,100/21728,0.5029084615227846,0.5597274463582914,0.4114551346804159,UBC,1
REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1/151,100/21728,0.5029084615227846,0.5597274463582914,0.4114551346804159,KDELR1,1
GAVIN_FOXP3_TARGETS_CLUSTER_T7,GAVIN_FOXP3_TARGETS_CLUSTER_T7,1/151,101/21728,0.5063790007455542,0.5624633602843461,0.41346630250904914,JAK2,1
KEGG_GNRH_SIGNALING_PATHWAY,KEGG_GNRH_SIGNALING_PATHWAY,1/151,101/21728,0.5063790007455542,0.5624633602843461,0.41346630250904914,MAP2K3,1
REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH,REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH,1/151,101/21728,0.5063790007455542,0.5624633602843461,0.41346630250904914,PRDX1,1
WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,1/151,101/21728,0.5063790007455542,0.5624633602843461,0.41346630250904914,DUSP5,1
WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,1/151,101/21728,0.5063790007455542,0.5624633602843461,0.41346630250904914,MAP2K3,1
HAN_SATB1_TARGETS_DN,HAN_SATB1_TARGETS_DN,3/151,388/21728,0.5076246601146143,0.5636216250193439,0.41431774185803005,SDF4/SLC33A1/NPAS2,3
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,1/151,102/21728,0.5098254690900965,0.5647109860974036,0.41511853019171796,FNDC3B,1
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,1/151,102/21728,0.5098254690900965,0.5647109860974036,0.41511853019171796,PDLIM4,1
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,1/151,102/21728,0.5098254690900965,0.5647109860974036,0.41511853019171796,MAP2K3,1
KOBAYASHI_EGFR_SIGNALING_24HR_UP,KOBAYASHI_EGFR_SIGNALING_24HR_UP,1/151,102/21728,0.5098254690900965,0.5647109860974036,0.41511853019171796,BCAM,1
REACTOME_INTERLEUKIN_1_SIGNALING,REACTOME_INTERLEUKIN_1_SIGNALING,1/151,102/21728,0.5098254690900965,0.5647109860974036,0.41511853019171796,UBC,1
TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA,TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA,1/151,102/21728,0.5098254690900965,0.5647109860974036,0.41511853019171796,WDR1,1
HUMMERICH_SKIN_CANCER_PROGRESSION_DN,HUMMERICH_SKIN_CANCER_PROGRESSION_DN,1/151,103/21728,0.513248032401268,0.5680490175341524,0.41757231405261475,BCAM,1
WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,1/151,103/21728,0.513248032401268,0.5680490175341524,0.41757231405261475,CSNK1A1,1
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,3/151,392/21728,0.5145018097480114,0.5692098874870473,0.4184256684948928,CTNND1/ATP6V1A/PAFAH2,3
CADWELL_ATG16L1_TARGETS_UP,CADWELL_ATG16L1_TARGETS_UP,1/151,104/21728,0.5166468553888941,0.5709009404416657,0.4196687599775801,SSR1,1
REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,1/151,104/21728,0.5166468553888941,0.5709009404416657,0.4196687599775801,ACTB,1
WP_TOLLLIKE_RECEPTOR_SIGNALING_PATHWAY,WP_TOLLLIKE_RECEPTOR_SIGNALING_PATHWAY,1/151,104/21728,0.5166468553888941,0.5709009404416657,0.4196687599775801,MAP2K3,1
HSIAO_LIVER_SPECIFIC_GENES,HSIAO_LIVER_SPECIFIC_GENES,2/151,249/21728,0.5182131686555753,0.5724040487177687,0.4207736934987197,ATP13A3/FURIN,2
GHANDHI_DIRECT_IRRADIATION_UP,GHANDHI_DIRECT_IRRADIATION_UP,1/151,105/21728,0.5200221016354849,0.5730350647930889,0.42123755283944997,BIRC3,1
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN,1/151,105/21728,0.5200221016354849,0.5730350647930889,0.42123755283944997,MGAT4B,1
LEIN_CHOROID_PLEXUS_MARKERS,LEIN_CHOROID_PLEXUS_MARKERS,1/151,105/21728,0.5200221016354849,0.5730350647930889,0.42123755283944997,PERP,1
RICKMAN_HEAD_AND_NECK_CANCER_A,RICKMAN_HEAD_AND_NECK_CANCER_A,1/151,105/21728,0.5200221016354849,0.5730350647930889,0.42123755283944997,MOXD1,1
STEIN_ESRRA_TARGETS_DN,STEIN_ESRRA_TARGETS_DN,1/151,105/21728,0.5200221016354849,0.5730350647930889,0.42123755283944997,PRPS2,1
WOO_LIVER_CANCER_RECURRENCE_UP,WOO_LIVER_CANCER_RECURRENCE_UP,1/151,105/21728,0.5200221016354849,0.5730350647930889,0.42123755283944997,LAMA5,1
REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1/151,106/21728,0.5233739336039,0.5760431012486665,0.423448757691036,PTGES3,1
REACTOME_STIMULI_SENSING_CHANNELS,REACTOME_STIMULI_SENSING_CHANNELS,1/151,106/21728,0.5233739336039,0.5760431012486665,0.423448757691036,UBC,1
WANG_HCP_PROSTATE_CANCER,WANG_HCP_PROSTATE_CANCER,1/151,106/21728,0.5233739336039,0.5760431012486665,0.423448757691036,PPP1R15A,1
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,3/151,398/21728,0.5247223559881098,0.5772984970039482,0.4243715979643285,ACTB/BIRC3/TPM1,3
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,1/151,107/21728,0.5267025126449605,0.5792476564242678,0.4258044232742524,DUSP5,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,1/151,108/21728,0.530007999005009,0.5824217647293967,0.4281377073907884,ARSJ,1
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP,1/151,108/21728,0.530007999005009,0.5824217647293967,0.4281377073907884,DIPK2A,1
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,1/151,109/21728,0.5332905518334201,0.5853343156828293,0.430278720936944,SLC4A7,1
REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS,REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS,1/151,109/21728,0.5332905518334201,0.5853343156828293,0.430278720936944,SLC35D1,1
WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,1/151,109/21728,0.5332905518334201,0.5853343156828293,0.430278720936944,ITGB3,1
LE_EGR2_TARGETS_UP,LE_EGR2_TARGETS_UP,1/151,110/21728,0.5365503291900577,0.5886796265758216,0.43273785591947783,SLC4A7,1
JAEGER_METASTASIS_DN,JAEGER_METASTASIS_DN,2/151,259/21728,0.5393941962876037,0.5915661576340162,0.434859742264405,CTNND1/PERP,2
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP,1/151,111/21728,0.5397874880526861,0.5917638681177435,0.4350050790604458,AKAP12,1
PASINI_SUZ12_TARGETS_UP,PASINI_SUZ12_TARGETS_UP,1/151,112/21728,0.5430021843243262,0.5949837084281099,0.4373719807322698,CHURC1-FNTB,1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,3/151,409/21728,0.5431528742165899,0.5949837084281099,0.4373719807322698,PKD2/FEM1B/LOXL1,3
BROWNE_HCMV_INFECTION_12HR_UP,BROWNE_HCMV_INFECTION_12HR_UP,1/151,113/21728,0.5461945728405655,0.5976087134112213,0.43930161949822644,PML,1
HOSHIDA_LIVER_CANCER_SURVIVAL_DN,HOSHIDA_LIVER_CANCER_SURVIVAL_DN,1/151,113/21728,0.5461945728405655,0.5976087134112213,0.43930161949822644,ITPRID2,1
REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1/151,113/21728,0.5461945728405655,0.5976087134112213,0.43930161949822644,SSR1,1
AFFAR_YY1_TARGETS_DN,AFFAR_YY1_TARGETS_DN,2/151,263/21728,0.5476865280776149,0.5990051870077221,0.4403281659637683,API5/LDLR,2
CERVERA_SDHB_TARGETS_2,CERVERA_SDHB_TARGETS_2,1/151,114/21728,0.549364807376817,0.6001319051878874,0.4411564154690999,MOXD1,1
MATZUK_SPERMATOZOA,MATZUK_SPERMATOZOA,1/151,114/21728,0.549364807376817,0.6001319051878874,0.4411564154690999,PRKAR1A,1
WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,1/151,114/21728,0.549364807376817,0.6001319051878874,0.4411564154690999,LDLR,1
MCLACHLAN_DENTAL_CARIES_UP,MCLACHLAN_DENTAL_CARIES_UP,2/151,265/21728,0.5517937239702566,0.6016782543869312,0.44229313535320625,BIRC3/SLC2A3,2
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,2/151,265/21728,0.5517937239702566,0.6016782543869312,0.44229313535320625,ATP1A1/EPHA2,2
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,2/151,265/21728,0.5517937239702566,0.6016782543869312,0.44229313535320625,FEM1B/HUS1,2
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,2/151,265/21728,0.5517937239702566,0.6016782543869312,0.44229313535320625,FEM1C/EPHA2,2
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN,1/151,115/21728,0.5525130406555298,0.6016782543869312,0.44229313535320625,PGRMC2,1
HOSHIDA_LIVER_CANCER_SUBCLASS_S2,HOSHIDA_LIVER_CANCER_SUBCLASS_S2,1/151,115/21728,0.5525130406555298,0.6016782543869312,0.44229313535320625,BCAM,1
KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION,KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION,1/151,115/21728,0.5525130406555298,0.6016782543869312,0.44229313535320625,ARAF,1
MARZEC_IL2_SIGNALING_UP,MARZEC_IL2_SIGNALING_UP,1/151,115/21728,0.5525130406555298,0.6016782543869312,0.44229313535320625,BIRC3,1
REACTOME_NONSENSE_MEDIATED_DECAY_NMD,REACTOME_NONSENSE_MEDIATED_DECAY_NMD,1/151,116/21728,0.5556394243533513,0.6048457370116027,0.4446215489380885,ETF1,1
CAIRO_HEPATOBLASTOMA_DN,CAIRO_HEPATOBLASTOMA_DN,2/151,267/21728,0.5558748350584808,0.604864979158817,0.44463569382293394,EPHA2/MAP2K3,2
DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN,DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN,1/151,117/21728,0.5587441091082396,0.6075112074765908,0.44658093384282,ACTG1,1
WP_WNT_SIGNALING,WP_WNT_SIGNALING,1/151,117/21728,0.5587441091082396,0.6075112074765908,0.44658093384282,CSNK1A1,1
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,1/151,118/21728,0.5618272445265292,0.6103856414918648,0.4486939276625431,PERP,1
REACTOME_SELENOAMINO_ACID_METABOLISM,REACTOME_SELENOAMINO_ACID_METABOLISM,1/151,118/21728,0.5618272445265292,0.6103856414918648,0.4486939276625431,RARS1,1
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN,ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN,1/151,119/21728,0.5648889791899484,0.6129928063240925,0.45061045214987655,TPM1,1
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN,1/151,119/21728,0.5648889791899484,0.6129928063240925,0.45061045214987655,BCAM,1
WP_SPINAL_CORD_INJURY,WP_SPINAL_CORD_INJURY,1/151,119/21728,0.5648889791899484,0.6129928063240925,0.45061045214987655,EFNB2,1
REACTOME_CHROMATIN_MODIFYING_ENZYMES,REACTOME_CHROMATIN_MODIFYING_ENZYMES,2/151,272/21728,0.5659630510056821,0.613918530142048,0.4512909508830939,ACTB/JAK2,2
HOOI_ST7_TARGETS_DN,HOOI_ST7_TARGETS_DN,1/151,120/21728,0.5679294606625904,0.6150908544719985,0.4521527254274856,PDLIM4,1
REACTOME_EUKARYOTIC_TRANSLATION_INITIATION,REACTOME_EUKARYOTIC_TRANSLATION_INITIATION,1/151,120/21728,0.5679294606625904,0.6150908544719985,0.4521527254274856,EIF4H,1
REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1/151,120/21728,0.5679294606625904,0.6150908544719985,0.4521527254274856,NPAS2,1
REACTOME_SYNTHESIS_OF_DNA,REACTOME_SYNTHESIS_OF_DNA,1/151,120/21728,0.5679294606625904,0.6150908544719985,0.4521527254274856,UBC,1
WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,1/151,121/21728,0.570948835497834,0.6181199785709209,0.4543794317864373,PNKP,1
NABA_CORE_MATRISOME,NABA_CORE_MATRISOME,2/151,275/21728,0.5719371387930916,0.618948722854386,0.45498864095241126,LAMC1/LAMA5,2
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN,1/151,122/21728,0.5739472492452228,0.6199165856933238,0.4557001160414718,BCAM,1
HOLLERN_EMT_BREAST_TUMOR_DN,HOLLERN_EMT_BREAST_TUMOR_DN,1/151,122/21728,0.5739472492452228,0.6199165856933238,0.4557001160414718,SORT1,1
LEE_NEURAL_CREST_STEM_CELL_DN,LEE_NEURAL_CREST_STEM_CELL_DN,1/151,122/21728,0.5739472492452228,0.6199165856933238,0.4557001160414718,EPHA2,1
REACTOME_RAB_REGULATION_OF_TRAFFICKING,REACTOME_RAB_REGULATION_OF_TRAFFICKING,1/151,122/21728,0.5739472492452228,0.6199165856933238,0.4557001160414718,RAB21,1
WP_CELL_CYCLE,WP_CELL_CYCLE,1/151,122/21728,0.5739472492452228,0.6199165856933238,0.4557001160414718,YWHAZ,1
MARKEY_RB1_CHRONIC_LOF_DN,MARKEY_RB1_CHRONIC_LOF_DN,1/151,123/21728,0.5769248464572923,0.622648493962066,0.4577083393150726,SEPTIN11,1
REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1/151,123/21728,0.5769248464572923,0.622648493962066,0.4577083393150726,SLC2A3,1
FORTSCHEGGER_PHF8_TARGETS_UP,FORTSCHEGGER_PHF8_TARGETS_UP,2/151,278/21728,0.5778519035767966,0.6234068303442101,0.4582657916970814,CALU/SLC2A3,2
REACTOME_CYTOPROTECTION_BY_HMOX1,REACTOME_CYTOPROTECTION_BY_HMOX1,1/151,124/21728,0.5798817706963548,0.6248687195478951,0.45934042511572765,UBC,1
REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,1/151,124/21728,0.5798817706963548,0.6248687195478951,0.45934042511572765,SDC4,1
REACTOME_TCR_SIGNALING,REACTOME_TCR_SIGNALING,1/151,124/21728,0.5798817706963548,0.6248687195478951,0.45934042511572765,UBC,1
CUI_TCF21_TARGETS_2_UP,CUI_TCF21_TARGETS_2_UP,3/151,433/21728,0.5819069630259726,0.6268078880520169,0.460765906112278,ACTB/PDLIM4/PCDH8,3
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP,1/151,125/21728,0.5828181645412377,0.627059977186506,0.46095121660483557,ATP1A1,1
KEGG_CELL_CYCLE,KEGG_CELL_CYCLE,1/151,125/21728,0.5828181645412377,0.627059977186506,0.46095121660483557,YWHAZ,1
LIU_VMYB_TARGETS_UP,LIU_VMYB_TARGETS_UP,1/151,125/21728,0.5828181645412377,0.627059977186506,0.46095121660483557,SEC24A,1
BHAT_ESR1_TARGETS_VIA_AKT1_UP,BHAT_ESR1_TARGETS_VIA_AKT1_UP,2/151,281/21728,0.5837072253565102,0.6277733921952712,0.46147564732629537,STK24/SBNO2,2
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,1/151,126/21728,0.5857341695939746,0.6287362917820948,0.46218347393325904,AKAP12,1
EPPERT_HSC_R,EPPERT_HSC_R,1/151,126/21728,0.5857341695939746,0.6287362917820948,0.46218347393325904,HSP90B1,1
INGRAM_SHH_TARGETS_UP,INGRAM_SHH_TARGETS_UP,1/151,126/21728,0.5857341695939746,0.6287362917820948,0.46218347393325904,AKAP12,1
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3,MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3,1/151,126/21728,0.5857341695939746,0.6287362917820948,0.46218347393325904,ESR2,1
WHITFIELD_CELL_CYCLE_M_G1,WHITFIELD_CELL_CYCLE_M_G1,1/151,126/21728,0.5857341695939746,0.6287362917820948,0.46218347393325904,HSPA8,1
VECCHI_GASTRIC_CANCER_EARLY_UP,VECCHI_GASTRIC_CANCER_EARLY_UP,3/151,436/21728,0.586604793827243,0.6294276235040869,0.46269167125077815,HUS1/HSPA8/LAMA5,3
KEGG_SPLICEOSOME,KEGG_SPLICEOSOME,1/151,127/21728,0.5886299264864527,0.6313567319611451,0.46410975711591884,HSPA8,1
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,2/151,285/21728,0.591421703109418,0.6339515767886293,0.46601722517901595,AKAP12/TPM1,2
REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,1/151,128/21728,0.5915055748870148,0.6339515767886293,0.46601722517901595,PCYT1A,1
LU_EZH2_TARGETS_UP,LU_EZH2_TARGETS_UP,2/151,288/21728,0.5971380251628405,0.6393115776871677,0.4699573569448317,PPFIBP1/SDC4,2
KEGG_PARKINSONS_DISEASE,KEGG_PARKINSONS_DISEASE,1/151,130/21728,0.5971971001073435,0.6393115776871677,0.4699573569448317,VDAC1,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,1/151,130/21728,0.5971971001073435,0.6393115776871677,0.4699573569448317,AKAP12,1
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,1/151,131/21728,0.6000132515048708,0.6413377501656526,0.4714467944834853,DUSP5,1
REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS,REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS,1/151,131/21728,0.6000132515048708,0.6413377501656526,0.4714467944834853,UBC,1
SANSOM_APC_TARGETS_UP,SANSOM_APC_TARGETS_UP,1/151,131/21728,0.6000132515048708,0.6413377501656526,0.4714467944834853,RECQL,1
WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,1/151,131/21728,0.6000132515048708,0.6413377501656526,0.4714467944834853,SEPTIN11,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,1/151,132/21728,0.602809843578898,0.6440791328700687,0.473461982406098,EFNB2,1
POOLA_INVASIVE_BREAST_CANCER_UP,POOLA_INVASIVE_BREAST_CANCER_UP,2/151,292/21728,0.604667027220141,0.6458150717483859,0.47473806949030684,CALU/LOXL1,2
NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON,NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON,1/151,133/21728,0.6055870112775267,0.646300698167103,0.4750950530272365,FLOT2,1
REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION,REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION,1/151,133/21728,0.6055870112775267,0.646300698167103,0.4750950530272365,PRKAR1A,1
BASAKI_YBX1_TARGETS_UP,BASAKI_YBX1_TARGETS_UP,2/151,293/21728,0.6065327139256174,0.647061397575025,0.47565424246733673,WDR1/EPHA2,2
REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT,REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT,1/151,134/21728,0.6083448886240002,0.64874552806045,0.47689224524924145,KDELR1,1
IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR,IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR,1/151,135/21728,0.6110836087229988,0.650674969666587,0.47831057601196575,SSR1,1
SERVITJA_LIVER_HNF1A_TARGETS_UP,SERVITJA_LIVER_HNF1A_TARGETS_UP,1/151,135/21728,0.6110836087229988,0.650674969666587,0.47831057601196575,AKAP12,1
TSENG_IRS1_TARGETS_DN,TSENG_IRS1_TARGETS_DN,1/151,135/21728,0.6110836087229988,0.650674969666587,0.47831057601196575,PML,1
MIKKELSEN_NPC_ICP_WITH_H3K4ME3,MIKKELSEN_NPC_ICP_WITH_H3K4ME3,3/151,452/21728,0.6110910712239472,0.650674969666587,0.47831057601196575,CTNND1/PAFAH2/PML,3
BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP,BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP,2/151,296/21728,0.612090036118905,0.6512394179771421,0.47872550144960624,HIVEP3/PPP1R15A,2
ENK_UV_RESPONSE_EPIDERMIS_UP,ENK_UV_RESPONSE_EPIDERMIS_UP,2/151,296/21728,0.612090036118905,0.6512394179771421,0.47872550144960624,RALB/PRKAG1,2
REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION,REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION,1/151,136/21728,0.6138033037668938,0.6525624102045278,0.479698031827814,UBC,1
REACTOME_HCMV_EARLY_EVENTS,REACTOME_HCMV_EARLY_EVENTS,1/151,136/21728,0.6138033037668938,0.6525624102045278,0.479698031827814,PML,1
KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,1/151,137/21728,0.6165041050419588,0.6549324679948612,0.4814402591451747,ARAF,1
LI_INDUCED_T_TO_NATURAL_KILLER_DN,LI_INDUCED_T_TO_NATURAL_KILLER_DN,1/151,137/21728,0.6165041050419588,0.6549324679948612,0.4814402591451747,PDLIM4,1
MUELLER_PLURINET,MUELLER_PLURINET,2/151,299/21728,0.6175877887988749,0.6555822993057985,0.48191794954842526,HSPA9/HSPA8,2
SABATES_COLORECTAL_ADENOMA_DN,SABATES_COLORECTAL_ADENOMA_DN,2/151,299/21728,0.6175877887988749,0.6555822993057985,0.48191794954842526,AKAP12/UNC5C,2
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION,NOUZOVA_TRETINOIN_AND_H4_ACETYLATION,1/151,138/21728,0.6191861429345373,0.6567607071149346,0.48278419605281087,RECQL,1
WP_MEASLES_VIRUS_INFECTION,WP_MEASLES_VIRUS_INFECTION,1/151,138/21728,0.6191861429345373,0.6567607071149346,0.48278419605281087,HSPA8,1
DURAND_STROMA_S_UP,DURAND_STROMA_S_UP,2/151,300/21728,0.619407146379096,0.6567607071149346,0.48278419605281087,PDLIM4/LOXL1,2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,1/151,139/21728,0.6218495469371721,0.6585962796002531,0.4841335237105419,PCYT1A,1
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS,KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS,1/151,139/21728,0.6218495469371721,0.6585962796002531,0.4841335237105419,ACTN4,1
ODONNELL_TFRC_TARGETS_DN,ODONNELL_TFRC_TARGETS_DN,1/151,139/21728,0.6218495469371721,0.6585962796002531,0.4841335237105419,CD151,1
FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,1/151,140/21728,0.6244944456546896,0.6606418773909853,0.4856372407784896,PTPN14,1
REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,1/151,140/21728,0.6244944456546896,0.6606418773909853,0.4856372407784896,UBC,1
REACTOME_HATS_ACETYLATE_HISTONES,REACTOME_HATS_ACETYLATE_HISTONES,1/151,140/21728,0.6244944456546896,0.6606418773909853,0.4856372407784896,ACTB,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,2/151,304/21728,0.6266185271034312,0.6626365695825397,0.48710353718696797,LAMC1/EFNB2,2
DARWICHE_SKIN_TUMOR_PROMOTER_UP,DARWICHE_SKIN_TUMOR_PROMOTER_UP,1/151,143/21728,0.6323193829557223,0.6684106719372134,0.49134807455503543,LDHA,1
REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2/151,308/21728,0.633724417855729,0.6696410927361032,0.4922525557606912,UBC/TRIP12,2
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP,1/151,144/21728,0.6348915290374313,0.6701096761648876,0.4925970110112849,IQGAP1,1
WP_ECTODERM_DIFFERENTIATION,WP_ECTODERM_DIFFERENTIATION,1/151,144/21728,0.6348915290374313,0.6701096761648876,0.4925970110112849,RRBP1,1
WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,1/151,144/21728,0.6348915290374313,0.6701096761648876,0.4925970110112849,SLC2A3,1
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,1/151,145/21728,0.6374457997525604,0.6720646369132415,0.49403410087214905,BIRC3,1
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK,1/151,145/21728,0.6374457997525604,0.6720646369132415,0.49403410087214905,SORT1,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,3/151,470/21728,0.6374695170145397,0.6720646369132415,0.49403410087214905,API5/PRPS2/EML1,3
BROWNE_HCMV_INFECTION_24HR_UP,BROWNE_HCMV_INFECTION_24HR_UP,1/151,146/21728,0.6399823185051601,0.673435939699748,0.49504214429824983,TRIP10,1
KAUFFMANN_DNA_REPLICATION_GENES,KAUFFMANN_DNA_REPLICATION_GENES,1/151,146/21728,0.6399823185051601,0.673435939699748,0.49504214429824983,PNKP,1
REACTOME_DNA_REPLICATION_PRE_INITIATION,REACTOME_DNA_REPLICATION_PRE_INITIATION,1/151,146/21728,0.6399823185051601,0.673435939699748,0.49504214429824983,UBC,1
REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1/151,146/21728,0.6399823185051601,0.673435939699748,0.49504214429824983,ACTB,1
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,1/151,146/21728,0.6399823185051601,0.673435939699748,0.49504214429824983,DUSP5,1
CHANDRAN_METASTASIS_DN,CHANDRAN_METASTASIS_DN,2/151,313/21728,0.6424589083269656,0.6755746992489466,0.4966143444897717,MOXD1/DNAJC10,2
BENPORATH_PROLIFERATION,BENPORATH_PROLIFERATION,1/151,147/21728,0.6425012078530299,0.6755746992489466,0.4966143444897717,GARS1,1
BRUINS_UVC_RESPONSE_EARLY_LATE,BRUINS_UVC_RESPONSE_EARLY_LATE,2/151,314/21728,0.6441861470660777,0.6770900932839817,0.49772830926108325,ARIH1/PTPN12,2
RODWELL_AGING_KIDNEY_DN,RODWELL_AGING_KIDNEY_DN,1/151,148/21728,0.6450025895134808,0.6776918281650718,0.498170644022674,APLP2,1
GOZGIT_ESR1_TARGETS_UP,GOZGIT_ESR1_TARGETS_UP,1/151,149/21728,0.6474865843690629,0.6800445109176774,0.4999000989656679,LAMC1,1
DARWICHE_PAPILLOMA_RISK_HIGH_UP,DARWICHE_PAPILLOMA_RISK_HIGH_UP,1/151,150/21728,0.6499533124732508,0.6821194945412508,0.5014254175325021,LDHA,1
DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,1/151,150/21728,0.6499533124732508,0.6821194945412508,0.5014254175325021,LDHA,1
KEGG_WNT_SIGNALING_PATHWAY,KEGG_WNT_SIGNALING_PATHWAY,1/151,151/21728,0.6524028930560917,0.684173362366864,0.5029352138955387,CSNK1A1,1
SMID_BREAST_CANCER_ERBB2_UP,SMID_BREAST_CANCER_ERBB2_UP,1/151,151/21728,0.6524028930560917,0.684173362366864,0.5029352138955387,LDLR,1
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,3/151,483/21728,0.6557375099253088,0.6874108688952859,0.5053151019881227,BIRC3/PPP1R15A/NRIP1,3
SMID_BREAST_CANCER_NORMAL_LIKE_UP,SMID_BREAST_CANCER_NORMAL_LIKE_UP,3/151,484/21728,0.6571153418226079,0.6884779459749089,0.5060995093749093,BIRC3/MET/SLC12A4,3
WILCOX_RESPONSE_TO_PROGESTERONE_UP,WILCOX_RESPONSE_TO_PROGESTERONE_UP,1/151,153/21728,0.6572510844944054,0.6884779459749089,0.5060995093749093,LDLR,1
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP,DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP,2/151,323/21728,0.6594379339964811,0.6902481464364072,0.5074007821176272,NRIP1/JAK2,2
JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,2/151,323/21728,0.6594379339964811,0.6902481464364072,0.5074007821176272,PKD2/NRIP1,2
BIDUS_METASTASIS_DN,BIDUS_METASTASIS_DN,1/151,155/21728,0.6620320962680626,0.6916604601100705,0.5084389726094264,PPFIBP1,1
DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1/151,155/21728,0.6620320962680626,0.6916604601100705,0.5084389726094264,IARS2,1
KEGG_JAK_STAT_SIGNALING_PATHWAY,KEGG_JAK_STAT_SIGNALING_PATHWAY,1/151,155/21728,0.6620320962680626,0.6916604601100705,0.5084389726094264,JAK2,1
REACTOME_CDC42_GTPASE_CYCLE,REACTOME_CDC42_GTPASE_CYCLE,1/151,155/21728,0.6620320962680626,0.6916604601100705,0.5084389726094264,IQGAP1,1
WP_MALE_INFERTILITY,WP_MALE_INFERTILITY,1/151,155/21728,0.6620320962680626,0.6916604601100705,0.5084389726094264,ESR2,1
BROWNE_HCMV_INFECTION_14HR_UP,BROWNE_HCMV_INFECTION_14HR_UP,1/151,157/21728,0.6667468531413909,0.6958011863361322,0.5114828166769341,ATP6V1C1,1
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,1/151,157/21728,0.6667468531413909,0.6958011863361322,0.5114828166769341,TRIP12,1
REACTOME_INFLUENZA_INFECTION,REACTOME_INFLUENZA_INFECTION,1/151,157/21728,0.6667468531413909,0.6958011863361322,0.5114828166769341,CLTC,1
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,2/151,329/21728,0.6693143286184875,0.6979821573887149,0.5130860465060465,PRKAR1A/LRP12,2
MEISSNER_NPC_HCP_WITH_H3K4ME2,MEISSNER_NPC_HCP_WITH_H3K4ME2,3/151,493/21728,0.6693392610811868,0.6979821573887149,0.5130860465060465,PERP/ITGB3/TPM1,3
KEGG_PURINE_METABOLISM,KEGG_PURINE_METABOLISM,1/151,159/21728,0.6713962672331033,0.6998644766880153,0.5144697377040467,PRPS2,1
ASTON_MAJOR_DEPRESSIVE_DISORDER_DN,ASTON_MAJOR_DEPRESSIVE_DISORDER_DN,1/151,160/21728,0.6736967523574857,0.7012100329895449,0.5154588549125524,SNX19,1
REACTOME_HCMV_INFECTION,REACTOME_HCMV_INFECTION,1/151,160/21728,0.6736967523574857,0.7012100329895449,0.5154588549125524,PML,1
SENGUPTA_EBNA1_ANTICORRELATED,SENGUPTA_EBNA1_ANTICORRELATED,1/151,160/21728,0.6736967523574857,0.7012100329895449,0.5154588549125524,MAP2K3,1
WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,1/151,160/21728,0.6736967523574857,0.7012100329895449,0.5154588549125524,PRKAG1,1
YANG_BCL3_TARGETS_UP,YANG_BCL3_TARGETS_UP,2/151,333/21728,0.6757701789003766,0.7031047029907289,0.5168516251002289,AKAP12/SLC2A3,2
REACTOME_S_PHASE,REACTOME_S_PHASE,1/151,162/21728,0.6782498352592241,0.7054204576376356,0.5185539342264457,UBC,1
MULLIGHAN_NPM1_SIGNATURE_3_UP,MULLIGHAN_NPM1_SIGNATURE_3_UP,2/151,335/21728,0.6789598167232119,0.7058945998716627,0.5189024757496972,FEM1B/HUS1,2
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,2/151,336/21728,0.6805451002359463,0.7072780727480205,0.519919465397734,LAMC1/FNDC3B,2
BROWNE_HCMV_INFECTION_6HR_DN,BROWNE_HCMV_INFECTION_6HR_DN,1/151,164/21728,0.6827398014731081,0.7084987555070207,0.5208167881791597,ITGB3,1
DARWICHE_PAPILLOMA_RISK_LOW_UP,DARWICHE_PAPILLOMA_RISK_LOW_UP,1/151,164/21728,0.6827398014731081,0.7084987555070207,0.5208167881791597,LDHA,1
LIU_CMYB_TARGETS_UP,LIU_CMYB_TARGETS_UP,1/151,164/21728,0.6827398014731081,0.7084987555070207,0.5208167881791597,SH2D4A,1
WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,1/151,164/21728,0.6827398014731081,0.7084987555070207,0.5208167881791597,MAP2K3,1
BROWN_MYELOID_CELL_DEVELOPMENT_UP,BROWN_MYELOID_CELL_DEVELOPMENT_UP,1/151,165/21728,0.6849613879124311,0.7105387362288027,0.5223163761448514,IQGAP1,1
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,2/151,339/21728,0.6852629389286741,0.7105862054288378,0.5223512707104488,MET/ZNF330,2
KEGG_ALZHEIMERS_DISEASE,KEGG_ALZHEIMERS_DISEASE,1/151,166/21728,0.6871675201957506,0.7120296050368501,0.5234123124442004,NCSTN,1
REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,1/151,166/21728,0.6871675201957506,0.7120296050368501,0.5234123124442004,UBC,1
DURAND_STROMA_NS_UP,DURAND_STROMA_NS_UP,1/151,167/21728,0.689358305116001,0.7137671903139212,0.5246896097946298,SLC2A3,1
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN,GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN,1/151,167/21728,0.689358305116001,0.7137671903139212,0.5246896097946298,SCFD1,1
WHITFIELD_CELL_CYCLE_G2,WHITFIELD_CELL_CYCLE_G2,1/151,168/21728,0.6915338487330637,0.7157529924666359,0.5261493711436754,MET,1
OHGUCHI_LIVER_HNF4A_TARGETS_DN,OHGUCHI_LIVER_HNF4A_TARGETS_DN,1/151,169/21728,0.6936942563787644,0.7174544468429662,0.5274001087019645,PERP,1
SERVITJA_ISLET_HNF1A_TARGETS_UP,SERVITJA_ISLET_HNF1A_TARGETS_UP,1/151,169/21728,0.6936942563787644,0.7174544468429662,0.5274001087019645,AKAP12,1
MIKKELSEN_NPC_HCP_WITH_H3K27ME3,MIKKELSEN_NPC_HCP_WITH_H3K27ME3,2/151,345/21728,0.6945285774035115,0.7180500141521976,0.5278379096871143,STBD1/NPAS2,2
FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,1/151,170/21728,0.695839632661839,0.7186031596782858,0.5282445264582147,ARAF,1
LIN_NPAS4_TARGETS_UP,LIN_NPAS4_TARGETS_UP,1/151,170/21728,0.695839632661839,0.7186031596782858,0.5282445264582147,RPS6KA3,1
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN,1/151,170/21728,0.695839632661839,0.7186031596782858,0.5282445264582147,CBFB,1
MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3,MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3,2/151,350/21728,0.7020782708158064,0.7243499438960148,0.5324689822887607,STBD1/NPAS2,2
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,1/151,173/21728,0.702186608679614,0.7243499438960148,0.5324689822887607,FNDC3B,1
MOHANKUMAR_HOXA1_TARGETS_DN,MOHANKUMAR_HOXA1_TARGETS_DN,1/151,173/21728,0.702186608679614,0.7243499438960148,0.5324689822887607,EML1,1
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,1/151,176/21728,0.7084019999604536,0.7304902583111136,0.5369827218080256,LDHA,1
REACTOME_FATTY_ACID_METABOLISM,REACTOME_FATTY_ACID_METABOLISM,1/151,177/21728,0.710445026037197,0.7323251511433518,0.5383315498533979,PTGES3,1
KEGG_CALCIUM_SIGNALING_PATHWAY,KEGG_CALCIUM_SIGNALING_PATHWAY,1/151,178/21728,0.7124738321746561,0.7338718226849072,0.5394685066911902,VDAC1,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,1/151,178/21728,0.7124738321746561,0.7338718226849072,0.5394685066911902,PRKAR1A,1
BENPORATH_NOS_TARGETS,BENPORATH_NOS_TARGETS,1/151,179/21728,0.7144885166916689,0.7354016670505581,0.5405930938873414,ICMT,1
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,1/151,179/21728,0.7144885166916689,0.7354016670505581,0.5405930938873414,ATP1A1,1
LEE_LIVER_CANCER_SURVIVAL_DN,LEE_LIVER_CANCER_SURVIVAL_DN,1/151,180/21728,0.7164891772318127,0.7371877534629541,0.5419060443780572,ACTR3,1
BROWNE_HCMV_INFECTION_18HR_DN,BROWNE_HCMV_INFECTION_18HR_DN,1/151,182/21728,0.7204488136071081,0.7409873395781363,0.5446991166615833,LOXL1,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,1/151,183/21728,0.7224079813944158,0.7427273768740514,0.5459782164888257,SDF4,1
WP_CILIOPATHIES,WP_CILIOPATHIES,1/151,184/21728,0.7243535091182236,0.744176793021607,0.5470436809753012,PKD2,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17,1/151,184/21728,0.7243535091182236,0.744176793021607,0.5470436809753012,ACTB,1
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,1/151,185/21728,0.7262854911142851,0.7458858019650587,0.5482999718889827,TPM1,1
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,1/151,186/21728,0.728204021070268,0.7473035724171424,0.5493421736536154,MAP2K3,1
REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1/151,186/21728,0.728204021070268,0.7473035724171424,0.5493421736536154,UBC,1
LEE_LIVER_CANCER_SURVIVAL_UP,LEE_LIVER_CANCER_SURVIVAL_UP,1/151,187/21728,0.7301091920301784,0.7489820293426276,0.5505760058067892,SLC35D1,1
REACTOME_MRNA_SPLICING,REACTOME_MRNA_SPLICING,1/151,188/21728,0.7320010963987522,0.75064564259717,0.5517989263910082,HSPA8,1
REACTOME_DNA_REPLICATION,REACTOME_DNA_REPLICATION,1/151,189/21728,0.7338798259458175,0.7522945226854174,0.5530110166381379,UBC,1
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN,1/151,190/21728,0.7357454718106293,0.7539287793028138,0.554212357185199,LDLR,1
REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1/151,191/21728,0.7375981245061718,0.7549917427701346,0.5549937406593387,PVR,1
REACTOME_SEPARATION_OF_SISTER_CHROMATIDS,REACTOME_SEPARATION_OF_SISTER_CHROMATIDS,1/151,191/21728,0.7375981245061718,0.7549917427701346,0.5549937406593387,UBC,1
SHEPARD_CRASH_AND_BURN_MUTANT_DN,SHEPARD_CRASH_AND_BURN_MUTANT_DN,1/151,191/21728,0.7375981245061718,0.7549917427701346,0.5549937406593387,ATP1A1,1
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,2/151,377/21728,0.7402213957732219,0.7573978038519374,0.556762433963381,MCFD2/PAFAH2,2
WIERENGA_STAT5A_TARGETS_DN,WIERENGA_STAT5A_TARGETS_DN,1/151,193/21728,0.7412648093356533,0.7581861709626085,0.5573419619065062,EFNB2,1
BENPORATH_ES_1,BENPORATH_ES_1,2/151,379/21728,0.7428752281686333,0.7592032055536022,0.5580895831055998,HSPA4/HSPA8,2
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP,PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP,1/151,194/21728,0.7430790194025358,0.7592032055536022,0.5580895831055998,PRPS2,1
RIGGI_EWING_SARCOMA_PROGENITOR_DN,RIGGI_EWING_SARCOMA_PROGENITOR_DN,1/151,194/21728,0.7430790194025358,0.7592032055536022,0.5580895831055998,MOXD1,1
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,2/151,383/21728,0.7481138681400656,0.7640662962106993,0.5616644366067056,WWTR1/PTPN14,2
YAMAZAKI_TCEB3_TARGETS_DN,YAMAZAKI_TCEB3_TARGETS_DN,1/151,199/21728,0.7519622502245839,0.7677144914090017,0.564346221565482,VDAC1,1
FISCHER_G1_S_CELL_CYCLE,FISCHER_G1_S_CELL_CYCLE,1/151,200/21728,0.7537019362395443,0.7686431640504604,0.5650288879761636,ICMT,1
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,1/151,200/21728,0.7537019362395443,0.7686431640504604,0.5650288879761636,FURIN,1
REACTOME_MITOTIC_G2_G2_M_PHASES,REACTOME_MITOTIC_G2_G2_M_PHASES,1/151,200/21728,0.7537019362395443,0.7686431640504604,0.5650288879761636,UBC,1
FOSTER_KDM1A_TARGETS_DN,FOSTER_KDM1A_TARGETS_DN,1/151,202/21728,0.7571450274950937,0.7715879994062254,0.5671936337569918,BCAM,1
REACTOME_CILIUM_ASSEMBLY,REACTOME_CILIUM_ASSEMBLY,1/151,202/21728,0.7571450274950937,0.7715879994062254,0.5671936337569918,PKD2,1
REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1/151,203/21728,0.7588485999585445,0.7730404879665701,0.5682613567713031,KDELR1,1
LINSLEY_MIR16_TARGETS,LINSLEY_MIR16_TARGETS,1/151,206/21728,0.763888415997557,0.7778893033875415,0.5718257165593689,RPS6KA3,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,1/151,207/21728,0.7655449929506454,0.7792905791194183,0.5728557930702405,ADAM9,1
BILD_MYC_ONCOGENIC_SIGNATURE,BILD_MYC_ONCOGENIC_SIGNATURE,1/151,209/21728,0.7688235880928338,0.7823413654658946,0.5750984233275872,AKAP12,1
MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,1/151,210/21728,0.7704457656195768,0.7837049933691631,0.5761008249540284,PCDH8,1
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,2/151,402/21728,0.7717694231631312,0.7844818333198244,0.5766718792923571,FLOT2/PRKAG1,2
MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN,1/151,211/21728,0.7720566350958963,0.7844818333198244,0.5766718792923571,CALU,1
REACTOME_PHOSPHOLIPID_METABOLISM,REACTOME_PHOSPHOLIPID_METABOLISM,1/151,211/21728,0.7720566350958963,0.7844818333198244,0.5766718792923571,PCYT1A,1
REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,1/151,216/21728,0.7799440836387311,0.792206458628298,0.5823502443025645,RPS6KA3,1
KIM_WT1_TARGETS_12HR_DN,KIM_WT1_TARGETS_12HR_DN,1/151,217/21728,0.7814887305042272,0.7934852680338973,0.5832902959288245,CTNNA1,1
BROWNE_HCMV_INFECTION_1HR_DN,BROWNE_HCMV_INFECTION_1HR_DN,1/151,218/21728,0.7830226062744778,0.7947522105336132,0.5842216242034064,HSPA4,1
PEDRIOLI_MIR31_TARGETS_UP,PEDRIOLI_MIR31_TARGETS_UP,1/151,223/21728,0.7905330122041443,0.8020820700887921,0.5896097972688632,STBD1,1
CAIRO_LIVER_DEVELOPMENT_DN,CAIRO_LIVER_DEVELOPMENT_DN,1/151,224/21728,0.7920038103979212,0.8032809730870483,0.5904911097680549,JAK2,1
PUJANA_BRCA2_PCC_NETWORK,PUJANA_BRCA2_PCC_NETWORK,2/151,425/21728,0.7978118560225197,0.8088764000111531,0.594604302990276,ZNF330/RECQL,2
RAO_BOUND_BY_SALL4,RAO_BOUND_BY_SALL4,1/151,229/21728,0.7992053237493236,0.8099935751096756,0.5954255373850066,AKAP12,1
OSMAN_BLADDER_CANCER_DN,OSMAN_BLADDER_CANCER_DN,2/151,427/21728,0.799948330929918,0.8104509348370942,0.5957617421029755,PRKAR1A/PML,2
MOOTHA_HUMAN_MITODB_6_2002,MOOTHA_HUMAN_MITODB_6_2002,2/151,431/21728,0.8041617698500504,0.8144226746786147,0.5986813644335237,HSPA9/SBNO2,2
ODONNELL_TFRC_TARGETS_UP,ODONNELL_TFRC_TARGETS_UP,2/151,434/21728,0.8072703140713116,0.8172287667121495,0.6007441201248798,PPP1R15A/SLC2A3,2
JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,1/151,235/21728,0.8075208655956986,0.8172287667121495,0.6007441201248798,SLC2A3,1
BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,1/151,236/21728,0.8088731360695761,0.8177036288214273,0.6010931908277705,IQGAP1,1
GAL_LEUKEMIC_STEM_CELL_DN,GAL_LEUKEMIC_STEM_CELL_DN,1/151,236/21728,0.8088731360695761,0.8177036288214273,0.6010931908277705,FNTB,1
REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE,REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE,1/151,236/21728,0.8088731360695761,0.8177036288214273,0.6010931908277705,UBC,1
SANSOM_APC_MYC_TARGETS,SANSOM_APC_MYC_TARGETS,1/151,241/21728,0.8154942210358789,0.8240971065979162,0.6057930305028068,FEM1B,1
REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1/151,242/21728,0.8167908363206362,0.8248073221732924,0.606315109323704,HSPA8,1
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,1/151,242/21728,0.8167908363206362,0.8248073221732924,0.606315109323704,IARS2,1
MOOTHA_MITOCHONDRIA,MOOTHA_MITOCHONDRIA,2/151,450/21728,0.8231230565708976,0.8308996552158262,0.6107935777798124,HSPA9/SBNO2,2
BILD_E2F3_ONCOGENIC_SIGNATURE,BILD_E2F3_ONCOGENIC_SIGNATURE,1/151,248/21728,0.8243826171382324,0.8318688377806064,0.6115060229981344,EPHA2,1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,2/151,453/21728,0.8259628486938367,0.8331607820157872,0.6124557300256253,ATP1A1/NRIP1,2
VERHAAK_AML_WITH_NPM1_MUTATED_DN,VERHAAK_AML_WITH_NPM1_MUTATED_DN,1/151,250/21728,0.8268431040036188,0.8335011685497822,0.6127059478559272,LAMC1,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,2/151,454/21728,0.8269003673589632,0.8335011685497822,0.6127059478559272,FEM1B/FLOT2,2
MCCABE_BOUND_BY_HOXC6,MCCABE_BOUND_BY_HOXC6,2/151,458/21728,0.830605499267401,0.836932200567588,0.6152280963590318,ARIH1/SBNO2,2
BROWNE_HCMV_INFECTION_4HR_DN,BROWNE_HCMV_INFECTION_4HR_DN,1/151,254/21728,0.8316618087039704,0.8373890919099781,0.6155639567675942,PAFAH2,1
PLASARI_TGFB1_TARGETS_10HR_DN,PLASARI_TGFB1_TARGETS_10HR_DN,1/151,254/21728,0.8316618087039704,0.8373890919099781,0.6155639567675942,UNC5C,1
MASSARWEH_TAMOXIFEN_RESISTANCE_DN,MASSARWEH_TAMOXIFEN_RESISTANCE_DN,1/151,257/21728,0.8351882004745951,0.8406350800429078,0.6179500796799063,NRIP1,1
FOSTER_KDM1A_TARGETS_UP,FOSTER_KDM1A_TARGETS_UP,1/151,265/21728,0.8442372103929375,0.8491277952467705,0.6241930668708024,PDLIM4,1
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,1/151,265/21728,0.8442372103929375,0.8491277952467705,0.6241930668708024,MET,1
HOSHIDA_LIVER_CANCER_SUBCLASS_S3,HOSHIDA_LIVER_CANCER_SUBCLASS_S3,1/151,266/21728,0.8453330581882443,0.8499222713163022,0.6247770855040075,SLC35D1,1
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,2/151,476/21728,0.8464142192853648,0.8504008043969886,0.6251288547346285,BIRC3/HSPA8,2
ROZANOV_MMP14_TARGETS_UP,ROZANOV_MMP14_TARGETS_UP,1/151,267/21728,0.8464212469970027,0.8504008043969886,0.6251288547346285,TPM1,1
MEISSNER_BRAIN_HCP_WITH_H3K27ME3,MEISSNER_BRAIN_HCP_WITH_H3K27ME3,1/151,271/21728,0.8506984703810466,0.854080358047903,0.6278336912632837,LOXL1,1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,1/151,271/21728,0.8506984703810466,0.854080358047903,0.6278336912632837,PAFAH2,1
BENPORATH_OCT4_TARGETS,BENPORATH_OCT4_TARGETS,1/151,290/21728,0.8694535032825741,0.8725945925285371,0.6414434881229821,ICMT,1
WALLACE_PROSTATE_CANCER_RACE_UP,WALLACE_PROSTATE_CANCER_RACE_UP,1/151,303/21728,0.8809178889396977,0.8837811106805634,0.649666687401119,SEPTIN11,1
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,1/151,308/21728,0.8850558937677617,0.8876120118725062,0.652482779368975,NUS1,1
REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,1/151,314/21728,0.8898333415535262,0.8920812063643797,0.6557680801587271,PRKAR1A,1
RICKMAN_METASTASIS_UP,RICKMAN_METASTASIS_UP,1/151,351/21728,0.9152297317123472,0.9172107484476554,0.674240783596094,TRIP12,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN,1/151,360/21728,0.9204700009609579,0.9221297016478691,0.6778567016016316,PRDX1,1
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1/151,374/21728,0.9279889360146808,0.9293270599310683,0.683147473103055,RARS1,1
HATADA_METHYLATED_IN_LUNG_CANCER_UP,HATADA_METHYLATED_IN_LUNG_CANCER_UP,1/151,377/21728,0.9295058597658723,0.9305107309656192,0.6840175885996367,ACTB,1
VECCHI_GASTRIC_CANCER_EARLY_DN,VECCHI_GASTRIC_CANCER_EARLY_DN,1/151,384/21728,0.9329230267130959,0.9335951614585664,0.6862849506383308,DUSP5,1
REACTOME_M_PHASE,REACTOME_M_PHASE,1/151,415/21728,0.9461827648176584,0.946523486014928,0.6957885502136941,UBC,1
LIM_MAMMARY_STEM_CELL_DN,LIM_MAMMARY_STEM_CELL_DN,1/151,416/21728,0.9465640533510669,0.9465640533510669,0.6958183712254442,PKN1,1
